id	sid	tid	token	lemma	pos
iajs-2976	1	1	ihjpas	ihjpas	PROPN
iajs-2976	1	2	.	.	PUNCT
iajs-2976	2	1	36(2)2023	36(2)2023	NUM
iajs-2976	2	2	85	85	NUM
iajs-2976	2	3	this	this	DET
iajs-2976	2	4	work	work	NOUN
iajs-2976	2	5	is	be	AUX
iajs-2976	2	6	licensed	license	VERB
iajs-2976	2	7	under	under	ADP
iajs-2976	2	8	a	a	DET
iajs-2976	2	9	creative	creative	ADJ
iajs-2976	2	10	commons	common	NOUN
iajs-2976	2	11	attribution	attribution	NOUN
iajs-2976	2	12	4.0	4.0	NUM
iajs-2976	2	13	international	international	ADJ
iajs-2976	2	14	license	license	NOUN
iajs-2976	2	15	.	.	PUNCT
iajs-2976	3	1	abstract	abstract	ADJ
iajs-2976	3	2	oxidative	oxidative	ADJ
iajs-2976	3	3	stress	stress	NOUN
iajs-2976	3	4	and	and	CCONJ
iajs-2976	3	5	inflammation	inflammation	NOUN
iajs-2976	3	6	are	be	AUX
iajs-2976	3	7	connected	connect	VERB
iajs-2976	3	8	to	to	ADP
iajs-2976	3	9	the	the	DET
iajs-2976	3	10	development	development	NOUN
iajs-2976	3	11	of	of	ADP
iajs-2976	3	12	metabolic	metabolic	NOUN
iajs-2976	3	13	disorders	disorder	NOUN
iajs-2976	3	14	,	,	PUNCT
iajs-2976	3	15	such	such	ADJ
iajs-2976	3	16	as	as	ADP
iajs-2976	3	17	diabetes	diabete	NOUN
iajs-2976	3	18	.	.	PUNCT
iajs-2976	4	1	diabetic	diabetic	ADJ
iajs-2976	4	2	-	-	PUNCT
iajs-2976	4	3	related	relate	VERB
iajs-2976	4	4	oxidative	oxidative	ADJ
iajs-2976	4	5	stress	stress	NOUN
iajs-2976	4	6	is	be	AUX
iajs-2976	4	7	caused	cause	VERB
iajs-2976	4	8	by	by	ADP
iajs-2976	4	9	the	the	DET
iajs-2976	4	10	overproduction	overproduction	NOUN
iajs-2976	4	11	of	of	ADP
iajs-2976	4	12	oxidative	oxidative	ADJ
iajs-2976	4	13	-	-	PUNCT
iajs-2976	4	14	free	free	ADJ
iajs-2976	4	15	radicals	radical	NOUN
iajs-2976	4	16	,	,	PUNCT
iajs-2976	4	17	which	which	PRON
iajs-2976	4	18	have	have	AUX
iajs-2976	4	19	been	be	AUX
iajs-2976	4	20	implicated	implicate	VERB
iajs-2976	4	21	in	in	ADP
iajs-2976	4	22	the	the	DET
iajs-2976	4	23	mechanism	mechanism	NOUN
iajs-2976	4	24	of	of	ADP
iajs-2976	4	25	inflammation	inflammation	NOUN
iajs-2976	4	26	and	and	CCONJ
iajs-2976	4	27	damage	damage	NOUN
iajs-2976	4	28	to	to	ADP
iajs-2976	4	29	tissues	tissue	NOUN
iajs-2976	4	30	.	.	PUNCT
iajs-2976	5	1	our	our	PRON
iajs-2976	5	2	study	study	NOUN
iajs-2976	5	3	aimed	aim	VERB
iajs-2976	5	4	to	to	PART
iajs-2976	5	5	investigate	investigate	VERB
iajs-2976	5	6	the	the	DET
iajs-2976	5	7	effects	effect	NOUN
iajs-2976	5	8	of	of	ADP
iajs-2976	5	9	ubiquinone	ubiquinone	PROPN
iajs-2976	5	10	treatment	treatment	NOUN
iajs-2976	5	11	on	on	ADP
iajs-2976	5	12	serum	serum	NOUN
iajs-2976	5	13	indicators	indicator	NOUN
iajs-2976	5	14	of	of	ADP
iajs-2976	5	15	oxidative	oxidative	ADJ
iajs-2976	5	16	stress	stress	NOUN
iajs-2976	5	17	(	(	PUNCT
iajs-2976	5	18	malondialdehyde	malondialdehyde	NOUN
iajs-2976	5	19	(	(	PUNCT
iajs-2976	5	20	mda	mda	PROPN
iajs-2976	5	21	)	)	PUNCT
iajs-2976	5	22	)	)	PUNCT
iajs-2976	5	23	,	,	PUNCT
iajs-2976	5	24	inflammation	inflammation	NOUN
iajs-2976	5	25	(	(	PUNCT
iajs-2976	5	26	interleukin	interleukin	NOUN
iajs-2976	5	27	6	6	NUM
iajs-2976	5	28	(	(	PUNCT
iajs-2976	5	29	il-6	il-6	NUM
iajs-2976	5	30	)	)	PUNCT
iajs-2976	5	31	)	)	PUNCT
iajs-2976	5	32	,	,	PUNCT
iajs-2976	5	33	vascular	vascular	ADJ
iajs-2976	5	34	homeostasis	homeostasis	NOUN
iajs-2976	5	35	(	(	PUNCT
iajs-2976	5	36	nitric	nitric	ADJ
iajs-2976	5	37	oxide	oxide	NOUN
iajs-2976	5	38	(	(	PUNCT
iajs-2976	5	39	no	no	NOUN
iajs-2976	5	40	)	)	PUNCT
iajs-2976	5	41	)	)	PUNCT
iajs-2976	5	42	,	,	PUNCT
iajs-2976	5	43	and	and	CCONJ
iajs-2976	5	44	myopathy	myopathy	ADJ
iajs-2976	5	45	(	(	PUNCT
iajs-2976	5	46	myoglobin	myoglobin	X
iajs-2976	5	47	(	(	PUNCT
iajs-2976	5	48	mb	mb	NOUN
iajs-2976	5	49	)	)	PUNCT
iajs-2976	5	50	)	)	PUNCT
iajs-2976	5	51	in	in	ADP
iajs-2976	5	52	addition	addition	NOUN
iajs-2976	5	53	to	to	ADP
iajs-2976	5	54	measuring	measure	VERB
iajs-2976	5	55	blood	blood	NOUN
iajs-2976	5	56	components	component	NOUN
iajs-2976	5	57	parameters	parameter	NOUN
iajs-2976	5	58	in	in	ADP
iajs-2976	5	59	streptozotocin	streptozotocin	NOUN
iajs-2976	5	60	-	-	PUNCT
iajs-2976	5	61	induced	induce	VERB
iajs-2976	5	62	diabetic	diabetic	ADJ
iajs-2976	5	63	rats	rat	NOUN
iajs-2976	5	64	.	.	PUNCT
iajs-2976	6	1	rats	rat	NOUN
iajs-2976	6	2	were	be	AUX
iajs-2976	6	3	separated	separate	VERB
iajs-2976	6	4	into	into	ADP
iajs-2976	6	5	three	three	NUM
iajs-2976	6	6	groups	group	NOUN
iajs-2976	6	7	;	;	PUNCT
iajs-2976	6	8	negative	negative	ADJ
iajs-2976	6	9	control	control	NOUN
iajs-2976	6	10	group	group	NOUN
iajs-2976	6	11	(	(	PUNCT
iajs-2976	6	12	n	n	CCONJ
iajs-2976	6	13	)	)	PUNCT
iajs-2976	6	14	,	,	PUNCT
iajs-2976	6	15	diabetic	diabetic	ADJ
iajs-2976	6	16	control	control	NOUN
iajs-2976	6	17	group	group	NOUN
iajs-2976	6	18	(	(	PUNCT
iajs-2976	6	19	d	d	NOUN
iajs-2976	6	20	)	)	PUNCT
iajs-2976	6	21	,	,	PUNCT
iajs-2976	6	22	and	and	CCONJ
iajs-2976	6	23	ubiquinone	ubiquinone	PROPN
iajs-2976	6	24	-	-	PUNCT
iajs-2976	6	25	treated	treat	VERB
iajs-2976	6	26	diabetic	diabetic	ADJ
iajs-2976	6	27	group	group	NOUN
iajs-2976	6	28	(	(	PUNCT
iajs-2976	6	29	t	t	PROPN
iajs-2976	6	30	)	)	PUNCT
iajs-2976	6	31	.	.	PUNCT
iajs-2976	7	1	after	after	ADP
iajs-2976	7	2	21	21	NUM
iajs-2976	7	3	days	day	NOUN
iajs-2976	7	4	,	,	PUNCT
iajs-2976	7	5	the	the	DET
iajs-2976	7	6	blood	blood	NOUN
iajs-2976	7	7	and	and	CCONJ
iajs-2976	7	8	serum	serum	NOUN
iajs-2976	7	9	samples	sample	NOUN
iajs-2976	7	10	were	be	AUX
iajs-2976	7	11	taken	take	VERB
iajs-2976	7	12	to	to	PART
iajs-2976	7	13	evaluate	evaluate	VERB
iajs-2976	7	14	fasting	fast	VERB
iajs-2976	7	15	blood	blood	NOUN
iajs-2976	7	16	glucose	glucose	NOUN
iajs-2976	7	17	(	(	PUNCT
iajs-2976	7	18	fbg	fbg	PROPN
iajs-2976	7	19	)	)	PUNCT
iajs-2976	7	20	,	,	PUNCT
iajs-2976	7	21	mda	mda	PROPN
iajs-2976	7	22	,	,	PUNCT
iajs-2976	7	23	il6	il6	PROPN
iajs-2976	7	24	,	,	PUNCT
iajs-2976	7	25	no	no	INTJ
iajs-2976	7	26	,	,	PUNCT
iajs-2976	7	27	mb	mb	ADP
iajs-2976	7	28	,	,	PUNCT
iajs-2976	7	29	and	and	CCONJ
iajs-2976	7	30	hematological	hematological	ADJ
iajs-2976	7	31	parameters	parameter	NOUN
iajs-2976	7	32	.	.	PUNCT
iajs-2976	8	1	in	in	ADP
iajs-2976	8	2	hyperglycemic	hyperglycemic	ADJ
iajs-2976	8	3	rats	rat	NOUN
iajs-2976	8	4	,	,	PUNCT
iajs-2976	8	5	the	the	DET
iajs-2976	8	6	levels	level	NOUN
iajs-2976	8	7	of	of	ADP
iajs-2976	8	8	fbg	fbg	PROPN
iajs-2976	8	9	and	and	CCONJ
iajs-2976	8	10	serum	serum	NOUN
iajs-2976	8	11	levels	level	NOUN
iajs-2976	8	12	of	of	ADP
iajs-2976	8	13	il-6	il-6	NUM
iajs-2976	8	14	,	,	PUNCT
iajs-2976	8	15	mda	mda	PROPN
iajs-2976	8	16	,	,	PUNCT
iajs-2976	8	17	and	and	CCONJ
iajs-2976	8	18	mb	mb	ADP
iajs-2976	8	19	significantly	significantly	ADV
iajs-2976	8	20	increased	increase	VERB
iajs-2976	8	21	,	,	PUNCT
iajs-2976	8	22	while	while	SCONJ
iajs-2976	8	23	no	no	DET
iajs-2976	8	24	levels	level	NOUN
iajs-2976	8	25	decreased	decrease	VERB
iajs-2976	8	26	.	.	PUNCT
iajs-2976	9	1	hyperglycemic	hyperglycemic	ADJ
iajs-2976	9	2	condition	condition	NOUN
iajs-2976	9	3	significantly	significantly	ADV
iajs-2976	9	4	lowered	lower	VERB
iajs-2976	9	5	the	the	DET
iajs-2976	9	6	count	count	NOUN
iajs-2976	9	7	of	of	ADP
iajs-2976	9	8	wbc	wbc	PROPN
iajs-2976	9	9	(	(	PUNCT
iajs-2976	9	10	p	p	NOUN
iajs-2976	9	11	=	=	NOUN
iajs-2976	9	12	0.0098	0.0098	NUM
iajs-2976	9	13	)	)	PUNCT
iajs-2976	9	14	but	but	CCONJ
iajs-2976	9	15	insignificantly	insignificantly	ADV
iajs-2976	9	16	decreased	decrease	VERB
iajs-2976	9	17	values	value	NOUN
iajs-2976	9	18	of	of	ADP
iajs-2976	9	19	platelets	platelet	NOUN
iajs-2976	9	20	and	and	CCONJ
iajs-2976	9	21	rbc	rbc	PROPN
iajs-2976	9	22	.	.	PROPN
iajs-2976	10	1	ubiquinone	ubiquinone	PROPN
iajs-2976	10	2	treatment	treatment	NOUN
iajs-2976	10	3	significantly	significantly	ADV
iajs-2976	10	4	reduced	reduce	VERB
iajs-2976	10	5	blood	blood	NOUN
iajs-2976	10	6	glucose	glucose	NOUN
iajs-2976	10	7	,	,	PUNCT
iajs-2976	10	8	il-6	il-6	NUM
iajs-2976	10	9	,	,	PUNCT
iajs-2976	10	10	mda	mda	PROPN
iajs-2976	10	11	,	,	PUNCT
iajs-2976	10	12	and	and	CCONJ
iajs-2976	10	13	mb	mb	ADP
iajs-2976	10	14	levels	level	NOUN
iajs-2976	10	15	in	in	ADP
iajs-2976	10	16	diabetic	diabetic	ADJ
iajs-2976	10	17	rats	rat	NOUN
iajs-2976	10	18	and	and	CCONJ
iajs-2976	10	19	raised	raise	VERB
iajs-2976	10	20	no	no	DET
iajs-2976	10	21	levels	level	NOUN
iajs-2976	10	22	.	.	PUNCT
iajs-2976	11	1	the	the	DET
iajs-2976	11	2	effects	effect	NOUN
iajs-2976	11	3	of	of	ADP
iajs-2976	11	4	ubiquinone	ubiquinone	PROPN
iajs-2976	11	5	on	on	ADP
iajs-2976	11	6	wbc	wbc	PROPN
iajs-2976	11	7	(	(	PUNCT
iajs-2976	11	8	p	p	NOUN
iajs-2976	11	9	=	=	NOUN
iajs-2976	11	10	0.648	0.648	NUM
iajs-2976	11	11	)	)	PUNCT
iajs-2976	11	12	,	,	PUNCT
iajs-2976	11	13	rbc	rbc	PROPN
iajs-2976	11	14	(	(	PUNCT
iajs-2976	11	15	p	p	NOUN
iajs-2976	11	16	=	=	NOUN
iajs-2976	11	17	0.001	0.001	NUM
iajs-2976	11	18	)	)	PUNCT
iajs-2976	11	19	,	,	PUNCT
iajs-2976	11	20	and	and	CCONJ
iajs-2976	11	21	(	(	PUNCT
iajs-2976	11	22	p	p	X
iajs-2976	11	23	=	=	NOUN
iajs-2976	11	24	0.398	0.398	NUM
iajs-2976	11	25	)	)	PUNCT
iajs-2976	11	26	were	be	AUX
iajs-2976	11	27	insignificant	insignificant	ADJ
iajs-2976	11	28	,	,	PUNCT
iajs-2976	11	29	and	and	CCONJ
iajs-2976	11	30	only	only	ADJ
iajs-2976	11	31	minor	minor	ADJ
iajs-2976	11	32	variations	variation	NOUN
iajs-2976	11	33	in	in	ADP
iajs-2976	11	34	wbc	wbc	PROPN
iajs-2976	11	35	and	and	CCONJ
iajs-2976	11	36	platelet	platelet	NOUN
iajs-2976	11	37	levels	level	NOUN
iajs-2976	11	38	were	be	AUX
iajs-2976	11	39	observed	observe	VERB
iajs-2976	11	40	.	.	PUNCT
iajs-2976	12	1	our	our	PRON
iajs-2976	12	2	data	datum	NOUN
iajs-2976	12	3	support	support	NOUN
iajs-2976	12	4	that	that	PRON
iajs-2976	12	5	ubiquinone	ubiquinone	PROPN
iajs-2976	12	6	supplementation	supplementation	NOUN
iajs-2976	12	7	could	could	AUX
iajs-2976	12	8	reduce	reduce	VERB
iajs-2976	12	9	proinflammation	proinflammation	NOUN
iajs-2976	12	10	,	,	PUNCT
iajs-2976	12	11	oxidative	oxidative	ADJ
iajs-2976	12	12	stress	stress	NOUN
iajs-2976	12	13	,	,	PUNCT
iajs-2976	12	14	and	and	CCONJ
iajs-2976	12	15	myopathy	myopathy	ADJ
iajs-2976	12	16	markers	marker	NOUN
iajs-2976	12	17	and	and	CCONJ
iajs-2976	12	18	elevate	elevate	VERB
iajs-2976	12	19	no	no	DET
iajs-2976	12	20	levels	level	NOUN
iajs-2976	12	21	in	in	ADP
iajs-2976	12	22	diabetic	diabetic	ADJ
iajs-2976	12	23	rats	rat	NOUN
iajs-2976	12	24	.	.	PUNCT
iajs-2976	13	1	the	the	DET
iajs-2976	13	2	current	current	ADJ
iajs-2976	13	3	study	study	NOUN
iajs-2976	13	4	indicates	indicate	VERB
iajs-2976	13	5	ubiquinone	ubiquinone	PROPN
iajs-2976	13	6	may	may	AUX
iajs-2976	13	7	positively	positively	ADV
iajs-2976	13	8	impact	impact	VERB
iajs-2976	13	9	diabetic	diabetic	ADJ
iajs-2976	13	10	complications	complication	NOUN
iajs-2976	13	11	;	;	PUNCT
iajs-2976	13	12	however	however	ADV
iajs-2976	13	13	,	,	PUNCT
iajs-2976	13	14	additional	additional	ADJ
iajs-2976	13	15	research	research	NOUN
iajs-2976	13	16	is	be	AUX
iajs-2976	13	17	required	require	VERB
iajs-2976	13	18	to	to	PART
iajs-2976	13	19	determine	determine	VERB
iajs-2976	13	20	its	its	PRON
iajs-2976	13	21	therapeutic	therapeutic	ADJ
iajs-2976	13	22	benefit	benefit	NOUN
iajs-2976	13	23	when	when	SCONJ
iajs-2976	13	24	added	add	VERB
iajs-2976	13	25	to	to	ADP
iajs-2976	13	26	standard	standard	ADJ
iajs-2976	13	27	diabetes	diabetes	NOUN
iajs-2976	13	28	treatment	treatment	NOUN
iajs-2976	13	29	.	.	PUNCT
iajs-2976	14	1	keywords	keyword	NOUN
iajs-2976	14	2	:	:	PUNCT
iajs-2976	14	3	diabetes	diabetes	NOUN
iajs-2976	14	4	mellitus	mellitus	NOUN
iajs-2976	14	5	,	,	PUNCT
iajs-2976	14	6	hyperglycemia	hyperglycemia	NOUN
iajs-2976	14	7	,	,	PUNCT
iajs-2976	14	8	oxidative	oxidative	ADJ
iajs-2976	14	9	stress	stress	NOUN
iajs-2976	14	10	,	,	PUNCT
iajs-2976	14	11	antioxidant	antioxidant	NOUN
iajs-2976	14	12	,	,	PUNCT
iajs-2976	14	13	ubiquinone	ubiquinone	PROPN
iajs-2976	14	14	supplementation	supplementation	NOUN
iajs-2976	14	15	.	.	PUNCT
iajs-2976	15	1	1	1	X
iajs-2976	15	2	.	.	X
iajs-2976	15	3	introduction	introduction	NOUN
iajs-2976	15	4	diabetes	diabetes	NOUN
iajs-2976	15	5	mellitus	mellitus	NOUN
iajs-2976	15	6	(	(	PUNCT
iajs-2976	15	7	dm	dm	PROPN
iajs-2976	15	8	)	)	PUNCT
iajs-2976	15	9	is	be	AUX
iajs-2976	15	10	a	a	DET
iajs-2976	15	11	chronic	chronic	ADJ
iajs-2976	15	12	disease	disease	NOUN
iajs-2976	15	13	of	of	ADP
iajs-2976	15	14	significant	significant	ADJ
iajs-2976	15	15	concern	concern	NOUN
iajs-2976	15	16	that	that	PRON
iajs-2976	15	17	is	be	AUX
iajs-2976	15	18	predicted	predict	VERB
iajs-2976	15	19	to	to	PART
iajs-2976	15	20	be	be	AUX
iajs-2976	15	21	the	the	DET
iajs-2976	15	22	seventh	seventh	ADJ
iajs-2976	15	23	worldwide	worldwide	ADJ
iajs-2976	15	24	leading	leading	ADJ
iajs-2976	15	25	cause	cause	NOUN
iajs-2976	15	26	of	of	ADP
iajs-2976	15	27	death	death	NOUN
iajs-2976	15	28	by	by	ADP
iajs-2976	15	29	2030	2030	NUM
iajs-2976	15	30	,	,	PUNCT
iajs-2976	15	31	and	and	CCONJ
iajs-2976	15	32	diabetes	diabetes	NOUN
iajs-2976	15	33	-	-	PUNCT
iajs-2976	15	34	related	relate	VERB
iajs-2976	15	35	global	global	ADJ
iajs-2976	15	36	health	health	NOUN
iajs-2976	15	37	expenditures	expenditure	NOUN
iajs-2976	15	38	doi.org/10.30526/36.2.2976	doi.org/10.30526/36.2.2976	NOUN
iajs-2976	15	39	article	article	NOUN
iajs-2976	15	40	history	history	NOUN
iajs-2976	15	41	:	:	PUNCT
iajs-2976	15	42	received	receive	VERB
iajs-2976	15	43	17august	17august	NUM
iajs-2976	15	44	2022	2022	NUM
iajs-2976	15	45	,	,	PUNCT
iajs-2976	15	46	accepted	accept	VERB
iajs-2976	15	47	12	12	NUM
iajs-2976	15	48	september	september	PROPN
iajs-2976	15	49	2022	2022	NUM
iajs-2976	15	50	,	,	PUNCT
iajs-2976	15	51	published	publish	VERB
iajs-2976	15	52	in	in	ADP
iajs-2976	15	53	april	april	PROPN
iajs-2976	15	54	2023	2023	NUM
iajs-2976	15	55	.	.	PUNCT
iajs-2976	16	1	ibn	ibn	PROPN
iajs-2976	16	2	al	al	PROPN
iajs-2976	16	3	-	-	PUNCT
iajs-2976	16	4	haitham	haitham	PROPN
iajs-2976	16	5	journal	journal	PROPN
iajs-2976	16	6	for	for	ADP
iajs-2976	16	7	pure	pure	ADJ
iajs-2976	16	8	and	and	CCONJ
iajs-2976	16	9	applied	applied	ADJ
iajs-2976	16	10	sciences	sciences	PROPN
iajs-2976	16	11	journal	journal	PROPN
iajs-2976	16	12	homepage	homepage	NOUN
iajs-2976	16	13	:	:	PUNCT
iajs-2976	16	14	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	VERB
iajs-2976	16	15	an	an	DET
iajs-2976	16	16	investigation	investigation	NOUN
iajs-2976	16	17	into	into	ADP
iajs-2976	16	18	the	the	DET
iajs-2976	16	19	effects	effect	NOUN
iajs-2976	16	20	of	of	ADP
iajs-2976	16	21	ubiquinone	ubiquinone	PROPN
iajs-2976	16	22	on	on	ADP
iajs-2976	16	23	inflammation	inflammation	NOUN
iajs-2976	16	24	,	,	PUNCT
iajs-2976	16	25	diabetic	diabetic	ADJ
iajs-2976	16	26	myopathy	myopathy	ADJ
iajs-2976	16	27	and	and	CCONJ
iajs-2976	16	28	endotheliopathy	endotheliopathy	ADJ
iajs-2976	16	29	,	,	PUNCT
iajs-2976	16	30	and	and	CCONJ
iajs-2976	16	31	cbc	cbc	NOUN
iajs-2976	16	32	parameters	parameter	NOUN
iajs-2976	16	33	in	in	ADP
iajs-2976	16	34	diabetic	diabetic	ADJ
iajs-2976	16	35	rats	rat	NOUN
iajs-2976	16	36	yousif	yousif	PROPN
iajs-2976	16	37	jameel	jameel	PROPN
iajs-2976	16	38	jbrael	jbrael	PROPN
iajs-2976	16	39	department	department	PROPN
iajs-2976	16	40	of	of	ADP
iajs-2976	16	41	pharmacology	pharmacology	NOUN
iajs-2976	16	42	and	and	CCONJ
iajs-2976	16	43	toxicology	toxicology	NOUN
iajs-2976	16	44	,	,	PUNCT
iajs-2976	16	45	college	college	NOUN
iajs-2976	16	46	of	of	ADP
iajs-2976	16	47	pharmacy	pharmacy	NOUN
iajs-2976	16	48	,	,	PUNCT
iajs-2976	16	49	hawler	hawler	PROPN
iajs-2976	16	50	medical	medical	PROPN
iajs-2976	16	51	university	university	PROPN
iajs-2976	16	52	,	,	PUNCT
iajs-2976	16	53	erbil	erbil	PROPN
iajs-2976	16	54	,	,	PUNCT
iajs-2976	16	55	iraq	iraq	PROPN
iajs-2976	16	56	.	.	PUNCT
iajs-2976	17	1	yousifjbrael@gmail.com	yousifjbrael@gmail.com	X
iajs-2976	17	2	badraldin	badraldin	VERB
iajs-2976	17	3	kareem	kareem	PROPN
iajs-2976	17	4	hamad	hamad	PROPN
iajs-2976	17	5	university	university	PROPN
iajs-2976	17	6	of	of	ADP
iajs-2976	17	7	kurdistan	kurdistan	PROPN
iajs-2976	17	8	hawler	hawler	PROPN
iajs-2976	17	9	(	(	PUNCT
iajs-2976	17	10	ukh	ukh	PROPN
iajs-2976	17	11	)	)	PUNCT
iajs-2976	17	12	,	,	PUNCT
iajs-2976	17	13	school	school	NOUN
iajs-2976	17	14	of	of	ADP
iajs-2976	17	15	medicine	medicine	NOUN
iajs-2976	17	16	,	,	PUNCT
iajs-2976	17	17	erbil	erbil	PROPN
iajs-2976	17	18	,	,	PUNCT
iajs-2976	17	19	iraq	iraq	PROPN
iajs-2976	17	20	.	.	PUNCT
iajs-2976	18	1	badraldin.hamad@hmu.edu.krd	badraldin.hamad@hmu.edu.krd	PROPN
iajs-2976	18	2	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-2976	18	3	mailto:yousifjbrael@gmail.com	mailto:yousifjbrael@gmail.com	PROPN
iajs-2976	18	4	mailto:badraldin.hamad@hmu.edu.krd	mailto:badraldin.hamad@hmu.edu.krd	PROPN
iajs-2976	18	5	ihjpas	ihjpa	VERB
iajs-2976	18	6	.	.	PUNCT
iajs-2976	19	1	36(2)2023	36(2)2023	NUM
iajs-2976	19	2	86	86	NUM
iajs-2976	19	3	will	will	AUX
iajs-2976	19	4	increase	increase	VERB
iajs-2976	19	5	dramatically	dramatically	ADV
iajs-2976	19	6	over	over	ADP
iajs-2976	19	7	the	the	DET
iajs-2976	19	8	next	next	ADJ
iajs-2976	19	9	decade	decade	NOUN
iajs-2976	20	1	[	[	X
iajs-2976	20	2	1	1	NUM
iajs-2976	20	3	,	,	PUNCT
iajs-2976	20	4	2	2	NUM
iajs-2976	20	5	]	]	PUNCT
iajs-2976	20	6	.	.	PUNCT
iajs-2976	21	1	it	it	PRON
iajs-2976	21	2	is	be	AUX
iajs-2976	21	3	a	a	DET
iajs-2976	21	4	complex	complex	ADJ
iajs-2976	21	5	metabolic	metabolic	NOUN
iajs-2976	21	6	disorder	disorder	NOUN
iajs-2976	21	7	and	and	CCONJ
iajs-2976	21	8	elevated	elevated	ADJ
iajs-2976	21	9	blood	blood	NOUN
iajs-2976	21	10	glucose	glucose	NOUN
iajs-2976	21	11	–	–	PUNCT
iajs-2976	21	12	hyperglycemia	hyperglycemia	NOUN
iajs-2976	21	13	is	be	AUX
iajs-2976	21	14	the	the	DET
iajs-2976	21	15	major	major	ADJ
iajs-2976	21	16	clinical	clinical	ADJ
iajs-2976	21	17	hallmark	hallmark	NOUN
iajs-2976	21	18	of	of	ADP
iajs-2976	21	19	unregulated	unregulated	ADJ
iajs-2976	21	20	diabetes	diabetes	NOUN
iajs-2976	21	21	.	.	PUNCT
iajs-2976	22	1	hyperglycemia	hyperglycemia	NOUN
iajs-2976	22	2	is	be	AUX
iajs-2976	22	3	believed	believe	VERB
iajs-2976	22	4	to	to	PART
iajs-2976	22	5	generate	generate	VERB
iajs-2976	22	6	reactive	reactive	ADJ
iajs-2976	22	7	oxygen	oxygen	NOUN
iajs-2976	22	8	species	specie	NOUN
iajs-2976	22	9	(	(	PUNCT
iajs-2976	22	10	ros	ros	PROPN
iajs-2976	22	11	)	)	PUNCT
iajs-2976	22	12	via	via	ADP
iajs-2976	22	13	activation	activation	NOUN
iajs-2976	22	14	of	of	ADP
iajs-2976	22	15	the	the	DET
iajs-2976	22	16	hexosamine	hexosamine	ADJ
iajs-2976	22	17	pathway	pathway	NOUN
iajs-2976	22	18	,	,	PUNCT
iajs-2976	22	19	stimulation	stimulation	NOUN
iajs-2976	22	20	of	of	ADP
iajs-2976	22	21	protein	protein	NOUN
iajs-2976	22	22	kinase	kinase	NOUN
iajs-2976	22	23	c	c	PROPN
iajs-2976	22	24	signaling	signal	VERB
iajs-2976	22	25	,	,	PUNCT
iajs-2976	22	26	and	and	CCONJ
iajs-2976	22	27	formation	formation	NOUN
iajs-2976	22	28	of	of	ADP
iajs-2976	22	29	advanced	advanced	ADJ
iajs-2976	22	30	glycation	glycation	NOUN
iajs-2976	22	31	end	end	NOUN
iajs-2976	22	32	products	product	NOUN
iajs-2976	22	33	(	(	PUNCT
iajs-2976	22	34	ages	age	NOUN
iajs-2976	22	35	)	)	PUNCT
iajs-2976	22	36	,	,	PUNCT
iajs-2976	22	37	resulting	result	VERB
iajs-2976	22	38	in	in	ADP
iajs-2976	22	39	oxidative	oxidative	ADJ
iajs-2976	22	40	stress	stress	NOUN
iajs-2976	22	41	in	in	ADP
iajs-2976	22	42	various	various	ADJ
iajs-2976	22	43	organs	organ	NOUN
iajs-2976	22	44	[	[	X
iajs-2976	22	45	3	3	NUM
iajs-2976	22	46	,	,	PUNCT
iajs-2976	22	47	4	4	NUM
iajs-2976	22	48	]	]	PUNCT
iajs-2976	22	49	.	.	PUNCT
iajs-2976	23	1	the	the	DET
iajs-2976	23	2	oxidative	oxidative	ADJ
iajs-2976	23	3	stress	stress	NOUN
iajs-2976	23	4	role	role	NOUN
iajs-2976	23	5	has	have	AUX
iajs-2976	23	6	been	be	AUX
iajs-2976	23	7	included	include	VERB
iajs-2976	23	8	as	as	ADP
iajs-2976	23	9	a	a	DET
iajs-2976	23	10	crucial	crucial	ADJ
iajs-2976	23	11	factor	factor	NOUN
iajs-2976	23	12	in	in	ADP
iajs-2976	23	13	unraveling	unravel	VERB
iajs-2976	23	14	the	the	DET
iajs-2976	23	15	complex	complex	ADJ
iajs-2976	23	16	mechanism	mechanism	NOUN
iajs-2976	23	17	behind	behind	ADP
iajs-2976	23	18	diabetes	diabetes	NOUN
iajs-2976	23	19	complications	complication	NOUN
iajs-2976	23	20	.	.	PUNCT
iajs-2976	24	1	the	the	DET
iajs-2976	24	2	physiological	physiological	ADJ
iajs-2976	24	3	and	and	CCONJ
iajs-2976	24	4	pathophysiological	pathophysiological	ADJ
iajs-2976	24	5	role	role	NOUN
iajs-2976	24	6	of	of	ADP
iajs-2976	24	7	oxidative	oxidative	ADJ
iajs-2976	24	8	stress	stress	NOUN
iajs-2976	24	9	has	have	AUX
iajs-2976	24	10	been	be	AUX
iajs-2976	24	11	investigated	investigate	VERB
iajs-2976	24	12	in	in	ADP
iajs-2976	24	13	cardiomyocyte	cardiomyocyte	NOUN
iajs-2976	24	14	metabolism	metabolism	NOUN
iajs-2976	24	15	and	and	CCONJ
iajs-2976	24	16	coronary	coronary	ADJ
iajs-2976	24	17	blood	blood	NOUN
iajs-2976	24	18	circulation	circulation	NOUN
iajs-2976	24	19	in	in	ADP
iajs-2976	24	20	diabetic	diabetic	ADJ
iajs-2976	24	21	patients	patient	NOUN
iajs-2976	24	22	[	[	X
iajs-2976	24	23	5	5	NUM
iajs-2976	24	24	,	,	PUNCT
iajs-2976	24	25	6	6	NUM
iajs-2976	24	26	]	]	PUNCT
iajs-2976	24	27	.	.	PUNCT
iajs-2976	25	1	heightened	heighten	VERB
iajs-2976	25	2	antioxidant	antioxidant	ADJ
iajs-2976	25	3	defense	defense	NOUN
iajs-2976	25	4	system	system	NOUN
iajs-2976	25	5	consumption	consumption	NOUN
iajs-2976	25	6	,	,	PUNCT
iajs-2976	25	7	overproduction	overproduction	NOUN
iajs-2976	25	8	of	of	ADP
iajs-2976	25	9	free	free	ADJ
iajs-2976	25	10	radicals	radical	NOUN
iajs-2976	25	11	,	,	PUNCT
iajs-2976	25	12	and	and	CCONJ
iajs-2976	25	13	lipid	lipid	NOUN
iajs-2976	25	14	peroxidation	peroxidation	NOUN
iajs-2976	25	15	have	have	AUX
iajs-2976	25	16	been	be	AUX
iajs-2976	25	17	reported	report	VERB
iajs-2976	25	18	in	in	ADP
iajs-2976	25	19	diabetic	diabetic	ADJ
iajs-2976	25	20	rats	rat	NOUN
iajs-2976	25	21	.	.	PUNCT
iajs-2976	26	1	in	in	ADP
iajs-2976	26	2	recent	recent	ADJ
iajs-2976	26	3	years	year	NOUN
iajs-2976	26	4	,	,	PUNCT
iajs-2976	26	5	the	the	DET
iajs-2976	26	6	pivotal	pivotal	ADJ
iajs-2976	26	7	and	and	CCONJ
iajs-2976	26	8	crucial	crucial	ADJ
iajs-2976	26	9	role	role	NOUN
iajs-2976	26	10	of	of	ADP
iajs-2976	26	11	oxidative	oxidative	ADJ
iajs-2976	26	12	stress	stress	NOUN
iajs-2976	26	13	in	in	ADP
iajs-2976	26	14	the	the	DET
iajs-2976	26	15	pathogenesis	pathogenesis	NOUN
iajs-2976	26	16	of	of	ADP
iajs-2976	26	17	several	several	ADJ
iajs-2976	26	18	diabetes	diabetes	NOUN
iajs-2976	26	19	-	-	PUNCT
iajs-2976	26	20	related	relate	VERB
iajs-2976	26	21	complications	complication	NOUN
iajs-2976	26	22	has	have	AUX
iajs-2976	26	23	attracted	attract	VERB
iajs-2976	26	24	considerable	considerable	ADJ
iajs-2976	26	25	attention	attention	NOUN
iajs-2976	26	26	[	[	X
iajs-2976	26	27	7	7	NUM
iajs-2976	26	28	,	,	PUNCT
iajs-2976	26	29	8	8	NUM
iajs-2976	26	30	]	]	PUNCT
iajs-2976	26	31	.	.	PUNCT
iajs-2976	27	1	hyperglycemia	hyperglycemia	NOUN
iajs-2976	27	2	increases	increase	VERB
iajs-2976	27	3	the	the	DET
iajs-2976	27	4	production	production	NOUN
iajs-2976	27	5	of	of	ADP
iajs-2976	27	6	ages	age	NOUN
iajs-2976	27	7	by	by	ADP
iajs-2976	27	8	increasing	increase	VERB
iajs-2976	27	9	nonenzymatic	nonenzymatic	ADJ
iajs-2976	27	10	glycation	glycation	NOUN
iajs-2976	27	11	and	and	CCONJ
iajs-2976	27	12	binding	bind	VERB
iajs-2976	27	13	ages	age	NOUN
iajs-2976	27	14	to	to	ADP
iajs-2976	27	15	their	their	PRON
iajs-2976	27	16	receptors	receptor	NOUN
iajs-2976	27	17	,	,	PUNCT
iajs-2976	27	18	leading	lead	VERB
iajs-2976	27	19	to	to	ADP
iajs-2976	27	20	an	an	DET
iajs-2976	27	21	elevated	elevated	ADJ
iajs-2976	27	22	formation	formation	NOUN
iajs-2976	27	23	of	of	ADP
iajs-2976	27	24	intracellular	intracellular	ADJ
iajs-2976	27	25	ros	ro	NOUN
iajs-2976	27	26	through	through	ADP
iajs-2976	27	27	nicotinamide	nicotinamide	NOUN
iajs-2976	27	28	adenine	adenine	ADJ
iajs-2976	27	29	dinucleotide	dinucleotide	NOUN
iajs-2976	27	30	phosphate	phosphate	NOUN
iajs-2976	27	31	(	(	PUNCT
iajs-2976	27	32	nadph	nadph	ADJ
iajs-2976	27	33	)	)	PUNCT
iajs-2976	27	34	oxidase	oxidase	NOUN
iajs-2976	27	35	.	.	PUNCT
iajs-2976	28	1	correspondingly	correspondingly	ADV
iajs-2976	28	2	,	,	PUNCT
iajs-2976	28	3	the	the	DET
iajs-2976	28	4	synthesis	synthesis	NOUN
iajs-2976	28	5	of	of	ADP
iajs-2976	28	6	diacylglycerol	diacylglycerol	NOUN
iajs-2976	28	7	(	(	PUNCT
iajs-2976	28	8	which	which	PRON
iajs-2976	28	9	is	be	AUX
iajs-2976	28	10	elevated	elevate	VERB
iajs-2976	28	11	in	in	ADP
iajs-2976	28	12	diabetes	diabetes	NOUN
iajs-2976	28	13	)	)	PUNCT
iajs-2976	28	14	activates	activate	VERB
iajs-2976	28	15	protein	protein	NOUN
iajs-2976	28	16	kinase	kinase	PROPN
iajs-2976	28	17	c	c	X
iajs-2976	28	18	,	,	PUNCT
iajs-2976	28	19	leading	lead	VERB
iajs-2976	28	20	to	to	ADP
iajs-2976	28	21	the	the	DET
iajs-2976	28	22	formation	formation	NOUN
iajs-2976	28	23	of	of	ADP
iajs-2976	28	24	ros	ros	PROPN
iajs-2976	28	25	via	via	ADP
iajs-2976	28	26	nadph	nadph	ADJ
iajs-2976	28	27	oxidase	oxidase	NOUN
iajs-2976	29	1	[	[	X
iajs-2976	29	2	9	9	NUM
iajs-2976	29	3	,	,	PUNCT
iajs-2976	29	4	10	10	NUM
iajs-2976	29	5	]	]	PUNCT
iajs-2976	29	6	.	.	PUNCT
iajs-2976	30	1	they	they	PRON
iajs-2976	30	2	can	can	AUX
iajs-2976	30	3	oxidize	oxidize	VERB
iajs-2976	30	4	essential	essential	ADJ
iajs-2976	30	5	cell	cell	NOUN
iajs-2976	30	6	constituents	constituent	NOUN
iajs-2976	30	7	(	(	PUNCT
iajs-2976	30	8	nucleic	nucleic	ADJ
iajs-2976	30	9	acids	acid	NOUN
iajs-2976	30	10	,	,	PUNCT
iajs-2976	30	11	proteins	protein	NOUN
iajs-2976	30	12	,	,	PUNCT
iajs-2976	30	13	and	and	CCONJ
iajs-2976	30	14	lipids	lipids	ADJ
iajs-2976	30	15	)	)	PUNCT
iajs-2976	30	16	and	and	CCONJ
iajs-2976	30	17	produce	produce	VERB
iajs-2976	30	18	toxic	toxic	ADJ
iajs-2976	30	19	byproducts	byproduct	NOUN
iajs-2976	30	20	that	that	PRON
iajs-2976	30	21	result	result	VERB
iajs-2976	30	22	in	in	ADP
iajs-2976	30	23	tissue	tissue	NOUN
iajs-2976	30	24	damage	damage	NOUN
iajs-2976	30	25	.	.	PUNCT
iajs-2976	31	1	in	in	ADP
iajs-2976	31	2	addition	addition	NOUN
iajs-2976	31	3	,	,	PUNCT
iajs-2976	31	4	they	they	PRON
iajs-2976	31	5	alter	alter	VERB
iajs-2976	31	6	the	the	DET
iajs-2976	31	7	structure	structure	NOUN
iajs-2976	31	8	of	of	ADP
iajs-2976	31	9	biological	biological	ADJ
iajs-2976	31	10	molecules	molecule	NOUN
iajs-2976	31	11	,	,	PUNCT
iajs-2976	31	12	even	even	ADV
iajs-2976	31	13	destroying	destroy	VERB
iajs-2976	31	14	them	they	PRON
iajs-2976	31	15	[	[	X
iajs-2976	31	16	11	11	NUM
iajs-2976	31	17	,	,	PUNCT
iajs-2976	31	18	12	12	NUM
iajs-2976	31	19	]	]	PUNCT
iajs-2976	31	20	.	.	PUNCT
iajs-2976	32	1	various	various	ADJ
iajs-2976	32	2	study	study	NOUN
iajs-2976	32	3	articles	article	NOUN
iajs-2976	32	4	investigated	investigate	VERB
iajs-2976	32	5	the	the	DET
iajs-2976	32	6	effect	effect	NOUN
iajs-2976	32	7	of	of	ADP
iajs-2976	32	8	antioxidant	antioxidant	ADJ
iajs-2976	32	9	defense	defense	NOUN
iajs-2976	32	10	and	and	CCONJ
iajs-2976	32	11	oxidative	oxidative	ADJ
iajs-2976	32	12	stress	stress	NOUN
iajs-2976	32	13	on	on	ADP
iajs-2976	32	14	the	the	DET
iajs-2976	32	15	onset	onset	NOUN
iajs-2976	32	16	of	of	ADP
iajs-2976	32	17	diabetes	diabetes	NOUN
iajs-2976	32	18	and	and	CCONJ
iajs-2976	32	19	its	its	PRON
iajs-2976	32	20	related	related	ADJ
iajs-2976	32	21	conditions	condition	NOUN
iajs-2976	32	22	[	[	X
iajs-2976	32	23	9	9	NUM
iajs-2976	32	24	,	,	PUNCT
iajs-2976	32	25	13	13	NUM
iajs-2976	32	26	-	-	SYM
iajs-2976	32	27	15	15	NUM
iajs-2976	32	28	]	]	PUNCT
iajs-2976	32	29	.	.	PUNCT
iajs-2976	33	1	it	it	PRON
iajs-2976	33	2	has	have	AUX
iajs-2976	33	3	been	be	AUX
iajs-2976	33	4	reported	report	VERB
iajs-2976	33	5	frequently	frequently	ADV
iajs-2976	33	6	that	that	SCONJ
iajs-2976	33	7	the	the	DET
iajs-2976	33	8	development	development	NOUN
iajs-2976	33	9	and	and	CCONJ
iajs-2976	33	10	progression	progression	NOUN
iajs-2976	33	11	of	of	ADP
iajs-2976	33	12	diabetes	diabetes	NOUN
iajs-2976	33	13	are	be	AUX
iajs-2976	33	14	associated	associate	VERB
iajs-2976	33	15	with	with	ADP
iajs-2976	33	16	insufficient	insufficient	ADJ
iajs-2976	33	17	biological	biological	ADJ
iajs-2976	33	18	antioxidants	antioxidant	NOUN
iajs-2976	33	19	which	which	PRON
iajs-2976	33	20	resulting	result	VERB
iajs-2976	33	21	oxidative	oxidative	ADJ
iajs-2976	33	22	stress	stress	NOUN
iajs-2976	34	1	[	[	X
iajs-2976	34	2	16	16	NUM
iajs-2976	34	3	]	]	PUNCT
iajs-2976	34	4	.	.	PUNCT
iajs-2976	35	1	analyzing	analyze	VERB
iajs-2976	35	2	and	and	CCONJ
iajs-2976	35	3	exploring	explore	VERB
iajs-2976	35	4	the	the	DET
iajs-2976	35	5	extraction	extraction	NOUN
iajs-2976	35	6	of	of	ADP
iajs-2976	35	7	natural	natural	ADJ
iajs-2976	35	8	antioxidants	antioxidant	NOUN
iajs-2976	35	9	to	to	PART
iajs-2976	35	10	replace	replace	VERB
iajs-2976	35	11	synthetic	synthetic	ADJ
iajs-2976	35	12	antioxidants	antioxidant	NOUN
iajs-2976	35	13	has	have	AUX
iajs-2976	35	14	recently	recently	ADV
iajs-2976	35	15	caught	catch	VERB
iajs-2976	35	16	the	the	DET
iajs-2976	35	17	attention	attention	NOUN
iajs-2976	35	18	of	of	ADP
iajs-2976	35	19	investigators	investigator	NOUN
iajs-2976	35	20	[	[	X
iajs-2976	35	21	17	17	NUM
iajs-2976	35	22	,	,	PUNCT
iajs-2976	35	23	18	18	NUM
iajs-2976	35	24	]	]	PUNCT
iajs-2976	35	25	.	.	PUNCT
iajs-2976	36	1	it	it	PRON
iajs-2976	36	2	was	be	AUX
iajs-2976	36	3	suggested	suggest	VERB
iajs-2976	36	4	that	that	SCONJ
iajs-2976	36	5	emerging	emerge	VERB
iajs-2976	36	6	evidence	evidence	NOUN
iajs-2976	36	7	supports	support	VERB
iajs-2976	36	8	the	the	DET
iajs-2976	36	9	protective	protective	ADJ
iajs-2976	36	10	impact	impact	NOUN
iajs-2976	36	11	of	of	ADP
iajs-2976	36	12	dietary	dietary	ADJ
iajs-2976	36	13	antioxidants	antioxidant	NOUN
iajs-2976	36	14	as	as	ADP
iajs-2976	36	15	a	a	DET
iajs-2976	36	16	potential	potential	ADJ
iajs-2976	36	17	supplementary	supplementary	ADJ
iajs-2976	36	18	treatment	treatment	NOUN
iajs-2976	36	19	for	for	ADP
iajs-2976	36	20	delaying	delay	VERB
iajs-2976	36	21	or	or	CCONJ
iajs-2976	36	22	preventing	prevent	VERB
iajs-2976	36	23	diabetic	diabetic	ADJ
iajs-2976	36	24	consequences	consequence	NOUN
iajs-2976	36	25	[	[	X
iajs-2976	36	26	19	19	NUM
iajs-2976	36	27	]	]	PUNCT
iajs-2976	36	28	.	.	PUNCT
iajs-2976	37	1	accordingly	accordingly	ADV
iajs-2976	37	2	,	,	PUNCT
iajs-2976	37	3	further	further	ADJ
iajs-2976	37	4	research	research	NOUN
iajs-2976	37	5	is	be	AUX
iajs-2976	37	6	required	require	VERB
iajs-2976	37	7	to	to	PART
iajs-2976	37	8	specify	specify	VERB
iajs-2976	37	9	the	the	DET
iajs-2976	37	10	natural	natural	ADJ
iajs-2976	37	11	source	source	NOUN
iajs-2976	37	12	of	of	ADP
iajs-2976	37	13	antioxidants	antioxidant	NOUN
iajs-2976	37	14	in	in	ADP
iajs-2976	37	15	order	order	NOUN
iajs-2976	37	16	to	to	PART
iajs-2976	37	17	improve	improve	VERB
iajs-2976	37	18	the	the	DET
iajs-2976	37	19	public	public	ADJ
iajs-2976	37	20	health	health	NOUN
iajs-2976	37	21	of	of	ADP
iajs-2976	37	22	diabetic	diabetic	ADJ
iajs-2976	37	23	patients	patient	NOUN
iajs-2976	37	24	.	.	PUNCT
iajs-2976	38	1	ubiquinone	ubiquinone	PROPN
iajs-2976	38	2	(	(	PUNCT
iajs-2976	38	3	coenzyme	coenzyme	PROPN
iajs-2976	38	4	q10	q10	PROPN
iajs-2976	38	5	)	)	PUNCT
iajs-2976	38	6	is	be	AUX
iajs-2976	38	7	a	a	DET
iajs-2976	38	8	potent	potent	ADJ
iajs-2976	38	9	lipophilic	lipophilic	ADJ
iajs-2976	38	10	antioxidant	antioxidant	NOUN
iajs-2976	38	11	found	find	VERB
iajs-2976	38	12	in	in	ADP
iajs-2976	38	13	the	the	DET
iajs-2976	38	14	inner	inner	ADJ
iajs-2976	38	15	membrane	membrane	NOUN
iajs-2976	38	16	of	of	ADP
iajs-2976	38	17	mitochondria	mitochondria	NOUN
iajs-2976	38	18	.	.	PUNCT
iajs-2976	39	1	it	it	PRON
iajs-2976	39	2	is	be	AUX
iajs-2976	39	3	an	an	DET
iajs-2976	39	4	endogenously	endogenously	ADV
iajs-2976	39	5	synthesized	synthesize	VERB
iajs-2976	39	6	constituent	constituent	NOUN
iajs-2976	39	7	that	that	SCONJ
iajs-2976	39	8	functions	function	NOUN
iajs-2976	39	9	as	as	ADP
iajs-2976	39	10	a	a	DET
iajs-2976	39	11	crucial	crucial	ADJ
iajs-2976	39	12	cofactor	cofactor	NOUN
iajs-2976	39	13	in	in	ADP
iajs-2976	39	14	the	the	DET
iajs-2976	39	15	mitochondrial	mitochondrial	ADJ
iajs-2976	39	16	electron	electron	NOUN
iajs-2976	39	17	transport	transport	NOUN
iajs-2976	39	18	system	system	NOUN
iajs-2976	39	19	[	[	X
iajs-2976	39	20	20	20	NUM
iajs-2976	39	21	,	,	PUNCT
iajs-2976	39	22	21	21	NUM
iajs-2976	39	23	]	]	PUNCT
iajs-2976	39	24	.	.	PUNCT
iajs-2976	40	1	ubiquinone	ubiquinone	PROPN
iajs-2976	40	2	is	be	AUX
iajs-2976	40	3	also	also	ADV
iajs-2976	40	4	involved	involve	VERB
iajs-2976	40	5	in	in	ADP
iajs-2976	40	6	the	the	DET
iajs-2976	40	7	recycling	recycling	NOUN
iajs-2976	40	8	and	and	CCONJ
iajs-2976	40	9	regenerating	regenerating	NOUN
iajs-2976	40	10	of	of	ADP
iajs-2976	40	11	other	other	ADJ
iajs-2976	40	12	antioxidants	antioxidant	NOUN
iajs-2976	40	13	,	,	PUNCT
iajs-2976	40	14	including	include	VERB
iajs-2976	40	15	tocopherol	tocopherol	NOUN
iajs-2976	40	16	,	,	PUNCT
iajs-2976	40	17	β	β	NOUN
iajs-2976	40	18	-	-	NOUN
iajs-2976	40	19	carotene	carotene	ADJ
iajs-2976	40	20	,	,	PUNCT
iajs-2976	40	21	and	and	CCONJ
iajs-2976	40	22	ascorbate	ascorbate	NOUN
iajs-2976	40	23	[	[	X
iajs-2976	40	24	22	22	NUM
iajs-2976	40	25	,	,	PUNCT
iajs-2976	40	26	23	23	NUM
iajs-2976	40	27	]	]	PUNCT
iajs-2976	40	28	.	.	PUNCT
iajs-2976	41	1	furthermore	furthermore	ADV
iajs-2976	41	2	,	,	PUNCT
iajs-2976	41	3	like	like	ADP
iajs-2976	41	4	other	other	ADJ
iajs-2976	41	5	antioxidants	antioxidant	NOUN
iajs-2976	41	6	,	,	PUNCT
iajs-2976	41	7	ubiquinone	ubiquinone	PROPN
iajs-2976	41	8	hinders	hinder	VERB
iajs-2976	41	9	certain	certain	ADJ
iajs-2976	41	10	enzymes	enzyme	NOUN
iajs-2976	41	11	that	that	PRON
iajs-2976	41	12	catalyze	catalyze	VERB
iajs-2976	41	13	the	the	DET
iajs-2976	41	14	free	free	ADJ
iajs-2976	41	15	radicals	radical	NOUN
iajs-2976	41	16	formation	formation	NOUN
iajs-2976	41	17	,	,	PUNCT
iajs-2976	41	18	thus	thus	ADV
iajs-2976	41	19	attenuating	attenuate	VERB
iajs-2976	41	20	oxidative	oxidative	ADJ
iajs-2976	41	21	stress	stress	NOUN
iajs-2976	41	22	and	and	CCONJ
iajs-2976	41	23	preventing	prevent	VERB
iajs-2976	41	24	the	the	DET
iajs-2976	41	25	initiation	initiation	NOUN
iajs-2976	41	26	and	and	CCONJ
iajs-2976	41	27	spread	spread	VERB
iajs-2976	41	28	of	of	ADP
iajs-2976	41	29	lipid	lipid	NOUN
iajs-2976	41	30	peroxidation	peroxidation	NOUN
iajs-2976	41	31	in	in	ADP
iajs-2976	41	32	cell	cell	NOUN
iajs-2976	41	33	membranes	membrane	NOUN
iajs-2976	41	34	.	.	PUNCT
iajs-2976	42	1	enhancing	enhance	VERB
iajs-2976	42	2	the	the	DET
iajs-2976	42	3	enzyme	enzyme	NOUN
iajs-2976	42	4	's	's	PART
iajs-2976	42	5	potential	potential	NOUN
iajs-2976	42	6	to	to	PART
iajs-2976	42	7	scavenge	scavenge	VERB
iajs-2976	42	8	free	free	ADJ
iajs-2976	42	9	radicals	radical	NOUN
iajs-2976	42	10	is	be	AUX
iajs-2976	42	11	an	an	DET
iajs-2976	42	12	additional	additional	ADJ
iajs-2976	42	13	protective	protective	ADJ
iajs-2976	42	14	effect	effect	NOUN
iajs-2976	42	15	of	of	ADP
iajs-2976	42	16	ubiquinone	ubiquinone	PROPN
iajs-2976	42	17	[	[	X
iajs-2976	42	18	24	24	NUM
iajs-2976	42	19	,	,	PUNCT
iajs-2976	42	20	25	25	NUM
iajs-2976	42	21	]	]	PUNCT
iajs-2976	42	22	.	.	PUNCT
iajs-2976	43	1	this	this	DET
iajs-2976	43	2	research	research	NOUN
iajs-2976	43	3	intends	intend	VERB
iajs-2976	43	4	to	to	PART
iajs-2976	43	5	investigate	investigate	VERB
iajs-2976	43	6	the	the	DET
iajs-2976	43	7	ubiquinone	ubiquinone	PROPN
iajs-2976	43	8	effect	effect	NOUN
iajs-2976	43	9	on	on	ADP
iajs-2976	43	10	hyperglycemia	hyperglycemia	NOUN
iajs-2976	43	11	consequences	consequence	NOUN
iajs-2976	43	12	that	that	PRON
iajs-2976	43	13	could	could	AUX
iajs-2976	43	14	be	be	AUX
iajs-2976	43	15	deduced	deduce	VERB
iajs-2976	43	16	from	from	ADP
iajs-2976	43	17	the	the	DET
iajs-2976	43	18	interpretation	interpretation	NOUN
iajs-2976	43	19	of	of	ADP
iajs-2976	43	20	markers	marker	NOUN
iajs-2976	43	21	of	of	ADP
iajs-2976	43	22	oxidative	oxidative	ADJ
iajs-2976	43	23	stress	stress	NOUN
iajs-2976	43	24	,	,	PUNCT
iajs-2976	43	25	inflammation	inflammation	NOUN
iajs-2976	43	26	,	,	PUNCT
iajs-2976	43	27	myopathy	myopathy	ADJ
iajs-2976	43	28	,	,	PUNCT
iajs-2976	43	29	and	and	CCONJ
iajs-2976	43	30	endotheliopathy	endotheliopathy	ADJ
iajs-2976	43	31	.	.	PUNCT
iajs-2976	44	1	lipid	lipid	NOUN
iajs-2976	44	2	oxidation	oxidation	NOUN
iajs-2976	44	3	products	product	NOUN
iajs-2976	44	4	are	be	AUX
iajs-2976	44	5	the	the	DET
iajs-2976	44	6	major	major	ADJ
iajs-2976	44	7	damaging	damaging	ADJ
iajs-2976	44	8	influence	influence	NOUN
iajs-2976	44	9	of	of	ADP
iajs-2976	44	10	ros	ros	PROPN
iajs-2976	44	11	formation	formation	NOUN
iajs-2976	44	12	,	,	PUNCT
iajs-2976	44	13	as	as	SCONJ
iajs-2976	44	14	they	they	PRON
iajs-2976	44	15	consider	consider	VERB
iajs-2976	44	16	irreversible	irreversible	ADJ
iajs-2976	44	17	oxidative	oxidative	ADJ
iajs-2976	44	18	modifications	modification	NOUN
iajs-2976	44	19	in	in	ADP
iajs-2976	44	20	membranes	membrane	NOUN
iajs-2976	44	21	[	[	X
iajs-2976	44	22	26	26	NUM
iajs-2976	44	23	]	]	PUNCT
iajs-2976	44	24	.	.	PUNCT
iajs-2976	45	1	mda	mda	PROPN
iajs-2976	45	2	is	be	AUX
iajs-2976	45	3	one	one	NUM
iajs-2976	45	4	of	of	ADP
iajs-2976	45	5	the	the	DET
iajs-2976	45	6	most	most	ADV
iajs-2976	45	7	extensively	extensively	ADV
iajs-2976	45	8	researched	research	VERB
iajs-2976	45	9	end	end	NOUN
iajs-2976	45	10	-	-	PUNCT
iajs-2976	45	11	products	product	NOUN
iajs-2976	45	12	of	of	ADP
iajs-2976	45	13	lipid	lipid	NOUN
iajs-2976	45	14	oxidation	oxidation	NOUN
iajs-2976	45	15	and	and	CCONJ
iajs-2976	45	16	is	be	AUX
iajs-2976	45	17	frequently	frequently	ADV
iajs-2976	45	18	used	use	VERB
iajs-2976	45	19	as	as	ADP
iajs-2976	45	20	an	an	DET
iajs-2976	45	21	indicator	indicator	NOUN
iajs-2976	45	22	of	of	ADP
iajs-2976	45	23	free	free	ADJ
iajs-2976	45	24	radical	radical	ADJ
iajs-2976	45	25	-	-	PUNCT
iajs-2976	45	26	induced	induce	VERB
iajs-2976	45	27	injuries	injury	NOUN
iajs-2976	45	28	or	or	CCONJ
iajs-2976	45	29	oxidative	oxidative	ADJ
iajs-2976	45	30	stress	stress	NOUN
iajs-2976	45	31	[	[	X
iajs-2976	45	32	27	27	NUM
iajs-2976	45	33	,	,	PUNCT
iajs-2976	45	34	28	28	NUM
iajs-2976	45	35	]	]	PUNCT
iajs-2976	45	36	.	.	PUNCT
iajs-2976	46	1	individuals	individual	NOUN
iajs-2976	46	2	with	with	ADP
iajs-2976	46	3	diabetes	diabetes	NOUN
iajs-2976	46	4	have	have	AUX
iajs-2976	46	5	elevated	elevate	VERB
iajs-2976	46	6	blood	blood	NOUN
iajs-2976	46	7	levels	level	NOUN
iajs-2976	46	8	of	of	ADP
iajs-2976	46	9	interleukin-6	interleukin-6	PROPN
iajs-2976	46	10	(	(	PUNCT
iajs-2976	46	11	il-6	il-6	NUM
iajs-2976	46	12	)	)	PUNCT
iajs-2976	46	13	,	,	PUNCT
iajs-2976	46	14	which	which	PRON
iajs-2976	46	15	is	be	AUX
iajs-2976	46	16	known	know	VERB
iajs-2976	46	17	as	as	ADP
iajs-2976	46	18	an	an	DET
iajs-2976	46	19	inflammatory	inflammatory	ADJ
iajs-2976	46	20	biomarker	biomarker	NOUN
iajs-2976	46	21	,	,	PUNCT
iajs-2976	46	22	and	and	CCONJ
iajs-2976	46	23	raising	raise	VERB
iajs-2976	46	24	its	its	PRON
iajs-2976	46	25	level	level	NOUN
iajs-2976	46	26	is	be	AUX
iajs-2976	46	27	regarded	regard	VERB
iajs-2976	46	28	as	as	ADP
iajs-2976	46	29	the	the	DET
iajs-2976	46	30	development	development	NOUN
iajs-2976	46	31	of	of	ADP
iajs-2976	46	32	atherosclerosis	atherosclerosis	NOUN
iajs-2976	46	33	and	and	CCONJ
iajs-2976	46	34	vascular	vascular	ADJ
iajs-2976	46	35	disease	disease	NOUN
iajs-2976	46	36	[	[	X
iajs-2976	46	37	29	29	NUM
iajs-2976	46	38	]	]	PUNCT
iajs-2976	46	39	.	.	PUNCT
iajs-2976	47	1	furthermore	furthermore	ADV
iajs-2976	47	2	,	,	PUNCT
iajs-2976	47	3	free	free	ADJ
iajs-2976	47	4	radicals	radical	NOUN
iajs-2976	47	5	,	,	PUNCT
iajs-2976	47	6	particularly	particularly	ADV
iajs-2976	47	7	superoxide	superoxide	NOUN
iajs-2976	47	8	anions	anion	NOUN
iajs-2976	47	9	,	,	PUNCT
iajs-2976	47	10	potentially	potentially	ADV
iajs-2976	47	11	interact	interact	VERB
iajs-2976	47	12	with	with	ADP
iajs-2976	47	13	endotheliumderived	endotheliumderive	VERB
iajs-2976	47	14	nitric	nitric	ADJ
iajs-2976	47	15	oxide	oxide	NOUN
iajs-2976	47	16	(	(	PUNCT
iajs-2976	47	17	no	no	NOUN
iajs-2976	47	18	)	)	PUNCT
iajs-2976	47	19	and	and	CCONJ
iajs-2976	47	20	suppress	suppress	VERB
iajs-2976	47	21	endothelial	endothelial	ADJ
iajs-2976	47	22	nitric	nitric	ADJ
iajs-2976	47	23	oxide	oxide	NOUN
iajs-2976	47	24	synthase	synthase	NOUN
iajs-2976	47	25	(	(	PUNCT
iajs-2976	47	26	enos	enos	PROPN
iajs-2976	47	27	)	)	PUNCT
iajs-2976	47	28	.	.	PUNCT
iajs-2976	48	1	this	this	DET
iajs-2976	48	2	interaction	interaction	NOUN
iajs-2976	48	3	ihjpas	ihjpa	VERB
iajs-2976	48	4	.	.	PUNCT
iajs-2976	49	1	36(2)2023	36(2)2023	NUM
iajs-2976	49	2	87	87	NUM
iajs-2976	49	3	is	be	AUX
iajs-2976	49	4	one	one	NUM
iajs-2976	49	5	of	of	ADP
iajs-2976	49	6	the	the	DET
iajs-2976	49	7	most	most	ADV
iajs-2976	49	8	influential	influential	ADJ
iajs-2976	49	9	pathways	pathway	NOUN
iajs-2976	49	10	behind	behind	ADP
iajs-2976	49	11	diabetic	diabetic	ADJ
iajs-2976	49	12	endothelial	endothelial	ADJ
iajs-2976	49	13	dysfunction	dysfunction	NOUN
iajs-2976	49	14	[	[	X
iajs-2976	49	15	30	30	NUM
iajs-2976	49	16	]	]	PUNCT
iajs-2976	49	17	.	.	PUNCT
iajs-2976	50	1	the	the	DET
iajs-2976	50	2	main	main	ADJ
iajs-2976	50	3	regulator	regulator	NOUN
iajs-2976	50	4	of	of	ADP
iajs-2976	50	5	vascular	vascular	ADJ
iajs-2976	50	6	homeostasis	homeostasis	NOUN
iajs-2976	50	7	,	,	PUNCT
iajs-2976	50	8	no	no	INTJ
iajs-2976	50	9	,	,	PUNCT
iajs-2976	50	10	is	be	AUX
iajs-2976	50	11	produced	produce	VERB
iajs-2976	50	12	by	by	ADP
iajs-2976	50	13	enos	eno	NOUN
iajs-2976	50	14	in	in	ADP
iajs-2976	50	15	endothelial	endothelial	ADJ
iajs-2976	50	16	cells	cell	NOUN
iajs-2976	50	17	from	from	ADP
iajs-2976	50	18	l	l	NOUN
iajs-2976	50	19	-	-	NOUN
iajs-2976	50	20	arginine	arginine	NOUN
iajs-2976	50	21	.	.	PUNCT
iajs-2976	51	1	it	it	PRON
iajs-2976	51	2	has	have	VERB
iajs-2976	51	3	a	a	DET
iajs-2976	51	4	substantial	substantial	ADJ
iajs-2976	51	5	role	role	NOUN
iajs-2976	51	6	in	in	ADP
iajs-2976	51	7	protecting	protect	VERB
iajs-2976	51	8	against	against	ADP
iajs-2976	51	9	the	the	DET
iajs-2976	51	10	onset	onset	NOUN
iajs-2976	51	11	and	and	CCONJ
iajs-2976	51	12	development	development	NOUN
iajs-2976	51	13	of	of	ADP
iajs-2976	51	14	cardiovascular	cardiovascular	ADJ
iajs-2976	51	15	disease	disease	NOUN
iajs-2976	51	16	[	[	X
iajs-2976	51	17	31	31	NUM
iajs-2976	51	18	]	]	PUNCT
iajs-2976	51	19	.	.	PUNCT
iajs-2976	52	1	reduced	reduce	VERB
iajs-2976	52	2	no	no	DET
iajs-2976	52	3	bioavailability	bioavailability	NOUN
iajs-2976	52	4	is	be	AUX
iajs-2976	52	5	characteristic	characteristic	ADJ
iajs-2976	52	6	of	of	ADP
iajs-2976	52	7	hyperglycemia	hyperglycemia	NOUN
iajs-2976	52	8	-	-	PUNCT
iajs-2976	52	9	induced	induce	VERB
iajs-2976	52	10	endothelial	endothelial	ADJ
iajs-2976	52	11	dysfunction	dysfunction	NOUN
iajs-2976	52	12	[	[	X
iajs-2976	52	13	32	32	NUM
iajs-2976	52	14	]	]	PUNCT
iajs-2976	52	15	.	.	PUNCT
iajs-2976	53	1	this	this	DET
iajs-2976	53	2	study	study	NOUN
iajs-2976	53	3	aimed	aim	VERB
iajs-2976	53	4	to	to	PART
iajs-2976	53	5	examine	examine	VERB
iajs-2976	53	6	ubiquinone	ubiquinone	PROPN
iajs-2976	53	7	impact	impact	NOUN
iajs-2976	53	8	on	on	ADP
iajs-2976	53	9	glycemic	glycemic	ADJ
iajs-2976	53	10	status	status	NOUN
iajs-2976	53	11	and	and	CCONJ
iajs-2976	53	12	hyperglycemia	hyperglycemia	NOUN
iajs-2976	53	13	-	-	PUNCT
iajs-2976	53	14	induced	induce	VERB
iajs-2976	53	15	complications	complication	NOUN
iajs-2976	53	16	in	in	ADP
iajs-2976	53	17	stz	stz	ADJ
iajs-2976	53	18	-	-	PUNCT
iajs-2976	53	19	induced	induce	VERB
iajs-2976	53	20	diabetic	diabetic	ADJ
iajs-2976	53	21	rats	rat	NOUN
iajs-2976	53	22	.	.	PUNCT
iajs-2976	54	1	by	by	ADP
iajs-2976	54	2	assessing	assess	VERB
iajs-2976	54	3	mda	mda	PROPN
iajs-2976	54	4	,	,	PUNCT
iajs-2976	54	5	il-6	il-6	PRON
iajs-2976	54	6	,	,	PUNCT
iajs-2976	54	7	no	no	INTJ
iajs-2976	54	8	,	,	PUNCT
iajs-2976	54	9	and	and	CCONJ
iajs-2976	54	10	mb	mb	ADP
iajs-2976	54	11	levels	level	NOUN
iajs-2976	54	12	in	in	ADP
iajs-2976	54	13	hyperglycemic	hyperglycemic	ADJ
iajs-2976	54	14	rodents	rodent	NOUN
iajs-2976	54	15	,	,	PUNCT
iajs-2976	54	16	the	the	DET
iajs-2976	54	17	current	current	ADJ
iajs-2976	54	18	study	study	NOUN
iajs-2976	54	19	will	will	AUX
iajs-2976	54	20	evaluate	evaluate	VERB
iajs-2976	54	21	the	the	DET
iajs-2976	54	22	preventive	preventive	ADJ
iajs-2976	54	23	effect	effect	NOUN
iajs-2976	54	24	of	of	ADP
iajs-2976	54	25	ubiquinone	ubiquinone	PROPN
iajs-2976	54	26	against	against	ADP
iajs-2976	54	27	oxidative	oxidative	ADJ
iajs-2976	54	28	stress	stress	NOUN
iajs-2976	54	29	,	,	PUNCT
iajs-2976	54	30	inflammation	inflammation	NOUN
iajs-2976	54	31	,	,	PUNCT
iajs-2976	54	32	and	and	CCONJ
iajs-2976	54	33	myopathy	myopathy	ADJ
iajs-2976	54	34	.	.	PUNCT
iajs-2976	55	1	another	another	DET
iajs-2976	55	2	objective	objective	NOUN
iajs-2976	55	3	is	be	AUX
iajs-2976	55	4	to	to	PART
iajs-2976	55	5	investigate	investigate	VERB
iajs-2976	55	6	the	the	DET
iajs-2976	55	7	antioxidant	antioxidant	ADJ
iajs-2976	55	8	potential	potential	NOUN
iajs-2976	55	9	of	of	ADP
iajs-2976	55	10	ubiquinone	ubiquinone	PROPN
iajs-2976	55	11	on	on	ADP
iajs-2976	55	12	blood	blood	NOUN
iajs-2976	55	13	component	component	NOUN
iajs-2976	55	14	parameters	parameter	NOUN
iajs-2976	55	15	to	to	PART
iajs-2976	55	16	gain	gain	VERB
iajs-2976	55	17	a	a	DET
iajs-2976	55	18	deeper	deep	ADJ
iajs-2976	55	19	understanding	understanding	NOUN
iajs-2976	55	20	of	of	ADP
iajs-2976	55	21	the	the	DET
iajs-2976	55	22	role	role	NOUN
iajs-2976	55	23	of	of	ADP
iajs-2976	55	24	ubiquinone	ubiquinone	PROPN
iajs-2976	55	25	in	in	ADP
iajs-2976	55	26	mitigating	mitigate	VERB
iajs-2976	55	27	diabetic	diabetic	ADJ
iajs-2976	55	28	complications	complication	NOUN
iajs-2976	55	29	.	.	PUNCT
iajs-2976	56	1	2	2	X
iajs-2976	56	2	.	.	X
iajs-2976	56	3	materials	material	NOUN
iajs-2976	56	4	and	and	CCONJ
iajs-2976	56	5	methods	method	NOUN
iajs-2976	56	6	chemicals	chemical	VERB
iajs-2976	56	7	the	the	DET
iajs-2976	56	8	streptozotocin	streptozotocin	PROPN
iajs-2976	56	9	(	(	PUNCT
iajs-2976	56	10	stz	stz	NOUN
iajs-2976	56	11	)	)	PUNCT
iajs-2976	56	12	,	,	PUNCT
iajs-2976	56	13	with	with	ADP
iajs-2976	56	14	high	high	ADJ
iajs-2976	56	15	purity	purity	NOUN
iajs-2976	56	16	at	at	ADP
iajs-2976	56	17	97.5	97.5	NUM
iajs-2976	56	18	percent	percent	NOUN
iajs-2976	56	19	,	,	PUNCT
iajs-2976	56	20	was	be	AUX
iajs-2976	56	21	purchased	purchase	VERB
iajs-2976	56	22	from	from	ADP
iajs-2976	56	23	shanghai	shanghai	PROPN
iajs-2976	56	24	macklin	macklin	PROPN
iajs-2976	56	25	biochemical	biochemical	PROPN
iajs-2976	56	26	co.	co.	PROPN
iajs-2976	56	27	,	,	PUNCT
iajs-2976	56	28	ltd	ltd	PROPN
iajs-2976	56	29	.	.	PROPN
iajs-2976	57	1	ubiquinone	ubiquinone	PROPN
iajs-2976	57	2	200	200	NUM
iajs-2976	57	3	mg	mg	NOUN
iajs-2976	57	4	which	which	PRON
iajs-2976	57	5	had	have	AUX
iajs-2976	57	6	been	be	AUX
iajs-2976	57	7	purchased	purchase	VERB
iajs-2976	57	8	was	be	AUX
iajs-2976	57	9	in	in	ADP
iajs-2976	57	10	the	the	DET
iajs-2976	57	11	gel	gel	NOUN
iajs-2976	57	12	form	form	NOUN
iajs-2976	57	13	manufactured	manufacture	VERB
iajs-2976	57	14	by	by	ADP
iajs-2976	57	15	america	america	PROPN
iajs-2976	57	16	(	(	PUNCT
iajs-2976	57	17	nature	nature	PROPN
iajs-2976	57	18	’s	’s	PART
iajs-2976	57	19	bounty	bounty	PROPN
iajs-2976	57	20	pharmaceutical	pharmaceutical	PROPN
iajs-2976	57	21	inc	inc	PROPN
iajs-2976	57	22	.	.	PROPN
iajs-2976	57	23	,	,	PUNCT
iajs-2976	57	24	usa	usa	PROPN
iajs-2976	57	25	.	.	PROPN
iajs-2976	57	26	)	)	PUNCT
iajs-2976	57	27	.	.	PUNCT
iajs-2976	58	1	rat	rat	PROPN
iajs-2976	58	2	malondialdehyde	malondialdehyde	PROPN
iajs-2976	58	3	(	(	PUNCT
iajs-2976	58	4	mda	mda	PROPN
iajs-2976	58	5	)	)	PUNCT
iajs-2976	58	6	enzyme	enzyme	NOUN
iajs-2976	58	7	linking	link	VERB
iajs-2976	58	8	immune	immune	NOUN
iajs-2976	58	9	-	-	PUNCT
iajs-2976	58	10	absorbent	absorbent	NOUN
iajs-2976	58	11	assay	assay	NOUN
iajs-2976	58	12	(	(	PUNCT
iajs-2976	58	13	elisa	elisa	NOUN
iajs-2976	58	14	)	)	PUNCT
iajs-2976	58	15	kit	kit	NOUN
iajs-2976	58	16	(	(	PUNCT
iajs-2976	58	17	catalogue	catalogue	NOUN
iajs-2976	58	18	number	number	NOUN
iajs-2976	58	19	:	:	PUNCT
iajs-2976	58	20	201	201	NUM
iajs-2976	58	21	-	-	SYM
iajs-2976	58	22	11	11	NUM
iajs-2976	58	23	-	-	PUNCT
iajs-2976	58	24	0157	0157	NUM
iajs-2976	58	25	,	,	PUNCT
iajs-2976	58	26	48	48	NUM
iajs-2976	58	27	tests	test	NOUN
iajs-2976	58	28	)	)	PUNCT
iajs-2976	58	29	,	,	PUNCT
iajs-2976	58	30	interleukin	interleukin	NOUN
iajs-2976	58	31	6	6	NUM
iajs-2976	58	32	(	(	PUNCT
iajs-2976	58	33	il-6	il-6	NUM
iajs-2976	58	34	)	)	PUNCT
iajs-2976	58	35	elisa	elisa	NOUN
iajs-2976	58	36	kit	kit	NOUN
iajs-2976	58	37	(	(	PUNCT
iajs-2976	58	38	catalogue	catalogue	NOUN
iajs-2976	58	39	number	number	NOUN
iajs-2976	58	40	:	:	PUNCT
iajs-2976	58	41	201	201	NUM
iajs-2976	58	42	-	-	SYM
iajs-2976	58	43	11	11	NUM
iajs-2976	58	44	-	-	PUNCT
iajs-2976	58	45	0136	0136	NUM
iajs-2976	58	46	,	,	PUNCT
iajs-2976	58	47	48	48	NUM
iajs-2976	58	48	tests	test	NOUN
iajs-2976	58	49	)	)	PUNCT
iajs-2976	58	50	,	,	PUNCT
iajs-2976	58	51	and	and	CCONJ
iajs-2976	58	52	nitric	nitric	ADJ
iajs-2976	58	53	oxide	oxide	NOUN
iajs-2976	58	54	(	(	PUNCT
iajs-2976	58	55	no	no	NOUN
iajs-2976	58	56	)	)	PUNCT
iajs-2976	58	57	elisa	elisa	NOUN
iajs-2976	58	58	kit	kit	NOUN
iajs-2976	58	59	(	(	PUNCT
iajs-2976	58	60	catalogue	catalogue	NOUN
iajs-2976	58	61	number	number	NOUN
iajs-2976	58	62	:	:	PUNCT
iajs-2976	58	63	201	201	NUM
iajs-2976	58	64	-	-	SYM
iajs-2976	58	65	11	11	NUM
iajs-2976	58	66	-	-	PUNCT
iajs-2976	58	67	0704	0704	NUM
iajs-2976	58	68	,	,	PUNCT
iajs-2976	58	69	48	48	NUM
iajs-2976	58	70	tests	test	NOUN
iajs-2976	58	71	)	)	PUNCT
iajs-2976	58	72	were	be	AUX
iajs-2976	58	73	purchased	purchase	VERB
iajs-2976	58	74	from	from	ADP
iajs-2976	58	75	sunred	sunre	VERB
iajs-2976	58	76	biotechnology	biotechnology	NOUN
iajs-2976	58	77	company	company	NOUN
iajs-2976	58	78	,	,	PUNCT
iajs-2976	58	79	shanghai	shanghai	PROPN
iajs-2976	58	80	,	,	PUNCT
iajs-2976	58	81	china	china	PROPN
iajs-2976	58	82	.	.	PUNCT
iajs-2976	59	1	the	the	DET
iajs-2976	59	2	myoglobin	myoglobin	NOUN
iajs-2976	59	3	(	(	PUNCT
iajs-2976	59	4	mb	mb	NOUN
iajs-2976	59	5	)	)	PUNCT
iajs-2976	59	6	kit	kit	NOUN
iajs-2976	59	7	was	be	AUX
iajs-2976	59	8	obtained	obtain	VERB
iajs-2976	59	9	from	from	ADP
iajs-2976	59	10	hotgen	hotgen	PROPN
iajs-2976	59	11	biotech	biotech	NOUN
iajs-2976	59	12	.	.	PUNCT
iajs-2976	60	1	blood	blood	NOUN
iajs-2976	60	2	component	component	NOUN
iajs-2976	60	3	parameters	parameter	NOUN
iajs-2976	60	4	were	be	AUX
iajs-2976	60	5	measured	measure	VERB
iajs-2976	60	6	using	use	VERB
iajs-2976	60	7	the	the	DET
iajs-2976	60	8	swelab	swelab	ADJ
iajs-2976	60	9	alfa	alfa	NOUN
iajs-2976	60	10	standard	standard	NOUN
iajs-2976	60	11	(	(	PUNCT
iajs-2976	60	12	boule	boule	PROPN
iajs-2976	60	13	medical	medical	PROPN
iajs-2976	60	14	ab	ab	PROPN
iajs-2976	60	15	,	,	PUNCT
iajs-2976	60	16	sweden	sweden	PROPN
iajs-2976	60	17	)	)	PUNCT
iajs-2976	60	18	.	.	PUNCT
iajs-2976	61	1	experimental	experimental	ADJ
iajs-2976	61	2	animals	animal	NOUN
iajs-2976	61	3	a	a	DET
iajs-2976	61	4	total	total	NOUN
iajs-2976	61	5	of	of	ADP
iajs-2976	61	6	24	24	NUM
iajs-2976	61	7	mature	mature	ADJ
iajs-2976	61	8	sprague	sprague	NOUN
iajs-2976	61	9	-	-	PUNCT
iajs-2976	61	10	dawley	dawley	NOUN
iajs-2976	61	11	albino	albino	NOUN
iajs-2976	61	12	rats	rat	NOUN
iajs-2976	61	13	weighing	weigh	VERB
iajs-2976	61	14	250	250	NUM
iajs-2976	61	15	-	-	SYM
iajs-2976	61	16	350	350	NUM
iajs-2976	61	17	g	g	NOUN
iajs-2976	61	18	were	be	AUX
iajs-2976	61	19	purchased	purchase	VERB
iajs-2976	61	20	from	from	ADP
iajs-2976	61	21	the	the	DET
iajs-2976	61	22	animal	animal	NOUN
iajs-2976	61	23	house	house	NOUN
iajs-2976	61	24	of	of	ADP
iajs-2976	61	25	the	the	DET
iajs-2976	61	26	university	university	PROPN
iajs-2976	61	27	of	of	ADP
iajs-2976	61	28	soran	soran	NOUN
iajs-2976	61	29	,	,	PUNCT
iajs-2976	61	30	and	and	CCONJ
iajs-2976	61	31	allowed	allow	VERB
iajs-2976	61	32	to	to	PART
iajs-2976	61	33	adapt	adapt	VERB
iajs-2976	61	34	to	to	ADP
iajs-2976	61	35	the	the	DET
iajs-2976	61	36	new	new	ADJ
iajs-2976	61	37	location	location	NOUN
iajs-2976	61	38	for	for	ADP
iajs-2976	61	39	one	one	NUM
iajs-2976	61	40	week	week	NOUN
iajs-2976	61	41	.	.	PUNCT
iajs-2976	62	1	under	under	ADP
iajs-2976	62	2	standard	standard	ADJ
iajs-2976	62	3	laboratory	laboratory	NOUN
iajs-2976	62	4	settings	setting	NOUN
iajs-2976	62	5	,	,	PUNCT
iajs-2976	62	6	the	the	DET
iajs-2976	62	7	animals	animal	NOUN
iajs-2976	62	8	were	be	AUX
iajs-2976	62	9	kept	keep	VERB
iajs-2976	62	10	at	at	ADP
iajs-2976	62	11	a	a	DET
iajs-2976	62	12	temperature	temperature	NOUN
iajs-2976	62	13	range	range	NOUN
iajs-2976	62	14	of	of	ADP
iajs-2976	62	15	22	22	NUM
iajs-2976	62	16	to	to	PART
iajs-2976	62	17	26	26	NUM
iajs-2976	62	18	°	°	NOUN
iajs-2976	62	19	c	c	NOUN
iajs-2976	62	20	with	with	ADP
iajs-2976	62	21	a	a	DET
iajs-2976	62	22	12	12	NUM
iajs-2976	62	23	-	-	PUNCT
iajs-2976	62	24	hs	hs	PROPN
iajs-2976	62	25	.	.	PROPN
iajs-2976	62	26	light:12	light:12	X
iajs-2976	62	27	-	-	PUNCT
iajs-2976	62	28	hs	hs	INTJ
iajs-2976	62	29	.	.	PROPN
iajs-2976	62	30	dark	dark	ADJ
iajs-2976	62	31	cycle	cycle	NOUN
iajs-2976	62	32	.	.	PUNCT
iajs-2976	63	1	before	before	SCONJ
iajs-2976	63	2	and	and	CCONJ
iajs-2976	63	3	during	during	ADP
iajs-2976	63	4	the	the	DET
iajs-2976	63	5	experiments	experiment	NOUN
iajs-2976	63	6	,	,	PUNCT
iajs-2976	63	7	rats	rat	NOUN
iajs-2976	63	8	were	be	AUX
iajs-2976	63	9	fed	feed	VERB
iajs-2976	63	10	with	with	ADP
iajs-2976	63	11	rat	rat	NOUN
iajs-2976	63	12	chow	chow	PROPN
iajs-2976	63	13	(	(	PUNCT
iajs-2976	63	14	according	accord	VERB
iajs-2976	63	15	to	to	ADP
iajs-2976	63	16	the	the	DET
iajs-2976	63	17	national	national	ADJ
iajs-2976	63	18	center	center	NOUN
iajs-2976	63	19	for	for	ADP
iajs-2976	63	20	drug	drug	NOUN
iajs-2976	63	21	research	research	NOUN
iajs-2976	63	22	and	and	CCONJ
iajs-2976	63	23	quality	quality	NOUN
iajs-2976	63	24	control	control	NOUN
iajs-2976	63	25	,	,	PUNCT
iajs-2976	63	26	baghdad	baghdad	PROPN
iajs-2976	63	27	)	)	PUNCT
iajs-2976	63	28	and	and	CCONJ
iajs-2976	63	29	tap	tap	NOUN
iajs-2976	63	30	water	water	NOUN
iajs-2976	63	31	.	.	PUNCT
iajs-2976	64	1	the	the	DET
iajs-2976	64	2	rats	rat	NOUN
iajs-2976	64	3	were	be	AUX
iajs-2976	64	4	randomly	randomly	ADV
iajs-2976	64	5	assigned	assign	VERB
iajs-2976	64	6	into	into	ADP
iajs-2976	64	7	three	three	NUM
iajs-2976	64	8	groups	group	NOUN
iajs-2976	64	9	of	of	ADP
iajs-2976	64	10	8	8	NUM
iajs-2976	64	11	animals	animal	NOUN
iajs-2976	64	12	per	per	ADP
iajs-2976	64	13	group	group	NOUN
iajs-2976	64	14	;	;	PUNCT
iajs-2976	64	15	negative	negative	ADJ
iajs-2976	64	16	control	control	NOUN
iajs-2976	64	17	,	,	PUNCT
iajs-2976	64	18	diabetic	diabetic	ADJ
iajs-2976	64	19	control	control	NOUN
iajs-2976	64	20	,	,	PUNCT
iajs-2976	64	21	and	and	CCONJ
iajs-2976	64	22	diabetic	diabetic	ADJ
iajs-2976	64	23	rats	rat	NOUN
iajs-2976	64	24	treated	treat	VERB
iajs-2976	64	25	with	with	ADP
iajs-2976	64	26	ubiquinone	ubiquinone	PROPN
iajs-2976	64	27	.	.	PUNCT
iajs-2976	65	1	all	all	DET
iajs-2976	65	2	study	study	NOUN
iajs-2976	65	3	protocols	protocol	NOUN
iajs-2976	65	4	,	,	PUNCT
iajs-2976	65	5	including	include	VERB
iajs-2976	65	6	diabetes	diabetes	NOUN
iajs-2976	65	7	induction	induction	NOUN
iajs-2976	65	8	and	and	CCONJ
iajs-2976	65	9	sacrifice	sacrifice	NOUN
iajs-2976	65	10	operations	operation	NOUN
iajs-2976	65	11	,	,	PUNCT
iajs-2976	65	12	were	be	AUX
iajs-2976	65	13	approved	approve	VERB
iajs-2976	65	14	by	by	ADP
iajs-2976	65	15	the	the	DET
iajs-2976	65	16	institutional	institutional	ADJ
iajs-2976	65	17	ethics	ethic	NOUN
iajs-2976	65	18	committee	committee	PROPN
iajs-2976	65	19	at	at	ADP
iajs-2976	65	20	hawler	hawler	PROPN
iajs-2976	65	21	medical	medical	PROPN
iajs-2976	65	22	university	university	PROPN
iajs-2976	65	23	.	.	PUNCT
iajs-2976	66	1	experimental	experimental	ADJ
iajs-2976	66	2	design	design	NOUN
iajs-2976	66	3	after	after	ADP
iajs-2976	66	4	acclimatizing	acclimatize	VERB
iajs-2976	66	5	for	for	ADP
iajs-2976	66	6	7	7	NUM
iajs-2976	66	7	days	day	NOUN
iajs-2976	66	8	,	,	PUNCT
iajs-2976	66	9	the	the	DET
iajs-2976	66	10	rodents	rodent	NOUN
iajs-2976	66	11	were	be	AUX
iajs-2976	66	12	randomly	randomly	ADV
iajs-2976	66	13	allocated	allocate	VERB
iajs-2976	66	14	into	into	ADP
iajs-2976	66	15	three	three	NUM
iajs-2976	66	16	groups	group	NOUN
iajs-2976	66	17	:	:	PUNCT
iajs-2976	66	18	group	group	NOUN
iajs-2976	66	19	n	n	CCONJ
iajs-2976	66	20	:	:	PUNCT
iajs-2976	66	21	negative	negative	ADJ
iajs-2976	66	22	control	control	PROPN
iajs-2976	66	23	group	group	NOUN
iajs-2976	66	24	(	(	PUNCT
iajs-2976	66	25	n	n	NOUN
iajs-2976	66	26	=	=	SYM
iajs-2976	66	27	7	7	NUM
iajs-2976	66	28	)	)	PUNCT
iajs-2976	66	29	group	group	NOUN
iajs-2976	67	1	d	d	NOUN
iajs-2976	67	2	:	:	PUNCT
iajs-2976	67	3	diabetic	diabetic	ADJ
iajs-2976	67	4	control	control	NOUN
iajs-2976	67	5	group	group	NOUN
iajs-2976	67	6	(	(	PUNCT
iajs-2976	67	7	n	n	NOUN
iajs-2976	67	8	=	=	SYM
iajs-2976	67	9	7	7	NUM
iajs-2976	67	10	)	)	PUNCT
iajs-2976	67	11	group	group	NOUN
iajs-2976	67	12	t	t	PROPN
iajs-2976	67	13	:	:	PUNCT
iajs-2976	67	14	ubiquinone	ubiquinone	PROPN
iajs-2976	67	15	treatment	treatment	NOUN
iajs-2976	67	16	group	group	NOUN
iajs-2976	67	17	(	(	PUNCT
iajs-2976	67	18	treat	treat	VERB
iajs-2976	67	19	with	with	ADP
iajs-2976	67	20	ubiquinone	ubiquinone	PROPN
iajs-2976	67	21	,	,	PUNCT
iajs-2976	67	22	5	5	NUM
iajs-2976	67	23	gm	gm	NOUN
iajs-2976	67	24	per	per	ADP
iajs-2976	67	25	kg	kg	NOUN
iajs-2976	67	26	of	of	ADP
iajs-2976	67	27	food	food	NOUN
iajs-2976	67	28	)	)	PUNCT
iajs-2976	67	29	(	(	PUNCT
iajs-2976	67	30	n	n	NOUN
iajs-2976	67	31	=	=	SYM
iajs-2976	67	32	7	7	NUM
iajs-2976	67	33	)	)	PUNCT
iajs-2976	67	34	in	in	ADP
iajs-2976	67	35	the	the	DET
iajs-2976	67	36	second	second	ADJ
iajs-2976	67	37	and	and	CCONJ
iajs-2976	67	38	third	third	ADJ
iajs-2976	67	39	groups	group	NOUN
iajs-2976	67	40	(	(	PUNCT
iajs-2976	67	41	16	16	NUM
iajs-2976	67	42	rats	rat	NOUN
iajs-2976	67	43	)	)	PUNCT
iajs-2976	67	44	,	,	PUNCT
iajs-2976	67	45	we	we	PRON
iajs-2976	67	46	induced	induce	VERB
iajs-2976	67	47	diabetes	diabete	NOUN
iajs-2976	67	48	.	.	PUNCT
iajs-2976	68	1	rats	rat	NOUN
iajs-2976	68	2	from	from	ADP
iajs-2976	68	3	the	the	DET
iajs-2976	68	4	negative	negative	ADJ
iajs-2976	68	5	control	control	PROPN
iajs-2976	68	6	group	group	NOUN
iajs-2976	68	7	(	(	PUNCT
iajs-2976	68	8	group	group	NOUN
iajs-2976	68	9	n	n	CCONJ
iajs-2976	68	10	)	)	PUNCT
iajs-2976	68	11	and	and	CCONJ
iajs-2976	68	12	the	the	DET
iajs-2976	68	13	diabetic	diabetic	PROPN
iajs-2976	68	14	control	control	PROPN
iajs-2976	68	15	group	group	NOUN
iajs-2976	68	16	(	(	PUNCT
iajs-2976	68	17	group	group	NOUN
iajs-2976	68	18	d	d	PROPN
iajs-2976	68	19	)	)	PUNCT
iajs-2976	68	20	received	receive	VERB
iajs-2976	68	21	the	the	DET
iajs-2976	68	22	rat	rat	NOUN
iajs-2976	68	23	’s	’s	PART
iajs-2976	68	24	standard	standard	ADJ
iajs-2976	68	25	diet	diet	NOUN
iajs-2976	68	26	without	without	ADP
iajs-2976	68	27	any	any	DET
iajs-2976	68	28	supplementation	supplementation	NOUN
iajs-2976	68	29	.	.	PUNCT
iajs-2976	69	1	the	the	DET
iajs-2976	69	2	third	third	ADJ
iajs-2976	69	3	group	group	NOUN
iajs-2976	69	4	(	(	PUNCT
iajs-2976	69	5	group	group	NOUN
iajs-2976	69	6	t	t	PROPN
iajs-2976	69	7	)	)	PUNCT
iajs-2976	69	8	was	be	AUX
iajs-2976	69	9	providedwith	providedwith	VERB
iajs-2976	69	10	the	the	DET
iajs-2976	69	11	ubiquinone	ubiquinone	PROPN
iajs-2976	69	12	-	-	PUNCT
iajs-2976	69	13	enriched	enrich	VERB
iajs-2976	69	14	diet	diet	NOUN
iajs-2976	69	15	,	,	PUNCT
iajs-2976	69	16	which	which	PRON
iajs-2976	69	17	was	be	AUX
iajs-2976	69	18	the	the	DET
iajs-2976	69	19	basic	basic	ADJ
iajs-2976	69	20	diet	diet	NOUN
iajs-2976	69	21	enriched	enrich	VERB
iajs-2976	69	22	with	with	ADP
iajs-2976	69	23	5	5	NUM
iajs-2976	69	24	g	g	NOUN
iajs-2976	69	25	of	of	ADP
iajs-2976	69	26	ubiquinone	ubiquinone	PROPN
iajs-2976	69	27	per	per	ADP
iajs-2976	69	28	kilogram	kilogram	PROPN
iajs-2976	69	29	of	of	ADP
iajs-2976	69	30	food	food	NOUN
iajs-2976	69	31	[	[	X
iajs-2976	69	32	33	33	NUM
iajs-2976	69	33	-	-	SYM
iajs-2976	69	34	37	37	NUM
iajs-2976	69	35	]	]	PUNCT
iajs-2976	69	36	.	.	PUNCT
iajs-2976	70	1	all	all	DET
iajs-2976	70	2	groups	group	NOUN
iajs-2976	70	3	had	have	VERB
iajs-2976	70	4	unrestricted	unrestricted	ADJ
iajs-2976	70	5	access	access	NOUN
iajs-2976	70	6	to	to	ADP
iajs-2976	70	7	their	their	PRON
iajs-2976	70	8	respective	respective	ADJ
iajs-2976	70	9	diets	diet	NOUN
iajs-2976	70	10	for	for	ADP
iajs-2976	70	11	a	a	DET
iajs-2976	70	12	period	period	NOUN
iajs-2976	70	13	of	of	ADP
iajs-2976	70	14	three	three	NUM
iajs-2976	70	15	weeks	week	NOUN
iajs-2976	70	16	.	.	PUNCT
iajs-2976	71	1	ihjpas	ihjpas	PROPN
iajs-2976	71	2	.	.	PUNCT
iajs-2976	72	1	36(2)2023	36(2)2023	NUM
iajs-2976	72	2	88	88	NUM
iajs-2976	72	3	diabetes	diabetes	NOUN
iajs-2976	72	4	induction	induction	NOUN
iajs-2976	72	5	the	the	DET
iajs-2976	72	6	administered	administer	VERB
iajs-2976	72	7	dose	dose	NOUN
iajs-2976	72	8	of	of	ADP
iajs-2976	72	9	stz	stz	NOUN
iajs-2976	72	10	,	,	PUNCT
iajs-2976	72	11	a	a	DET
iajs-2976	72	12	diabetogenic	diabetogenic	ADJ
iajs-2976	72	13	drug	drug	NOUN
iajs-2976	72	14	that	that	PRON
iajs-2976	72	15	damages	damage	VERB
iajs-2976	72	16	pancreatic	pancreatic	ADJ
iajs-2976	72	17	β	β	NOUN
iajs-2976	72	18	-	-	NOUN
iajs-2976	72	19	cells	cell	NOUN
iajs-2976	72	20	,	,	PUNCT
iajs-2976	72	21	specifies	specify	VERB
iajs-2976	72	22	the	the	DET
iajs-2976	72	23	establishment	establishment	NOUN
iajs-2976	72	24	of	of	ADP
iajs-2976	72	25	a	a	DET
iajs-2976	72	26	diabetic	diabetic	ADJ
iajs-2976	72	27	state	state	NOUN
iajs-2976	72	28	in	in	ADP
iajs-2976	72	29	rats	rat	NOUN
iajs-2976	72	30	[	[	X
iajs-2976	72	31	38	38	NUM
iajs-2976	72	32	,	,	PUNCT
iajs-2976	72	33	39	39	NUM
iajs-2976	72	34	]	]	PUNCT
iajs-2976	72	35	.	.	PUNCT
iajs-2976	73	1	the	the	DET
iajs-2976	73	2	most	most	ADV
iajs-2976	73	3	typical	typical	ADJ
iajs-2976	73	4	method	method	NOUN
iajs-2976	73	5	is	be	AUX
iajs-2976	73	6	to	to	PART
iajs-2976	73	7	administer	administer	VERB
iajs-2976	73	8	a	a	DET
iajs-2976	73	9	single	single	ADJ
iajs-2976	73	10	dose	dose	NOUN
iajs-2976	73	11	of	of	ADP
iajs-2976	73	12	stz	stz	NOUN
iajs-2976	73	13	(	(	PUNCT
iajs-2976	73	14	40–70	40–70	NUM
iajs-2976	73	15	mg	mg	PROPN
iajs-2976	73	16	/	/	SYM
iajs-2976	73	17	kg	kg	NOUN
iajs-2976	73	18	)	)	PUNCT
iajs-2976	73	19	intraperitoneally	intraperitoneally	ADV
iajs-2976	73	20	to	to	ADP
iajs-2976	73	21	rats	rat	NOUN
iajs-2976	73	22	between	between	ADP
iajs-2976	73	23	8	8	NUM
iajs-2976	73	24	and	and	CCONJ
iajs-2976	73	25	10	10	NUM
iajs-2976	73	26	weeks	week	NOUN
iajs-2976	73	27	of	of	ADP
iajs-2976	73	28	age	age	NOUN
iajs-2976	73	29	[	[	X
iajs-2976	73	30	40	40	NUM
iajs-2976	73	31	]	]	PUNCT
iajs-2976	73	32	.	.	PUNCT
iajs-2976	74	1	diabetes	diabetes	NOUN
iajs-2976	74	2	induction	induction	NOUN
iajs-2976	74	3	procedure	procedure	NOUN
iajs-2976	74	4	was	be	AUX
iajs-2976	74	5	followed	follow	VERB
iajs-2976	74	6	to	to	ADP
iajs-2976	74	7	the	the	DET
iajs-2976	74	8	protocol	protocol	NOUN
iajs-2976	74	9	written	write	VERB
iajs-2976	74	10	by	by	ADP
iajs-2976	74	11	brian	brian	PROPN
iajs-2976	74	12	l.	l.	PROPN
iajs-2976	74	13	furman	furman	PROPN
iajs-2976	75	1	[	[	X
iajs-2976	75	2	41	41	NUM
iajs-2976	75	3	]	]	PUNCT
iajs-2976	75	4	.	.	PUNCT
iajs-2976	76	1	induction	induction	NOUN
iajs-2976	76	2	of	of	ADP
iajs-2976	76	3	experimental	experimental	ADJ
iajs-2976	76	4	diabetes	diabetes	NOUN
iajs-2976	76	5	was	be	AUX
iajs-2976	76	6	performed	perform	VERB
iajs-2976	76	7	following	follow	VERB
iajs-2976	76	8	an	an	DET
iajs-2976	76	9	overnight	overnight	ADJ
iajs-2976	76	10	fast	fast	NOUN
iajs-2976	76	11	(	(	PUNCT
iajs-2976	76	12	8	8	NUM
iajs-2976	76	13	hrs	hrs	NOUN
iajs-2976	76	14	.	.	PUNCT
iajs-2976	76	15	)	)	PUNCT
iajs-2976	77	1	with	with	ADP
iajs-2976	77	2	a	a	DET
iajs-2976	77	3	single	single	ADJ
iajs-2976	77	4	intraperitoneal	intraperitoneal	ADJ
iajs-2976	77	5	injection	injection	NOUN
iajs-2976	77	6	of	of	ADP
iajs-2976	77	7	stz	stz	NOUN
iajs-2976	77	8	which	which	PRON
iajs-2976	77	9	was	be	AUX
iajs-2976	77	10	dissolved	dissolve	VERB
iajs-2976	77	11	in	in	ADP
iajs-2976	77	12	citrate	citrate	NOUN
iajs-2976	77	13	buffer	buffer	NOUN
iajs-2976	77	14	(	(	PUNCT
iajs-2976	77	15	ph	ph	NOUN
iajs-2976	77	16	4.4	4.4	NUM
iajs-2976	77	17	to	to	ADP
iajs-2976	77	18	4.5	4.5	NUM
iajs-2976	77	19	,	,	PUNCT
iajs-2976	77	20	0.1	0.1	NUM
iajs-2976	77	21	mol	mol	ADP
iajs-2976	77	22	/	/	SYM
iajs-2976	77	23	l	l	NOUN
iajs-2976	77	24	citric	citric	ADJ
iajs-2976	77	25	acid	acid	NOUN
iajs-2976	77	26	,	,	PUNCT
iajs-2976	77	27	0.1	0.1	NUM
iajs-2976	77	28	mol	mol	NOUN
iajs-2976	77	29	/	/	SYM
iajs-2976	77	30	l	l	NOUN
iajs-2976	77	31	trisodium	trisodium	ADJ
iajs-2976	77	32	citrate	citrate	NOUN
iajs-2976	77	33	)	)	PUNCT
iajs-2976	77	34	at	at	ADP
iajs-2976	77	35	dose	dose	NOUN
iajs-2976	77	36	45	45	NUM
iajs-2976	77	37	mg	mg	PROPN
iajs-2976	77	38	/	/	SYM
iajs-2976	77	39	kg	kg	PROPN
iajs-2976	77	40	of	of	ADP
iajs-2976	77	41	body	body	NOUN
iajs-2976	77	42	weight	weight	NOUN
iajs-2976	77	43	.	.	PUNCT
iajs-2976	78	1	seventy	seventy	NUM
iajs-2976	78	2	-	-	PUNCT
iajs-2976	78	3	two	two	NUM
iajs-2976	78	4	hours	hour	NOUN
iajs-2976	78	5	after	after	ADP
iajs-2976	78	6	stz	stz	ADJ
iajs-2976	78	7	injection	injection	NOUN
iajs-2976	78	8	,	,	PUNCT
iajs-2976	78	9	hyperglycemia	hyperglycemia	NOUN
iajs-2976	78	10	was	be	AUX
iajs-2976	78	11	validated	validate	VERB
iajs-2976	78	12	by	by	ADP
iajs-2976	78	13	applying	apply	VERB
iajs-2976	78	14	a	a	DET
iajs-2976	78	15	small	small	ADJ
iajs-2976	78	16	volume	volume	NOUN
iajs-2976	78	17	of	of	ADP
iajs-2976	78	18	peripheral	peripheral	ADJ
iajs-2976	78	19	blood	blood	NOUN
iajs-2976	78	20	from	from	ADP
iajs-2976	78	21	the	the	DET
iajs-2976	78	22	animals	animal	NOUN
iajs-2976	78	23	'	'	PART
iajs-2976	78	24	tails	tail	NOUN
iajs-2976	78	25	to	to	PART
iajs-2976	78	26	test	test	NOUN
iajs-2976	78	27	strips	strip	NOUN
iajs-2976	78	28	.	.	PUNCT
iajs-2976	79	1	bayer	bayer	PROPN
iajs-2976	79	2	contour	contour	NOUN
iajs-2976	79	3	®	®	NOUN
iajs-2976	79	4	ts	ts	ADP
iajs-2976	79	5	blood	blood	NOUN
iajs-2976	79	6	glucose	glucose	NOUN
iajs-2976	79	7	monitoring	monitoring	NOUN
iajs-2976	79	8	system	system	NOUN
iajs-2976	79	9	was	be	AUX
iajs-2976	79	10	used	use	VERB
iajs-2976	79	11	for	for	ADP
iajs-2976	79	12	the	the	DET
iajs-2976	79	13	measurement	measurement	NOUN
iajs-2976	79	14	of	of	ADP
iajs-2976	79	15	rat	rat	NOUN
iajs-2976	79	16	’s	’s	PART
iajs-2976	79	17	blood	blood	NOUN
iajs-2976	79	18	sugar	sugar	NOUN
iajs-2976	79	19	.	.	PUNCT
iajs-2976	80	1	rodents	rodent	NOUN
iajs-2976	80	2	with	with	ADP
iajs-2976	80	3	fasting	fast	VERB
iajs-2976	80	4	blood	blood	NOUN
iajs-2976	80	5	glucose	glucose	NOUN
iajs-2976	80	6	levels	level	NOUN
iajs-2976	80	7	of	of	ADP
iajs-2976	80	8	more	more	ADJ
iajs-2976	80	9	than	than	ADP
iajs-2976	80	10	250	250	NUM
iajs-2976	80	11	mg	mg	NUM
iajs-2976	80	12	/	/	SYM
iajs-2976	80	13	dl	dl	PROPN
iajs-2976	80	14	were	be	AUX
iajs-2976	80	15	considered	consider	VERB
iajs-2976	80	16	diabetics	diabetic	NOUN
iajs-2976	80	17	[	[	X
iajs-2976	80	18	42	42	NUM
iajs-2976	80	19	]	]	PUNCT
iajs-2976	80	20	,	,	PUNCT
iajs-2976	80	21	and	and	CCONJ
iajs-2976	80	22	were	be	AUX
iajs-2976	80	23	separated	separate	VERB
iajs-2976	80	24	into	into	ADP
iajs-2976	80	25	various	various	ADJ
iajs-2976	80	26	experimental	experimental	ADJ
iajs-2976	80	27	groups	group	NOUN
iajs-2976	80	28	(	(	PUNCT
iajs-2976	80	29	diabetic	diabetic	ADJ
iajs-2976	80	30	control	control	NOUN
iajs-2976	80	31	group	group	NOUN
iajs-2976	80	32	and	and	CCONJ
iajs-2976	80	33	ubiquinone	ubiquinone	PROPN
iajs-2976	80	34	-	-	PUNCT
iajs-2976	80	35	treated	treat	VERB
iajs-2976	80	36	diabeticgroup	diabeticgroup	NOUN
iajs-2976	80	37	)	)	PUNCT
iajs-2976	80	38	.	.	PUNCT
iajs-2976	81	1	another	another	DET
iajs-2976	81	2	group	group	NOUN
iajs-2976	81	3	of	of	ADP
iajs-2976	81	4	rats	rat	NOUN
iajs-2976	81	5	received	receive	VERB
iajs-2976	81	6	a	a	DET
iajs-2976	81	7	single	single	ADJ
iajs-2976	81	8	intraperitoneal	intraperitoneal	NOUN
iajs-2976	81	9	administration	administration	NOUN
iajs-2976	81	10	of	of	ADP
iajs-2976	81	11	the	the	DET
iajs-2976	81	12	citrate	citrate	NOUN
iajs-2976	81	13	buffer	buffer	NOUN
iajs-2976	81	14	and	and	CCONJ
iajs-2976	81	15	were	be	AUX
iajs-2976	81	16	deemed	deem	VERB
iajs-2976	81	17	non	non	ADJ
iajs-2976	81	18	-	-	ADJ
iajs-2976	81	19	diabetic	diabetic	ADJ
iajs-2976	81	20	.	.	PUNCT
iajs-2976	82	1	blood	blood	NOUN
iajs-2976	82	2	and	and	CCONJ
iajs-2976	82	3	serum	serum	NOUN
iajs-2976	82	4	collection	collection	NOUN
iajs-2976	82	5	on	on	ADP
iajs-2976	82	6	the	the	DET
iajs-2976	82	7	final	final	ADJ
iajs-2976	82	8	day	day	NOUN
iajs-2976	82	9	of	of	ADP
iajs-2976	82	10	the	the	DET
iajs-2976	82	11	three	three	NUM
iajs-2976	82	12	-	-	PUNCT
iajs-2976	82	13	week	week	NOUN
iajs-2976	82	14	treatment	treatment	NOUN
iajs-2976	82	15	period	period	NOUN
iajs-2976	82	16	,	,	PUNCT
iajs-2976	82	17	the	the	DET
iajs-2976	82	18	animals	animal	NOUN
iajs-2976	82	19	were	be	AUX
iajs-2976	82	20	fasted	fast	VERB
iajs-2976	82	21	overnight	overnight	ADV
iajs-2976	82	22	,	,	PUNCT
iajs-2976	82	23	sacrificed	sacrifice	VERB
iajs-2976	82	24	the	the	DET
iajs-2976	82	25	next	next	ADJ
iajs-2976	82	26	day	day	NOUN
iajs-2976	82	27	,	,	PUNCT
iajs-2976	82	28	and	and	CCONJ
iajs-2976	82	29	collected	collect	VERB
iajs-2976	82	30	blood	blood	NOUN
iajs-2976	82	31	samples	sample	NOUN
iajs-2976	82	32	.	.	PUNCT
iajs-2976	83	1	the	the	DET
iajs-2976	83	2	blood	blood	NOUN
iajs-2976	83	3	collection	collection	NOUN
iajs-2976	83	4	procedure	procedure	NOUN
iajs-2976	83	5	began	begin	VERB
iajs-2976	83	6	with	with	ADP
iajs-2976	83	7	anesthetizing	anesthetize	VERB
iajs-2976	83	8	rats	rat	NOUN
iajs-2976	83	9	using	use	VERB
iajs-2976	83	10	a	a	DET
iajs-2976	83	11	combination	combination	NOUN
iajs-2976	83	12	of	of	ADP
iajs-2976	83	13	ketamine	ketamine	PROPN
iajs-2976	83	14	(	(	PUNCT
iajs-2976	83	15	45	45	NUM
iajs-2976	83	16	mg	mg	PROPN
iajs-2976	83	17	/	/	SYM
iajs-2976	83	18	kg	kg	NOUN
iajs-2976	83	19	)	)	PUNCT
iajs-2976	83	20	and	and	CCONJ
iajs-2976	83	21	xylazine	xylazine	NOUN
iajs-2976	83	22	(	(	PUNCT
iajs-2976	83	23	5	5	NUM
iajs-2976	83	24	mg	mg	PROPN
iajs-2976	83	25	/	/	SYM
iajs-2976	83	26	kg	kg	PROPN
iajs-2976	83	27	)	)	PUNCT
iajs-2976	83	28	,	,	PUNCT
iajs-2976	83	29	followed	follow	VERB
iajs-2976	83	30	by	by	ADP
iajs-2976	83	31	a	a	DET
iajs-2976	83	32	heart	heart	NOUN
iajs-2976	83	33	puncture	puncture	NOUN
iajs-2976	83	34	with	with	ADP
iajs-2976	83	35	a	a	DET
iajs-2976	83	36	sterile	sterile	ADJ
iajs-2976	83	37	,	,	PUNCT
iajs-2976	83	38	disposable	disposable	ADJ
iajs-2976	83	39	syringe	syringe	NOUN
iajs-2976	83	40	.	.	PUNCT
iajs-2976	84	1	a	a	DET
iajs-2976	84	2	portion	portion	NOUN
iajs-2976	84	3	of	of	ADP
iajs-2976	84	4	blood	blood	NOUN
iajs-2976	84	5	was	be	AUX
iajs-2976	84	6	obtained	obtain	VERB
iajs-2976	84	7	into	into	ADP
iajs-2976	84	8	edtacontaining	edtacontaine	VERB
iajs-2976	84	9	tubes	tube	NOUN
iajs-2976	84	10	and	and	CCONJ
iajs-2976	84	11	was	be	AUX
iajs-2976	84	12	immediately	immediately	ADV
iajs-2976	84	13	analyzed	analyze	VERB
iajs-2976	84	14	for	for	ADP
iajs-2976	84	15	blood	blood	NOUN
iajs-2976	84	16	component	component	NOUN
iajs-2976	84	17	parameters	parameter	NOUN
iajs-2976	84	18	and	and	CCONJ
iajs-2976	84	19	blood	blood	NOUN
iajs-2976	84	20	glucose	glucose	NOUN
iajs-2976	84	21	levels	level	NOUN
iajs-2976	84	22	.	.	PUNCT
iajs-2976	85	1	another	another	DET
iajs-2976	85	2	portion	portion	NOUN
iajs-2976	85	3	of	of	ADP
iajs-2976	85	4	the	the	DET
iajs-2976	85	5	blood	blood	NOUN
iajs-2976	85	6	was	be	AUX
iajs-2976	85	7	poured	pour	VERB
iajs-2976	85	8	into	into	ADP
iajs-2976	85	9	numbered	number	VERB
iajs-2976	85	10	gel	gel	NOUN
iajs-2976	85	11	tubes	tube	NOUN
iajs-2976	85	12	at	at	ADP
iajs-2976	85	13	room	room	NOUN
iajs-2976	85	14	temperature	temperature	NOUN
iajs-2976	85	15	and	and	CCONJ
iajs-2976	85	16	allowed	allow	VERB
iajs-2976	85	17	to	to	PART
iajs-2976	85	18	coagulate	coagulate	VERB
iajs-2976	85	19	for	for	ADP
iajs-2976	85	20	10	10	NUM
iajs-2976	85	21	to	to	PART
iajs-2976	85	22	20	20	NUM
iajs-2976	85	23	minutes	minute	NOUN
iajs-2976	85	24	.	.	PUNCT
iajs-2976	86	1	then	then	ADV
iajs-2976	86	2	,	,	PUNCT
iajs-2976	86	3	the	the	DET
iajs-2976	86	4	blood	blood	NOUN
iajs-2976	86	5	sample	sample	NOUN
iajs-2976	86	6	was	be	AUX
iajs-2976	86	7	centrifuged	centrifuge	VERB
iajs-2976	86	8	between	between	ADP
iajs-2976	86	9	2000	2000	NUM
iajs-2976	86	10	and	and	CCONJ
iajs-2976	86	11	3000	3000	NUM
iajs-2976	86	12	rpm	rpm	NOUN
iajs-2976	86	13	for	for	ADP
iajs-2976	86	14	20	20	NUM
iajs-2976	86	15	minutes	minute	NOUN
iajs-2976	86	16	to	to	PART
iajs-2976	86	17	separate	separate	VERB
iajs-2976	86	18	the	the	DET
iajs-2976	86	19	serum	serum	NOUN
iajs-2976	86	20	for	for	ADP
iajs-2976	86	21	biochemical	biochemical	ADJ
iajs-2976	86	22	analysis	analysis	NOUN
iajs-2976	86	23	.	.	PUNCT
iajs-2976	87	1	measurement	measurement	NOUN
iajs-2976	87	2	of	of	ADP
iajs-2976	87	3	serum	serum	NOUN
iajs-2976	87	4	biomarkers	biomarker	NOUN
iajs-2976	87	5	evaluation	evaluation	NOUN
iajs-2976	87	6	of	of	ADP
iajs-2976	87	7	mda	mda	PROPN
iajs-2976	87	8	,	,	PUNCT
iajs-2976	87	9	il-6	il-6	NOUN
iajs-2976	87	10	and	and	CCONJ
iajs-2976	87	11	no	no	DET
iajs-2976	87	12	oxidative	oxidative	ADJ
iajs-2976	87	13	stress	stress	NOUN
iajs-2976	87	14	(	(	PUNCT
iajs-2976	87	15	malondialdehyde	malondialdehyde	NOUN
iajs-2976	87	16	(	(	PUNCT
iajs-2976	87	17	mda	mda	PROPN
iajs-2976	87	18	)	)	PUNCT
iajs-2976	87	19	)	)	PUNCT
iajs-2976	87	20	,	,	PUNCT
iajs-2976	87	21	inflammation	inflammation	NOUN
iajs-2976	87	22	(	(	PUNCT
iajs-2976	87	23	il-6	il-6	NUM
iajs-2976	87	24	)	)	PUNCT
iajs-2976	87	25	,	,	PUNCT
iajs-2976	87	26	and	and	CCONJ
iajs-2976	87	27	vascular	vascular	ADJ
iajs-2976	87	28	homeostasis	homeostasis	NOUN
iajs-2976	87	29	(	(	PUNCT
iajs-2976	87	30	nitric	nitric	ADJ
iajs-2976	87	31	oxide	oxide	NOUN
iajs-2976	87	32	(	(	PUNCT
iajs-2976	87	33	no	no	NOUN
iajs-2976	87	34	)	)	PUNCT
iajs-2976	87	35	)	)	PUNCT
iajs-2976	87	36	markers	marker	NOUN
iajs-2976	87	37	were	be	AUX
iajs-2976	87	38	evaluated	evaluate	VERB
iajs-2976	87	39	using	use	VERB
iajs-2976	87	40	rat	rat	NOUN
iajs-2976	87	41	elisa	elisa	PROPN
iajs-2976	87	42	kits	kit	NOUN
iajs-2976	87	43	through	through	ADP
iajs-2976	87	44	microplate	microplate	NOUN
iajs-2976	87	45	reader	reader	NOUN
iajs-2976	87	46	according	accord	VERB
iajs-2976	87	47	to	to	ADP
iajs-2976	87	48	the	the	DET
iajs-2976	87	49	absorbance	absorbance	NOUN
iajs-2976	87	50	principle	principle	NOUN
iajs-2976	87	51	.	.	PUNCT
iajs-2976	88	1	mda	mda	PROPN
iajs-2976	88	2	,	,	PUNCT
iajs-2976	88	3	il-6	il-6	NOUN
iajs-2976	88	4	and	and	CCONJ
iajs-2976	88	5	no	no	DET
iajs-2976	88	6	rat	rat	NOUN
iajs-2976	88	7	kits	kit	NOUN
iajs-2976	88	8	were	be	AUX
iajs-2976	88	9	purchased	purchase	VERB
iajs-2976	88	10	to	to	PART
iajs-2976	88	11	assess	assess	VERB
iajs-2976	88	12	mda	mda	PROPN
iajs-2976	88	13	,	,	PUNCT
iajs-2976	88	14	il-6	il-6	NOUN
iajs-2976	88	15	and	and	CCONJ
iajs-2976	88	16	no	no	PRON
iajs-2976	88	17	according	accord	VERB
iajs-2976	88	18	to	to	ADP
iajs-2976	88	19	the	the	DET
iajs-2976	88	20	supplier	supplier	NOUN
iajs-2976	88	21	's	's	PART
iajs-2976	88	22	instructions	instruction	NOUN
iajs-2976	88	23	and	and	CCONJ
iajs-2976	88	24	the	the	DET
iajs-2976	88	25	protocol	protocol	NOUN
iajs-2976	88	26	of	of	ADP
iajs-2976	88	27	the	the	DET
iajs-2976	88	28	respective	respective	ADJ
iajs-2976	88	29	kits	kit	NOUN
iajs-2976	88	30	.	.	PUNCT
iajs-2976	89	1	our	our	PRON
iajs-2976	89	2	elisa	elisa	PROPN
iajs-2976	89	3	kits	kit	NOUN
iajs-2976	89	4	for	for	ADP
iajs-2976	89	5	assessment	assessment	NOUN
iajs-2976	89	6	of	of	ADP
iajs-2976	89	7	mda	mda	PROPN
iajs-2976	89	8	,	,	PUNCT
iajs-2976	89	9	il-6	il-6	NOUN
iajs-2976	89	10	and	and	CCONJ
iajs-2976	89	11	no	no	PRON
iajs-2976	89	12	were	be	AUX
iajs-2976	89	13	designed	design	VERB
iajs-2976	89	14	to	to	PART
iajs-2976	89	15	apply	apply	VERB
iajs-2976	89	16	the	the	DET
iajs-2976	89	17	double	double	ADJ
iajs-2976	89	18	-	-	PUNCT
iajs-2976	89	19	antibody	antibody	NOUN
iajs-2976	89	20	sandwich	sandwich	NOUN
iajs-2976	89	21	elisa	elisa	NOUN
iajs-2976	89	22	technique	technique	NOUN
iajs-2976	89	23	.	.	PUNCT
iajs-2976	90	1	measurement	measurement	NOUN
iajs-2976	90	2	of	of	ADP
iajs-2976	90	3	the	the	DET
iajs-2976	90	4	optical	optical	ADJ
iajs-2976	90	5	density	density	NOUN
iajs-2976	90	6	(	(	PUNCT
iajs-2976	90	7	od	od	NOUN
iajs-2976	90	8	)	)	PUNCT
iajs-2976	90	9	is	be	AUX
iajs-2976	90	10	spectrophotometrically	spectrophotometrically	ADV
iajs-2976	90	11	accomplished	accomplish	VERB
iajs-2976	90	12	at	at	ADP
iajs-2976	90	13	the	the	DET
iajs-2976	90	14	wavelength	wavelength	NOUN
iajs-2976	90	15	of	of	ADP
iajs-2976	90	16	450	450	NUM
iajs-2976	90	17	nm	nm	NOUN
iajs-2976	90	18	.	.	PUNCT
iajs-2976	91	1	calculate	calculate	VERB
iajs-2976	91	2	the	the	DET
iajs-2976	91	3	standard	standard	ADJ
iajs-2976	91	4	curve	curve	NOUN
iajs-2976	91	5	linear	linear	PROPN
iajs-2976	91	6	regression	regression	NOUN
iajs-2976	91	7	equation	equation	NOUN
iajs-2976	91	8	based	base	VERB
iajs-2976	91	9	on	on	ADP
iajs-2976	91	10	the	the	DET
iajs-2976	91	11	concentration	concentration	NOUN
iajs-2976	91	12	of	of	ADP
iajs-2976	91	13	the	the	DET
iajs-2976	91	14	standards	standard	NOUN
iajs-2976	91	15	and	and	CCONJ
iajs-2976	91	16	the	the	DET
iajs-2976	91	17	respective	respective	ADJ
iajs-2976	91	18	od	od	PROPN
iajs-2976	91	19	values	value	NOUN
iajs-2976	91	20	,	,	PUNCT
iajs-2976	91	21	and	and	CCONJ
iajs-2976	91	22	then	then	ADV
iajs-2976	91	23	enter	enter	VERB
iajs-2976	91	24	the	the	DET
iajs-2976	91	25	sample	sample	NOUN
iajs-2976	91	26	's	's	PART
iajs-2976	91	27	od	od	PROPN
iajs-2976	91	28	values	value	NOUN
iajs-2976	91	29	into	into	ADP
iajs-2976	91	30	the	the	DET
iajs-2976	91	31	regression	regression	NOUN
iajs-2976	91	32	equation	equation	NOUN
iajs-2976	91	33	to	to	PART
iajs-2976	91	34	determine	determine	VERB
iajs-2976	91	35	the	the	DET
iajs-2976	91	36	related	related	ADJ
iajs-2976	91	37	sample	sample	NOUN
iajs-2976	91	38	's	's	PART
iajs-2976	91	39	concentration	concentration	NOUN
iajs-2976	91	40	.	.	PUNCT
iajs-2976	92	1	evaluation	evaluation	NOUN
iajs-2976	92	2	of	of	ADP
iajs-2976	92	3	serum	serum	NOUN
iajs-2976	92	4	levels	level	NOUN
iajs-2976	92	5	of	of	ADP
iajs-2976	92	6	myoglobin	myoglobin	X
iajs-2976	92	7	up	up	ADP
iajs-2976	92	8	converting	convert	VERB
iajs-2976	92	9	phosphor	phosphor	NOUN
iajs-2976	92	10	immunoassay	immunoassay	NOUN
iajs-2976	92	11	analyzer	analyzer	NOUN
iajs-2976	92	12	was	be	AUX
iajs-2976	92	13	employed	employ	VERB
iajs-2976	92	14	for	for	ADP
iajs-2976	92	15	quantitative	quantitative	ADJ
iajs-2976	92	16	assessment	assessment	NOUN
iajs-2976	92	17	of	of	ADP
iajs-2976	92	18	serum	serum	NOUN
iajs-2976	92	19	concentration	concentration	NOUN
iajs-2976	92	20	of	of	ADP
iajs-2976	92	21	mb	mb	NOUN
iajs-2976	92	22	by	by	ADP
iajs-2976	92	23	using	use	VERB
iajs-2976	92	24	commercially	commercially	ADV
iajs-2976	92	25	available	available	ADJ
iajs-2976	92	26	kits	kit	NOUN
iajs-2976	92	27	(	(	PUNCT
iajs-2976	92	28	hotgen	hotgen	PROPN
iajs-2976	92	29	biotech	biotech	PROPN
iajs-2976	92	30	co.	co.	PROPN
iajs-2976	92	31	,	,	PUNCT
iajs-2976	92	32	ltd	ltd	PROPN
iajs-2976	92	33	)	)	PUNCT
iajs-2976	92	34	.	.	PUNCT
iajs-2976	93	1	either	either	CCONJ
iajs-2976	93	2	plasma	plasma	NOUN
iajs-2976	93	3	or	or	CCONJ
iajs-2976	93	4	serum	serum	NOUN
iajs-2976	93	5	biomarker	biomarker	NOUN
iajs-2976	93	6	levels	level	NOUN
iajs-2976	93	7	are	be	AUX
iajs-2976	93	8	evaluated	evaluate	VERB
iajs-2976	93	9	using	use	VERB
iajs-2976	93	10	a	a	DET
iajs-2976	93	11	technique	technique	NOUN
iajs-2976	93	12	that	that	PRON
iajs-2976	93	13	consists	consist	VERB
iajs-2976	93	14	of	of	ADP
iajs-2976	93	15	a	a	DET
iajs-2976	93	16	combination	combination	NOUN
iajs-2976	93	17	of	of	ADP
iajs-2976	93	18	up	up	ADV
iajs-2976	93	19	-	-	PUNCT
iajs-2976	93	20	converting	convert	VERB
iajs-2976	93	21	phosphor	phosphor	NOUN
iajs-2976	93	22	technology	technology	NOUN
iajs-2976	93	23	(	(	PUNCT
iajs-2976	93	24	upt	upt	PROPN
iajs-2976	93	25	)	)	PUNCT
iajs-2976	93	26	employing	employ	VERB
iajs-2976	93	27	immunochromatography	immunochromatography	NOUN
iajs-2976	93	28	.	.	PUNCT
iajs-2976	94	1	in	in	ADP
iajs-2976	94	2	comparison	comparison	NOUN
iajs-2976	94	3	to	to	ADP
iajs-2976	94	4	other	other	ADJ
iajs-2976	94	5	methods	method	NOUN
iajs-2976	94	6	,	,	PUNCT
iajs-2976	94	7	the	the	DET
iajs-2976	94	8	technical	technical	ADJ
iajs-2976	94	9	data	datum	NOUN
iajs-2976	94	10	of	of	ADP
iajs-2976	94	11	upt	upt	PROPN
iajs-2976	94	12	are	be	AUX
iajs-2976	94	13	uncomplicated	uncomplicated	ADJ
iajs-2976	94	14	to	to	PART
iajs-2976	94	15	comprehend	comprehend	VERB
iajs-2976	94	16	,	,	PUNCT
iajs-2976	94	17	there	there	PRON
iajs-2976	94	18	is	be	VERB
iajs-2976	94	19	no	no	DET
iajs-2976	94	20	background	background	NOUN
iajs-2976	94	21	interference	interference	NOUN
iajs-2976	94	22	with	with	ADP
iajs-2976	94	23	a	a	DET
iajs-2976	94	24	specified	specified	ADJ
iajs-2976	94	25	signal	signal	NOUN
iajs-2976	94	26	,	,	PUNCT
iajs-2976	94	27	and	and	CCONJ
iajs-2976	94	28	the	the	DET
iajs-2976	94	29	luminescence	luminescence	NOUN
iajs-2976	94	30	is	be	AUX
iajs-2976	94	31	persistent	persistent	ADJ
iajs-2976	94	32	without	without	ADP
iajs-2976	94	33	a	a	DET
iajs-2976	94	34	ihjpas	ihjpa	NOUN
iajs-2976	94	35	.	.	PUNCT
iajs-2976	95	1	36(2)2023	36(2)2023	NUM
iajs-2976	95	2	89	89	NUM
iajs-2976	95	3	quench	quench	NOUN
iajs-2976	95	4	.	.	PUNCT
iajs-2976	96	1	hotgen	hotgen	PROPN
iajs-2976	96	2	produced	produce	VERB
iajs-2976	96	3	a	a	DET
iajs-2976	96	4	poct	poct	NOUN
iajs-2976	96	5	platform	platform	NOUN
iajs-2976	96	6	relying	rely	VERB
iajs-2976	96	7	on	on	ADP
iajs-2976	96	8	upt	upt	PROPN
iajs-2976	96	9	(	(	PUNCT
iajs-2976	96	10	upt-3a	upt-3a	NOUN
iajs-2976	96	11	)	)	PUNCT
iajs-2976	96	12	series	series	NOUN
iajs-2976	96	13	immunoassay	immunoassay	PROPN
iajs-2976	96	14	analyzer	analyzer	NOUN
iajs-2976	96	15	and	and	CCONJ
iajs-2976	96	16	support	support	NOUN
iajs-2976	96	17	reagents	reagent	NOUN
iajs-2976	96	18	used	use	VERB
iajs-2976	96	19	in	in	ADP
iajs-2976	96	20	our	our	PRON
iajs-2976	96	21	study	study	NOUN
iajs-2976	96	22	[	[	X
iajs-2976	96	23	43	43	NUM
iajs-2976	96	24	,	,	PUNCT
iajs-2976	96	25	44	44	NUM
iajs-2976	96	26	]	]	PUNCT
iajs-2976	96	27	.	.	PUNCT
iajs-2976	97	1	evaluation	evaluation	NOUN
iajs-2976	97	2	of	of	ADP
iajs-2976	97	3	blood	blood	NOUN
iajs-2976	97	4	component	component	NOUN
iajs-2976	97	5	parameters	parameter	NOUN
iajs-2976	97	6	blood	blood	NOUN
iajs-2976	97	7	collected	collect	VERB
iajs-2976	97	8	via	via	ADP
iajs-2976	97	9	heart	heart	NOUN
iajs-2976	97	10	puncture	puncture	NOUN
iajs-2976	97	11	was	be	AUX
iajs-2976	97	12	blended	blend	VERB
iajs-2976	97	13	by	by	ADP
iajs-2976	97	14	a	a	DET
iajs-2976	97	15	blood	blood	NOUN
iajs-2976	97	16	rolling	roll	VERB
iajs-2976	97	17	mixer	mixer	NOUN
iajs-2976	97	18	machine	machine	NOUN
iajs-2976	97	19	and	and	CCONJ
iajs-2976	97	20	evaluated	evaluate	VERB
iajs-2976	97	21	hematological	hematological	ADJ
iajs-2976	97	22	values	value	NOUN
iajs-2976	97	23	such	such	ADJ
iajs-2976	97	24	as	as	ADP
iajs-2976	97	25	wbc	wbc	PROPN
iajs-2976	97	26	,	,	PUNCT
iajs-2976	97	27	platelets	platelet	NOUN
iajs-2976	97	28	(	(	PUNCT
iajs-2976	97	29	plt	plt	NOUN
iajs-2976	97	30	)	)	PUNCT
iajs-2976	97	31	,	,	PUNCT
iajs-2976	97	32	and	and	CCONJ
iajs-2976	97	33	rbc	rbc	PROPN
iajs-2976	97	34	,	,	PUNCT
iajs-2976	97	35	employing	employ	VERB
iajs-2976	97	36	the	the	DET
iajs-2976	97	37	automatic	automatic	ADJ
iajs-2976	97	38	hematology	hematology	NOUN
iajs-2976	97	39	analyzer	analyzer	NOUN
iajs-2976	97	40	swelab	swelab	NOUN
iajs-2976	97	41	alfa	alfa	PROPN
iajs-2976	97	42	standard	standard	NOUN
iajs-2976	97	43	(	(	PUNCT
iajs-2976	97	44	boule	boule	PROPN
iajs-2976	97	45	medical	medical	PROPN
iajs-2976	97	46	ab	ab	PROPN
iajs-2976	97	47	,	,	PUNCT
iajs-2976	97	48	sweden	sweden	PROPN
iajs-2976	97	49	)	)	PUNCT
iajs-2976	97	50	at	at	ADP
iajs-2976	97	51	ala	ala	PROPN
iajs-2976	97	52	private	private	ADJ
iajs-2976	97	53	laboratory	laboratory	NOUN
iajs-2976	97	54	in	in	ADP
iajs-2976	97	55	soran	soran	PROPN
iajs-2976	97	56	city	city	PROPN
iajs-2976	97	57	.	.	PUNCT
iajs-2976	98	1	3	3	X
iajs-2976	98	2	.	.	X
iajs-2976	98	3	statistical	statistical	ADJ
iajs-2976	98	4	analysis	analysis	NOUN
iajs-2976	98	5	graphpad	graphpad	NOUN
iajs-2976	98	6	prism	prism	NOUN
iajs-2976	98	7	9	9	NUM
iajs-2976	98	8	(	(	PUNCT
iajs-2976	98	9	san	san	PROPN
iajs-2976	98	10	ca	ca	PROPN
iajs-2976	98	11	,	,	PUNCT
iajs-2976	98	12	usa	usa	PROPN
iajs-2976	98	13	)	)	PUNCT
iajs-2976	98	14	was	be	AUX
iajs-2976	98	15	used	use	VERB
iajs-2976	98	16	to	to	PART
iajs-2976	98	17	conduct	conduct	VERB
iajs-2976	98	18	statistical	statistical	ADJ
iajs-2976	98	19	analysis	analysis	NOUN
iajs-2976	98	20	.	.	PUNCT
iajs-2976	99	1	before	before	ADP
iajs-2976	99	2	conducting	conduct	VERB
iajs-2976	99	3	the	the	DET
iajs-2976	99	4	analysis	analysis	NOUN
iajs-2976	99	5	,	,	PUNCT
iajs-2976	99	6	we	we	PRON
iajs-2976	99	7	conducted	conduct	VERB
iajs-2976	99	8	normality	normality	NOUN
iajs-2976	99	9	and	and	CCONJ
iajs-2976	99	10	lognormality	lognormality	NOUN
iajs-2976	99	11	tests	test	NOUN
iajs-2976	99	12	to	to	PART
iajs-2976	99	13	confirm	confirm	VERB
iajs-2976	99	14	that	that	SCONJ
iajs-2976	99	15	our	our	PRON
iajs-2976	99	16	data	datum	NOUN
iajs-2976	99	17	passed	pass	VERB
iajs-2976	99	18	normality	normality	NOUN
iajs-2976	99	19	tests	test	NOUN
iajs-2976	99	20	(	(	PUNCT
iajs-2976	99	21	alpha	alpha	NOUN
iajs-2976	99	22	=	=	NOUN
iajs-2976	99	23	0.05	0.05	NUM
iajs-2976	99	24	)	)	PUNCT
iajs-2976	99	25	,	,	PUNCT
iajs-2976	99	26	relying	rely	VERB
iajs-2976	99	27	on	on	ADP
iajs-2976	99	28	the	the	DET
iajs-2976	99	29	shapiro	shapiro	PROPN
iajs-2976	99	30	-	-	PUNCT
iajs-2976	99	31	wilk	wilk	NOUN
iajs-2976	99	32	tests	test	NOUN
iajs-2976	99	33	.	.	PUNCT
iajs-2976	100	1	in	in	ADP
iajs-2976	100	2	order	order	NOUN
iajs-2976	100	3	to	to	PART
iajs-2976	100	4	compare	compare	VERB
iajs-2976	100	5	the	the	DET
iajs-2976	100	6	means	mean	NOUN
iajs-2976	100	7	of	of	ADP
iajs-2976	100	8	each	each	DET
iajs-2976	100	9	parameter	parameter	NOUN
iajs-2976	100	10	for	for	ADP
iajs-2976	100	11	the	the	DET
iajs-2976	100	12	three	three	NUM
iajs-2976	100	13	groups	group	NOUN
iajs-2976	100	14	(	(	PUNCT
iajs-2976	100	15	negative	negative	ADJ
iajs-2976	100	16	control	control	NOUN
iajs-2976	100	17	=	=	SYM
iajs-2976	100	18	n	n	CCONJ
iajs-2976	100	19	,	,	PUNCT
iajs-2976	100	20	diabetic	diabetic	ADJ
iajs-2976	100	21	control	control	NOUN
iajs-2976	100	22	=	=	SYM
iajs-2976	100	23	d	d	NOUN
iajs-2976	100	24	,	,	PUNCT
iajs-2976	100	25	and	and	CCONJ
iajs-2976	100	26	ubiquinonetreated	ubiquinonetreated	ADJ
iajs-2976	100	27	group	group	NOUN
iajs-2976	100	28	=	=	PROPN
iajs-2976	100	29	t	t	PROPN
iajs-2976	100	30	)	)	PUNCT
iajs-2976	100	31	,	,	PUNCT
iajs-2976	100	32	we	we	PRON
iajs-2976	100	33	conducted	conduct	VERB
iajs-2976	100	34	one	one	NUM
iajs-2976	100	35	-	-	PUNCT
iajs-2976	100	36	way	way	NOUN
iajs-2976	100	37	anova	anova	PROPN
iajs-2976	100	38	.	.	PUNCT
iajs-2976	101	1	in	in	ADP
iajs-2976	101	2	relation	relation	NOUN
iajs-2976	101	3	to	to	ADP
iajs-2976	101	4	multiple	multiple	ADJ
iajs-2976	101	5	comparisons	comparison	NOUN
iajs-2976	101	6	,	,	PUNCT
iajs-2976	101	7	the	the	DET
iajs-2976	101	8	mean	mean	NOUN
iajs-2976	101	9	of	of	ADP
iajs-2976	101	10	columns	column	NOUN
iajs-2976	101	11	n	n	ADP
iajs-2976	101	12	and	and	CCONJ
iajs-2976	101	13	t	t	PROPN
iajs-2976	101	14	has	have	AUX
iajs-2976	101	15	been	be	AUX
iajs-2976	101	16	compared	compare	VERB
iajs-2976	101	17	with	with	ADP
iajs-2976	101	18	columns	column	NOUN
iajs-2976	101	19	d.	d.	PROPN
iajs-2976	101	20	dunnett	dunnett	PROPN
iajs-2976	101	21	is	be	AUX
iajs-2976	101	22	suggested	suggest	VERB
iajs-2976	101	23	when	when	SCONJ
iajs-2976	101	24	performing	perform	VERB
iajs-2976	101	25	numerous	numerous	ADJ
iajs-2976	101	26	comparisons	comparison	NOUN
iajs-2976	101	27	using	use	VERB
iajs-2976	101	28	statistical	statistical	ADJ
iajs-2976	101	29	hypothesis	hypothesis	NOUN
iajs-2976	101	30	testing	testing	NOUN
iajs-2976	101	31	.	.	PUNCT
iajs-2976	102	1	all	all	DET
iajs-2976	102	2	values	value	NOUN
iajs-2976	102	3	were	be	AUX
iajs-2976	102	4	provided	provide	VERB
iajs-2976	102	5	as	as	ADP
iajs-2976	102	6	mean	mean	NOUN
iajs-2976	102	7	±	±	NUM
iajs-2976	102	8	standard	standard	ADJ
iajs-2976	102	9	error	error	NOUN
iajs-2976	102	10	of	of	ADP
iajs-2976	102	11	mean	mean	NOUN
iajs-2976	102	12	,	,	PUNCT
iajs-2976	102	13	and	and	CCONJ
iajs-2976	102	14	the	the	DET
iajs-2976	102	15	results	result	NOUN
iajs-2976	102	16	at	at	ADP
iajs-2976	102	17	p	p	NOUN
iajs-2976	102	18	<	<	X
iajs-2976	102	19	0.05	0.05	NUM
iajs-2976	102	20	were	be	AUX
iajs-2976	102	21	considered	consider	VERB
iajs-2976	102	22	as	as	ADP
iajs-2976	102	23	statistically	statistically	ADV
iajs-2976	102	24	significant	significant	ADJ
iajs-2976	102	25	.	.	PUNCT
iajs-2976	103	1	4	4	X
iajs-2976	103	2	.	.	NOUN
iajs-2976	103	3	results	result	VERB
iajs-2976	103	4	effect	effect	NOUN
iajs-2976	103	5	of	of	ADP
iajs-2976	103	6	ubiquinone	ubiquinone	PROPN
iajs-2976	103	7	supplementation	supplementation	NOUN
iajs-2976	103	8	on	on	ADP
iajs-2976	103	9	blood	blood	NOUN
iajs-2976	103	10	glucose	glucose	NOUN
iajs-2976	103	11	as	as	SCONJ
iajs-2976	103	12	shown	show	VERB
iajs-2976	103	13	in	in	ADP
iajs-2976	103	14	table	table	NOUN
iajs-2976	103	15	1	1	NUM
iajs-2976	103	16	.	.	PUNCT
iajs-2976	103	17	and	and	CCONJ
iajs-2976	103	18	figure	figure	VERB
iajs-2976	103	19	1	1	NUM
iajs-2976	103	20	,	,	PUNCT
iajs-2976	103	21	the	the	DET
iajs-2976	103	22	ubiquinone	ubiquinone	PROPN
iajs-2976	103	23	-	-	PUNCT
iajs-2976	103	24	treated	treat	VERB
iajs-2976	103	25	group	group	NOUN
iajs-2976	103	26	(	(	PUNCT
iajs-2976	103	27	5	5	NUM
iajs-2976	103	28	g	g	NOUN
iajs-2976	103	29	of	of	ADP
iajs-2976	103	30	ubiquinone	ubiquinone	PROPN
iajs-2976	103	31	per	per	ADP
iajs-2976	103	32	kilogram	kilogram	PROPN
iajs-2976	103	33	of	of	ADP
iajs-2976	103	34	diet	diet	PROPN
iajs-2976	103	35	)	)	PUNCT
iajs-2976	103	36	revealed	reveal	VERB
iajs-2976	103	37	a	a	DET
iajs-2976	103	38	significant	significant	ADJ
iajs-2976	103	39	drop	drop	NOUN
iajs-2976	103	40	in	in	ADP
iajs-2976	103	41	blood	blood	NOUN
iajs-2976	103	42	glucose	glucose	NOUN
iajs-2976	103	43	(	(	PUNCT
iajs-2976	103	44	from	from	ADP
iajs-2976	103	45	4.685±0.35	4.685±0.35	NUM
iajs-2976	103	46	to	to	ADP
iajs-2976	103	47	2.701±0.3861	2.701±0.3861	PROPN
iajs-2976	103	48	(	(	PUNCT
iajs-2976	103	49	mg	mg	PROPN
iajs-2976	103	50	/	/	SYM
iajs-2976	103	51	ml	ml	NOUN
iajs-2976	103	52	)	)	PUNCT
iajs-2976	103	53	,	,	PUNCT
iajs-2976	103	54	p	p	NOUN
iajs-2976	103	55	=	=	PROPN
iajs-2976	103	56	0.0012	0.0012	NUM
iajs-2976	103	57	)	)	PUNCT
iajs-2976	103	58	compared	compare	VERB
iajs-2976	103	59	to	to	ADP
iajs-2976	103	60	the	the	DET
iajs-2976	103	61	diabetic	diabetic	ADJ
iajs-2976	103	62	group	group	NOUN
iajs-2976	103	63	.	.	PUNCT
iajs-2976	104	1	table	table	NOUN
iajs-2976	104	2	1	1	NUM
iajs-2976	104	3	.	.	PUNCT
iajs-2976	105	1	the	the	DET
iajs-2976	105	2	impact	impact	NOUN
iajs-2976	105	3	of	of	ADP
iajs-2976	105	4	ubiquinone	ubiquinone	PROPN
iajs-2976	105	5	supplement	supplement	NOUN
iajs-2976	105	6	on	on	ADP
iajs-2976	105	7	hyperglycemia	hyperglycemia	NOUN
iajs-2976	105	8	and	and	CCONJ
iajs-2976	105	9	oxidation	oxidation	NOUN
iajs-2976	105	10	markers	marker	NOUN
iajs-2976	105	11	in	in	ADP
iajs-2976	105	12	diabetic	diabetic	ADJ
iajs-2976	105	13	rats	rat	NOUN
iajs-2976	105	14	marker	marker	NOUN
iajs-2976	105	15	negative	negative	ADJ
iajs-2976	105	16	control	control	NOUN
iajs-2976	105	17	(	(	PUNCT
iajs-2976	105	18	n	n	CCONJ
iajs-2976	105	19	)	)	PUNCT
iajs-2976	105	20	diabetic	diabetic	ADJ
iajs-2976	105	21	control	control	NOUN
iajs-2976	105	22	(	(	PUNCT
iajs-2976	105	23	d	d	X
iajs-2976	105	24	)	)	PUNCT
iajs-2976	105	25	ubiquinone	ubiquinone	PROPN
iajs-2976	105	26	treatment	treatment	NOUN
iajs-2976	105	27	(	(	PUNCT
iajs-2976	105	28	t	t	NOUN
iajs-2976	105	29	)	)	PUNCT
iajs-2976	105	30	p	p	NOUN
iajs-2976	105	31	-	-	PUNCT
iajs-2976	105	32	value	value	NOUN
iajs-2976	105	33	d	d	NOUN
iajs-2976	105	34	vs.	vs.	ADP
iajs-2976	105	35	n	n	CCONJ
iajs-2976	105	36	p	p	NOUN
iajs-2976	105	37	-	-	PUNCT
iajs-2976	105	38	value	value	NOUN
iajs-2976	105	39	d	d	X
iajs-2976	105	40	vs.	vs.	ADP
iajs-2976	105	41	t	t	NOUN
iajs-2976	105	42	glucose	glucose	NOUN
iajs-2976	105	43	(	(	PUNCT
iajs-2976	105	44	mg	mg	NOUN
iajs-2976	105	45	/	/	SYM
iajs-2976	105	46	ml	ml	NOUN
iajs-2976	105	47	)	)	PUNCT
iajs-2976	105	48	0.9590±0.09	0.9590±0.09	NOUN
iajs-2976	105	49	4.685±0.35	4.685±0.35	NOUN
iajs-2976	105	50	2.701±0.3861	2.701±0.3861	ADJ
iajs-2976	105	51	<	<	X
iajs-2976	105	52	0.0001	0.0001	NUM
iajs-2976	105	53	0.0012	0.0012	NUM
iajs-2976	105	54	mda	mda	PROPN
iajs-2976	105	55	(	(	PUNCT
iajs-2976	105	56	nmol	nmol	PROPN
iajs-2976	105	57	/	/	SYM
iajs-2976	105	58	ml	ml	NOUN
iajs-2976	105	59	)	)	PUNCT
iajs-2976	105	60	4.32±0.38	4.32±0.38	NOUN
iajs-2976	105	61	8.522±0.22	8.522±0.22	NUM
iajs-2976	105	62	5.083±0.32	5.083±0.32	NUM
iajs-2976	105	63	<	<	X
iajs-2976	105	64	0.0001	0.0001	NUM
iajs-2976	105	65	<	<	NOUN
iajs-2976	105	66	0.0001	0.0001	NUM
iajs-2976	105	67	values	value	NOUN
iajs-2976	105	68	are	be	AUX
iajs-2976	105	69	expressed	express	VERB
iajs-2976	105	70	as	as	ADP
iajs-2976	105	71	mean	mean	ADJ
iajs-2976	105	72	±sem	±sem	NOUN
iajs-2976	105	73	,	,	PUNCT
iajs-2976	105	74	p<0.05	p<0.05	NOUN
iajs-2976	105	75	indicates	indicate	VERB
iajs-2976	105	76	significant	significant	ADJ
iajs-2976	105	77	difference	difference	NOUN
iajs-2976	105	78	.	.	PUNCT
iajs-2976	106	1	ihjpas	ihjpas	PROPN
iajs-2976	106	2	.	.	PUNCT
iajs-2976	107	1	36(2)2023	36(2)2023	NUM
iajs-2976	107	2	90	90	NUM
iajs-2976	107	3	figure	figure	NOUN
iajs-2976	107	4	1	1	NUM
iajs-2976	107	5	.	.	PUNCT
iajs-2976	107	6	effect	effect	NOUN
iajs-2976	107	7	of	of	ADP
iajs-2976	107	8	ubiquinone	ubiquinone	PROPN
iajs-2976	107	9	on	on	ADP
iajs-2976	107	10	blood	blood	NOUN
iajs-2976	107	11	glucose	glucose	NOUN
iajs-2976	107	12	and	and	CCONJ
iajs-2976	107	13	serum	serum	NOUN
iajs-2976	107	14	mda	mda	PROPN
iajs-2976	107	15	levels	level	NOUN
iajs-2976	107	16	.	.	PUNCT
iajs-2976	108	1	after	after	ADP
iajs-2976	108	2	three	three	NUM
iajs-2976	108	3	weeks	week	NOUN
iajs-2976	108	4	,	,	PUNCT
iajs-2976	108	5	blood	blood	NOUN
iajs-2976	108	6	glucose	glucose	NOUN
iajs-2976	108	7	levels	level	NOUN
iajs-2976	108	8	(	(	PUNCT
iajs-2976	108	9	a	a	X
iajs-2976	108	10	)	)	PUNCT
iajs-2976	108	11	and	and	CCONJ
iajs-2976	108	12	serum	serum	NOUN
iajs-2976	108	13	levels	level	NOUN
iajs-2976	108	14	of	of	ADP
iajs-2976	108	15	mda	mda	PROPN
iajs-2976	108	16	(	(	PUNCT
iajs-2976	108	17	b	b	NOUN
iajs-2976	108	18	)	)	PUNCT
iajs-2976	108	19	were	be	AUX
iajs-2976	108	20	measured	measure	VERB
iajs-2976	108	21	in	in	ADP
iajs-2976	108	22	three	three	NUM
iajs-2976	108	23	groups	group	NOUN
iajs-2976	108	24	of	of	ADP
iajs-2976	108	25	experimental	experimental	ADJ
iajs-2976	108	26	rats	rat	NOUN
iajs-2976	108	27	;	;	PUNCT
iajs-2976	108	28	the	the	DET
iajs-2976	108	29	negative	negative	ADJ
iajs-2976	108	30	control	control	PROPN
iajs-2976	108	31	group	group	NOUN
iajs-2976	108	32	(	(	PUNCT
iajs-2976	108	33	n	n	CCONJ
iajs-2976	108	34	)	)	PUNCT
iajs-2976	108	35	,	,	PUNCT
iajs-2976	108	36	the	the	DET
iajs-2976	108	37	diabetic	diabetic	ADJ
iajs-2976	108	38	control	control	NOUN
iajs-2976	108	39	group	group	NOUN
iajs-2976	108	40	(	(	PUNCT
iajs-2976	108	41	d	d	NOUN
iajs-2976	108	42	)	)	PUNCT
iajs-2976	108	43	,	,	PUNCT
iajs-2976	108	44	and	and	CCONJ
iajs-2976	108	45	the	the	DET
iajs-2976	108	46	ubiquinone	ubiquinone	PROPN
iajs-2976	108	47	treatment	treatment	NOUN
iajs-2976	108	48	group	group	NOUN
iajs-2976	108	49	(	(	PUNCT
iajs-2976	108	50	t	t	PROPN
iajs-2976	108	51	)	)	PUNCT
iajs-2976	108	52	.	.	PUNCT
iajs-2976	109	1	glucose	glucose	NOUN
iajs-2976	109	2	levels	level	NOUN
iajs-2976	109	3	were	be	AUX
iajs-2976	109	4	assessed	assess	VERB
iajs-2976	109	5	by	by	ADP
iajs-2976	109	6	bayer	bayer	PROPN
iajs-2976	109	7	contour	contour	NOUN
iajs-2976	109	8	®	®	NOUN
iajs-2976	109	9	ts	ts	ADP
iajs-2976	109	10	blood	blood	NOUN
iajs-2976	109	11	glucose	glucose	NOUN
iajs-2976	109	12	monitoring	monitoring	NOUN
iajs-2976	109	13	system	system	NOUN
iajs-2976	109	14	.	.	PUNCT
iajs-2976	110	1	serum	serum	NOUN
iajs-2976	110	2	levels	level	NOUN
iajs-2976	110	3	of	of	ADP
iajs-2976	110	4	mda	mda	PROPN
iajs-2976	110	5	were	be	AUX
iajs-2976	110	6	evaluated	evaluate	VERB
iajs-2976	110	7	by	by	ADP
iajs-2976	110	8	elisa	elisa	PROPN
iajs-2976	110	9	.	.	PUNCT
iajs-2976	111	1	data	datum	NOUN
iajs-2976	111	2	are	be	AUX
iajs-2976	111	3	shown	show	VERB
iajs-2976	111	4	as	as	ADP
iajs-2976	111	5	the	the	DET
iajs-2976	111	6	mean	mean	NOUN
iajs-2976	111	7	±	±	PROPN
iajs-2976	111	8	se	se	X
iajs-2976	111	9	(	(	PUNCT
iajs-2976	111	10	n=7	n=7	PROPN
iajs-2976	111	11	)	)	PUNCT
iajs-2976	111	12	.	.	PUNCT
iajs-2976	112	1	during	during	ADP
iajs-2976	112	2	the	the	DET
iajs-2976	112	3	same	same	ADJ
iajs-2976	112	4	medication	medication	NOUN
iajs-2976	112	5	period	period	NOUN
iajs-2976	112	6	,	,	PUNCT
iajs-2976	112	7	the	the	DET
iajs-2976	112	8	bars	bar	NOUN
iajs-2976	112	9	were	be	AUX
iajs-2976	112	10	marked	mark	VERB
iajs-2976	112	11	by	by	ADP
iajs-2976	112	12	different	different	ADJ
iajs-2976	112	13	asterisks	asterisk	NOUN
iajs-2976	112	14	(	(	PUNCT
iajs-2976	112	15	∗	∗	NOUN
iajs-2976	112	16	,	,	PUNCT
iajs-2976	112	17	∗∗	∗∗	NOUN
iajs-2976	112	18	)	)	PUNCT
iajs-2976	112	19	differ	differ	VERB
iajs-2976	112	20	significantly	significantly	ADV
iajs-2976	112	21	from	from	ADP
iajs-2976	112	22	each	each	DET
iajs-2976	112	23	another	another	PRON
iajs-2976	112	24	(	(	PUNCT
iajs-2976	112	25	p	p	X
iajs-2976	112	26	<	<	X
iajs-2976	112	27	0.05	0.05	NUM
iajs-2976	112	28	)	)	PUNCT
iajs-2976	112	29	.	.	PUNCT
iajs-2976	113	1	the	the	DET
iajs-2976	113	2	non	non	ADJ
iajs-2976	113	3	-	-	ADJ
iajs-2976	113	4	asterisk	asterisk	ADJ
iajs-2976	113	5	bars	bar	NOUN
iajs-2976	113	6	are	be	AUX
iajs-2976	113	7	not	not	PART
iajs-2976	113	8	significantly	significantly	ADV
iajs-2976	113	9	different	different	ADJ
iajs-2976	113	10	from	from	ADP
iajs-2976	113	11	one	one	NUM
iajs-2976	113	12	another	another	PRON
iajs-2976	113	13	(	(	PUNCT
iajs-2976	113	14	p	p	X
iajs-2976	113	15	>	>	X
iajs-2976	113	16	0.05	0.05	NUM
iajs-2976	113	17	)	)	PUNCT
iajs-2976	113	18	.	.	PUNCT
iajs-2976	114	1	effect	effect	NOUN
iajs-2976	114	2	of	of	ADP
iajs-2976	114	3	ubiquinone	ubiquinone	PROPN
iajs-2976	114	4	supplementation	supplementation	NOUN
iajs-2976	114	5	on	on	ADP
iajs-2976	114	6	mda	mda	PROPN
iajs-2976	114	7	serum	serum	PROPN
iajs-2976	114	8	levels	level	NOUN
iajs-2976	114	9	the	the	DET
iajs-2976	114	10	results	result	NOUN
iajs-2976	114	11	were	be	AUX
iajs-2976	114	12	evaluated	evaluate	VERB
iajs-2976	114	13	at	at	ADP
iajs-2976	114	14	the	the	DET
iajs-2976	114	15	end	end	NOUN
iajs-2976	114	16	of	of	ADP
iajs-2976	114	17	21	21	NUM
iajs-2976	114	18	days	day	NOUN
iajs-2976	114	19	of	of	ADP
iajs-2976	114	20	the	the	DET
iajs-2976	114	21	study	study	NOUN
iajs-2976	114	22	in	in	ADP
iajs-2976	114	23	all	all	DET
iajs-2976	114	24	groups	group	NOUN
iajs-2976	114	25	of	of	ADP
iajs-2976	114	26	the	the	DET
iajs-2976	114	27	experimental	experimental	ADJ
iajs-2976	114	28	animals	animal	NOUN
iajs-2976	114	29	,	,	PUNCT
iajs-2976	114	30	and	and	CCONJ
iajs-2976	114	31	mda	mda	PROPN
iajs-2976	114	32	serum	serum	PROPN
iajs-2976	114	33	levels	level	NOUN
iajs-2976	114	34	values	value	NOUN
iajs-2976	114	35	are	be	AUX
iajs-2976	114	36	presented	present	VERB
iajs-2976	114	37	in	in	ADP
iajs-2976	114	38	table	table	NOUN
iajs-2976	114	39	1	1	NUM
iajs-2976	114	40	.	.	PUNCT
iajs-2976	114	41	;	;	PUNCT
iajs-2976	114	42	also	also	ADV
iajs-2976	114	43	,	,	PUNCT
iajs-2976	114	44	the	the	DET
iajs-2976	114	45	changes	change	NOUN
iajs-2976	114	46	in	in	ADP
iajs-2976	114	47	mda	mda	PROPN
iajs-2976	114	48	serum	serum	NOUN
iajs-2976	114	49	levels	level	NOUN
iajs-2976	114	50	are	be	AUX
iajs-2976	114	51	shown	show	VERB
iajs-2976	114	52	in	in	ADP
iajs-2976	114	53	figure	figure	NOUN
iajs-2976	114	54	1	1	NUM
iajs-2976	114	55	.	.	PUNCT
iajs-2976	115	1	there	there	PRON
iajs-2976	115	2	was	be	VERB
iajs-2976	115	3	a	a	DET
iajs-2976	115	4	significant	significant	ADJ
iajs-2976	115	5	difference	difference	NOUN
iajs-2976	115	6	between	between	ADP
iajs-2976	115	7	serum	serum	NOUN
iajs-2976	115	8	mda	mda	PROPN
iajs-2976	115	9	levels	level	NOUN
iajs-2976	115	10	of	of	ADP
iajs-2976	115	11	group	group	NOUN
iajs-2976	115	12	d	d	PROPN
iajs-2976	115	13	rats	rat	NOUN
iajs-2976	115	14	with	with	ADP
iajs-2976	115	15	group	group	NOUN
iajs-2976	115	16	n	n	NOUN
iajs-2976	115	17	and	and	CCONJ
iajs-2976	115	18	t.	t.	NOUN
iajs-2976	115	19	the	the	DET
iajs-2976	115	20	concentration	concentration	NOUN
iajs-2976	115	21	of	of	ADP
iajs-2976	115	22	mda	mda	PROPN
iajs-2976	115	23	,	,	PUNCT
iajs-2976	115	24	as	as	ADP
iajs-2976	115	25	an	an	DET
iajs-2976	115	26	end	end	NOUN
iajs-2976	115	27	product	product	NOUN
iajs-2976	115	28	of	of	ADP
iajs-2976	115	29	lipid	lipid	NOUN
iajs-2976	115	30	peroxidation	peroxidation	NOUN
iajs-2976	115	31	,	,	PUNCT
iajs-2976	115	32	increased	increase	VERB
iajs-2976	115	33	dramatically	dramatically	ADV
iajs-2976	115	34	in	in	ADP
iajs-2976	115	35	the	the	DET
iajs-2976	115	36	serum	serum	NOUN
iajs-2976	115	37	of	of	ADP
iajs-2976	115	38	the	the	DET
iajs-2976	115	39	diabetic	diabetic	ADJ
iajs-2976	115	40	rats	rat	NOUN
iajs-2976	115	41	as	as	SCONJ
iajs-2976	115	42	compared	compare	VERB
iajs-2976	115	43	to	to	ADP
iajs-2976	115	44	the	the	DET
iajs-2976	115	45	non	non	ADJ
iajs-2976	115	46	-	-	ADJ
iajs-2976	115	47	diabetic	diabetic	ADJ
iajs-2976	115	48	rats	rat	NOUN
iajs-2976	115	49	(	(	PUNCT
iajs-2976	115	50	from	from	ADP
iajs-2976	115	51	4.32±0.38	4.32±0.38	NUM
iajs-2976	115	52	to	to	ADP
iajs-2976	115	53	8.522±0.22	8.522±0.22	NUM
iajs-2976	115	54	nmol	nmol	NOUN
iajs-2976	115	55	/	/	SYM
iajs-2976	115	56	ml	ml	NOUN
iajs-2976	115	57	,	,	PUNCT
iajs-2976	115	58	p<0.0001	p<0.0001	NOUN
iajs-2976	115	59	)	)	PUNCT
iajs-2976	115	60	.	.	PUNCT
iajs-2976	116	1	treatment	treatment	NOUN
iajs-2976	116	2	of	of	ADP
iajs-2976	116	3	diabetic	diabetic	ADJ
iajs-2976	116	4	rats	rat	NOUN
iajs-2976	116	5	with	with	ADP
iajs-2976	116	6	ubiquinone	ubiquinone	PROPN
iajs-2976	116	7	remarkably	remarkably	ADV
iajs-2976	116	8	diminished	diminish	VERB
iajs-2976	116	9	mda	mda	PROPN
iajs-2976	116	10	levels	level	NOUN
iajs-2976	116	11	in	in	ADP
iajs-2976	116	12	serum	serum	NOUN
iajs-2976	116	13	as	as	SCONJ
iajs-2976	116	14	compared	compare	VERB
iajs-2976	116	15	to	to	ADP
iajs-2976	116	16	diabetic	diabetic	ADJ
iajs-2976	116	17	controls	control	NOUN
iajs-2976	116	18	(	(	PUNCT
iajs-2976	116	19	from	from	ADP
iajs-2976	116	20	8.522±0.22	8.522±0.22	NUM
iajs-2976	116	21	to	to	ADP
iajs-2976	116	22	5.083±0.32	5.083±0.32	NUM
iajs-2976	116	23	nmol	nmol	NOUN
iajs-2976	116	24	/	/	SYM
iajs-2976	116	25	ml	ml	NOUN
iajs-2976	116	26	,	,	PUNCT
iajs-2976	116	27	p<0.0001	p<0.0001	NOUN
iajs-2976	116	28	)	)	PUNCT
iajs-2976	116	29	.	.	PUNCT
iajs-2976	117	1	effect	effect	NOUN
iajs-2976	117	2	of	of	ADP
iajs-2976	117	3	ubiquinone	ubiquinone	PROPN
iajs-2976	117	4	supplementation	supplementation	NOUN
iajs-2976	117	5	on	on	ADP
iajs-2976	117	6	il-6	il-6	NUM
iajs-2976	117	7	serum	serum	NOUN
iajs-2976	117	8	levels	level	NOUN
iajs-2976	117	9	the	the	DET
iajs-2976	117	10	results	result	NOUN
iajs-2976	117	11	were	be	AUX
iajs-2976	117	12	assessed	assess	VERB
iajs-2976	117	13	at	at	ADP
iajs-2976	117	14	the	the	DET
iajs-2976	117	15	end	end	NOUN
iajs-2976	117	16	of	of	ADP
iajs-2976	117	17	21	21	NUM
iajs-2976	117	18	days	day	NOUN
iajs-2976	117	19	of	of	ADP
iajs-2976	117	20	the	the	DET
iajs-2976	117	21	study	study	NOUN
iajs-2976	117	22	in	in	ADP
iajs-2976	117	23	all	all	DET
iajs-2976	117	24	groups	group	NOUN
iajs-2976	117	25	,	,	PUNCT
iajs-2976	117	26	and	and	CCONJ
iajs-2976	117	27	the	the	DET
iajs-2976	117	28	il-6	il-6	NOUN
iajs-2976	117	29	values	value	NOUN
iajs-2976	117	30	are	be	AUX
iajs-2976	117	31	shown	show	VERB
iajs-2976	117	32	in	in	ADP
iajs-2976	117	33	table	table	NOUN
iajs-2976	117	34	2	2	NUM
iajs-2976	117	35	.	.	PUNCT
iajs-2976	118	1	also	also	ADV
iajs-2976	118	2	,	,	PUNCT
iajs-2976	118	3	figure	figure	NOUN
iajs-2976	118	4	2	2	NUM
iajs-2976	118	5	shows	show	VERB
iajs-2976	118	6	the	the	DET
iajs-2976	118	7	changes	change	NOUN
iajs-2976	118	8	in	in	ADP
iajs-2976	118	9	serum	serum	NOUN
iajs-2976	118	10	levels	level	NOUN
iajs-2976	118	11	of	of	ADP
iajs-2976	118	12	il-6	il-6	NOUN
iajs-2976	118	13	in	in	ADP
iajs-2976	118	14	all	all	DET
iajs-2976	118	15	groups	group	NOUN
iajs-2976	118	16	of	of	ADP
iajs-2976	118	17	our	our	PRON
iajs-2976	118	18	experimental	experimental	ADJ
iajs-2976	118	19	animals	animal	NOUN
iajs-2976	118	20	.	.	PUNCT
iajs-2976	119	1	group	group	NOUN
iajs-2976	119	2	n	n	NOUN
iajs-2976	119	3	rats	rat	NOUN
iajs-2976	119	4	had	have	VERB
iajs-2976	119	5	significantly	significantly	ADV
iajs-2976	119	6	lower	low	ADJ
iajs-2976	119	7	levels	level	NOUN
iajs-2976	119	8	of	of	ADP
iajs-2976	119	9	serum	serum	NOUN
iajs-2976	119	10	il-6	il-6	NUM
iajs-2976	119	11	than	than	ADP
iajs-2976	119	12	groups	group	NOUN
iajs-2976	119	13	p	p	NOUN
iajs-2976	119	14	and	and	CCONJ
iajs-2976	119	15	t	t	NOUN
iajs-2976	119	16	animals	animal	NOUN
iajs-2976	119	17	.	.	PUNCT
iajs-2976	120	1	il-6	il-6	NOUN
iajs-2976	120	2	,	,	PUNCT
iajs-2976	120	3	a	a	DET
iajs-2976	120	4	proinflammatory	proinflammatory	ADJ
iajs-2976	120	5	marker	marker	NOUN
iajs-2976	120	6	,	,	PUNCT
iajs-2976	120	7	was	be	AUX
iajs-2976	120	8	significantly	significantly	ADV
iajs-2976	120	9	increased	increase	VERB
iajs-2976	120	10	in	in	ADP
iajs-2976	120	11	the	the	DET
iajs-2976	120	12	serum	serum	NOUN
iajs-2976	120	13	of	of	ADP
iajs-2976	120	14	diabetic	diabetic	ADJ
iajs-2976	120	15	control	control	NOUN
iajs-2976	120	16	rats	rat	NOUN
iajs-2976	120	17	relative	relative	ADJ
iajs-2976	120	18	to	to	ADP
iajs-2976	120	19	normal	normal	ADJ
iajs-2976	120	20	control	control	NOUN
iajs-2976	120	21	rats	rat	NOUN
iajs-2976	120	22	(	(	PUNCT
iajs-2976	120	23	p	p	X
iajs-2976	120	24	=	=	NOUN
iajs-2976	120	25	0.0493	0.0493	NUM
iajs-2976	120	26	)	)	PUNCT
iajs-2976	120	27	.	.	PUNCT
iajs-2976	121	1	compared	compare	VERB
iajs-2976	121	2	to	to	ADP
iajs-2976	121	3	untreated	untreated	ADJ
iajs-2976	121	4	diabetic	diabetic	ADJ
iajs-2976	121	5	rats	rat	NOUN
iajs-2976	121	6	,	,	PUNCT
iajs-2976	121	7	treatment	treatment	NOUN
iajs-2976	121	8	with	with	ADP
iajs-2976	121	9	ubiquinone	ubiquinone	PROPN
iajs-2976	121	10	significantly	significantly	ADV
iajs-2976	121	11	decreased	decrease	VERB
iajs-2976	121	12	serum	serum	PROPN
iajs-2976	121	13	il-6	il-6	NOUN
iajs-2976	121	14	levels	level	NOUN
iajs-2976	121	15	(	(	PUNCT
iajs-2976	121	16	from	from	ADP
iajs-2976	121	17	66.49±1.87	66.49±1.87	NUM
iajs-2976	121	18	to	to	ADP
iajs-2976	121	19	56.71±3.54	56.71±3.54	NUM
iajs-2976	121	20	pg	pg	NOUN
iajs-2976	121	21	/	/	SYM
iajs-2976	121	22	ml	ml	PROPN
iajs-2976	121	23	,	,	PUNCT
iajs-2976	121	24	p	p	X
iajs-2976	121	25	=	=	NOUN
iajs-2976	121	26	0.0233	0.0233	NUM
iajs-2976	121	27	)	)	PUNCT
iajs-2976	121	28	.	.	PUNCT
iajs-2976	122	1	ihjpas	ihjpas	PROPN
iajs-2976	122	2	.	.	PUNCT
iajs-2976	123	1	36(2)2023	36(2)2023	NUM
iajs-2976	123	2	91	91	NUM
iajs-2976	123	3	table	table	NOUN
iajs-2976	123	4	2	2	NUM
iajs-2976	123	5	.	.	PUNCT
iajs-2976	124	1	the	the	DET
iajs-2976	124	2	impact	impact	NOUN
iajs-2976	124	3	of	of	ADP
iajs-2976	124	4	ubiquinone	ubiquinone	PROPN
iajs-2976	124	5	supplement	supplement	NOUN
iajs-2976	124	6	on	on	ADP
iajs-2976	124	7	inflammation	inflammation	NOUN
iajs-2976	124	8	and	and	CCONJ
iajs-2976	124	9	muscle	muscle	NOUN
iajs-2976	124	10	cell	cell	NOUN
iajs-2976	124	11	injury	injury	NOUN
iajs-2976	124	12	markers	marker	NOUN
iajs-2976	124	13	in	in	ADP
iajs-2976	124	14	diabetic	diabetic	ADJ
iajs-2976	124	15	rats	rat	NOUN
iajs-2976	124	16	marker	marker	NOUN
iajs-2976	124	17	negative	negative	ADJ
iajs-2976	124	18	control	control	NOUN
iajs-2976	124	19	(	(	PUNCT
iajs-2976	124	20	n	n	CCONJ
iajs-2976	124	21	)	)	PUNCT
iajs-2976	124	22	diabetic	diabetic	ADJ
iajs-2976	124	23	control	control	NOUN
iajs-2976	124	24	(	(	PUNCT
iajs-2976	124	25	d	d	X
iajs-2976	124	26	)	)	PUNCT
iajs-2976	124	27	ubiquinone	ubiquinone	PROPN
iajs-2976	124	28	treatment	treatment	NOUN
iajs-2976	124	29	(	(	PUNCT
iajs-2976	124	30	t	t	NOUN
iajs-2976	124	31	)	)	PUNCT
iajs-2976	124	32	p	p	NOUN
iajs-2976	124	33	-	-	PUNCT
iajs-2976	124	34	value	value	NOUN
iajs-2976	124	35	d	d	NOUN
iajs-2976	124	36	vs.	vs.	ADP
iajs-2976	124	37	n	n	CCONJ
iajs-2976	124	38	p	p	NOUN
iajs-2976	124	39	-	-	PUNCT
iajs-2976	124	40	value	value	NOUN
iajs-2976	124	41	d	d	X
iajs-2976	124	42	vs.	vs.	ADP
iajs-2976	124	43	t	t	PROPN
iajs-2976	124	44	il-6	il-6	NUM
iajs-2976	124	45	(	(	PUNCT
iajs-2976	124	46	pg	pg	NOUN
iajs-2976	124	47	/	/	SYM
iajs-2976	124	48	ml	ml	NOUN
iajs-2976	124	49	)	)	PUNCT
iajs-2976	124	50	58.04±1.35	58.04±1.35	NOUN
iajs-2976	124	51	66.49±1.87	66.49±1.87	NUM
iajs-2976	124	52	56.71±3.54	56.71±3.54	NUM
iajs-2976	124	53	0.0493	0.0493	NUM
iajs-2976	124	54	0.0233	0.0233	NUM
iajs-2976	124	55	no	no	INTJ
iajs-2976	124	56	(	(	PUNCT
iajs-2976	124	57	pg	pg	NOUN
iajs-2976	124	58	/	/	SYM
iajs-2976	124	59	ml	ml	NOUN
iajs-2976	124	60	)	)	PUNCT
iajs-2976	124	61	44.20±1.91	44.20±1.91	NOUN
iajs-2976	124	62	18.19±0.79	18.19±0.79	NUM
iajs-2976	124	63	71.00±7.78	71.00±7.78	NOUN
iajs-2976	124	64	0.0370	0.0370	NUM
iajs-2976	124	65	0.0005	0.0005	NUM
iajs-2976	124	66	mb	mb	X
iajs-2976	124	67	(	(	PUNCT
iajs-2976	124	68	ng	ng	PROPN
iajs-2976	124	69	/	/	SYM
iajs-2976	124	70	ml	ml	NOUN
iajs-2976	124	71	)	)	PUNCT
iajs-2976	124	72	3.90±0.30	3.90±0.30	NUM
iajs-2976	124	73	29.65±11.42	29.65±11.42	NUM
iajs-2976	124	74	3.900±0.33	3.900±0.33	NUM
iajs-2976	124	75	0.0019	0.0019	NUM
iajs-2976	124	76	0.0031	0.0031	NUM
iajs-2976	124	77	values	value	NOUN
iajs-2976	124	78	are	be	AUX
iajs-2976	124	79	expressed	express	VERB
iajs-2976	124	80	as	as	ADP
iajs-2976	124	81	mean	mean	ADJ
iajs-2976	124	82	±sem	±sem	NOUN
iajs-2976	124	83	,	,	PUNCT
iajs-2976	124	84	p<0.05	p<0.05	NOUN
iajs-2976	124	85	indicates	indicate	VERB
iajs-2976	124	86	significant	significant	ADJ
iajs-2976	124	87	difference	difference	NOUN
iajs-2976	124	88	figure	figure	NOUN
iajs-2976	124	89	2	2	NUM
iajs-2976	124	90	effect	effect	NOUN
iajs-2976	124	91	of	of	ADP
iajs-2976	124	92	ubiquinone	ubiquinone	PROPN
iajs-2976	124	93	on	on	ADP
iajs-2976	124	94	serum	serum	NOUN
iajs-2976	124	95	levels	level	NOUN
iajs-2976	124	96	of	of	ADP
iajs-2976	124	97	il-6	il-6	NUM
iajs-2976	124	98	,	,	PUNCT
iajs-2976	124	99	no	no	INTJ
iajs-2976	124	100	,	,	PUNCT
iajs-2976	124	101	and	and	CCONJ
iajs-2976	124	102	mb	mb	ADP
iajs-2976	124	103	.	.	NOUN
iajs-2976	125	1	after	after	ADP
iajs-2976	125	2	three	three	NUM
iajs-2976	125	3	weeks	week	NOUN
iajs-2976	125	4	,	,	PUNCT
iajs-2976	125	5	serum	serum	NOUN
iajs-2976	125	6	levels	level	NOUN
iajs-2976	125	7	of	of	ADP
iajs-2976	125	8	il-6	il-6	NOUN
iajs-2976	125	9	(	(	PUNCT
iajs-2976	125	10	a	a	X
iajs-2976	125	11	)	)	PUNCT
iajs-2976	125	12	,	,	PUNCT
iajs-2976	125	13	no	no	DET
iajs-2976	125	14	(	(	PUNCT
iajs-2976	125	15	b	b	NOUN
iajs-2976	125	16	)	)	PUNCT
iajs-2976	125	17	,	,	PUNCT
iajs-2976	125	18	and	and	CCONJ
iajs-2976	125	19	mb	mb	X
iajs-2976	125	20	(	(	PUNCT
iajs-2976	125	21	c	c	X
iajs-2976	125	22	)	)	PUNCT
iajs-2976	125	23	were	be	AUX
iajs-2976	125	24	measured	measure	VERB
iajs-2976	125	25	in	in	ADP
iajs-2976	125	26	three	three	NUM
iajs-2976	125	27	groups	group	NOUN
iajs-2976	125	28	of	of	ADP
iajs-2976	125	29	experimental	experimental	ADJ
iajs-2976	125	30	rats	rat	NOUN
iajs-2976	125	31	;	;	PUNCT
iajs-2976	125	32	the	the	DET
iajs-2976	125	33	negative	negative	ADJ
iajs-2976	125	34	control	control	PROPN
iajs-2976	125	35	group	group	NOUN
iajs-2976	125	36	(	(	PUNCT
iajs-2976	125	37	n	n	CCONJ
iajs-2976	125	38	)	)	PUNCT
iajs-2976	125	39	,	,	PUNCT
iajs-2976	125	40	the	the	DET
iajs-2976	125	41	diabetic	diabetic	ADJ
iajs-2976	125	42	control	control	NOUN
iajs-2976	125	43	group	group	NOUN
iajs-2976	125	44	(	(	PUNCT
iajs-2976	125	45	d	d	NOUN
iajs-2976	125	46	)	)	PUNCT
iajs-2976	125	47	,	,	PUNCT
iajs-2976	125	48	and	and	CCONJ
iajs-2976	125	49	the	the	DET
iajs-2976	125	50	ubiquinone	ubiquinone	PROPN
iajs-2976	125	51	treatment	treatment	NOUN
iajs-2976	125	52	group	group	NOUN
iajs-2976	125	53	(	(	PUNCT
iajs-2976	125	54	t	t	PROPN
iajs-2976	125	55	)	)	PUNCT
iajs-2976	125	56	.	.	PUNCT
iajs-2976	126	1	serum	serum	NOUN
iajs-2976	126	2	levels	level	NOUN
iajs-2976	126	3	of	of	ADP
iajs-2976	126	4	il-6	il-6	NUM
iajs-2976	126	5	were	be	AUX
iajs-2976	126	6	evaluated	evaluate	VERB
iajs-2976	126	7	by	by	ADP
iajs-2976	126	8	elisa	elisa	PROPN
iajs-2976	126	9	.	.	PUNCT
iajs-2976	127	1	serum	serum	PROPN
iajs-2976	127	2	levels	level	NOUN
iajs-2976	127	3	of	of	ADP
iajs-2976	127	4	mb	mb	ADV
iajs-2976	127	5	were	be	AUX
iajs-2976	127	6	measured	measure	VERB
iajs-2976	127	7	by	by	ADP
iajs-2976	127	8	up	up	ADP
iajs-2976	127	9	converting	convert	VERB
iajs-2976	127	10	phosphor	phosphor	NOUN
iajs-2976	127	11	immunoassay	immunoassay	PROPN
iajs-2976	127	12	analyzer	analyzer	NOUN
iajs-2976	127	13	.	.	PUNCT
iajs-2976	128	1	during	during	ADP
iajs-2976	128	2	the	the	DET
iajs-2976	128	3	same	same	ADJ
iajs-2976	128	4	medication	medication	NOUN
iajs-2976	128	5	period	period	NOUN
iajs-2976	128	6	,	,	PUNCT
iajs-2976	128	7	the	the	DET
iajs-2976	128	8	bars	bar	NOUN
iajs-2976	128	9	were	be	AUX
iajs-2976	128	10	marked	mark	VERB
iajs-2976	128	11	by	by	ADP
iajs-2976	128	12	different	different	ADJ
iajs-2976	128	13	asterisks	asterisk	NOUN
iajs-2976	128	14	(	(	PUNCT
iajs-2976	128	15	∗	∗	NOUN
iajs-2976	128	16	,	,	PUNCT
iajs-2976	128	17	∗∗	∗∗	NOUN
iajs-2976	128	18	)	)	PUNCT
iajs-2976	128	19	differ	differ	VERB
iajs-2976	128	20	significantly	significantly	ADV
iajs-2976	128	21	from	from	ADP
iajs-2976	128	22	each	each	DET
iajs-2976	128	23	another	another	PRON
iajs-2976	128	24	(	(	PUNCT
iajs-2976	128	25	p	p	X
iajs-2976	128	26	<	<	X
iajs-2976	128	27	0.05	0.05	NUM
iajs-2976	128	28	)	)	PUNCT
iajs-2976	128	29	.	.	PUNCT
iajs-2976	129	1	the	the	DET
iajs-2976	129	2	non	non	ADJ
iajs-2976	129	3	-	-	ADJ
iajs-2976	129	4	asterisk	asterisk	ADJ
iajs-2976	129	5	bars	bar	NOUN
iajs-2976	129	6	are	be	AUX
iajs-2976	129	7	not	not	PART
iajs-2976	129	8	significantly	significantly	ADV
iajs-2976	129	9	different	different	ADJ
iajs-2976	129	10	from	from	ADP
iajs-2976	129	11	one	one	NUM
iajs-2976	129	12	another	another	PRON
iajs-2976	129	13	(	(	PUNCT
iajs-2976	129	14	p	p	X
iajs-2976	129	15	>	>	X
iajs-2976	129	16	0.05	0.05	NUM
iajs-2976	129	17	)	)	PUNCT
iajs-2976	129	18	.	.	PUNCT
iajs-2976	130	1	effect	effect	NOUN
iajs-2976	130	2	of	of	ADP
iajs-2976	130	3	ubiquinone	ubiquinone	PROPN
iajs-2976	130	4	supplementation	supplementation	NOUN
iajs-2976	130	5	on	on	ADP
iajs-2976	130	6	no	no	DET
iajs-2976	130	7	serum	serum	NOUN
iajs-2976	130	8	levels	level	NOUN
iajs-2976	130	9	in	in	ADP
iajs-2976	130	10	our	our	PRON
iajs-2976	130	11	study	study	NOUN
iajs-2976	130	12	,	,	PUNCT
iajs-2976	130	13	the	the	DET
iajs-2976	130	14	recorded	record	VERB
iajs-2976	130	15	nitric	nitric	ADJ
iajs-2976	130	16	oxide	oxide	NOUN
iajs-2976	130	17	values	value	NOUN
iajs-2976	130	18	in	in	ADP
iajs-2976	130	19	the	the	DET
iajs-2976	130	20	normal	normal	ADJ
iajs-2976	130	21	and	and	CCONJ
iajs-2976	130	22	ubiquinone	ubiquinone	PROPN
iajs-2976	130	23	-	-	PUNCT
iajs-2976	130	24	treated	treat	VERB
iajs-2976	130	25	groups	group	NOUN
iajs-2976	130	26	were	be	AUX
iajs-2976	130	27	significantly	significantly	ADV
iajs-2976	130	28	higher	high	ADJ
iajs-2976	130	29	than	than	ADP
iajs-2976	130	30	in	in	ADP
iajs-2976	130	31	the	the	DET
iajs-2976	130	32	diabetic	diabetic	ADJ
iajs-2976	130	33	group	group	NOUN
iajs-2976	130	34	(	(	PUNCT
iajs-2976	130	35	table	table	NOUN
iajs-2976	130	36	2	2	NUM
iajs-2976	130	37	and	and	CCONJ
iajs-2976	130	38	figure	figure	NOUN
iajs-2976	130	39	2	2	NUM
iajs-2976	130	40	)	)	PUNCT
iajs-2976	130	41	.	.	PUNCT
iajs-2976	131	1	compared	compare	VERB
iajs-2976	131	2	to	to	ADP
iajs-2976	131	3	normal	normal	ADJ
iajs-2976	131	4	controls	control	NOUN
iajs-2976	131	5	,	,	PUNCT
iajs-2976	131	6	there	there	PRON
iajs-2976	131	7	was	be	VERB
iajs-2976	131	8	a	a	DET
iajs-2976	131	9	significant	significant	ADJ
iajs-2976	131	10	drop	drop	NOUN
iajs-2976	131	11	in	in	ADP
iajs-2976	131	12	serum	serum	NOUN
iajs-2976	131	13	no	no	DET
iajs-2976	131	14	levels	level	NOUN
iajs-2976	131	15	in	in	ADP
iajs-2976	131	16	the	the	DET
iajs-2976	131	17	stz	stz	NOUN
iajs-2976	131	18	-	-	PUNCT
iajs-2976	131	19	treated	treat	VERB
iajs-2976	131	20	group	group	NOUN
iajs-2976	131	21	(	(	PUNCT
iajs-2976	131	22	p	p	X
iajs-2976	131	23	=	=	NOUN
iajs-2976	131	24	0.0370	0.0370	NUM
iajs-2976	131	25	)	)	PUNCT
iajs-2976	131	26	.	.	PUNCT
iajs-2976	132	1	serum	serum	VERB
iajs-2976	132	2	no	no	DET
iajs-2976	132	3	levels	level	NOUN
iajs-2976	132	4	were	be	AUX
iajs-2976	132	5	changed	change	VERB
iajs-2976	132	6	toward	toward	ADP
iajs-2976	132	7	normalcy	normalcy	NOUN
iajs-2976	132	8	in	in	ADP
iajs-2976	132	9	ubiquinone	ubiquinone	PROPN
iajs-2976	132	10	-	-	PUNCT
iajs-2976	132	11	treated	treat	VERB
iajs-2976	132	12	groups	group	NOUN
iajs-2976	132	13	and	and	CCONJ
iajs-2976	132	14	raised	raise	VERB
iajs-2976	132	15	from	from	ADP
iajs-2976	132	16	18.19±0.79	18.19±0.79	NUM
iajs-2976	132	17	in	in	ADP
iajs-2976	132	18	group	group	NOUN
iajs-2976	132	19	d	d	PROPN
iajs-2976	132	20	to	to	ADP
iajs-2976	132	21	71.00±7.78	71.00±7.78	PROPN
iajs-2976	132	22	pg	pg	VERB
iajs-2976	132	23	/	/	SYM
iajs-2976	132	24	ml	ml	PROPN
iajs-2976	132	25	,	,	PUNCT
iajs-2976	132	26	p	p	X
iajs-2976	132	27	=	=	NOUN
iajs-2976	132	28	0.0005	0.0005	NUM
iajs-2976	132	29	)	)	PUNCT
iajs-2976	132	30	in	in	ADP
iajs-2976	132	31	group	group	NOUN
iajs-2976	132	32	t.	t.	NOUN
iajs-2976	132	33	effect	effect	NOUN
iajs-2976	132	34	of	of	ADP
iajs-2976	132	35	ubiquinone	ubiquinone	PROPN
iajs-2976	132	36	supplementation	supplementation	NOUN
iajs-2976	132	37	on	on	ADP
iajs-2976	132	38	serum	serum	NOUN
iajs-2976	132	39	levels	level	NOUN
iajs-2976	132	40	of	of	ADP
iajs-2976	132	41	mb	mb	NOUN
iajs-2976	132	42	as	as	SCONJ
iajs-2976	132	43	illustrated	illustrate	VERB
iajs-2976	132	44	in	in	ADP
iajs-2976	132	45	figure	figure	NOUN
iajs-2976	132	46	2	2	NUM
iajs-2976	132	47	and	and	CCONJ
iajs-2976	132	48	documented	document	VERB
iajs-2976	132	49	parameters	parameter	NOUN
iajs-2976	132	50	values	value	NOUN
iajs-2976	132	51	in	in	ADP
iajs-2976	132	52	table	table	NOUN
iajs-2976	132	53	2	2	NUM
iajs-2976	132	54	,	,	PUNCT
iajs-2976	132	55	the	the	DET
iajs-2976	132	56	highest	high	ADJ
iajs-2976	132	57	serum	serum	NOUN
iajs-2976	132	58	values	value	NOUN
iajs-2976	132	59	of	of	ADP
iajs-2976	132	60	mb	mb	ADP
iajs-2976	132	61	levels	level	NOUN
iajs-2976	132	62	were	be	AUX
iajs-2976	132	63	witnessed	witness	VERB
iajs-2976	132	64	in	in	ADP
iajs-2976	132	65	diabetic	diabetic	ADJ
iajs-2976	132	66	control	control	NOUN
iajs-2976	132	67	rats	rat	NOUN
iajs-2976	132	68	(	(	PUNCT
iajs-2976	132	69	group	group	NOUN
iajs-2976	132	70	d	d	NOUN
iajs-2976	132	71	)	)	PUNCT
iajs-2976	132	72	.	.	PUNCT
iajs-2976	133	1	serum	serum	PROPN
iajs-2976	133	2	mb	mb	PROPN
iajs-2976	133	3	levels	level	NOUN
iajs-2976	133	4	were	be	AUX
iajs-2976	133	5	significantly	significantly	ADV
iajs-2976	133	6	decreased	decrease	VERB
iajs-2976	133	7	in	in	ADP
iajs-2976	133	8	the	the	DET
iajs-2976	133	9	diabetic	diabetic	ADJ
iajs-2976	133	10	ubiquinone	ubiquinone	PROPN
iajs-2976	133	11	-	-	PUNCT
iajs-2976	133	12	treated	treat	VERB
iajs-2976	133	13	group	group	NOUN
iajs-2976	133	14	(	(	PUNCT
iajs-2976	133	15	group	group	NOUN
iajs-2976	133	16	t	t	PROPN
iajs-2976	133	17	)	)	PUNCT
iajs-2976	133	18	compared	compare	VERB
iajs-2976	133	19	with	with	ADP
iajs-2976	133	20	untreated	untreated	ADJ
iajs-2976	133	21	rats	rat	NOUN
iajs-2976	133	22	in	in	ADP
iajs-2976	133	23	group	group	NOUN
iajs-2976	133	24	d	d	PROPN
iajs-2976	133	25	(	(	PUNCT
iajs-2976	133	26	from	from	ADP
iajs-2976	133	27	29.65±11.42	29.65±11.42	NUM
iajs-2976	133	28	to	to	ADP
iajs-2976	133	29	3.900±0.33	3.900±0.33	PROPN
iajs-2976	133	30	ng	ng	PROPN
iajs-2976	133	31	/	/	SYM
iajs-2976	133	32	ml	ml	PROPN
iajs-2976	133	33	,	,	PUNCT
iajs-2976	133	34	p	p	X
iajs-2976	133	35	=	=	PROPN
iajs-2976	133	36	0.0031	0.0031	NUM
iajs-2976	133	37	)	)	PUNCT
iajs-2976	133	38	.	.	PUNCT
iajs-2976	134	1	effects	effect	NOUN
iajs-2976	134	2	of	of	ADP
iajs-2976	134	3	ubiquinone	ubiquinone	PROPN
iajs-2976	134	4	supplementation	supplementation	NOUN
iajs-2976	134	5	on	on	ADP
iajs-2976	134	6	blood	blood	NOUN
iajs-2976	134	7	component	component	NOUN
iajs-2976	134	8	parameters	parameter	NOUN
iajs-2976	134	9	table	table	VERB
iajs-2976	134	10	3	3	NUM
iajs-2976	134	11	and	and	CCONJ
iajs-2976	134	12	figure	figure	NOUN
iajs-2976	134	13	3	3	NUM
iajs-2976	134	14	demonstrated	demonstrate	VERB
iajs-2976	134	15	the	the	DET
iajs-2976	134	16	results	result	NOUN
iajs-2976	134	17	of	of	ADP
iajs-2976	134	18	total	total	ADJ
iajs-2976	134	19	wbc	wbc	PROPN
iajs-2976	134	20	,	,	PUNCT
iajs-2976	134	21	plt	plt	NOUN
iajs-2976	134	22	,	,	PUNCT
iajs-2976	134	23	and	and	CCONJ
iajs-2976	134	24	rbc	rbc	PROPN
iajs-2976	134	25	count	count	NOUN
iajs-2976	134	26	in	in	ADP
iajs-2976	134	27	all	all	DET
iajs-2976	134	28	groups	group	NOUN
iajs-2976	134	29	of	of	ADP
iajs-2976	134	30	rats	rat	NOUN
iajs-2976	134	31	.	.	PUNCT
iajs-2976	135	1	the	the	DET
iajs-2976	135	2	data	datum	NOUN
iajs-2976	135	3	from	from	ADP
iajs-2976	135	4	the	the	DET
iajs-2976	135	5	table	table	NOUN
iajs-2976	135	6	3	3	NUM
iajs-2976	135	7	showed	show	VERB
iajs-2976	135	8	a	a	DET
iajs-2976	135	9	significantly	significantly	ADJ
iajs-2976	135	10	(	(	PUNCT
iajs-2976	135	11	p<0.05	p<0.05	NOUN
iajs-2976	135	12	)	)	PUNCT
iajs-2976	135	13	decreased	decrease	VERB
iajs-2976	135	14	count	count	NOUN
iajs-2976	135	15	of	of	ADP
iajs-2976	135	16	leukocytes	leukocyte	NOUN
iajs-2976	135	17	ihjpas	ihjpa	NOUN
iajs-2976	135	18	.	.	PUNCT
iajs-2976	136	1	36(2)2023	36(2)2023	NUM
iajs-2976	136	2	92	92	NUM
iajs-2976	136	3	from	from	ADP
iajs-2976	136	4	13.74±0.79	13.74±0.79	NUM
iajs-2976	136	5	(	(	PUNCT
iajs-2976	136	6	109	109	NUM
iajs-2976	136	7	/	/	SYM
iajs-2976	136	8	l	l	NOUN
iajs-2976	136	9	)	)	PUNCT
iajs-2976	136	10	in	in	ADP
iajs-2976	136	11	normal	normal	ADJ
iajs-2976	136	12	control	control	NOUN
iajs-2976	136	13	rats	rat	NOUN
iajs-2976	136	14	(	(	PUNCT
iajs-2976	136	15	group	group	NOUN
iajs-2976	136	16	n	n	CCONJ
iajs-2976	136	17	)	)	PUNCT
iajs-2976	136	18	to	to	ADP
iajs-2976	136	19	6.88±1.8	6.88±1.8	NUM
iajs-2976	136	20	(	(	PUNCT
iajs-2976	136	21	109	109	NUM
iajs-2976	136	22	/	/	SYM
iajs-2976	136	23	l	l	NOUN
iajs-2976	136	24	)	)	PUNCT
iajs-2976	136	25	in	in	ADP
iajs-2976	136	26	diabetic	diabetic	ADJ
iajs-2976	136	27	control	control	NOUN
iajs-2976	136	28	rats	rat	NOUN
iajs-2976	136	29	(	(	PUNCT
iajs-2976	136	30	group	group	NOUN
iajs-2976	136	31	d	d	NOUN
iajs-2976	136	32	)	)	PUNCT
iajs-2976	136	33	.	.	PUNCT
iajs-2976	137	1	while	while	SCONJ
iajs-2976	137	2	values	value	NOUN
iajs-2976	137	3	of	of	ADP
iajs-2976	137	4	thrombocytes	thrombocyte	NOUN
iajs-2976	137	5	in	in	ADP
iajs-2976	137	6	the	the	DET
iajs-2976	137	7	diabetic	diabetic	PROPN
iajs-2976	137	8	control	control	NOUN
iajs-2976	137	9	group	group	NOUN
iajs-2976	137	10	did	do	AUX
iajs-2976	137	11	not	not	PART
iajs-2976	137	12	significantly	significantly	ADV
iajs-2976	137	13	but	but	CCONJ
iajs-2976	137	14	slightly	slightly	ADV
iajs-2976	137	15	change	change	VERB
iajs-2976	137	16	when	when	SCONJ
iajs-2976	137	17	compared	compare	VERB
iajs-2976	137	18	to	to	ADP
iajs-2976	137	19	normal	normal	ADJ
iajs-2976	137	20	rats	rat	NOUN
iajs-2976	137	21	.	.	PUNCT
iajs-2976	138	1	erythrocyte	erythrocyte	NOUN
iajs-2976	138	2	values	value	NOUN
iajs-2976	138	3	changes	change	NOUN
iajs-2976	138	4	between	between	ADP
iajs-2976	138	5	the	the	DET
iajs-2976	138	6	normal	normal	ADJ
iajs-2976	138	7	rat	rat	NOUN
iajs-2976	138	8	group	group	NOUN
iajs-2976	138	9	and	and	CCONJ
iajs-2976	138	10	diabetic	diabetic	ADJ
iajs-2976	138	11	control	control	NOUN
iajs-2976	138	12	group	group	NOUN
iajs-2976	138	13	were	be	AUX
iajs-2976	138	14	insignificant	insignificant	ADJ
iajs-2976	138	15	.	.	PUNCT
iajs-2976	139	1	oral	oral	ADJ
iajs-2976	139	2	administration	administration	NOUN
iajs-2976	139	3	of	of	ADP
iajs-2976	139	4	ubiquinone	ubiquinone	PROPN
iajs-2976	139	5	did	do	AUX
iajs-2976	139	6	not	not	PART
iajs-2976	139	7	significantly	significantly	ADV
iajs-2976	139	8	but	but	CCONJ
iajs-2976	139	9	slightly	slightly	ADV
iajs-2976	139	10	increase	increase	VERB
iajs-2976	139	11	wbc	wbc	PROPN
iajs-2976	139	12	and	and	CCONJ
iajs-2976	139	13	plt	plt	NOUN
iajs-2976	139	14	parameters	parameter	NOUN
iajs-2976	139	15	compared	compare	VERB
iajs-2976	139	16	to	to	ADP
iajs-2976	139	17	diabetic	diabetic	ADJ
iajs-2976	139	18	control	control	NOUN
iajs-2976	139	19	rats	rat	NOUN
iajs-2976	139	20	.	.	PUNCT
iajs-2976	140	1	rbc	rbc	PROPN
iajs-2976	140	2	count	count	NOUN
iajs-2976	140	3	in	in	ADP
iajs-2976	140	4	the	the	DET
iajs-2976	140	5	ubiquinone	ubiquinone	PROPN
iajs-2976	140	6	-	-	PUNCT
iajs-2976	140	7	treated	treat	VERB
iajs-2976	140	8	group	group	NOUN
iajs-2976	140	9	(	(	PUNCT
iajs-2976	140	10	group	group	NOUN
iajs-2976	140	11	t	t	PROPN
iajs-2976	140	12	)	)	PUNCT
iajs-2976	140	13	decreased	decrease	VERB
iajs-2976	140	14	insignificantly	insignificantly	ADV
iajs-2976	140	15	compared	compare	VERB
iajs-2976	140	16	to	to	ADP
iajs-2976	140	17	untreated	untreated	ADJ
iajs-2976	140	18	diabetic	diabetic	ADJ
iajs-2976	140	19	rats	rat	NOUN
iajs-2976	140	20	.	.	PUNCT
iajs-2976	141	1	table	table	NOUN
iajs-2976	141	2	3	3	NUM
iajs-2976	141	3	.	.	PUNCT
iajs-2976	142	1	the	the	DET
iajs-2976	142	2	impact	impact	NOUN
iajs-2976	142	3	of	of	ADP
iajs-2976	142	4	ubiquinone	ubiquinone	PROPN
iajs-2976	142	5	supplement	supplement	NOUN
iajs-2976	142	6	on	on	ADP
iajs-2976	142	7	blood	blood	NOUN
iajs-2976	142	8	component	component	NOUN
iajs-2976	142	9	parameters	parameter	NOUN
iajs-2976	142	10	in	in	ADP
iajs-2976	142	11	diabetic	diabetic	ADJ
iajs-2976	142	12	rats	rat	NOUN
iajs-2976	142	13	figure	figure	VERB
iajs-2976	142	14	3	3	NUM
iajs-2976	142	15	.	.	PUNCT
iajs-2976	142	16	effect	effect	NOUN
iajs-2976	142	17	of	of	ADP
iajs-2976	142	18	ubiquinone	ubiquinone	PROPN
iajs-2976	142	19	on	on	ADP
iajs-2976	142	20	blood	blood	NOUN
iajs-2976	142	21	levels	level	NOUN
iajs-2976	142	22	of	of	ADP
iajs-2976	142	23	blood	blood	NOUN
iajs-2976	142	24	component	component	NOUN
iajs-2976	142	25	parameters	parameter	NOUN
iajs-2976	142	26	.	.	PUNCT
iajs-2976	143	1	after	after	ADP
iajs-2976	143	2	three	three	NUM
iajs-2976	143	3	weeks	week	NOUN
iajs-2976	143	4	,	,	PUNCT
iajs-2976	143	5	blood	blood	NOUN
iajs-2976	143	6	levels	level	NOUN
iajs-2976	143	7	of	of	ADP
iajs-2976	143	8	wbc	wbc	PROPN
iajs-2976	143	9	,	,	PUNCT
iajs-2976	143	10	plt	plt	NOUN
iajs-2976	143	11	,	,	PUNCT
iajs-2976	143	12	and	and	CCONJ
iajs-2976	143	13	rbc	rbc	PROPN
iajs-2976	143	14	were	be	AUX
iajs-2976	143	15	measured	measure	VERB
iajs-2976	143	16	in	in	ADP
iajs-2976	143	17	three	three	NUM
iajs-2976	143	18	groups	group	NOUN
iajs-2976	143	19	of	of	ADP
iajs-2976	143	20	experimental	experimental	ADJ
iajs-2976	143	21	rats	rat	NOUN
iajs-2976	143	22	;	;	PUNCT
iajs-2976	143	23	the	the	DET
iajs-2976	143	24	negative	negative	ADJ
iajs-2976	143	25	control	control	PROPN
iajs-2976	143	26	group	group	NOUN
iajs-2976	143	27	(	(	PUNCT
iajs-2976	143	28	n	n	CCONJ
iajs-2976	143	29	)	)	PUNCT
iajs-2976	143	30	,	,	PUNCT
iajs-2976	143	31	the	the	DET
iajs-2976	143	32	diabetic	diabetic	ADJ
iajs-2976	143	33	control	control	NOUN
iajs-2976	143	34	group	group	NOUN
iajs-2976	143	35	(	(	PUNCT
iajs-2976	143	36	d	d	NOUN
iajs-2976	143	37	)	)	PUNCT
iajs-2976	143	38	,	,	PUNCT
iajs-2976	143	39	and	and	CCONJ
iajs-2976	143	40	the	the	DET
iajs-2976	143	41	ubiquinone	ubiquinone	PROPN
iajs-2976	143	42	treatment	treatment	NOUN
iajs-2976	143	43	group	group	NOUN
iajs-2976	143	44	(	(	PUNCT
iajs-2976	143	45	t	t	PROPN
iajs-2976	143	46	)	)	PUNCT
iajs-2976	143	47	.	.	PUNCT
iajs-2976	144	1	blood	blood	NOUN
iajs-2976	144	2	component	component	NOUN
iajs-2976	144	3	parameters	parameter	NOUN
iajs-2976	144	4	were	be	AUX
iajs-2976	144	5	evaluated	evaluate	VERB
iajs-2976	144	6	by	by	ADP
iajs-2976	144	7	the	the	DET
iajs-2976	144	8	automatic	automatic	ADJ
iajs-2976	144	9	hematology	hematology	NOUN
iajs-2976	144	10	analyzer	analyzer	NOUN
iajs-2976	144	11	swelab	swelab	NOUN
iajs-2976	144	12	alfa	alfa	PROPN
iajs-2976	144	13	standard	standard	NOUN
iajs-2976	144	14	(	(	PUNCT
iajs-2976	144	15	boule	boule	PROPN
iajs-2976	144	16	medical	medical	PROPN
iajs-2976	144	17	ab	ab	PROPN
iajs-2976	144	18	,	,	PUNCT
iajs-2976	144	19	sweden	sweden	PROPN
iajs-2976	144	20	)	)	PUNCT
iajs-2976	144	21	.	.	PUNCT
iajs-2976	145	1	data	datum	NOUN
iajs-2976	145	2	are	be	AUX
iajs-2976	145	3	presented	present	VERB
iajs-2976	145	4	as	as	ADP
iajs-2976	145	5	the	the	DET
iajs-2976	145	6	mean	mean	NOUN
iajs-2976	145	7	±	±	PROPN
iajs-2976	145	8	se	se	X
iajs-2976	145	9	(	(	PUNCT
iajs-2976	145	10	n=7	n=7	PROPN
iajs-2976	145	11	)	)	PUNCT
iajs-2976	145	12	.	.	PUNCT
iajs-2976	146	1	during	during	ADP
iajs-2976	146	2	the	the	DET
iajs-2976	146	3	same	same	ADJ
iajs-2976	146	4	medication	medication	NOUN
iajs-2976	146	5	period	period	NOUN
iajs-2976	146	6	,	,	PUNCT
iajs-2976	146	7	the	the	DET
iajs-2976	146	8	bars	bar	NOUN
iajs-2976	146	9	were	be	AUX
iajs-2976	146	10	marked	mark	VERB
iajs-2976	146	11	by	by	ADP
iajs-2976	146	12	different	different	ADJ
iajs-2976	146	13	asterisks	asterisk	NOUN
iajs-2976	146	14	(	(	PUNCT
iajs-2976	146	15	∗	∗	NOUN
iajs-2976	146	16	,	,	PUNCT
iajs-2976	146	17	∗∗	∗∗	NOUN
iajs-2976	146	18	)	)	PUNCT
iajs-2976	146	19	differ	differ	VERB
iajs-2976	146	20	significantly	significantly	ADV
iajs-2976	146	21	from	from	ADP
iajs-2976	146	22	each	each	DET
iajs-2976	146	23	another	another	PRON
iajs-2976	146	24	(	(	PUNCT
iajs-2976	146	25	p	p	X
iajs-2976	146	26	<	<	X
iajs-2976	146	27	0.05	0.05	NUM
iajs-2976	146	28	)	)	PUNCT
iajs-2976	146	29	.	.	PUNCT
iajs-2976	147	1	ns	n	VERB
iajs-2976	147	2	:	:	PUNCT
iajs-2976	147	3	not	not	PART
iajs-2976	147	4	significant	significant	ADJ
iajs-2976	147	5	.	.	PUNCT
iajs-2976	148	1	5	5	X
iajs-2976	148	2	.	.	X
iajs-2976	148	3	discussion	discussion	NOUN
iajs-2976	148	4	the	the	DET
iajs-2976	148	5	current	current	ADJ
iajs-2976	148	6	study	study	NOUN
iajs-2976	148	7	was	be	AUX
iajs-2976	148	8	performed	perform	VERB
iajs-2976	148	9	to	to	PART
iajs-2976	148	10	investigate	investigate	VERB
iajs-2976	148	11	the	the	DET
iajs-2976	148	12	modulating	modulating	ADJ
iajs-2976	148	13	impacts	impact	NOUN
iajs-2976	148	14	of	of	ADP
iajs-2976	148	15	ubiquinone	ubiquinone	PROPN
iajs-2976	148	16	on	on	ADP
iajs-2976	148	17	fasting	fast	VERB
iajs-2976	148	18	blood	blood	NOUN
iajs-2976	148	19	sugar	sugar	NOUN
iajs-2976	148	20	(	(	PUNCT
iajs-2976	148	21	fbg	fbg	PROPN
iajs-2976	148	22	)	)	PUNCT
iajs-2976	148	23	,	,	PUNCT
iajs-2976	148	24	pro	pro	ADJ
iajs-2976	148	25	-	-	ADJ
iajs-2976	148	26	inflammatory	inflammatory	ADJ
iajs-2976	148	27	adipocytokine	adipocytokine	NOUN
iajs-2976	148	28	(	(	PUNCT
iajs-2976	148	29	il-6	il-6	NUM
iajs-2976	148	30	)	)	PUNCT
iajs-2976	148	31	,	,	PUNCT
iajs-2976	148	32	and	and	CCONJ
iajs-2976	148	33	the	the	DET
iajs-2976	148	34	markers	marker	NOUN
iajs-2976	148	35	of	of	ADP
iajs-2976	148	36	diabetic	diabetic	ADJ
iajs-2976	148	37	myopathy	myopathy	ADJ
iajs-2976	148	38	,	,	PUNCT
iajs-2976	148	39	endotheliopathy	endotheliopathy	ADJ
iajs-2976	148	40	and	and	CCONJ
iajs-2976	148	41	blood	blood	NOUN
iajs-2976	148	42	components	component	NOUN
iajs-2976	148	43	in	in	ADP
iajs-2976	148	44	stz	stz	ADJ
iajs-2976	148	45	-	-	PUNCT
iajs-2976	148	46	induced	induce	VERB
iajs-2976	148	47	diabetic	diabetic	ADJ
iajs-2976	148	48	rats	rat	NOUN
iajs-2976	148	49	.	.	PUNCT
iajs-2976	149	1	the	the	DET
iajs-2976	149	2	results	result	NOUN
iajs-2976	149	3	of	of	ADP
iajs-2976	149	4	our	our	PRON
iajs-2976	149	5	study	study	NOUN
iajs-2976	149	6	showed	show	VERB
iajs-2976	149	7	that	that	SCONJ
iajs-2976	149	8	ubiquinone	ubiquinone	PROPN
iajs-2976	149	9	attenuates	attenuate	VERB
iajs-2976	149	10	hyperglycemia	hyperglycemia	NOUN
iajs-2976	149	11	and	and	CCONJ
iajs-2976	149	12	ameliorates	ameliorate	NOUN
iajs-2976	149	13	il-6	il-6	NUM
iajs-2976	149	14	,	,	PUNCT
iajs-2976	149	15	mda	mda	PROPN
iajs-2976	149	16	,	,	PUNCT
iajs-2976	149	17	no	no	INTJ
iajs-2976	149	18	and	and	CCONJ
iajs-2976	149	19	mb	mb	ADJ
iajs-2976	149	20	levels	level	NOUN
iajs-2976	149	21	.	.	PUNCT
iajs-2976	150	1	the	the	DET
iajs-2976	150	2	wbc	wbc	PROPN
iajs-2976	150	3	level	level	NOUN
iajs-2976	150	4	,	,	PUNCT
iajs-2976	150	5	however	however	ADV
iajs-2976	150	6	,	,	PUNCT
iajs-2976	150	7	has	have	AUX
iajs-2976	150	8	only	only	ADV
iajs-2976	150	9	been	be	AUX
iajs-2976	150	10	slightly	slightly	ADV
iajs-2976	150	11	altered	alter	VERB
iajs-2976	150	12	.	.	PUNCT
iajs-2976	151	1	parameters	parameter	NOUN
iajs-2976	151	2	negative	negative	ADJ
iajs-2976	151	3	control	control	NOUN
iajs-2976	151	4	(	(	PUNCT
iajs-2976	151	5	n	n	CCONJ
iajs-2976	151	6	)	)	PUNCT
iajs-2976	151	7	diabetic	diabetic	ADJ
iajs-2976	151	8	control	control	NOUN
iajs-2976	151	9	(	(	PUNCT
iajs-2976	151	10	d	d	X
iajs-2976	151	11	)	)	PUNCT
iajs-2976	151	12	ubiquinone	ubiquinone	PROPN
iajs-2976	151	13	treatment	treatment	NOUN
iajs-2976	151	14	(	(	PUNCT
iajs-2976	151	15	t	t	NOUN
iajs-2976	151	16	)	)	PUNCT
iajs-2976	151	17	p	p	NOUN
iajs-2976	151	18	-	-	PUNCT
iajs-2976	151	19	value	value	NOUN
iajs-2976	151	20	d	d	NOUN
iajs-2976	151	21	vs.	vs.	ADP
iajs-2976	151	22	n	n	CCONJ
iajs-2976	151	23	p	p	NOUN
iajs-2976	151	24	-	-	PUNCT
iajs-2976	151	25	value	value	NOUN
iajs-2976	151	26	d	d	X
iajs-2976	151	27	vs.	vs.	ADP
iajs-2976	151	28	t	t	PROPN
iajs-2976	151	29	wbc	wbc	PROPN
iajs-2976	151	30	(	(	PUNCT
iajs-2976	151	31	109	109	NUM
iajs-2976	151	32	/	/	SYM
iajs-2976	151	33	l	l	NOUN
iajs-2976	151	34	)	)	PUNCT
iajs-2976	151	35	13.74±0.79	13.74±0.79	NUM
iajs-2976	151	36	6.88±1.8	6.88±1.8	ADJ
iajs-2976	151	37	8.4±1.32	8.4±1.32	NUM
iajs-2976	151	38	0.0098	0.0098	NUM
iajs-2976	151	39	0.648	0.648	NUM
iajs-2976	151	40	plt	plt	NOUN
iajs-2976	151	41	(	(	PUNCT
iajs-2976	151	42	109	109	NUM
iajs-2976	151	43	/	/	SYM
iajs-2976	151	44	l	l	NOUN
iajs-2976	151	45	)	)	PUNCT
iajs-2976	151	46	586.8±68.39	586.8±68.39	NUM
iajs-2976	151	47	515.7±78.64	515.7±78.64	NUM
iajs-2976	151	48	624.4±52.43	624.4±52.43	NUM
iajs-2976	151	49	0.696	0.696	NUM
iajs-2976	151	50	0.398	0.398	NUM
iajs-2976	151	51	rbc	rbc	PROPN
iajs-2976	151	52	(	(	PUNCT
iajs-2976	151	53	1012	1012	NUM
iajs-2976	151	54	/	/	SYM
iajs-2976	151	55	l	l	NOUN
iajs-2976	151	56	)	)	PUNCT
iajs-2976	151	57	8.47±0.25	8.47±0.25	PROPN
iajs-2976	151	58	7.18±1.52	7.18±1.52	NUM
iajs-2976	151	59	7.05±0.29	7.05±0.29	NOUN
iajs-2976	151	60	0.43	0.43	NUM
iajs-2976	151	61	0.001	0.001	NUM
iajs-2976	151	62	values	value	NOUN
iajs-2976	151	63	are	be	AUX
iajs-2976	151	64	expressed	express	VERB
iajs-2976	151	65	as	as	ADP
iajs-2976	151	66	mean	mean	ADJ
iajs-2976	151	67	±sem	±sem	NOUN
iajs-2976	151	68	,	,	PUNCT
iajs-2976	151	69	p<0.05	p<0.05	NOUN
iajs-2976	151	70	indicates	indicate	VERB
iajs-2976	151	71	significant	significant	ADJ
iajs-2976	151	72	difference	difference	NOUN
iajs-2976	151	73	ihjpas	ihjpa	NOUN
iajs-2976	151	74	.	.	PUNCT
iajs-2976	152	1	36(2)2023	36(2)2023	NUM
iajs-2976	152	2	93	93	NUM
iajs-2976	152	3	diabetic	diabetic	ADJ
iajs-2976	152	4	model	model	NOUN
iajs-2976	152	5	validation	validation	NOUN
iajs-2976	152	6	and	and	CCONJ
iajs-2976	152	7	the	the	DET
iajs-2976	152	8	effect	effect	NOUN
iajs-2976	152	9	of	of	ADP
iajs-2976	152	10	ubiquinone	ubiquinone	PROPN
iajs-2976	152	11	on	on	ADP
iajs-2976	152	12	blood	blood	NOUN
iajs-2976	152	13	glucose	glucose	NOUN
iajs-2976	152	14	concentration	concentration	NOUN
iajs-2976	152	15	diabetes	diabetes	NOUN
iajs-2976	152	16	was	be	AUX
iajs-2976	152	17	confirmed	confirm	VERB
iajs-2976	152	18	by	by	ADP
iajs-2976	152	19	the	the	DET
iajs-2976	152	20	significant	significant	ADJ
iajs-2976	152	21	elevation	elevation	NOUN
iajs-2976	152	22	of	of	ADP
iajs-2976	152	23	fbg	fbg	PROPN
iajs-2976	152	24	in	in	ADP
iajs-2976	152	25	stz	stz	ADJ
iajs-2976	152	26	-	-	PUNCT
iajs-2976	152	27	induced	induce	VERB
iajs-2976	152	28	diabetic	diabetic	ADJ
iajs-2976	152	29	rats	rat	NOUN
iajs-2976	152	30	;	;	PUNCT
iajs-2976	152	31	this	this	PRON
iajs-2976	152	32	is	be	AUX
iajs-2976	152	33	caused	cause	VERB
iajs-2976	152	34	by	by	ADP
iajs-2976	152	35	the	the	DET
iajs-2976	152	36	destruction	destruction	NOUN
iajs-2976	152	37	of	of	ADP
iajs-2976	152	38	pancreatic	pancreatic	ADJ
iajs-2976	152	39	β	β	NOUN
iajs-2976	152	40	-	-	NOUN
iajs-2976	152	41	cells	cell	NOUN
iajs-2976	152	42	(	(	PUNCT
iajs-2976	152	43	β	β	NOUN
iajs-2976	152	44	-	-	NOUN
iajs-2976	152	45	cell	cell	NOUN
iajs-2976	152	46	failure	failure	NOUN
iajs-2976	152	47	)	)	PUNCT
iajs-2976	152	48	by	by	ADP
iajs-2976	152	49	a	a	DET
iajs-2976	152	50	diabetogenic	diabetogenic	ADJ
iajs-2976	152	51	agent	agent	NOUN
iajs-2976	152	52	(	(	PUNCT
iajs-2976	152	53	stz	stz	NOUN
iajs-2976	152	54	)	)	PUNCT
iajs-2976	152	55	.	.	PUNCT
iajs-2976	153	1	as	as	ADP
iajs-2976	153	2	stz	stz	ADJ
iajs-2976	153	3	toxicity	toxicity	NOUN
iajs-2976	153	4	progresses	progress	NOUN
iajs-2976	153	5	(	(	PUNCT
iajs-2976	153	6	figure	figure	NOUN
iajs-2976	153	7	4	4	NUM
iajs-2976	153	8	)	)	PUNCT
iajs-2976	153	9	,	,	PUNCT
iajs-2976	153	10	some	some	DET
iajs-2976	153	11	β	β	NOUN
iajs-2976	153	12	-	-	NOUN
iajs-2976	153	13	cells	cell	NOUN
iajs-2976	153	14	survive	survive	NOUN
iajs-2976	153	15	;	;	PUNCT
iajs-2976	153	16	however	however	ADV
iajs-2976	153	17	,	,	PUNCT
iajs-2976	153	18	hyperglycemic	hyperglycemic	ADJ
iajs-2976	153	19	toxicity	toxicity	NOUN
iajs-2976	153	20	impairs	impair	VERB
iajs-2976	153	21	these	these	DET
iajs-2976	153	22	surviving	survive	VERB
iajs-2976	153	23	β	β	NOUN
iajs-2976	153	24	-	-	NOUN
iajs-2976	153	25	cells	cell	NOUN
iajs-2976	153	26	further	far	ADV
iajs-2976	153	27	.	.	PUNCT
iajs-2976	154	1	a	a	DET
iajs-2976	154	2	high	high	ADJ
iajs-2976	154	3	glucose	glucose	NOUN
iajs-2976	154	4	level	level	NOUN
iajs-2976	154	5	increases	increase	VERB
iajs-2976	154	6	nonenzymatic	nonenzymatic	ADJ
iajs-2976	154	7	glycation	glycation	NOUN
iajs-2976	154	8	of	of	ADP
iajs-2976	154	9	proteins	protein	NOUN
iajs-2976	154	10	,	,	PUNCT
iajs-2976	154	11	as	as	ADV
iajs-2976	154	12	well	well	ADV
iajs-2976	154	13	as	as	ADP
iajs-2976	154	14	glucose	glucose	NOUN
iajs-2976	154	15	oxidation	oxidation	NOUN
iajs-2976	154	16	,	,	PUNCT
iajs-2976	154	17	all	all	PRON
iajs-2976	154	18	of	of	ADP
iajs-2976	154	19	which	which	PRON
iajs-2976	154	20	lead	lead	VERB
iajs-2976	154	21	to	to	PART
iajs-2976	154	22	oxidative	oxidative	ADJ
iajs-2976	154	23	stress	stress	NOUN
iajs-2976	154	24	[	[	X
iajs-2976	154	25	45	45	NUM
iajs-2976	154	26	]	]	PUNCT
iajs-2976	154	27	.	.	PUNCT
iajs-2976	155	1	a	a	DET
iajs-2976	155	2	number	number	NOUN
iajs-2976	155	3	of	of	ADP
iajs-2976	155	4	lines	line	NOUN
iajs-2976	155	5	of	of	ADP
iajs-2976	155	6	research	research	NOUN
iajs-2976	155	7	have	have	AUX
iajs-2976	155	8	described	describe	VERB
iajs-2976	155	9	the	the	DET
iajs-2976	155	10	consequences	consequence	NOUN
iajs-2976	155	11	of	of	ADP
iajs-2976	155	12	persistent	persistent	ADJ
iajs-2976	155	13	hyperglycemia	hyperglycemia	NOUN
iajs-2976	155	14	oxidative	oxidative	ADJ
iajs-2976	155	15	stress	stress	NOUN
iajs-2976	155	16	which	which	PRON
iajs-2976	155	17	weakens	weaken	VERB
iajs-2976	155	18	antioxidant	antioxidant	ADJ
iajs-2976	155	19	enzymes	enzyme	NOUN
iajs-2976	155	20	and	and	CCONJ
iajs-2976	155	21	other	other	ADJ
iajs-2976	155	22	antioxidant	antioxidant	ADJ
iajs-2976	155	23	molecules	molecule	NOUN
iajs-2976	155	24	[	[	X
iajs-2976	155	25	46	46	NUM
iajs-2976	155	26	]	]	PUNCT
iajs-2976	155	27	.	.	PUNCT
iajs-2976	156	1	figure	figure	NOUN
iajs-2976	156	2	4	4	NUM
iajs-2976	156	3	.	.	PUNCT
iajs-2976	157	1	a	a	DET
iajs-2976	157	2	schematic	schematic	ADJ
iajs-2976	157	3	diagram	diagram	NOUN
iajs-2976	157	4	demonstrating	demonstrate	VERB
iajs-2976	157	5	the	the	DET
iajs-2976	157	6	mechanism	mechanism	NOUN
iajs-2976	157	7	of	of	ADP
iajs-2976	157	8	β	β	NOUN
iajs-2976	157	9	-	-	NOUN
iajs-2976	157	10	cell	cell	NOUN
iajs-2976	157	11	destruction	destruction	NOUN
iajs-2976	157	12	by	by	ADP
iajs-2976	157	13	stz	stz	NOUN
iajs-2976	157	14	and	and	CCONJ
iajs-2976	157	15	hyperglycemia	hyperglycemia	NOUN
iajs-2976	157	16	and	and	CCONJ
iajs-2976	157	17	the	the	DET
iajs-2976	157	18	proposed	propose	VERB
iajs-2976	157	19	pathway	pathway	NOUN
iajs-2976	157	20	wherein	wherein	ADJ
iajs-2976	157	21	hyperglycemia	hyperglycemia	NOUN
iajs-2976	157	22	triggers	trigger	VERB
iajs-2976	157	23	the	the	DET
iajs-2976	157	24	release	release	NOUN
iajs-2976	157	25	of	of	ADP
iajs-2976	157	26	il-6	il-6	NUM
iajs-2976	157	27	and	and	CCONJ
iajs-2976	157	28	mda	mda	PROPN
iajs-2976	157	29	that	that	PRON
iajs-2976	157	30	causes	cause	VERB
iajs-2976	157	31	muscle	muscle	NOUN
iajs-2976	157	32	injury	injury	NOUN
iajs-2976	157	33	.	.	PUNCT
iajs-2976	158	1	a	a	DET
iajs-2976	158	2	glucose	glucose	NOUN
iajs-2976	158	3	overload	overload	NOUN
iajs-2976	158	4	activates	activate	VERB
iajs-2976	158	5	several	several	ADJ
iajs-2976	158	6	metabolic	metabolic	NOUN
iajs-2976	158	7	pathways	pathway	NOUN
iajs-2976	158	8	that	that	PRON
iajs-2976	158	9	produce	produce	VERB
iajs-2976	158	10	more	more	ADJ
iajs-2976	158	11	ros	ro	NOUN
iajs-2976	158	12	and	and	CCONJ
iajs-2976	158	13	oxidative	oxidative	ADJ
iajs-2976	158	14	stress	stress	NOUN
iajs-2976	158	15	,	,	PUNCT
iajs-2976	158	16	leading	lead	VERB
iajs-2976	158	17	to	to	ADP
iajs-2976	158	18	β	β	NOUN
iajs-2976	158	19	-	-	NOUN
iajs-2976	158	20	cells	cell	NOUN
iajs-2976	158	21	death	death	NOUN
iajs-2976	158	22	(	(	PUNCT
iajs-2976	158	23	figure	figure	NOUN
iajs-2976	158	24	4	4	NUM
iajs-2976	158	25	)	)	PUNCT
iajs-2976	158	26	.	.	PUNCT
iajs-2976	159	1	combined	combine	VERB
iajs-2976	159	2	with	with	ADP
iajs-2976	159	3	a	a	DET
iajs-2976	159	4	low	low	ADJ
iajs-2976	159	5	antioxidant	antioxidant	NOUN
iajs-2976	159	6	capacity	capacity	NOUN
iajs-2976	159	7	in	in	ADP
iajs-2976	159	8	cells	cell	NOUN
iajs-2976	159	9	,	,	PUNCT
iajs-2976	159	10	these	these	DET
iajs-2976	159	11	pathways	pathway	NOUN
iajs-2976	159	12	result	result	VERB
iajs-2976	159	13	in	in	ADP
iajs-2976	159	14	ros	ros	PROPN
iajs-2976	159	15	production	production	NOUN
iajs-2976	159	16	,	,	PUNCT
iajs-2976	159	17	causing	cause	VERB
iajs-2976	159	18	secondary	secondary	ADJ
iajs-2976	159	19	β	β	NOUN
iajs-2976	159	20	-	-	NOUN
iajs-2976	159	21	cell	cell	NOUN
iajs-2976	159	22	failure	failure	NOUN
iajs-2976	159	23	in	in	ADP
iajs-2976	159	24	diabetics	diabetic	NOUN
iajs-2976	159	25	[	[	X
iajs-2976	159	26	47	47	NUM
iajs-2976	159	27	]	]	PUNCT
iajs-2976	159	28	.	.	PUNCT
iajs-2976	160	1	in	in	ADP
iajs-2976	160	2	the	the	DET
iajs-2976	160	3	presence	presence	NOUN
iajs-2976	160	4	of	of	ADP
iajs-2976	160	5	high	high	ADJ
iajs-2976	160	6	levels	level	NOUN
iajs-2976	160	7	of	of	ADP
iajs-2976	160	8	free	free	ADJ
iajs-2976	160	9	radicals	radical	NOUN
iajs-2976	160	10	,	,	PUNCT
iajs-2976	160	11	pancreatic	pancreatic	ADJ
iajs-2976	160	12	islet	islet	NOUN
iajs-2976	160	13	cells	cell	NOUN
iajs-2976	160	14	die	die	VERB
iajs-2976	160	15	and	and	CCONJ
iajs-2976	160	16	become	become	VERB
iajs-2976	160	17	dysfunctional	dysfunctional	ADJ
iajs-2976	160	18	(	(	PUNCT
iajs-2976	160	19	rosinduced	rosinduce	VERB
iajs-2976	160	20	apoptosis	apoptosis	NOUN
iajs-2976	160	21	)	)	PUNCT
iajs-2976	160	22	.	.	PUNCT
iajs-2976	161	1	our	our	PRON
iajs-2976	161	2	data	datum	NOUN
iajs-2976	161	3	from	from	ADP
iajs-2976	161	4	analysis	analysis	NOUN
iajs-2976	161	5	reveal	reveal	VERB
iajs-2976	161	6	that	that	SCONJ
iajs-2976	161	7	the	the	DET
iajs-2976	161	8	administration	administration	NOUN
iajs-2976	161	9	of	of	ADP
iajs-2976	161	10	ubiquinone	ubiquinone	PROPN
iajs-2976	161	11	significantly	significantly	ADV
iajs-2976	161	12	lower	low	ADJ
iajs-2976	161	13	blood	blood	NOUN
iajs-2976	161	14	glucose	glucose	NOUN
iajs-2976	161	15	levels	level	NOUN
iajs-2976	161	16	in	in	ADP
iajs-2976	161	17	the	the	DET
iajs-2976	161	18	group	group	NOUN
iajs-2976	161	19	of	of	ADP
iajs-2976	161	20	diabetic	diabetic	ADJ
iajs-2976	161	21	rats	rat	NOUN
iajs-2976	161	22	.	.	PUNCT
iajs-2976	162	1	as	as	ADP
iajs-2976	162	2	per	per	ADP
iajs-2976	162	3	the	the	DET
iajs-2976	162	4	previous	previous	ADJ
iajs-2976	162	5	reports	report	NOUN
iajs-2976	162	6	,	,	PUNCT
iajs-2976	162	7	it	it	PRON
iajs-2976	162	8	was	be	AUX
iajs-2976	162	9	found	find	VERB
iajs-2976	162	10	that	that	SCONJ
iajs-2976	162	11	ubiquinone	ubiquinone	PROPN
iajs-2976	162	12	has	have	VERB
iajs-2976	162	13	an	an	DET
iajs-2976	162	14	anti	anti	ADJ
iajs-2976	162	15	-	-	ADJ
iajs-2976	162	16	diabetic	diabetic	ADJ
iajs-2976	162	17	effect	effect	NOUN
iajs-2976	162	18	[	[	X
iajs-2976	162	19	48	48	NUM
iajs-2976	162	20	-	-	SYM
iajs-2976	162	21	51	51	NUM
iajs-2976	162	22	]	]	PUNCT
iajs-2976	162	23	,	,	PUNCT
iajs-2976	162	24	while	while	SCONJ
iajs-2976	162	25	in	in	ADP
iajs-2976	162	26	contradictory	contradictory	ADJ
iajs-2976	162	27	some	some	DET
iajs-2976	162	28	the	the	DET
iajs-2976	162	29	literatures	literature	NOUN
iajs-2976	162	30	also	also	ADV
iajs-2976	162	31	revealed	reveal	VERB
iajs-2976	162	32	that	that	SCONJ
iajs-2976	162	33	ubiquinone	ubiquinone	PROPN
iajs-2976	162	34	did	do	AUX
iajs-2976	162	35	not	not	PART
iajs-2976	162	36	have	have	VERB
iajs-2976	162	37	any	any	DET
iajs-2976	162	38	effect	effect	NOUN
iajs-2976	162	39	on	on	ADP
iajs-2976	162	40	blood	blood	NOUN
iajs-2976	162	41	glucose	glucose	NOUN
iajs-2976	162	42	level	level	NOUN
iajs-2976	162	43	[	[	X
iajs-2976	162	44	52	52	NUM
iajs-2976	162	45	]	]	PUNCT
iajs-2976	162	46	.	.	PUNCT
iajs-2976	163	1	this	this	DET
iajs-2976	163	2	reduction	reduction	NOUN
iajs-2976	163	3	in	in	ADP
iajs-2976	163	4	the	the	DET
iajs-2976	163	5	levels	level	NOUN
iajs-2976	163	6	of	of	ADP
iajs-2976	163	7	fbg	fbg	PROPN
iajs-2976	163	8	would	would	AUX
iajs-2976	163	9	be	be	AUX
iajs-2976	163	10	due	due	ADJ
iajs-2976	163	11	to	to	ADP
iajs-2976	163	12	insulin	insulin	NOUN
iajs-2976	163	13	release	release	NOUN
iajs-2976	163	14	from	from	ADP
iajs-2976	163	15	survived	survive	VERB
iajs-2976	163	16	β	β	NOUN
iajs-2976	163	17	-	-	NOUN
iajs-2976	163	18	cells	cell	NOUN
iajs-2976	163	19	which	which	PRON
iajs-2976	163	20	have	have	AUX
iajs-2976	163	21	been	be	AUX
iajs-2976	163	22	protected	protect	VERB
iajs-2976	163	23	by	by	ADP
iajs-2976	163	24	the	the	DET
iajs-2976	163	25	antioxidant	antioxidant	ADJ
iajs-2976	163	26	impact	impact	NOUN
iajs-2976	163	27	of	of	ADP
iajs-2976	163	28	ubiquinone	ubiquinone	PROPN
iajs-2976	163	29	.	.	PUNCT
iajs-2976	164	1	ubiquinone	ubiquinone	PROPN
iajs-2976	164	2	's	's	PART
iajs-2976	164	3	protective	protective	ADJ
iajs-2976	164	4	mechanism	mechanism	NOUN
iajs-2976	164	5	is	be	AUX
iajs-2976	164	6	due	due	ADJ
iajs-2976	164	7	to	to	ADP
iajs-2976	164	8	its	its	PRON
iajs-2976	164	9	ability	ability	NOUN
iajs-2976	164	10	to	to	PART
iajs-2976	164	11	neutralize	neutralize	VERB
iajs-2976	164	12	free	free	ADJ
iajs-2976	164	13	radicals	radical	NOUN
iajs-2976	164	14	.	.	PUNCT
iajs-2976	165	1	the	the	DET
iajs-2976	165	2	ability	ability	NOUN
iajs-2976	165	3	of	of	ADP
iajs-2976	165	4	ubiquinone	ubiquinone	PROPN
iajs-2976	165	5	to	to	PART
iajs-2976	165	6	scavenge	scavenge	VERB
iajs-2976	165	7	ros	ros	PROPN
iajs-2976	165	8	may	may	AUX
iajs-2976	165	9	be	be	AUX
iajs-2976	165	10	one	one	NUM
iajs-2976	165	11	of	of	ADP
iajs-2976	165	12	the	the	DET
iajs-2976	165	13	reasons	reason	NOUN
iajs-2976	165	14	for	for	ADP
iajs-2976	165	15	its	its	PRON
iajs-2976	165	16	ability	ability	NOUN
iajs-2976	165	17	to	to	PART
iajs-2976	165	18	inhibit	inhibit	VERB
iajs-2976	165	19	nf	nf	ADJ
iajs-2976	165	20	-	-	PUNCT
iajs-2976	165	21	кb	кb	NOUN
iajs-2976	165	22	activation	activation	NOUN
iajs-2976	165	23	and	and	CCONJ
iajs-2976	165	24	protection	protection	NOUN
iajs-2976	165	25	of	of	ADP
iajs-2976	165	26	pancreatic	pancreatic	ADJ
iajs-2976	165	27	β	β	NOUN
iajs-2976	165	28	-	-	NOUN
iajs-2976	165	29	cells	cell	NOUN
iajs-2976	165	30	[	[	X
iajs-2976	165	31	49	49	NUM
iajs-2976	165	32	]	]	PUNCT
iajs-2976	165	33	.	.	PUNCT
iajs-2976	166	1	hence	hence	ADV
iajs-2976	166	2	,	,	PUNCT
iajs-2976	166	3	we	we	PRON
iajs-2976	166	4	focused	focus	VERB
iajs-2976	166	5	on	on	ADP
iajs-2976	166	6	the	the	DET
iajs-2976	166	7	antioxidative	antioxidative	ADJ
iajs-2976	166	8	properties	property	NOUN
iajs-2976	166	9	of	of	ADP
iajs-2976	166	10	ihjpas	ihjpas	PROPN
iajs-2976	166	11	.	.	PUNCT
iajs-2976	167	1	36(2)2023	36(2)2023	NUM
iajs-2976	167	2	94	94	NUM
iajs-2976	167	3	ubiquinone	ubiquinone	NOUN
iajs-2976	167	4	on	on	ADP
iajs-2976	167	5	pancreatic	pancreatic	ADJ
iajs-2976	167	6	β	β	NOUN
iajs-2976	167	7	-	-	NOUN
iajs-2976	167	8	cell	cell	NOUN
iajs-2976	167	9	oxidative	oxidative	ADJ
iajs-2976	167	10	injury	injury	NOUN
iajs-2976	167	11	.	.	PUNCT
iajs-2976	168	1	ubiquinone	ubiquinone	PROPN
iajs-2976	168	2	neutralizes	neutralize	VERB
iajs-2976	168	3	free	free	ADJ
iajs-2976	168	4	radicals	radical	NOUN
iajs-2976	168	5	and	and	CCONJ
iajs-2976	168	6	prevents	prevent	VERB
iajs-2976	168	7	their	their	PRON
iajs-2976	168	8	cytotoxic	cytotoxic	ADJ
iajs-2976	168	9	effect	effect	NOUN
iajs-2976	168	10	on	on	ADP
iajs-2976	168	11	surviving	survive	VERB
iajs-2976	168	12	β	β	NOUN
iajs-2976	168	13	-	-	NOUN
iajs-2976	168	14	cells	cell	NOUN
iajs-2976	168	15	after	after	ADP
iajs-2976	168	16	stz	stz	NOUN
iajs-2976	168	17	injection	injection	NOUN
iajs-2976	168	18	(	(	PUNCT
iajs-2976	168	19	figure	figure	NOUN
iajs-2976	168	20	4	4	NUM
iajs-2976	168	21	)	)	PUNCT
iajs-2976	168	22	.	.	PUNCT
iajs-2976	169	1	due	due	ADP
iajs-2976	169	2	to	to	ADP
iajs-2976	169	3	its	its	PRON
iajs-2976	169	4	glucose	glucose	NOUN
iajs-2976	169	5	lowering	lower	VERB
iajs-2976	169	6	effect	effect	NOUN
iajs-2976	169	7	,	,	PUNCT
iajs-2976	169	8	ubiquinone	ubiquinone	PROPN
iajs-2976	169	9	may	may	AUX
iajs-2976	169	10	stimulate	stimulate	VERB
iajs-2976	169	11	the	the	DET
iajs-2976	169	12	synthesis	synthesis	NOUN
iajs-2976	169	13	of	of	ADP
iajs-2976	169	14	insulin	insulin	NOUN
iajs-2976	169	15	from	from	ADP
iajs-2976	169	16	the	the	DET
iajs-2976	169	17	residual	residual	ADJ
iajs-2976	169	18	β	β	NOUN
iajs-2976	169	19	-	-	NOUN
iajs-2976	169	20	cells	cell	NOUN
iajs-2976	169	21	or	or	CCONJ
iajs-2976	169	22	recovered	recover	VERB
iajs-2976	169	23	β	β	NOUN
iajs-2976	169	24	-	-	NOUN
iajs-2976	169	25	cells	cell	NOUN
iajs-2976	169	26	.	.	PUNCT
iajs-2976	170	1	effect	effect	NOUN
iajs-2976	170	2	of	of	ADP
iajs-2976	170	3	ubiquinone	ubiquinone	PROPN
iajs-2976	170	4	on	on	ADP
iajs-2976	170	5	parameters	parameter	NOUN
iajs-2976	170	6	of	of	ADP
iajs-2976	170	7	oxidative	oxidative	ADJ
iajs-2976	170	8	stress	stress	NOUN
iajs-2976	170	9	,	,	PUNCT
iajs-2976	170	10	mda	mda	PROPN
iajs-2976	170	11	to	to	PART
iajs-2976	170	12	investigate	investigate	VERB
iajs-2976	170	13	the	the	DET
iajs-2976	170	14	protective	protective	ADJ
iajs-2976	170	15	effects	effect	NOUN
iajs-2976	170	16	of	of	ADP
iajs-2976	170	17	ubiquinone	ubiquinone	PROPN
iajs-2976	170	18	against	against	ADP
iajs-2976	170	19	oxidative	oxidative	ADJ
iajs-2976	170	20	stress	stress	NOUN
iajs-2976	170	21	in	in	ADP
iajs-2976	170	22	diabetic	diabetic	ADJ
iajs-2976	170	23	animals	animal	NOUN
iajs-2976	170	24	,	,	PUNCT
iajs-2976	170	25	the	the	DET
iajs-2976	170	26	levels	level	NOUN
iajs-2976	170	27	of	of	ADP
iajs-2976	170	28	mda	mda	PROPN
iajs-2976	170	29	in	in	ADP
iajs-2976	170	30	the	the	DET
iajs-2976	170	31	serum	serum	NOUN
iajs-2976	170	32	samples	sample	NOUN
iajs-2976	170	33	were	be	AUX
iajs-2976	170	34	measured	measure	VERB
iajs-2976	170	35	.	.	PUNCT
iajs-2976	171	1	after	after	ADP
iajs-2976	171	2	three	three	NUM
iajs-2976	171	3	weeks	week	NOUN
iajs-2976	171	4	,	,	PUNCT
iajs-2976	171	5	our	our	PRON
iajs-2976	171	6	results	result	NOUN
iajs-2976	171	7	showed	show	VERB
iajs-2976	171	8	that	that	SCONJ
iajs-2976	171	9	the	the	DET
iajs-2976	171	10	mda	mda	PROPN
iajs-2976	171	11	levels	level	NOUN
iajs-2976	171	12	in	in	ADP
iajs-2976	171	13	the	the	DET
iajs-2976	171	14	diabetic	diabetic	PROPN
iajs-2976	171	15	control	control	NOUN
iajs-2976	171	16	group	group	NOUN
iajs-2976	171	17	were	be	AUX
iajs-2976	171	18	considerably	considerably	ADV
iajs-2976	171	19	higher	high	ADJ
iajs-2976	171	20	than	than	ADP
iajs-2976	171	21	in	in	ADP
iajs-2976	171	22	the	the	DET
iajs-2976	171	23	normal	normal	ADJ
iajs-2976	171	24	control	control	NOUN
iajs-2976	171	25	group	group	NOUN
iajs-2976	171	26	.	.	PUNCT
iajs-2976	172	1	the	the	DET
iajs-2976	172	2	diabetic	diabetic	ADJ
iajs-2976	172	3	group	group	NOUN
iajs-2976	172	4	supplied	supply	VERB
iajs-2976	172	5	with	with	ADP
iajs-2976	172	6	ubiquinone	ubiquinone	PROPN
iajs-2976	172	7	at	at	ADP
iajs-2976	172	8	a	a	DET
iajs-2976	172	9	dose	dose	NOUN
iajs-2976	172	10	of	of	ADP
iajs-2976	172	11	5	5	NUM
iajs-2976	172	12	mg	mg	NOUN
iajs-2976	172	13	per	per	ADP
iajs-2976	172	14	kg	kg	NOUN
iajs-2976	172	15	of	of	ADP
iajs-2976	172	16	food	food	NOUN
iajs-2976	172	17	had	have	VERB
iajs-2976	172	18	their	their	PRON
iajs-2976	172	19	mda	mda	PROPN
iajs-2976	172	20	levels	level	NOUN
iajs-2976	172	21	lower	low	ADJ
iajs-2976	172	22	than	than	ADP
iajs-2976	172	23	the	the	DET
iajs-2976	172	24	diabetic	diabetic	ADJ
iajs-2976	172	25	control	control	NOUN
iajs-2976	172	26	group	group	NOUN
iajs-2976	172	27	.	.	PUNCT
iajs-2976	173	1	we	we	PRON
iajs-2976	173	2	noticed	notice	VERB
iajs-2976	173	3	a	a	DET
iajs-2976	173	4	significant	significant	ADJ
iajs-2976	173	5	increase	increase	NOUN
iajs-2976	173	6	in	in	ADP
iajs-2976	173	7	the	the	DET
iajs-2976	173	8	mda	mda	PROPN
iajs-2976	173	9	concentration	concentration	NOUN
iajs-2976	173	10	in	in	ADP
iajs-2976	173	11	the	the	DET
iajs-2976	173	12	diabetic	diabetic	ADJ
iajs-2976	173	13	rodents	rodent	NOUN
iajs-2976	173	14	'	'	PART
iajs-2976	173	15	serum	serum	NOUN
iajs-2976	173	16	,	,	PUNCT
iajs-2976	173	17	similar	similar	ADJ
iajs-2976	173	18	findings	finding	NOUN
iajs-2976	173	19	were	be	AUX
iajs-2976	173	20	reported	report	VERB
iajs-2976	173	21	by	by	ADP
iajs-2976	173	22	other	other	ADJ
iajs-2976	173	23	researchers	researcher	NOUN
iajs-2976	173	24	[	[	X
iajs-2976	173	25	53	53	NUM
iajs-2976	173	26	,	,	PUNCT
iajs-2976	173	27	54	54	NUM
iajs-2976	173	28	]	]	PUNCT
iajs-2976	173	29	.	.	PUNCT
iajs-2976	174	1	previous	previous	ADJ
iajs-2976	174	2	studies	study	NOUN
iajs-2976	174	3	have	have	AUX
iajs-2976	174	4	also	also	ADV
iajs-2976	174	5	suggested	suggest	VERB
iajs-2976	174	6	that	that	SCONJ
iajs-2976	174	7	high	high	ADJ
iajs-2976	174	8	level	level	NOUN
iajs-2976	174	9	of	of	ADP
iajs-2976	174	10	free	free	ADJ
iajs-2976	174	11	radicals	radical	NOUN
iajs-2976	174	12	could	could	AUX
iajs-2976	174	13	lead	lead	VERB
iajs-2976	174	14	to	to	ADP
iajs-2976	174	15	the	the	DET
iajs-2976	174	16	formation	formation	NOUN
iajs-2976	174	17	of	of	ADP
iajs-2976	174	18	lipid	lipid	ADJ
iajs-2976	174	19	peroxidation	peroxidation	NOUN
iajs-2976	174	20	in	in	ADP
iajs-2976	174	21	stz	stz	ADJ
iajs-2976	174	22	-	-	PUNCT
iajs-2976	174	23	induced	induce	VERB
iajs-2976	174	24	diabetes	diabetes	NOUN
iajs-2976	174	25	[	[	X
iajs-2976	174	26	55	55	NUM
iajs-2976	174	27	,	,	PUNCT
iajs-2976	174	28	56	56	NUM
iajs-2976	174	29	]	]	PUNCT
iajs-2976	174	30	.	.	PUNCT
iajs-2976	175	1	in	in	ADP
iajs-2976	175	2	light	light	NOUN
iajs-2976	175	3	of	of	ADP
iajs-2976	175	4	these	these	DET
iajs-2976	175	5	findings	finding	NOUN
iajs-2976	175	6	,	,	PUNCT
iajs-2976	175	7	we	we	PRON
iajs-2976	175	8	hypothesized	hypothesize	VERB
iajs-2976	175	9	that	that	SCONJ
iajs-2976	175	10	ubiquinone	ubiquinone	PROPN
iajs-2976	175	11	prevents	prevent	VERB
iajs-2976	175	12	membrane	membrane	NOUN
iajs-2976	175	13	lipid	lipid	NOUN
iajs-2976	175	14	peroxidation	peroxidation	NOUN
iajs-2976	175	15	by	by	ADP
iajs-2976	175	16	reacting	react	VERB
iajs-2976	175	17	with	with	ADP
iajs-2976	175	18	free	free	ADJ
iajs-2976	175	19	radicals	radical	NOUN
iajs-2976	175	20	.	.	PUNCT
iajs-2976	176	1	our	our	PRON
iajs-2976	176	2	research	research	NOUN
iajs-2976	176	3	validated	validate	VERB
iajs-2976	176	4	that	that	SCONJ
iajs-2976	176	5	ubiquinone	ubiquinone	PROPN
iajs-2976	176	6	supplementation	supplementation	NOUN
iajs-2976	176	7	substantially	substantially	ADV
iajs-2976	176	8	improved	improve	VERB
iajs-2976	176	9	this	this	DET
iajs-2976	176	10	oxidative	oxidative	ADJ
iajs-2976	176	11	status	status	NOUN
iajs-2976	176	12	by	by	ADP
iajs-2976	176	13	reducing	reduce	VERB
iajs-2976	176	14	mda	mda	PROPN
iajs-2976	176	15	concentration	concentration	NOUN
iajs-2976	176	16	(	(	PUNCT
iajs-2976	176	17	figure	figure	NOUN
iajs-2976	176	18	4	4	NUM
iajs-2976	176	19	)	)	PUNCT
iajs-2976	176	20	.	.	PUNCT
iajs-2976	177	1	the	the	DET
iajs-2976	177	2	beneficial	beneficial	ADJ
iajs-2976	177	3	role	role	NOUN
iajs-2976	177	4	of	of	ADP
iajs-2976	177	5	ubiquinone	ubiquinone	PROPN
iajs-2976	177	6	treatment	treatment	NOUN
iajs-2976	177	7	was	be	AUX
iajs-2976	177	8	proved	prove	VERB
iajs-2976	177	9	to	to	PART
iajs-2976	177	10	reduce	reduce	VERB
iajs-2976	177	11	lipid	lipid	NOUN
iajs-2976	177	12	peroxidation	peroxidation	NOUN
iajs-2976	177	13	and	and	CCONJ
iajs-2976	177	14	serum	serum	NOUN
iajs-2976	177	15	mda	mda	PROPN
iajs-2976	177	16	levels	level	NOUN
iajs-2976	177	17	,	,	PUNCT
iajs-2976	177	18	according	accord	VERB
iajs-2976	177	19	to	to	ADP
iajs-2976	177	20	the	the	DET
iajs-2976	177	21	findings	finding	NOUN
iajs-2976	177	22	of	of	ADP
iajs-2976	177	23	earlier	early	ADJ
iajs-2976	177	24	studies	study	NOUN
iajs-2976	177	25	[	[	X
iajs-2976	177	26	27	27	NUM
iajs-2976	177	27	,	,	PUNCT
iajs-2976	177	28	54	54	NUM
iajs-2976	177	29	,	,	PUNCT
iajs-2976	177	30	57	57	NUM
iajs-2976	177	31	]	]	PUNCT
iajs-2976	177	32	.	.	PUNCT
iajs-2976	178	1	effect	effect	NOUN
iajs-2976	178	2	of	of	ADP
iajs-2976	178	3	ubiquinone	ubiquinone	PROPN
iajs-2976	178	4	on	on	ADP
iajs-2976	178	5	the	the	DET
iajs-2976	178	6	proinflammatory	proinflammatory	ADJ
iajs-2976	178	7	adipocytokine	adipocytokine	NOUN
iajs-2976	178	8	(	(	PUNCT
iajs-2976	178	9	il-6	il-6	NOUN
iajs-2976	178	10	)	)	PUNCT
iajs-2976	178	11	hyperglycemia	hyperglycemia	NOUN
iajs-2976	178	12	and	and	CCONJ
iajs-2976	178	13	hyperlipidemia	hyperlipidemia	NOUN
iajs-2976	178	14	in	in	ADP
iajs-2976	178	15	diabetes	diabetes	NOUN
iajs-2976	178	16	and	and	CCONJ
iajs-2976	178	17	obesity	obesity	NOUN
iajs-2976	178	18	are	be	AUX
iajs-2976	178	19	associated	associate	VERB
iajs-2976	178	20	with	with	ADP
iajs-2976	178	21	diminished	diminished	ADJ
iajs-2976	178	22	antioxidant	antioxidant	ADJ
iajs-2976	178	23	enzymes	enzyme	NOUN
iajs-2976	178	24	and	and	CCONJ
iajs-2976	178	25	elevation	elevation	NOUN
iajs-2976	178	26	of	of	ADP
iajs-2976	178	27	ros	ros	PROPN
iajs-2976	178	28	levels	level	NOUN
iajs-2976	178	29	[	[	X
iajs-2976	178	30	58	58	NUM
iajs-2976	178	31	]	]	PUNCT
iajs-2976	178	32	.	.	PUNCT
iajs-2976	179	1	researchers	researcher	NOUN
iajs-2976	179	2	demonstrated	demonstrate	VERB
iajs-2976	179	3	that	that	SCONJ
iajs-2976	179	4	elevated	elevated	ADJ
iajs-2976	179	5	levels	level	NOUN
iajs-2976	179	6	of	of	ADP
iajs-2976	179	7	ros	ros	PROPN
iajs-2976	179	8	induced	induce	VERB
iajs-2976	179	9	by	by	ADP
iajs-2976	179	10	a	a	DET
iajs-2976	179	11	high	high	ADJ
iajs-2976	179	12	glucose	glucose	NOUN
iajs-2976	179	13	environment	environment	NOUN
iajs-2976	179	14	increases	increase	VERB
iajs-2976	179	15	pancreatic	pancreatic	ADJ
iajs-2976	179	16	expression	expression	NOUN
iajs-2976	179	17	of	of	ADP
iajs-2976	179	18	il-6	il-6	NOUN
iajs-2976	179	19	and	and	CCONJ
iajs-2976	179	20	triggers	trigger	VERB
iajs-2976	179	21	mitochondrial	mitochondrial	ADJ
iajs-2976	179	22	dysfunction	dysfunction	NOUN
iajs-2976	179	23	,	,	PUNCT
iajs-2976	179	24	inflammatory	inflammatory	ADJ
iajs-2976	179	25	response	response	NOUN
iajs-2976	179	26	,	,	PUNCT
iajs-2976	179	27	and	and	CCONJ
iajs-2976	179	28	apoptosis	apoptosis	NOUN
iajs-2976	179	29	(	(	PUNCT
iajs-2976	179	30	especially	especially	ADV
iajs-2976	179	31	pancreatic	pancreatic	ADJ
iajs-2976	179	32	apoptosis	apoptosis	NOUN
iajs-2976	179	33	)	)	PUNCT
iajs-2976	179	34	via	via	ADP
iajs-2976	179	35	the	the	DET
iajs-2976	179	36	stress	stress	NOUN
iajs-2976	179	37	signaling	signal	VERB
iajs-2976	179	38	pathway	pathway	NOUN
iajs-2976	180	1	[	[	X
iajs-2976	180	2	59	59	NUM
iajs-2976	180	3	,	,	PUNCT
iajs-2976	180	4	60	60	NUM
iajs-2976	180	5	]	]	PUNCT
iajs-2976	180	6	.	.	PUNCT
iajs-2976	181	1	in	in	ADP
iajs-2976	181	2	addition	addition	NOUN
iajs-2976	181	3	,	,	PUNCT
iajs-2976	181	4	mda	mda	PROPN
iajs-2976	181	5	caused	cause	VERB
iajs-2976	181	6	significant	significant	ADJ
iajs-2976	181	7	increases	increase	NOUN
iajs-2976	181	8	in	in	ADP
iajs-2976	181	9	the	the	DET
iajs-2976	181	10	levels	level	NOUN
iajs-2976	181	11	of	of	ADP
iajs-2976	181	12	several	several	ADJ
iajs-2976	181	13	major	major	ADJ
iajs-2976	181	14	proinflammatory	proinflammatory	ADJ
iajs-2976	181	15	biomarkers	biomarker	NOUN
iajs-2976	181	16	,	,	PUNCT
iajs-2976	181	17	including	include	VERB
iajs-2976	181	18	il-6	il-6	NUM
iajs-2976	181	19	,	,	PUNCT
iajs-2976	181	20	il-25	il-25	NOUN
iajs-2976	181	21	,	,	PUNCT
iajs-2976	181	22	il-8	il-8	NOUN
iajs-2976	181	23	,	,	PUNCT
iajs-2976	181	24	icam-1	icam-1	NUM
iajs-2976	181	25	,	,	PUNCT
iajs-2976	181	26	and	and	CCONJ
iajs-2976	181	27	primary	primary	ADJ
iajs-2976	181	28	peripheral	peripheral	ADJ
iajs-2976	181	29	blood	blood	NOUN
iajs-2976	181	30	lymphocytes	lymphocyte	NOUN
iajs-2976	181	31	(	(	PUNCT
iajs-2976	181	32	plcs	plcs	NOUN
iajs-2976	181	33	)	)	PUNCT
iajs-2976	182	1	[	[	X
iajs-2976	182	2	61	61	NUM
iajs-2976	182	3	]	]	PUNCT
iajs-2976	182	4	.	.	PUNCT
iajs-2976	183	1	consistent	consistent	ADJ
iajs-2976	183	2	with	with	ADP
iajs-2976	183	3	the	the	DET
iajs-2976	183	4	previous	previous	ADJ
iajs-2976	183	5	findings	finding	NOUN
iajs-2976	183	6	,	,	PUNCT
iajs-2976	183	7	our	our	PRON
iajs-2976	183	8	study	study	NOUN
iajs-2976	183	9	revealed	reveal	VERB
iajs-2976	183	10	an	an	DET
iajs-2976	183	11	increase	increase	NOUN
iajs-2976	183	12	in	in	ADP
iajs-2976	183	13	the	the	DET
iajs-2976	183	14	proinflammatory	proinflammatory	ADJ
iajs-2976	183	15	cytokine	cytokine	NOUN
iajs-2976	183	16	il-6	il-6	NOUN
iajs-2976	183	17	in	in	ADP
iajs-2976	183	18	diabetics	diabetic	NOUN
iajs-2976	183	19	rats	rat	NOUN
iajs-2976	183	20	compared	compare	VERB
iajs-2976	183	21	to	to	ADP
iajs-2976	183	22	the	the	DET
iajs-2976	183	23	control	control	NOUN
iajs-2976	183	24	group	group	NOUN
iajs-2976	183	25	(	(	PUNCT
iajs-2976	183	26	p	p	X
iajs-2976	183	27	=	=	NOUN
iajs-2976	183	28	0.0493	0.0493	NUM
iajs-2976	183	29	;	;	PUNCT
iajs-2976	183	30	table	table	NOUN
iajs-2976	183	31	2	2	NUM
iajs-2976	183	32	)	)	PUNCT
iajs-2976	183	33	.	.	PUNCT
iajs-2976	184	1	the	the	DET
iajs-2976	184	2	schematic	schematic	ADJ
iajs-2976	184	3	diagram	diagram	NOUN
iajs-2976	184	4	(	(	PUNCT
iajs-2976	184	5	figure	figure	NOUN
iajs-2976	184	6	4	4	NUM
iajs-2976	184	7	)	)	PUNCT
iajs-2976	184	8	illustrated	illustrate	VERB
iajs-2976	184	9	the	the	DET
iajs-2976	184	10	heightening	heighten	VERB
iajs-2976	184	11	effect	effect	NOUN
iajs-2976	184	12	of	of	ADP
iajs-2976	184	13	hyperglycemia	hyperglycemia	NOUN
iajs-2976	184	14	,	,	PUNCT
iajs-2976	184	15	oxidative	oxidative	ADJ
iajs-2976	184	16	stress	stress	NOUN
iajs-2976	184	17	,	,	PUNCT
iajs-2976	184	18	and	and	CCONJ
iajs-2976	184	19	mda	mda	VERB
iajs-2976	184	20	on	on	ADP
iajs-2976	184	21	il-6	il-6	NOUN
iajs-2976	184	22	in	in	ADV
iajs-2976	184	23	.	.	PUNCT
iajs-2976	185	1	normally	normally	ADV
iajs-2976	185	2	,	,	PUNCT
iajs-2976	185	3	there	there	PRON
iajs-2976	185	4	is	be	VERB
iajs-2976	185	5	a	a	DET
iajs-2976	185	6	balance	balance	NOUN
iajs-2976	185	7	between	between	ADP
iajs-2976	185	8	oxidants	oxidant	NOUN
iajs-2976	185	9	and	and	CCONJ
iajs-2976	185	10	antioxidant	antioxidant	ADJ
iajs-2976	185	11	defense	defense	NOUN
iajs-2976	185	12	,	,	PUNCT
iajs-2976	185	13	but	but	CCONJ
iajs-2976	185	14	hyperglycemia	hyperglycemia	NOUN
iajs-2976	185	15	elevates	elevate	VERB
iajs-2976	185	16	ros	ros	PROPN
iajs-2976	185	17	levels	level	NOUN
iajs-2976	185	18	,	,	PUNCT
iajs-2976	185	19	leading	lead	VERB
iajs-2976	185	20	to	to	ADP
iajs-2976	185	21	an	an	DET
iajs-2976	185	22	increment	increment	NOUN
iajs-2976	185	23	of	of	ADP
iajs-2976	185	24	oxidation	oxidation	NOUN
iajs-2976	185	25	of	of	ADP
iajs-2976	185	26	proteins	protein	NOUN
iajs-2976	185	27	,	,	PUNCT
iajs-2976	185	28	lipids	lipid	NOUN
iajs-2976	185	29	,	,	PUNCT
iajs-2976	185	30	and	and	CCONJ
iajs-2976	185	31	nucleic	nucleic	ADJ
iajs-2976	185	32	acids	acid	NOUN
iajs-2976	186	1	[	[	X
iajs-2976	186	2	62	62	NUM
iajs-2976	186	3	]	]	PUNCT
iajs-2976	186	4	.	.	PUNCT
iajs-2976	187	1	high	high	ADJ
iajs-2976	187	2	glucose	glucose	NOUN
iajs-2976	187	3	level	level	NOUN
iajs-2976	187	4	also	also	ADV
iajs-2976	187	5	stimulates	stimulate	VERB
iajs-2976	187	6	and	and	CCONJ
iajs-2976	187	7	enhances	enhance	VERB
iajs-2976	187	8	the	the	DET
iajs-2976	187	9	production	production	NOUN
iajs-2976	187	10	of	of	ADP
iajs-2976	187	11	reactive	reactive	ADJ
iajs-2976	187	12	species	specie	NOUN
iajs-2976	187	13	via	via	ADP
iajs-2976	187	14	nadph	nadph	ADJ
iajs-2976	187	15	oxidase	oxidase	NOUN
iajs-2976	187	16	activity	activity	NOUN
iajs-2976	187	17	,	,	PUNCT
iajs-2976	187	18	which	which	PRON
iajs-2976	187	19	intensifies	intensify	VERB
iajs-2976	187	20	proinflammatory	proinflammatory	ADJ
iajs-2976	187	21	biomarkers	biomarker	NOUN
iajs-2976	187	22	,	,	PUNCT
iajs-2976	187	23	such	such	ADJ
iajs-2976	187	24	as	as	ADP
iajs-2976	187	25	il-1β	il-1β	PROPN
iajs-2976	187	26	,	,	PUNCT
iajs-2976	187	27	il-6	il-6	NOUN
iajs-2976	187	28	,	,	PUNCT
iajs-2976	187	29	and	and	CCONJ
iajs-2976	187	30	tnf	tnf	PROPN
iajs-2976	187	31	-	-	PUNCT
iajs-2976	187	32	α	α	PROPN
iajs-2976	188	1	[	[	X
iajs-2976	188	2	63	63	NUM
iajs-2976	188	3	]	]	PUNCT
iajs-2976	188	4	.	.	PUNCT
iajs-2976	189	1	impairment	impairment	NOUN
iajs-2976	189	2	of	of	ADP
iajs-2976	189	3	endogenous	endogenous	ADJ
iajs-2976	189	4	antioxidant	antioxidant	ADJ
iajs-2976	189	5	defense	defense	NOUN
iajs-2976	189	6	system	system	NOUN
iajs-2976	189	7	results	result	VERB
iajs-2976	189	8	in	in	ADP
iajs-2976	189	9	the	the	DET
iajs-2976	189	10	production	production	NOUN
iajs-2976	189	11	of	of	ADP
iajs-2976	189	12	ages	age	NOUN
iajs-2976	189	13	[	[	X
iajs-2976	189	14	64	64	NUM
iajs-2976	189	15	]	]	PUNCT
iajs-2976	189	16	.	.	PUNCT
iajs-2976	190	1	ages	age	NOUN
iajs-2976	190	2	increase	increase	VERB
iajs-2976	190	3	il-6	il-6	PRON
iajs-2976	190	4	secretion	secretion	NOUN
iajs-2976	190	5	through	through	ADP
iajs-2976	190	6	ros	ros	PROPN
iajs-2976	190	7	and	and	CCONJ
iajs-2976	190	8	nf	nf	ADJ
iajs-2976	190	9	-	-	PUNCT
iajs-2976	190	10	κb	κb	NOUN
iajs-2976	190	11	activation	activation	NOUN
iajs-2976	190	12	[	[	X
iajs-2976	190	13	65	65	NUM
iajs-2976	190	14	]	]	PUNCT
iajs-2976	190	15	.	.	PUNCT
iajs-2976	191	1	in	in	ADP
iajs-2976	191	2	addition	addition	NOUN
iajs-2976	191	3	,	,	PUNCT
iajs-2976	191	4	ros	ros	PROPN
iajs-2976	191	5	enhance	enhance	VERB
iajs-2976	191	6	the	the	DET
iajs-2976	191	7	activation	activation	NOUN
iajs-2976	191	8	of	of	ADP
iajs-2976	191	9	nf	nf	NOUN
iajs-2976	191	10	-	-	PUNCT
iajs-2976	191	11	κb	κb	NOUN
iajs-2976	191	12	in	in	ADP
iajs-2976	191	13	the	the	DET
iajs-2976	191	14	cytoplasm	cytoplasm	NOUN
iajs-2976	191	15	and	and	CCONJ
iajs-2976	191	16	translocate	translocate	VERB
iajs-2976	191	17	the	the	DET
iajs-2976	191	18	signal	signal	ADJ
iajs-2976	191	19	transduction	transduction	NOUN
iajs-2976	191	20	pathway	pathway	NOUN
iajs-2976	191	21	into	into	ADP
iajs-2976	191	22	the	the	DET
iajs-2976	191	23	nucleus	nucleus	NOUN
iajs-2976	191	24	.	.	PUNCT
iajs-2976	192	1	in	in	ADP
iajs-2976	192	2	inflammation	inflammation	NOUN
iajs-2976	192	3	and	and	CCONJ
iajs-2976	192	4	apoptosis	apoptosis	NOUN
iajs-2976	192	5	,	,	PUNCT
iajs-2976	192	6	nf	nf	ADJ
iajs-2976	192	7	-	-	PUNCT
iajs-2976	192	8	κb	κb	NOUN
iajs-2976	192	9	acts	act	VERB
iajs-2976	192	10	as	as	ADP
iajs-2976	192	11	a	a	DET
iajs-2976	192	12	key	key	ADJ
iajs-2976	192	13	regulator	regulator	NOUN
iajs-2976	192	14	.	.	PUNCT
iajs-2976	193	1	phosphorylation	phosphorylation	NOUN
iajs-2976	193	2	of	of	ADP
iajs-2976	193	3	nf	nf	NOUN
iajs-2976	193	4	-	-	PUNCT
iajs-2976	193	5	κb	κb	NOUN
iajs-2976	193	6	induces	induce	VERB
iajs-2976	193	7	secretion	secretion	NOUN
iajs-2976	193	8	of	of	ADP
iajs-2976	193	9	pro	pro	ADJ
iajs-2976	193	10	-	-	ADJ
iajs-2976	193	11	inflammatory	inflammatory	ADJ
iajs-2976	193	12	cytokines	cytokine	NOUN
iajs-2976	193	13	such	such	ADJ
iajs-2976	193	14	as	as	ADP
iajs-2976	193	15	il-6	il-6	NOUN
iajs-2976	193	16	[	[	X
iajs-2976	193	17	66	66	NUM
iajs-2976	193	18	]	]	PUNCT
iajs-2976	193	19	.	.	PUNCT
iajs-2976	194	1	nf	nf	PROPN
iajs-2976	194	2	-	-	PUNCT
iajs-2976	194	3	κb	κb	NOUN
iajs-2976	194	4	,	,	PUNCT
iajs-2976	194	5	a	a	DET
iajs-2976	194	6	transcription	transcription	NOUN
iajs-2976	194	7	factor	factor	NOUN
iajs-2976	194	8	,	,	PUNCT
iajs-2976	194	9	is	be	AUX
iajs-2976	194	10	responsible	responsible	ADJ
iajs-2976	194	11	for	for	ADP
iajs-2976	194	12	the	the	DET
iajs-2976	194	13	upregulation	upregulation	NOUN
iajs-2976	194	14	of	of	ADP
iajs-2976	194	15	inflammatory	inflammatory	ADJ
iajs-2976	194	16	proteins	protein	NOUN
iajs-2976	194	17	such	such	ADJ
iajs-2976	194	18	as	as	ADP
iajs-2976	194	19	il-6	il-6	NUM
iajs-2976	194	20	,	,	PUNCT
iajs-2976	194	21	inos	ino	NOUN
iajs-2976	194	22	,	,	PUNCT
iajs-2976	194	23	and	and	CCONJ
iajs-2976	194	24	tnf	tnf	PROPN
iajs-2976	194	25	-	-	PUNCT
iajs-2976	194	26	a	a	NOUN
iajs-2976	194	27	by	by	ADP
iajs-2976	194	28	attaching	attach	VERB
iajs-2976	194	29	to	to	ADP
iajs-2976	194	30	their	their	PRON
iajs-2976	194	31	promoter	promoter	NOUN
iajs-2976	194	32	[	[	X
iajs-2976	194	33	67	67	NUM
iajs-2976	194	34	]	]	PUNCT
iajs-2976	194	35	.	.	PUNCT
iajs-2976	195	1	several	several	ADJ
iajs-2976	195	2	clinical	clinical	ADJ
iajs-2976	195	3	and	and	CCONJ
iajs-2976	195	4	experimental	experimental	ADJ
iajs-2976	195	5	pieces	piece	NOUN
iajs-2976	195	6	of	of	ADP
iajs-2976	195	7	research	research	NOUN
iajs-2976	195	8	have	have	AUX
iajs-2976	195	9	revealed	reveal	VERB
iajs-2976	195	10	the	the	DET
iajs-2976	195	11	importance	importance	NOUN
iajs-2976	195	12	of	of	ADP
iajs-2976	195	13	cytokines	cytokine	NOUN
iajs-2976	195	14	in	in	ADP
iajs-2976	195	15	developing	develop	VERB
iajs-2976	195	16	diabetes	diabetes	NOUN
iajs-2976	195	17	complications	complication	NOUN
iajs-2976	195	18	[	[	X
iajs-2976	195	19	68	68	NUM
iajs-2976	195	20	-	-	SYM
iajs-2976	195	21	70	70	NUM
iajs-2976	195	22	]	]	PUNCT
iajs-2976	195	23	.	.	PUNCT
iajs-2976	196	1	consequently	consequently	ADV
iajs-2976	196	2	,	,	PUNCT
iajs-2976	196	3	antioxidant	antioxidant	ADJ
iajs-2976	196	4	compounds	compound	NOUN
iajs-2976	196	5	could	could	AUX
iajs-2976	196	6	be	be	AUX
iajs-2976	196	7	a	a	DET
iajs-2976	196	8	crucial	crucial	ADJ
iajs-2976	196	9	defense	defense	NOUN
iajs-2976	196	10	to	to	ADP
iajs-2976	196	11	amelioration	amelioration	NOUN
iajs-2976	196	12	of	of	ADP
iajs-2976	196	13	the	the	DET
iajs-2976	196	14	damaging	damaging	ADJ
iajs-2976	196	15	effect	effect	NOUN
iajs-2976	196	16	of	of	ADP
iajs-2976	196	17	ros	ros	PROPN
iajs-2976	196	18	.	.	PROPN
iajs-2976	196	19	ihjpas	ihjpas	PROPN
iajs-2976	196	20	.	.	PUNCT
iajs-2976	197	1	36(2)2023	36(2)2023	NUM
iajs-2976	197	2	95	95	NUM
iajs-2976	197	3	in	in	ADP
iajs-2976	197	4	our	our	PRON
iajs-2976	197	5	data	datum	NOUN
iajs-2976	197	6	,	,	PUNCT
iajs-2976	197	7	we	we	PRON
iajs-2976	197	8	verified	verify	VERB
iajs-2976	197	9	a	a	DET
iajs-2976	197	10	substantial	substantial	ADJ
iajs-2976	197	11	decrement	decrement	NOUN
iajs-2976	197	12	in	in	ADP
iajs-2976	197	13	serum	serum	NOUN
iajs-2976	197	14	level	level	NOUN
iajs-2976	197	15	of	of	ADP
iajs-2976	197	16	il-6	il-6	NOUN
iajs-2976	197	17	in	in	ADP
iajs-2976	197	18	ubiquinone	ubiquinone	PROPN
iajs-2976	197	19	-	-	PUNCT
iajs-2976	197	20	treated	treat	VERB
iajs-2976	197	21	diabetic	diabetic	ADJ
iajs-2976	197	22	rats	rat	NOUN
iajs-2976	197	23	compared	compare	VERB
iajs-2976	197	24	with	with	ADP
iajs-2976	197	25	the	the	DET
iajs-2976	197	26	normal	normal	ADJ
iajs-2976	197	27	rats	rat	NOUN
iajs-2976	197	28	,	,	PUNCT
iajs-2976	197	29	as	as	SCONJ
iajs-2976	197	30	shown	show	VERB
iajs-2976	197	31	in	in	ADP
iajs-2976	197	32	table	table	NOUN
iajs-2976	197	33	2	2	NUM
iajs-2976	197	34	.	.	PUNCT
iajs-2976	198	1	also	also	ADV
iajs-2976	198	2	,	,	PUNCT
iajs-2976	198	3	other	other	ADJ
iajs-2976	198	4	studies	study	NOUN
iajs-2976	198	5	showed	show	VERB
iajs-2976	198	6	the	the	DET
iajs-2976	198	7	counteracting	counteract	VERB
iajs-2976	198	8	effect	effect	NOUN
iajs-2976	198	9	of	of	ADP
iajs-2976	198	10	antioxidants	antioxidant	NOUN
iajs-2976	198	11	against	against	ADP
iajs-2976	198	12	inflammatory	inflammatory	ADJ
iajs-2976	198	13	indicator	indicator	NOUN
iajs-2976	198	14	,	,	PUNCT
iajs-2976	198	15	il-6	il-6	X
iajs-2976	199	1	[	[	X
iajs-2976	199	2	71	71	NUM
iajs-2976	199	3	,	,	PUNCT
iajs-2976	199	4	72	72	NUM
iajs-2976	199	5	]	]	PUNCT
iajs-2976	199	6	.	.	PUNCT
iajs-2976	200	1	[	[	X
iajs-2976	200	2	73	73	NUM
iajs-2976	200	3	]	]	PUNCT
iajs-2976	200	4	.	.	PUNCT
iajs-2976	201	1	in	in	ADP
iajs-2976	201	2	support	support	NOUN
iajs-2976	201	3	of	of	ADP
iajs-2976	201	4	our	our	PRON
iajs-2976	201	5	findings	finding	NOUN
iajs-2976	201	6	,	,	PUNCT
iajs-2976	201	7	a	a	DET
iajs-2976	201	8	study	study	NOUN
iajs-2976	201	9	found	find	VERB
iajs-2976	201	10	that	that	SCONJ
iajs-2976	201	11	the	the	DET
iajs-2976	201	12	mrna	mrna	PROPN
iajs-2976	201	13	expression	expression	NOUN
iajs-2976	201	14	level	level	NOUN
iajs-2976	201	15	of	of	ADP
iajs-2976	201	16	proinflammatory	proinflammatory	ADJ
iajs-2976	201	17	cytokines	cytokine	NOUN
iajs-2976	201	18	,	,	PUNCT
iajs-2976	201	19	il6	il6	NOUN
iajs-2976	201	20	,	,	PUNCT
iajs-2976	201	21	was	be	AUX
iajs-2976	201	22	significantly	significantly	ADV
iajs-2976	201	23	downregulated	downregulate	VERB
iajs-2976	201	24	in	in	ADP
iajs-2976	201	25	the	the	DET
iajs-2976	201	26	animals	animal	NOUN
iajs-2976	201	27	treated	treat	VERB
iajs-2976	201	28	with	with	ADP
iajs-2976	201	29	ubiquinone	ubiquinone	PROPN
iajs-2976	201	30	compared	compare	VERB
iajs-2976	201	31	to	to	ADP
iajs-2976	201	32	untreated	untreated	ADJ
iajs-2976	201	33	diabetic	diabetic	ADJ
iajs-2976	201	34	rats	rat	NOUN
iajs-2976	201	35	[	[	X
iajs-2976	201	36	67	67	NUM
iajs-2976	201	37	]	]	PUNCT
iajs-2976	201	38	.	.	PUNCT
iajs-2976	202	1	ubiquinone	ubiquinone	PROPN
iajs-2976	202	2	having	have	VERB
iajs-2976	202	3	antioxidant	antioxidant	ADJ
iajs-2976	202	4	properties	property	NOUN
iajs-2976	202	5	neutralizes	neutralize	VERB
iajs-2976	202	6	and	and	CCONJ
iajs-2976	202	7	scavenges	scavenge	VERB
iajs-2976	202	8	free	free	ADJ
iajs-2976	202	9	radicals	radical	NOUN
iajs-2976	202	10	since	since	SCONJ
iajs-2976	202	11	we	we	PRON
iajs-2976	202	12	suggest	suggest	VERB
iajs-2976	202	13	that	that	SCONJ
iajs-2976	202	14	it	it	PRON
iajs-2976	202	15	elicits	elicit	VERB
iajs-2976	202	16	this	this	DET
iajs-2976	202	17	beneficial	beneficial	ADJ
iajs-2976	202	18	effect	effect	NOUN
iajs-2976	202	19	via	via	ADP
iajs-2976	202	20	reducing	reduce	VERB
iajs-2976	202	21	the	the	DET
iajs-2976	202	22	expression	expression	NOUN
iajs-2976	202	23	of	of	ADP
iajs-2976	202	24	nf‐κb	nf‐κb	X
iajs-2976	202	25	and	and	CCONJ
iajs-2976	202	26	,	,	PUNCT
iajs-2976	202	27	subsequently	subsequently	ADV
iajs-2976	202	28	,	,	PUNCT
iajs-2976	202	29	downregulating	downregulate	VERB
iajs-2976	202	30	the	the	DET
iajs-2976	202	31	levels	level	NOUN
iajs-2976	202	32	of	of	ADP
iajs-2976	202	33	tnf‐α	tnf‐α	PROPN
iajs-2976	202	34	and	and	CCONJ
iajs-2976	202	35	il-6	il-6	PRON
iajs-2976	202	36	.	.	PUNCT
iajs-2976	203	1	effect	effect	NOUN
iajs-2976	203	2	of	of	ADP
iajs-2976	203	3	ubiquinone	ubiquinone	PROPN
iajs-2976	203	4	on	on	ADP
iajs-2976	203	5	the	the	DET
iajs-2976	203	6	determinant	determinant	NOUN
iajs-2976	203	7	of	of	ADP
iajs-2976	203	8	vascular	vascular	ADJ
iajs-2976	203	9	homeostasis	homeostasis	NOUN
iajs-2976	203	10	,	,	PUNCT
iajs-2976	203	11	n0	n0	X
iajs-2976	203	12	in	in	ADP
iajs-2976	203	13	the	the	DET
iajs-2976	203	14	present	present	ADJ
iajs-2976	203	15	study	study	NOUN
iajs-2976	203	16	,	,	PUNCT
iajs-2976	203	17	we	we	PRON
iajs-2976	203	18	observed	observe	VERB
iajs-2976	203	19	that	that	PRON
iajs-2976	203	20	hyperglycemia	hyperglycemia	NOUN
iajs-2976	203	21	was	be	AUX
iajs-2976	203	22	accompanied	accompany	VERB
iajs-2976	203	23	by	by	ADP
iajs-2976	203	24	a	a	DET
iajs-2976	203	25	reduction	reduction	NOUN
iajs-2976	203	26	in	in	ADP
iajs-2976	203	27	no	no	DET
iajs-2976	203	28	levels	level	NOUN
iajs-2976	203	29	.	.	PUNCT
iajs-2976	204	1	these	these	DET
iajs-2976	204	2	findings	finding	NOUN
iajs-2976	204	3	are	be	AUX
iajs-2976	204	4	consistent	consistent	ADJ
iajs-2976	204	5	with	with	ADP
iajs-2976	204	6	previous	previous	ADJ
iajs-2976	204	7	studies	study	NOUN
iajs-2976	204	8	which	which	PRON
iajs-2976	204	9	reported	report	VERB
iajs-2976	204	10	that	that	SCONJ
iajs-2976	204	11	diabetes	diabetes	NOUN
iajs-2976	204	12	mellitus	mellitus	NOUN
iajs-2976	204	13	is	be	AUX
iajs-2976	204	14	correlated	correlate	VERB
iajs-2976	204	15	to	to	PART
iajs-2976	204	16	reduced	reduce	VERB
iajs-2976	204	17	nitric	nitric	ADJ
iajs-2976	204	18	oxide	oxide	NOUN
iajs-2976	204	19	synthesis	synthesis	NOUN
iajs-2976	204	20	from	from	ADP
iajs-2976	204	21	endothelial	endothelial	ADJ
iajs-2976	204	22	cells	cell	NOUN
iajs-2976	204	23	[	[	X
iajs-2976	204	24	74	74	NUM
iajs-2976	204	25	,	,	PUNCT
iajs-2976	204	26	75	75	NUM
iajs-2976	204	27	]	]	PUNCT
iajs-2976	204	28	.	.	PUNCT
iajs-2976	205	1	hyperglycemia	hyperglycemia	NOUN
iajs-2976	205	2	leads	lead	VERB
iajs-2976	205	3	to	to	ADP
iajs-2976	205	4	depletion	depletion	NOUN
iajs-2976	205	5	of	of	ADP
iajs-2976	205	6	the	the	DET
iajs-2976	205	7	nadph	nadph	PROPN
iajs-2976	205	8	required	require	VERB
iajs-2976	205	9	to	to	PART
iajs-2976	205	10	produce	produce	VERB
iajs-2976	205	11	nitric	nitric	ADJ
iajs-2976	205	12	oxide	oxide	NOUN
iajs-2976	205	13	from	from	ADP
iajs-2976	205	14	l	l	NOUN
iajs-2976	205	15	-	-	NOUN
iajs-2976	205	16	arginine	arginine	NOUN
iajs-2976	205	17	via	via	ADP
iajs-2976	205	18	nitric	nitric	ADJ
iajs-2976	205	19	oxide	oxide	NOUN
iajs-2976	205	20	synthase	synthase	NOUN
iajs-2976	205	21	[	[	X
iajs-2976	205	22	76	76	NUM
iajs-2976	205	23	]	]	PUNCT
iajs-2976	205	24	.	.	PUNCT
iajs-2976	206	1	conversely	conversely	ADV
iajs-2976	206	2	,	,	PUNCT
iajs-2976	206	3	a	a	DET
iajs-2976	206	4	number	number	NOUN
iajs-2976	206	5	of	of	ADP
iajs-2976	206	6	previous	previous	ADJ
iajs-2976	206	7	studies	study	NOUN
iajs-2976	206	8	have	have	AUX
iajs-2976	206	9	revealed	reveal	VERB
iajs-2976	206	10	an	an	DET
iajs-2976	206	11	increase	increase	NOUN
iajs-2976	206	12	in	in	ADP
iajs-2976	206	13	no	no	DET
iajs-2976	206	14	generation	generation	NOUN
iajs-2976	206	15	in	in	ADP
iajs-2976	206	16	diabetics	diabetic	NOUN
iajs-2976	206	17	[	[	X
iajs-2976	206	18	77	77	NUM
iajs-2976	206	19	,	,	PUNCT
iajs-2976	206	20	78	78	NUM
iajs-2976	206	21	]	]	PUNCT
iajs-2976	206	22	.	.	PUNCT
iajs-2976	207	1	they	they	PRON
iajs-2976	207	2	postulated	postulate	VERB
iajs-2976	207	3	that	that	SCONJ
iajs-2976	207	4	the	the	DET
iajs-2976	207	5	pro	pro	ADJ
iajs-2976	207	6	-	-	ADJ
iajs-2976	207	7	inflammatory	inflammatory	ADJ
iajs-2976	207	8	mediators	mediator	NOUN
iajs-2976	207	9	il-6	il-6	NOUN
iajs-2976	207	10	and	and	CCONJ
iajs-2976	207	11	tnf	tnf	PROPN
iajs-2976	207	12	-	-	PUNCT
iajs-2976	207	13	α	α	PROPN
iajs-2976	207	14	were	be	AUX
iajs-2976	207	15	the	the	DET
iajs-2976	207	16	most	most	ADV
iajs-2976	207	17	significant	significant	ADJ
iajs-2976	207	18	contributors	contributor	NOUN
iajs-2976	207	19	to	to	ADP
iajs-2976	207	20	the	the	DET
iajs-2976	207	21	excessive	excessive	ADJ
iajs-2976	207	22	generation	generation	NOUN
iajs-2976	207	23	of	of	ADP
iajs-2976	207	24	nitric	nitric	ADJ
iajs-2976	207	25	oxide	oxide	NOUN
iajs-2976	207	26	in	in	ADP
iajs-2976	207	27	hyperglycemic	hyperglycemic	ADJ
iajs-2976	207	28	condition	condition	NOUN
iajs-2976	207	29	[	[	X
iajs-2976	207	30	78	78	NUM
iajs-2976	207	31	]	]	PUNCT
iajs-2976	207	32	.	.	PUNCT
iajs-2976	208	1	in	in	ADP
iajs-2976	208	2	the	the	DET
iajs-2976	208	3	current	current	ADJ
iajs-2976	208	4	investigation	investigation	NOUN
iajs-2976	208	5	,	,	PUNCT
iajs-2976	208	6	no	no	DET
iajs-2976	208	7	concentration	concentration	NOUN
iajs-2976	208	8	in	in	ADP
iajs-2976	208	9	the	the	DET
iajs-2976	208	10	ubiquinone	ubiquinone	PROPN
iajs-2976	208	11	-	-	PUNCT
iajs-2976	208	12	treated	treat	VERB
iajs-2976	208	13	diabetic	diabetic	ADJ
iajs-2976	208	14	rodents	rodent	NOUN
iajs-2976	208	15	was	be	AUX
iajs-2976	208	16	significantly	significantly	ADV
iajs-2976	208	17	higher	high	ADJ
iajs-2976	208	18	than	than	ADP
iajs-2976	208	19	in	in	ADP
iajs-2976	208	20	the	the	DET
iajs-2976	208	21	diabetic	diabetic	ADJ
iajs-2976	208	22	group	group	NOUN
iajs-2976	208	23	.	.	PUNCT
iajs-2976	209	1	other	other	ADJ
iajs-2976	209	2	investigators	investigator	NOUN
iajs-2976	209	3	obtained	obtain	VERB
iajs-2976	209	4	the	the	DET
iajs-2976	209	5	same	same	ADJ
iajs-2976	209	6	results	result	NOUN
iajs-2976	209	7	and	and	CCONJ
iajs-2976	209	8	stated	state	VERB
iajs-2976	209	9	that	that	SCONJ
iajs-2976	209	10	ubiquinone	ubiquinone	PROPN
iajs-2976	209	11	could	could	AUX
iajs-2976	209	12	recouple	recouple	VERB
iajs-2976	209	13	endothelial	endothelial	ADJ
iajs-2976	209	14	nitric	nitric	ADJ
iajs-2976	209	15	oxide	oxide	NOUN
iajs-2976	209	16	synthase	synthase	NOUN
iajs-2976	209	17	and	and	CCONJ
iajs-2976	209	18	modify	modify	VERB
iajs-2976	209	19	no	no	DET
iajs-2976	209	20	-	-	PUNCT
iajs-2976	209	21	associated	associate	VERB
iajs-2976	209	22	signaling	signal	VERB
iajs-2976	209	23	[	[	X
iajs-2976	209	24	75	75	NUM
iajs-2976	209	25	,	,	PUNCT
iajs-2976	209	26	79	79	NUM
iajs-2976	209	27	]	]	PUNCT
iajs-2976	209	28	.	.	PUNCT
iajs-2976	210	1	as	as	SCONJ
iajs-2976	210	2	depicted	depict	VERB
iajs-2976	210	3	in	in	ADP
iajs-2976	210	4	figure	figure	NOUN
iajs-2976	210	5	4	4	NUM
iajs-2976	210	6	,	,	PUNCT
iajs-2976	210	7	it	it	PRON
iajs-2976	210	8	appears	appear	VERB
iajs-2976	210	9	that	that	SCONJ
iajs-2976	210	10	ubiquinone	ubiquinone	PROPN
iajs-2976	210	11	's	's	PART
iajs-2976	210	12	antioxidant	antioxidant	ADJ
iajs-2976	210	13	characteristics	characteristic	NOUN
iajs-2976	210	14	may	may	AUX
iajs-2976	210	15	protect	protect	VERB
iajs-2976	210	16	no	no	PRON
iajs-2976	210	17	from	from	ADP
iajs-2976	210	18	oxidative	oxidative	ADJ
iajs-2976	210	19	inactivation	inactivation	NOUN
iajs-2976	210	20	,	,	PUNCT
iajs-2976	210	21	allowing	allow	VERB
iajs-2976	210	22	its	its	PRON
iajs-2976	210	23	concentration	concentration	NOUN
iajs-2976	210	24	to	to	PART
iajs-2976	210	25	increase	increase	VERB
iajs-2976	210	26	in	in	ADP
iajs-2976	210	27	the	the	DET
iajs-2976	210	28	treated	treat	VERB
iajs-2976	210	29	group	group	NOUN
iajs-2976	210	30	.	.	PUNCT
iajs-2976	211	1	hyperglycemia	hyperglycemia	NOUN
iajs-2976	211	2	lowers	lower	VERB
iajs-2976	211	3	no	no	DET
iajs-2976	211	4	serum	serum	NOUN
iajs-2976	211	5	levels	level	NOUN
iajs-2976	211	6	,	,	PUNCT
iajs-2976	211	7	while	while	SCONJ
iajs-2976	211	8	ubiquinone	ubiquinone	PROPN
iajs-2976	211	9	normalizes	normalize	VERB
iajs-2976	211	10	them	they	PRON
iajs-2976	211	11	,	,	PUNCT
iajs-2976	211	12	which	which	PRON
iajs-2976	211	13	suggests	suggest	VERB
iajs-2976	211	14	ubiquinone	ubiquinone	PROPN
iajs-2976	211	15	's	's	PART
iajs-2976	211	16	protective	protective	ADJ
iajs-2976	211	17	role	role	NOUN
iajs-2976	211	18	in	in	ADP
iajs-2976	211	19	cardiovascular	cardiovascular	ADJ
iajs-2976	211	20	endothelial	endothelial	ADJ
iajs-2976	211	21	cells	cell	NOUN
iajs-2976	211	22	.	.	PUNCT
iajs-2976	212	1	effect	effect	NOUN
iajs-2976	212	2	of	of	ADP
iajs-2976	212	3	ubiquinone	ubiquinone	PROPN
iajs-2976	212	4	on	on	ADP
iajs-2976	212	5	serum	serum	NOUN
iajs-2976	212	6	level	level	NOUN
iajs-2976	212	7	of	of	ADP
iajs-2976	212	8	myopathy	myopathy	ADJ
iajs-2976	212	9	marker	marker	NOUN
iajs-2976	212	10	,	,	PUNCT
iajs-2976	212	11	mb	mb	ADP
iajs-2976	212	12	as	as	ADP
iajs-2976	212	13	to	to	ADP
iajs-2976	212	14	our	our	PRON
iajs-2976	212	15	investigation	investigation	NOUN
iajs-2976	212	16	,	,	PUNCT
iajs-2976	212	17	we	we	PRON
iajs-2976	212	18	studied	study	VERB
iajs-2976	212	19	the	the	DET
iajs-2976	212	20	protective	protective	ADJ
iajs-2976	212	21	role	role	NOUN
iajs-2976	212	22	of	of	ADP
iajs-2976	212	23	ubiquinone	ubiquinone	PROPN
iajs-2976	212	24	against	against	ADP
iajs-2976	212	25	muscle	muscle	NOUN
iajs-2976	212	26	cell	cell	NOUN
iajs-2976	212	27	injury	injury	NOUN
iajs-2976	212	28	in	in	ADP
iajs-2976	212	29	stz	stz	ADJ
iajs-2976	212	30	-	-	PUNCT
iajs-2976	212	31	induced	induce	VERB
iajs-2976	212	32	diabetic	diabetic	ADJ
iajs-2976	212	33	rats	rat	NOUN
iajs-2976	212	34	.	.	PUNCT
iajs-2976	213	1	we	we	PRON
iajs-2976	213	2	found	find	VERB
iajs-2976	213	3	higher	high	ADJ
iajs-2976	213	4	mb	mb	ADP
iajs-2976	213	5	levels	level	NOUN
iajs-2976	213	6	in	in	ADP
iajs-2976	213	7	diabetic	diabetic	ADJ
iajs-2976	213	8	rats	rat	NOUN
iajs-2976	213	9	than	than	ADP
iajs-2976	213	10	in	in	ADP
iajs-2976	213	11	normal	normal	ADJ
iajs-2976	213	12	rats	rat	NOUN
iajs-2976	213	13	.	.	PUNCT
iajs-2976	214	1	moreover	moreover	ADV
iajs-2976	214	2	,	,	PUNCT
iajs-2976	214	3	our	our	PRON
iajs-2976	214	4	data	datum	NOUN
iajs-2976	214	5	reveals	reveal	VERB
iajs-2976	214	6	that	that	SCONJ
iajs-2976	214	7	ubiquinone	ubiquinone	PROPN
iajs-2976	214	8	-	-	PUNCT
iajs-2976	214	9	treatment	treatment	NOUN
iajs-2976	214	10	diabetic	diabetic	ADJ
iajs-2976	214	11	rats	rat	NOUN
iajs-2976	214	12	had	have	VERB
iajs-2976	214	13	lower	low	ADJ
iajs-2976	214	14	mb	mb	ADP
iajs-2976	214	15	levels	level	NOUN
iajs-2976	214	16	compared	compare	VERB
iajs-2976	214	17	to	to	ADP
iajs-2976	214	18	diabetic	diabetic	ADJ
iajs-2976	214	19	rats	rat	NOUN
iajs-2976	214	20	without	without	ADP
iajs-2976	214	21	treatment	treatment	NOUN
iajs-2976	214	22	.	.	PUNCT
iajs-2976	215	1	cardiovascular	cardiovascular	ADJ
iajs-2976	215	2	biomarkers	biomarker	NOUN
iajs-2976	215	3	have	have	VERB
iajs-2976	215	4	a	a	DET
iajs-2976	215	5	critical	critical	ADJ
iajs-2976	215	6	role	role	NOUN
iajs-2976	215	7	in	in	ADP
iajs-2976	215	8	the	the	DET
iajs-2976	215	9	early	early	ADJ
iajs-2976	215	10	detection	detection	NOUN
iajs-2976	215	11	of	of	ADP
iajs-2976	215	12	acute	acute	ADJ
iajs-2976	215	13	myocardial	myocardial	ADJ
iajs-2976	215	14	infarction	infarction	NOUN
iajs-2976	215	15	.	.	PUNCT
iajs-2976	216	1	among	among	ADP
iajs-2976	216	2	numerous	numerous	ADJ
iajs-2976	216	3	cardiac	cardiac	ADJ
iajs-2976	216	4	indicators	indicator	NOUN
iajs-2976	216	5	,	,	PUNCT
iajs-2976	216	6	mb	mb	PROPN
iajs-2976	216	7	has	have	AUX
iajs-2976	216	8	been	be	AUX
iajs-2976	216	9	extensively	extensively	ADV
iajs-2976	216	10	recognized	recognize	VERB
iajs-2976	216	11	as	as	ADP
iajs-2976	216	12	one	one	NUM
iajs-2976	216	13	of	of	ADP
iajs-2976	216	14	the	the	DET
iajs-2976	216	15	most	most	ADV
iajs-2976	216	16	acceptable	acceptable	ADJ
iajs-2976	216	17	potential	potential	ADJ
iajs-2976	216	18	biomarkers	biomarker	NOUN
iajs-2976	216	19	for	for	ADP
iajs-2976	216	20	the	the	DET
iajs-2976	216	21	early	early	ADJ
iajs-2976	216	22	detection	detection	NOUN
iajs-2976	216	23	of	of	ADP
iajs-2976	216	24	myocardial	myocardial	ADJ
iajs-2976	216	25	infarction	infarction	NOUN
iajs-2976	216	26	,	,	PUNCT
iajs-2976	216	27	despite	despite	SCONJ
iajs-2976	216	28	the	the	DET
iajs-2976	216	29	fact	fact	NOUN
iajs-2976	216	30	that	that	SCONJ
iajs-2976	216	31	it	it	PRON
iajs-2976	216	32	is	be	AUX
iajs-2976	216	33	not	not	PART
iajs-2976	216	34	cardiac	cardiac	ADJ
iajs-2976	216	35	-	-	PUNCT
iajs-2976	216	36	specific	specific	ADJ
iajs-2976	216	37	[	[	X
iajs-2976	216	38	80	80	NUM
iajs-2976	216	39	-	-	SYM
iajs-2976	216	40	82	82	NUM
iajs-2976	216	41	]	]	PUNCT
iajs-2976	216	42	.	.	PUNCT
iajs-2976	217	1	a	a	DET
iajs-2976	217	2	study	study	NOUN
iajs-2976	217	3	observed	observe	VERB
iajs-2976	217	4	that	that	SCONJ
iajs-2976	217	5	mb	mb	PROPN
iajs-2976	217	6	levels	level	NOUN
iajs-2976	217	7	of	of	ADP
iajs-2976	217	8	diabetic	diabetic	ADJ
iajs-2976	217	9	patients	patient	NOUN
iajs-2976	217	10	were	be	AUX
iajs-2976	217	11	higher	high	ADJ
iajs-2976	217	12	than	than	ADP
iajs-2976	217	13	that	that	PRON
iajs-2976	217	14	of	of	ADP
iajs-2976	217	15	control	control	NOUN
iajs-2976	217	16	subjects	subject	NOUN
iajs-2976	217	17	[	[	X
iajs-2976	217	18	83	83	NUM
iajs-2976	217	19	]	]	PUNCT
iajs-2976	217	20	.	.	PUNCT
iajs-2976	218	1	similarly	similarly	ADV
iajs-2976	218	2	,	,	PUNCT
iajs-2976	218	3	in	in	ADP
iajs-2976	218	4	our	our	PRON
iajs-2976	218	5	work	work	NOUN
iajs-2976	218	6	,	,	PUNCT
iajs-2976	218	7	we	we	PRON
iajs-2976	218	8	found	find	VERB
iajs-2976	218	9	higher	high	ADJ
iajs-2976	218	10	serum	serum	NOUN
iajs-2976	218	11	level	level	NOUN
iajs-2976	218	12	of	of	ADP
iajs-2976	218	13	mb	mb	ADP
iajs-2976	218	14	in	in	ADP
iajs-2976	218	15	diabetics	diabetic	NOUN
iajs-2976	218	16	rats	rat	NOUN
iajs-2976	218	17	.	.	PUNCT
iajs-2976	219	1	focusing	focus	VERB
iajs-2976	219	2	on	on	ADP
iajs-2976	219	3	skeletal	skeletal	ADJ
iajs-2976	219	4	muscle	muscle	NOUN
iajs-2976	219	5	cell	cell	NOUN
iajs-2976	219	6	injury	injury	NOUN
iajs-2976	219	7	and	and	CCONJ
iajs-2976	219	8	ameliorating	ameliorate	VERB
iajs-2976	219	9	impact	impact	NOUN
iajs-2976	219	10	of	of	ADP
iajs-2976	219	11	ubiquinone	ubiquinone	PROPN
iajs-2976	219	12	in	in	ADP
iajs-2976	219	13	athletes	athlete	NOUN
iajs-2976	219	14	,	,	PUNCT
iajs-2976	219	15	a	a	DET
iajs-2976	219	16	study	study	NOUN
iajs-2976	219	17	shows	show	VERB
iajs-2976	219	18	lower	low	ADJ
iajs-2976	219	19	level	level	NOUN
iajs-2976	219	20	of	of	ADP
iajs-2976	219	21	mb	mb	NOUN
iajs-2976	219	22	in	in	ADP
iajs-2976	219	23	the	the	DET
iajs-2976	219	24	ubiquinone	ubiquinone	PROPN
iajs-2976	219	25	-	-	PUNCT
iajs-2976	219	26	treated	treat	VERB
iajs-2976	219	27	group	group	NOUN
iajs-2976	219	28	than	than	ADP
iajs-2976	219	29	in	in	ADP
iajs-2976	219	30	the	the	DET
iajs-2976	219	31	subjects	subject	NOUN
iajs-2976	219	32	with	with	ADP
iajs-2976	219	33	placebo	placebo	NOUN
iajs-2976	219	34	prescription	prescription	NOUN
iajs-2976	219	35	.	.	PUNCT
iajs-2976	220	1	they	they	PRON
iajs-2976	220	2	presented	present	VERB
iajs-2976	220	3	that	that	SCONJ
iajs-2976	220	4	300	300	NUM
iajs-2976	220	5	mg	mg	NUM
iajs-2976	220	6	/	/	SYM
iajs-2976	220	7	day	day	NOUN
iajs-2976	220	8	of	of	ADP
iajs-2976	220	9	ubiquinone	ubiquinone	PROPN
iajs-2976	220	10	supplementation	supplementation	NOUN
iajs-2976	220	11	over	over	ADP
iajs-2976	220	12	two	two	NUM
iajs-2976	220	13	weeks	week	NOUN
iajs-2976	220	14	raised	raise	VERB
iajs-2976	220	15	ubiquinone	ubiquinone	PROPN
iajs-2976	220	16	levels	level	NOUN
iajs-2976	220	17	in	in	ADP
iajs-2976	220	18	the	the	DET
iajs-2976	220	19	blood	blood	NOUN
iajs-2976	220	20	and	and	CCONJ
iajs-2976	220	21	decreased	decrease	VERB
iajs-2976	220	22	mb	mb	ADP
iajs-2976	220	23	concentrations	concentration	NOUN
iajs-2976	220	24	and	and	CCONJ
iajs-2976	220	25	creatine	creatine	PROPN
iajs-2976	220	26	kinase	kinase	NOUN
iajs-2976	220	27	activity	activity	NOUN
iajs-2976	220	28	in	in	ADP
iajs-2976	220	29	18	18	NUM
iajs-2976	220	30	elite	elite	ADJ
iajs-2976	220	31	athletes	athlete	NOUN
iajs-2976	220	32	included	include	VERB
iajs-2976	220	33	in	in	ADP
iajs-2976	220	34	a	a	DET
iajs-2976	220	35	randomized	randomized	ADJ
iajs-2976	220	36	clinical	clinical	ADJ
iajs-2976	220	37	trial	trial	NOUN
iajs-2976	220	38	compared	compare	VERB
iajs-2976	220	39	to	to	ADP
iajs-2976	220	40	the	the	DET
iajs-2976	220	41	non	non	ADJ
iajs-2976	220	42	-	-	ADJ
iajs-2976	220	43	treated	treat	VERB
iajs-2976	220	44	group	group	NOUN
iajs-2976	221	1	[	[	X
iajs-2976	221	2	84	84	NUM
iajs-2976	221	3	]	]	PUNCT
iajs-2976	221	4	.	.	PUNCT
iajs-2976	222	1	the	the	DET
iajs-2976	222	2	lowering	lower	VERB
iajs-2976	222	3	impact	impact	NOUN
iajs-2976	222	4	of	of	ADP
iajs-2976	222	5	ubiquinone	ubiquinone	PROPN
iajs-2976	222	6	on	on	ADP
iajs-2976	222	7	the	the	DET
iajs-2976	222	8	level	level	NOUN
iajs-2976	222	9	of	of	ADP
iajs-2976	222	10	myopathy	myopathy	ADJ
iajs-2976	222	11	marker	marker	NOUN
iajs-2976	222	12	(	(	PUNCT
iajs-2976	222	13	mb	mb	NOUN
iajs-2976	222	14	)	)	PUNCT
iajs-2976	222	15	is	be	AUX
iajs-2976	222	16	attributed	attribute	VERB
iajs-2976	222	17	to	to	ADP
iajs-2976	222	18	its	its	PRON
iajs-2976	222	19	potential	potential	NOUN
iajs-2976	222	20	to	to	PART
iajs-2976	222	21	attenuate	attenuate	VERB
iajs-2976	222	22	oxidative	oxidative	ADJ
iajs-2976	222	23	stress	stress	NOUN
iajs-2976	222	24	and	and	CCONJ
iajs-2976	222	25	pro	pro	ADJ
iajs-2976	222	26	-	-	ADJ
iajs-2976	222	27	inflammatory	inflammatory	ADJ
iajs-2976	222	28	signaling	signaling	NOUN
iajs-2976	222	29	and	and	CCONJ
iajs-2976	222	30	reduce	reduce	VERB
iajs-2976	222	31	lipid	lipid	NOUN
iajs-2976	222	32	peroxidation	peroxidation	NOUN
iajs-2976	222	33	[	[	X
iajs-2976	222	34	85	85	NUM
iajs-2976	222	35	]	]	PUNCT
iajs-2976	222	36	.	.	PUNCT
iajs-2976	223	1	ihjpas	ihjpas	PROPN
iajs-2976	223	2	.	.	PUNCT
iajs-2976	224	1	36(2)2023	36(2)2023	NUM
iajs-2976	224	2	96	96	NUM
iajs-2976	224	3	as	as	SCONJ
iajs-2976	224	4	shown	show	VERB
iajs-2976	224	5	in	in	ADP
iajs-2976	224	6	the	the	DET
iajs-2976	224	7	proposed	propose	VERB
iajs-2976	224	8	diagram	diagram	NOUN
iajs-2976	224	9	,	,	PUNCT
iajs-2976	224	10	hyperglycemia	hyperglycemia	NOUN
iajs-2976	224	11	can	can	AUX
iajs-2976	224	12	stimulate	stimulate	VERB
iajs-2976	224	13	the	the	DET
iajs-2976	224	14	adipocytes	adipocyte	NOUN
iajs-2976	224	15	to	to	PART
iajs-2976	224	16	release	release	VERB
iajs-2976	224	17	proinflammatory	proinflammatory	ADJ
iajs-2976	224	18	cytokines	cytokine	NOUN
iajs-2976	224	19	,	,	PUNCT
iajs-2976	224	20	which	which	PRON
iajs-2976	224	21	cause	cause	VERB
iajs-2976	224	22	inflammation	inflammation	NOUN
iajs-2976	224	23	and	and	CCONJ
iajs-2976	224	24	,	,	PUNCT
iajs-2976	224	25	finally	finally	ADV
iajs-2976	224	26	,	,	PUNCT
iajs-2976	224	27	muscle	muscle	NOUN
iajs-2976	224	28	cell	cell	NOUN
iajs-2976	224	29	apoptosis	apoptosis	NOUN
iajs-2976	224	30	.	.	PUNCT
iajs-2976	225	1	ubiquinone	ubiquinone	PROPN
iajs-2976	225	2	,	,	PUNCT
iajs-2976	225	3	a	a	DET
iajs-2976	225	4	powerful	powerful	ADJ
iajs-2976	225	5	antioxidant	antioxidant	NOUN
iajs-2976	225	6	,	,	PUNCT
iajs-2976	225	7	would	would	AUX
iajs-2976	225	8	protect	protect	VERB
iajs-2976	225	9	muscle	muscle	NOUN
iajs-2976	225	10	tissues	tissue	NOUN
iajs-2976	225	11	in	in	ADP
iajs-2976	225	12	humans	human	NOUN
iajs-2976	225	13	and	and	CCONJ
iajs-2976	225	14	animals	animal	NOUN
iajs-2976	225	15	with	with	ADP
iajs-2976	225	16	hyperglycemia	hyperglycemia	NOUN
iajs-2976	225	17	.	.	PUNCT
iajs-2976	226	1	first	first	ADV
iajs-2976	226	2	,	,	PUNCT
iajs-2976	226	3	it	it	PRON
iajs-2976	226	4	has	have	VERB
iajs-2976	226	5	an	an	DET
iajs-2976	226	6	inhibitory	inhibitory	ADJ
iajs-2976	226	7	impact	impact	NOUN
iajs-2976	226	8	on	on	ADP
iajs-2976	226	9	free	free	ADJ
iajs-2976	226	10	radical	radical	ADJ
iajs-2976	226	11	production	production	NOUN
iajs-2976	226	12	since	since	SCONJ
iajs-2976	226	13	it	it	PRON
iajs-2976	226	14	prevents	prevent	VERB
iajs-2976	226	15	indirect	indirect	ADJ
iajs-2976	226	16	cytotoxicity	cytotoxicity	NOUN
iajs-2976	226	17	by	by	ADP
iajs-2976	226	18	inhibiting	inhibit	VERB
iajs-2976	226	19	nf	nf	NOUN
iajs-2976	226	20	-	-	PUNCT
iajs-2976	226	21	кb	кb	NOUN
iajs-2976	226	22	activation	activation	NOUN
iajs-2976	226	23	,	,	PUNCT
iajs-2976	226	24	which	which	PRON
iajs-2976	226	25	stimulates	stimulate	VERB
iajs-2976	226	26	the	the	DET
iajs-2976	226	27	production	production	NOUN
iajs-2976	226	28	of	of	ADP
iajs-2976	226	29	il-6	il-6	NUM
iajs-2976	226	30	,	,	PUNCT
iajs-2976	226	31	and	and	CCONJ
iajs-2976	226	32	other	other	ADJ
iajs-2976	226	33	proinflammatory	proinflammatory	ADJ
iajs-2976	226	34	proteins	protein	NOUN
iajs-2976	226	35	.	.	PUNCT
iajs-2976	227	1	second	second	ADJ
iajs-2976	227	2	,	,	PUNCT
iajs-2976	227	3	by	by	ADP
iajs-2976	227	4	neutralizing	neutralize	VERB
iajs-2976	227	5	free	free	ADJ
iajs-2976	227	6	radicals	radical	NOUN
iajs-2976	227	7	,	,	PUNCT
iajs-2976	227	8	ubiquinone	ubiquinone	PROPN
iajs-2976	227	9	prevents	prevent	VERB
iajs-2976	227	10	direct	direct	ADJ
iajs-2976	227	11	cytotoxicity	cytotoxicity	NOUN
iajs-2976	227	12	,	,	PUNCT
iajs-2976	227	13	which	which	PRON
iajs-2976	227	14	occurs	occur	VERB
iajs-2976	227	15	when	when	SCONJ
iajs-2976	227	16	free	free	ADJ
iajs-2976	227	17	radicals	radical	NOUN
iajs-2976	227	18	react	react	VERB
iajs-2976	227	19	with	with	ADP
iajs-2976	227	20	vital	vital	ADJ
iajs-2976	227	21	cellular	cellular	ADJ
iajs-2976	227	22	components	component	NOUN
iajs-2976	227	23	like	like	ADP
iajs-2976	227	24	dna	dna	NOUN
iajs-2976	227	25	and	and	CCONJ
iajs-2976	227	26	proteins	protein	NOUN
iajs-2976	227	27	and	and	CCONJ
iajs-2976	227	28	damage	damage	VERB
iajs-2976	227	29	them	they	PRON
iajs-2976	227	30	.	.	PUNCT
iajs-2976	228	1	third	third	ADV
iajs-2976	228	2	,	,	PUNCT
iajs-2976	228	3	ubiquinone	ubiquinone	PROPN
iajs-2976	228	4	protects	protect	VERB
iajs-2976	228	5	pancreatic	pancreatic	ADJ
iajs-2976	228	6	β	β	NOUN
iajs-2976	228	7	-	-	NOUN
iajs-2976	228	8	cells	cell	NOUN
iajs-2976	228	9	and	and	CCONJ
iajs-2976	228	10	has	have	VERB
iajs-2976	228	11	hypoglycemic	hypoglycemic	ADJ
iajs-2976	228	12	properties	property	NOUN
iajs-2976	228	13	since	since	SCONJ
iajs-2976	228	14	it	it	PRON
iajs-2976	228	15	lowers	lower	VERB
iajs-2976	228	16	the	the	DET
iajs-2976	228	17	influence	influence	NOUN
iajs-2976	228	18	of	of	ADP
iajs-2976	228	19	hyperglycemia	hyperglycemia	NOUN
iajs-2976	228	20	on	on	ADP
iajs-2976	228	21	raising	raise	VERB
iajs-2976	228	22	il-6	il-6	NOUN
iajs-2976	228	23	;	;	PUNCT
iajs-2976	228	24	consequently	consequently	ADV
iajs-2976	228	25	,	,	PUNCT
iajs-2976	228	26	ubiquinone	ubiquinone	PROPN
iajs-2976	228	27	reduces	reduce	VERB
iajs-2976	228	28	inflammation	inflammation	NOUN
iajs-2976	228	29	and	and	CCONJ
iajs-2976	228	30	apoptosis	apoptosis	NOUN
iajs-2976	228	31	in	in	ADP
iajs-2976	228	32	cardiac	cardiac	ADJ
iajs-2976	228	33	and	and	CCONJ
iajs-2976	228	34	skeletal	skeletal	ADJ
iajs-2976	228	35	muscles	muscle	NOUN
iajs-2976	228	36	tissue	tissue	NOUN
iajs-2976	228	37	as	as	SCONJ
iajs-2976	228	38	illustrated	illustrate	VERB
iajs-2976	228	39	in	in	ADP
iajs-2976	228	40	figure	figure	NOUN
iajs-2976	228	41	4	4	NUM
iajs-2976	228	42	.	.	PUNCT
iajs-2976	229	1	effect	effect	NOUN
iajs-2976	229	2	of	of	ADP
iajs-2976	229	3	ubiquinone	ubiquinone	PROPN
iajs-2976	229	4	on	on	ADP
iajs-2976	229	5	blood	blood	NOUN
iajs-2976	229	6	component	component	NOUN
iajs-2976	229	7	parameters	parameter	NOUN
iajs-2976	229	8	several	several	ADJ
iajs-2976	229	9	studies	study	NOUN
iajs-2976	229	10	have	have	AUX
iajs-2976	229	11	documented	document	VERB
iajs-2976	229	12	the	the	DET
iajs-2976	229	13	effects	effect	NOUN
iajs-2976	229	14	of	of	ADP
iajs-2976	229	15	other	other	ADJ
iajs-2976	229	16	antioxidants	antioxidant	NOUN
iajs-2976	229	17	on	on	ADP
iajs-2976	229	18	hematological	hematological	ADJ
iajs-2976	229	19	parameters	parameter	NOUN
iajs-2976	229	20	,	,	PUNCT
iajs-2976	229	21	but	but	CCONJ
iajs-2976	229	22	none	none	NOUN
iajs-2976	229	23	have	have	AUX
iajs-2976	229	24	studied	study	VERB
iajs-2976	229	25	ubiquinone	ubiquinone	PROPN
iajs-2976	229	26	's	's	PART
iajs-2976	229	27	effects	effect	NOUN
iajs-2976	229	28	.	.	PUNCT
iajs-2976	230	1	wbc	wbc	PROPN
iajs-2976	230	2	counts	count	NOUN
iajs-2976	230	3	decreased	decrease	VERB
iajs-2976	230	4	in	in	ADP
iajs-2976	230	5	the	the	DET
iajs-2976	230	6	diabetic	diabetic	ADJ
iajs-2976	230	7	control	control	NOUN
iajs-2976	230	8	group	group	NOUN
iajs-2976	230	9	according	accord	VERB
iajs-2976	230	10	to	to	ADP
iajs-2976	230	11	our	our	PRON
iajs-2976	230	12	documented	document	VERB
iajs-2976	230	13	data	datum	NOUN
iajs-2976	230	14	(	(	PUNCT
iajs-2976	230	15	table	table	NOUN
iajs-2976	230	16	3	3	NUM
iajs-2976	230	17	and	and	CCONJ
iajs-2976	230	18	figure	figure	VERB
iajs-2976	230	19	3	3	NUM
iajs-2976	230	20	)	)	PUNCT
iajs-2976	230	21	.	.	PUNCT
iajs-2976	231	1	the	the	DET
iajs-2976	231	2	same	same	ADJ
iajs-2976	231	3	results	result	NOUN
iajs-2976	231	4	were	be	AUX
iajs-2976	231	5	obtained	obtain	VERB
iajs-2976	231	6	in	in	ADP
iajs-2976	231	7	diabetes	diabetes	NOUN
iajs-2976	231	8	subjects	subject	NOUN
iajs-2976	231	9	after	after	SCONJ
iajs-2976	231	10	alloxan	alloxan	NOUN
iajs-2976	231	11	-	-	PUNCT
iajs-2976	231	12	induced	induce	VERB
iajs-2976	231	13	hyperglycemia	hyperglycemia	NOUN
iajs-2976	231	14	was	be	AUX
iajs-2976	231	15	induced	induce	VERB
iajs-2976	231	16	in	in	ADP
iajs-2976	231	17	rats	rat	NOUN
iajs-2976	232	1	[	[	X
iajs-2976	232	2	86	86	NUM
iajs-2976	232	3	]	]	PUNCT
iajs-2976	232	4	.	.	PUNCT
iajs-2976	233	1	in	in	ADP
iajs-2976	233	2	contrast	contrast	NOUN
iajs-2976	233	3	to	to	ADP
iajs-2976	233	4	our	our	PRON
iajs-2976	233	5	findings	finding	NOUN
iajs-2976	233	6	,	,	PUNCT
iajs-2976	233	7	other	other	ADJ
iajs-2976	233	8	researchers	researcher	NOUN
iajs-2976	233	9	[	[	X
iajs-2976	233	10	87	87	NUM
iajs-2976	233	11	]	]	PUNCT
iajs-2976	233	12	found	find	VERB
iajs-2976	233	13	a	a	DET
iajs-2976	233	14	significant	significant	ADJ
iajs-2976	233	15	rise	rise	NOUN
iajs-2976	233	16	in	in	ADP
iajs-2976	233	17	leukocyte	leukocyte	NOUN
iajs-2976	233	18	counts	count	NOUN
iajs-2976	233	19	in	in	ADP
iajs-2976	233	20	diabetic	diabetic	ADJ
iajs-2976	233	21	animals	animal	NOUN
iajs-2976	233	22	and	and	CCONJ
iajs-2976	233	23	they	they	PRON
iajs-2976	233	24	attributed	attribute	VERB
iajs-2976	233	25	that	that	PRON
iajs-2976	233	26	to	to	PART
iajs-2976	233	27	stz	stz	VERB
iajs-2976	233	28	's	's	PART
iajs-2976	233	29	damaging	damaging	ADJ
iajs-2976	233	30	effects	effect	NOUN
iajs-2976	233	31	.	.	PUNCT
iajs-2976	234	1	in	in	ADP
iajs-2976	234	2	our	our	PRON
iajs-2976	234	3	experiment	experiment	NOUN
iajs-2976	234	4	,	,	PUNCT
iajs-2976	234	5	ubiquinone	ubiquinone	PROPN
iajs-2976	234	6	decreased	decrease	VERB
iajs-2976	234	7	wbc	wbc	ADJ
iajs-2976	234	8	counts	count	NOUN
iajs-2976	234	9	.	.	PUNCT
iajs-2976	235	1	in	in	ADP
iajs-2976	235	2	other	other	ADJ
iajs-2976	235	3	studies	study	NOUN
iajs-2976	235	4	,	,	PUNCT
iajs-2976	235	5	involving	involve	VERB
iajs-2976	235	6	p	p	ADJ
iajs-2976	235	7	-	-	PUNCT
iajs-2976	235	8	coumaric	coumaric	ADJ
iajs-2976	235	9	acid	acid	NOUN
iajs-2976	235	10	as	as	ADP
iajs-2976	235	11	an	an	DET
iajs-2976	235	12	antioxidant	antioxidant	NOUN
iajs-2976	235	13	,	,	PUNCT
iajs-2976	235	14	the	the	DET
iajs-2976	235	15	same	same	ADJ
iajs-2976	235	16	result	result	NOUN
iajs-2976	235	17	was	be	AUX
iajs-2976	235	18	observed	observe	VERB
iajs-2976	235	19	[	[	X
iajs-2976	235	20	86	86	NUM
iajs-2976	235	21	]	]	PUNCT
iajs-2976	235	22	.	.	PUNCT
iajs-2976	236	1	like	like	ADP
iajs-2976	236	2	other	other	ADJ
iajs-2976	236	3	studies	study	NOUN
iajs-2976	236	4	'	'	PART
iajs-2976	236	5	findings	finding	NOUN
iajs-2976	236	6	[	[	X
iajs-2976	236	7	88	88	NUM
iajs-2976	236	8	,	,	PUNCT
iajs-2976	236	9	89	89	NUM
iajs-2976	236	10	]	]	PUNCT
iajs-2976	236	11	,	,	PUNCT
iajs-2976	236	12	our	our	PRON
iajs-2976	236	13	results	result	NOUN
iajs-2976	236	14	showed	show	VERB
iajs-2976	236	15	that	that	SCONJ
iajs-2976	236	16	rats	rat	NOUN
iajs-2976	236	17	with	with	ADP
iajs-2976	236	18	diabetes	diabetes	NOUN
iajs-2976	236	19	had	have	VERB
iajs-2976	236	20	slightly	slightly	ADV
iajs-2976	236	21	lower	low	ADJ
iajs-2976	236	22	rbc	rbc	PROPN
iajs-2976	236	23	count	count	NOUN
iajs-2976	236	24	.	.	PUNCT
iajs-2976	237	1	the	the	DET
iajs-2976	237	2	non	non	ADJ
iajs-2976	237	3	-	-	ADJ
iajs-2976	237	4	enzymatic	enzymatic	ADJ
iajs-2976	237	5	glycosylation	glycosylation	NOUN
iajs-2976	237	6	of	of	ADP
iajs-2976	237	7	rbc	rbc	PROPN
iajs-2976	237	8	membrane	membrane	NOUN
iajs-2976	237	9	proteins	protein	NOUN
iajs-2976	237	10	would	would	AUX
iajs-2976	237	11	increase	increase	VERB
iajs-2976	237	12	under	under	ADP
iajs-2976	237	13	hyperglycemic	hyperglycemic	ADJ
iajs-2976	237	14	conditions	condition	NOUN
iajs-2976	237	15	.	.	PUNCT
iajs-2976	238	1	as	as	ADP
iajs-2976	238	2	a	a	DET
iajs-2976	238	3	result	result	NOUN
iajs-2976	238	4	of	of	ADP
iajs-2976	238	5	oxidation	oxidation	NOUN
iajs-2976	238	6	of	of	ADP
iajs-2976	238	7	glycosylated	glycosylated	ADJ
iajs-2976	238	8	membrane	membrane	NOUN
iajs-2976	238	9	proteins	protein	NOUN
iajs-2976	238	10	and	and	CCONJ
iajs-2976	238	11	hyperglycemia	hyperglycemia	NOUN
iajs-2976	238	12	in	in	ADP
iajs-2976	238	13	diabetes	diabetes	NOUN
iajs-2976	238	14	mellitus	mellitus	NOUN
iajs-2976	238	15	,	,	PUNCT
iajs-2976	238	16	lipid	lipid	NOUN
iajs-2976	238	17	peroxides	peroxide	NOUN
iajs-2976	238	18	are	be	AUX
iajs-2976	238	19	produced	produce	VERB
iajs-2976	238	20	,	,	PUNCT
iajs-2976	238	21	resulting	result	VERB
iajs-2976	238	22	in	in	ADP
iajs-2976	238	23	hemolysis	hemolysis	NOUN
iajs-2976	238	24	of	of	ADP
iajs-2976	238	25	rbcs	rbc	NOUN
iajs-2976	238	26	.	.	PUNCT
iajs-2976	239	1	several	several	ADJ
iajs-2976	239	2	pathological	pathological	ADJ
iajs-2976	239	3	consequences	consequence	NOUN
iajs-2976	239	4	of	of	ADP
iajs-2976	239	5	free	free	ADJ
iajs-2976	239	6	radical	radical	ADJ
iajs-2976	239	7	-	-	PUNCT
iajs-2976	239	8	induced	induce	VERB
iajs-2976	239	9	membrane	membrane	NOUN
iajs-2976	239	10	lipid	lipid	NOUN
iajs-2976	239	11	peroxidation	peroxidation	NOUN
iajs-2976	239	12	include	include	AUX
iajs-2976	239	13	decreased	decrease	VERB
iajs-2976	239	14	cellular	cellular	ADJ
iajs-2976	239	15	deformability	deformability	NOUN
iajs-2976	239	16	,	,	PUNCT
iajs-2976	239	17	increased	increase	VERB
iajs-2976	239	18	membrane	membrane	NOUN
iajs-2976	239	19	rigidity	rigidity	NOUN
iajs-2976	239	20	,	,	PUNCT
iajs-2976	239	21	reduced	reduce	VERB
iajs-2976	239	22	deformability	deformability	NOUN
iajs-2976	239	23	of	of	ADP
iajs-2976	239	24	erythrocyte	erythrocyte	NOUN
iajs-2976	239	25	membranes	membrane	NOUN
iajs-2976	239	26	,	,	PUNCT
iajs-2976	239	27	and	and	CCONJ
iajs-2976	239	28	increased	increase	VERB
iajs-2976	239	29	rbc	rbc	PROPN
iajs-2976	239	30	death	death	NOUN
iajs-2976	239	31	,	,	PUNCT
iajs-2976	239	32	leading	lead	VERB
iajs-2976	239	33	to	to	ADP
iajs-2976	239	34	diabetic	diabetic	ADJ
iajs-2976	239	35	anemia	anemia	NOUN
iajs-2976	239	36	.	.	PUNCT
iajs-2976	240	1	[	[	X
iajs-2976	240	2	90	90	NUM
iajs-2976	240	3	-	-	SYM
iajs-2976	240	4	93	93	NUM
iajs-2976	240	5	]	]	PUNCT
iajs-2976	240	6	.	.	PUNCT
iajs-2976	241	1	in	in	ADP
iajs-2976	241	2	our	our	PRON
iajs-2976	241	3	experiment	experiment	NOUN
iajs-2976	241	4	,	,	PUNCT
iajs-2976	241	5	the	the	DET
iajs-2976	241	6	administration	administration	NOUN
iajs-2976	241	7	of	of	ADP
iajs-2976	241	8	ubiquinone	ubiquinone	PROPN
iajs-2976	241	9	did	do	AUX
iajs-2976	241	10	not	not	PART
iajs-2976	241	11	improve	improve	VERB
iajs-2976	241	12	erythrocyte	erythrocyte	NOUN
iajs-2976	241	13	counts	count	NOUN
iajs-2976	241	14	and	and	CCONJ
iajs-2976	241	15	survival	survival	NOUN
iajs-2976	241	16	.	.	PUNCT
iajs-2976	242	1	rbc	rbc	PROPN
iajs-2976	242	2	count	count	PROPN
iajs-2976	242	3	was	be	AUX
iajs-2976	242	4	found	find	VERB
iajs-2976	242	5	to	to	PART
iajs-2976	242	6	be	be	AUX
iajs-2976	242	7	raised	raise	VERB
iajs-2976	242	8	after	after	ADP
iajs-2976	242	9	antioxidant	antioxidant	ADJ
iajs-2976	242	10	treatment	treatment	NOUN
iajs-2976	242	11	by	by	ADP
iajs-2976	242	12	other	other	ADJ
iajs-2976	242	13	researchers	researcher	NOUN
iajs-2976	242	14	(	(	PUNCT
iajs-2976	242	15	citrullus	citrullus	PROPN
iajs-2976	242	16	colocynthis	colocynthis	PROPN
iajs-2976	242	17	pulp	pulp	NOUN
iajs-2976	242	18	)	)	PUNCT
iajs-2976	242	19	therapy	therapy	NOUN
iajs-2976	242	20	[	[	X
iajs-2976	242	21	88	88	NUM
iajs-2976	242	22	]	]	PUNCT
iajs-2976	242	23	.	.	PUNCT
iajs-2976	243	1	according	accord	VERB
iajs-2976	243	2	to	to	ADP
iajs-2976	243	3	our	our	PRON
iajs-2976	243	4	data	datum	NOUN
iajs-2976	243	5	,	,	PUNCT
iajs-2976	243	6	hyperglycemia	hyperglycemia	NOUN
iajs-2976	243	7	had	have	VERB
iajs-2976	243	8	a	a	DET
iajs-2976	243	9	lowering	lower	VERB
iajs-2976	243	10	effect	effect	NOUN
iajs-2976	243	11	on	on	ADP
iajs-2976	243	12	platelet	platelet	NOUN
iajs-2976	243	13	count	count	NOUN
iajs-2976	243	14	.	.	PUNCT
iajs-2976	244	1	a	a	DET
iajs-2976	244	2	study	study	NOUN
iajs-2976	244	3	shows	show	VERB
iajs-2976	244	4	that	that	SCONJ
iajs-2976	244	5	in	in	ADP
iajs-2976	244	6	children	child	NOUN
iajs-2976	244	7	with	with	ADP
iajs-2976	244	8	proven	prove	VERB
iajs-2976	244	9	t1	t1	PROPN
iajs-2976	244	10	dm	dm	PROPN
iajs-2976	244	11	,	,	PUNCT
iajs-2976	244	12	the	the	DET
iajs-2976	244	13	platelet	platelet	NOUN
iajs-2976	244	14	count	count	NOUN
iajs-2976	244	15	is	be	AUX
iajs-2976	244	16	significantly	significantly	ADV
iajs-2976	244	17	reduced	reduce	VERB
iajs-2976	244	18	[	[	X
iajs-2976	244	19	94	94	NUM
iajs-2976	244	20	]	]	PUNCT
iajs-2976	244	21	.	.	PUNCT
iajs-2976	245	1	diabetes	diabetes	NOUN
iajs-2976	245	2	patients	patient	NOUN
iajs-2976	245	3	are	be	AUX
iajs-2976	245	4	at	at	ADP
iajs-2976	245	5	higher	high	ADJ
iajs-2976	245	6	risk	risk	NOUN
iajs-2976	245	7	of	of	ADP
iajs-2976	245	8	oxidative	oxidative	ADJ
iajs-2976	245	9	stress	stress	NOUN
iajs-2976	245	10	.	.	PUNCT
iajs-2976	246	1	oxidative	oxidative	ADJ
iajs-2976	246	2	stress	stress	NOUN
iajs-2976	246	3	generates	generate	VERB
iajs-2976	246	4	reactive	reactive	ADJ
iajs-2976	246	5	oxygen	oxygen	NOUN
iajs-2976	246	6	species	specie	NOUN
iajs-2976	246	7	and	and	CCONJ
iajs-2976	246	8	promotes	promote	VERB
iajs-2976	246	9	uncontrolled	uncontrolled	ADJ
iajs-2976	246	10	lipid	lipid	NOUN
iajs-2976	246	11	peroxidation	peroxidation	NOUN
iajs-2976	246	12	.	.	PUNCT
iajs-2976	247	1	the	the	DET
iajs-2976	247	2	vast	vast	ADJ
iajs-2976	247	3	majority	majority	NOUN
iajs-2976	247	4	of	of	ADP
iajs-2976	247	5	cell	cell	NOUN
iajs-2976	247	6	membranes	membrane	NOUN
iajs-2976	247	7	are	be	AUX
iajs-2976	247	8	composed	compose	VERB
iajs-2976	247	9	of	of	ADP
iajs-2976	247	10	lipids	lipid	NOUN
iajs-2976	247	11	,	,	PUNCT
iajs-2976	247	12	so	so	ADV
iajs-2976	247	13	unregulated	unregulated	ADJ
iajs-2976	247	14	lipid	lipid	NOUN
iajs-2976	247	15	peroxidation	peroxidation	NOUN
iajs-2976	247	16	could	could	AUX
iajs-2976	247	17	damage	damage	VERB
iajs-2976	247	18	cells	cell	NOUN
iajs-2976	247	19	.	.	PUNCT
iajs-2976	248	1	one	one	NUM
iajs-2976	248	2	of	of	ADP
iajs-2976	248	3	the	the	DET
iajs-2976	248	4	mechanisms	mechanism	NOUN
iajs-2976	248	5	underlying	underlie	VERB
iajs-2976	248	6	platelet	platelet	NOUN
iajs-2976	248	7	dysfunction	dysfunction	NOUN
iajs-2976	248	8	may	may	AUX
iajs-2976	248	9	involve	involve	VERB
iajs-2976	248	10	glycosylation	glycosylation	NOUN
iajs-2976	248	11	stress	stress	NOUN
iajs-2976	248	12	resulting	result	VERB
iajs-2976	248	13	in	in	ADP
iajs-2976	248	14	a	a	DET
iajs-2976	248	15	rise	rise	NOUN
iajs-2976	248	16	in	in	ADP
iajs-2976	248	17	lipid	lipid	ADJ
iajs-2976	248	18	peroxide	peroxide	NOUN
iajs-2976	248	19	levels	level	NOUN
iajs-2976	248	20	.	.	PUNCT
iajs-2976	249	1	a	a	DET
iajs-2976	249	2	rise	rise	NOUN
iajs-2976	249	3	of	of	ADP
iajs-2976	249	4	this	this	DET
iajs-2976	249	5	magnitude	magnitude	NOUN
iajs-2976	249	6	could	could	AUX
iajs-2976	249	7	trigger	trigger	VERB
iajs-2976	249	8	the	the	DET
iajs-2976	249	9	discharge	discharge	NOUN
iajs-2976	249	10	of	of	ADP
iajs-2976	249	11	arachidonic	arachidonic	ADJ
iajs-2976	249	12	acid	acid	NOUN
iajs-2976	249	13	from	from	ADP
iajs-2976	249	14	phospholipids	phospholipid	NOUN
iajs-2976	249	15	and	and	CCONJ
iajs-2976	249	16	consequently	consequently	ADV
iajs-2976	249	17	enhance	enhance	VERB
iajs-2976	249	18	platelet	platelet	NOUN
iajs-2976	249	19	activation	activation	NOUN
iajs-2976	249	20	.	.	PUNCT
iajs-2976	250	1	these	these	DET
iajs-2976	250	2	findings	finding	NOUN
iajs-2976	250	3	indicate	indicate	VERB
iajs-2976	250	4	that	that	SCONJ
iajs-2976	250	5	increased	increase	VERB
iajs-2976	250	6	lipid	lipid	NOUN
iajs-2976	250	7	peroxidation	peroxidation	NOUN
iajs-2976	250	8	and	and	CCONJ
iajs-2976	250	9	platelet	platelet	NOUN
iajs-2976	250	10	activation	activation	NOUN
iajs-2976	250	11	are	be	AUX
iajs-2976	250	12	initial	initial	ADJ
iajs-2976	250	13	circumstances	circumstance	NOUN
iajs-2976	250	14	in	in	ADP
iajs-2976	250	15	t1	t1	PROPN
iajs-2976	250	16	dm	dm	NOUN
iajs-2976	250	17	that	that	PRON
iajs-2976	250	18	may	may	AUX
iajs-2976	250	19	be	be	AUX
iajs-2976	250	20	associated	associate	VERB
iajs-2976	250	21	with	with	ADP
iajs-2976	250	22	an	an	DET
iajs-2976	250	23	acute	acute	ADJ
iajs-2976	250	24	response	response	NOUN
iajs-2976	250	25	to	to	ADP
iajs-2976	250	26	inflammation	inflammation	NOUN
iajs-2976	250	27	[	[	X
iajs-2976	250	28	95	95	NUM
iajs-2976	250	29	]	]	PUNCT
iajs-2976	250	30	.	.	PUNCT
iajs-2976	251	1	with	with	ADP
iajs-2976	251	2	respect	respect	NOUN
iajs-2976	251	3	of	of	ADP
iajs-2976	251	4	our	our	PRON
iajs-2976	251	5	data	datum	NOUN
iajs-2976	251	6	,	,	PUNCT
iajs-2976	251	7	supplementation	supplementation	NOUN
iajs-2976	251	8	of	of	ADP
iajs-2976	251	9	diabetic	diabetic	ADJ
iajs-2976	251	10	rats	rat	NOUN
iajs-2976	251	11	’	'	PUNCT
iajs-2976	251	12	food	food	NOUN
iajs-2976	251	13	with	with	ADP
iajs-2976	251	14	ubiquinone	ubiquinone	PROPN
iajs-2976	251	15	slightly	slightly	ADV
iajs-2976	251	16	increased	increase	VERB
iajs-2976	251	17	plt	plt	NOUN
iajs-2976	251	18	count	count	NOUN
iajs-2976	251	19	.	.	PUNCT
iajs-2976	252	1	ihjpas	ihjpas	PROPN
iajs-2976	252	2	.	.	PUNCT
iajs-2976	253	1	36(2)2023	36(2)2023	NUM
iajs-2976	253	2	97	97	NUM
iajs-2976	253	3	6	6	NUM
iajs-2976	253	4	.	.	PUNCT
iajs-2976	253	5	conclusions	conclusion	NOUN
iajs-2976	253	6	in	in	ADP
iajs-2976	253	7	conclusion	conclusion	NOUN
iajs-2976	253	8	,	,	PUNCT
iajs-2976	253	9	the	the	DET
iajs-2976	253	10	administration	administration	NOUN
iajs-2976	253	11	of	of	ADP
iajs-2976	253	12	ubiquinone	ubiquinone	PROPN
iajs-2976	253	13	had	have	VERB
iajs-2976	253	14	an	an	DET
iajs-2976	253	15	attenuating	attenuating	ADJ
iajs-2976	253	16	impact	impact	NOUN
iajs-2976	253	17	on	on	ADP
iajs-2976	253	18	glucose	glucose	NOUN
iajs-2976	253	19	levels	level	NOUN
iajs-2976	253	20	in	in	ADP
iajs-2976	253	21	stz	stz	ADJ
iajs-2976	253	22	-	-	PUNCT
iajs-2976	253	23	induced	induce	VERB
iajs-2976	253	24	diabetic	diabetic	ADJ
iajs-2976	253	25	rats	rat	NOUN
iajs-2976	253	26	.	.	PUNCT
iajs-2976	254	1	in	in	ADP
iajs-2976	254	2	diabetic	diabetic	ADJ
iajs-2976	254	3	rats	rat	NOUN
iajs-2976	254	4	,	,	PUNCT
iajs-2976	254	5	ubiquinone	ubiquinone	PROPN
iajs-2976	254	6	supplementation	supplementation	NOUN
iajs-2976	254	7	modulated	modulate	VERB
iajs-2976	254	8	the	the	DET
iajs-2976	254	9	level	level	NOUN
iajs-2976	254	10	of	of	ADP
iajs-2976	254	11	markers	marker	NOUN
iajs-2976	254	12	correlated	correlate	VERB
iajs-2976	254	13	with	with	ADP
iajs-2976	254	14	oxidative	oxidative	ADJ
iajs-2976	254	15	stress	stress	NOUN
iajs-2976	254	16	(	(	PUNCT
iajs-2976	254	17	mda	mda	PROPN
iajs-2976	254	18	)	)	PUNCT
iajs-2976	254	19	,	,	PUNCT
iajs-2976	254	20	inflammation	inflammation	NOUN
iajs-2976	254	21	(	(	PUNCT
iajs-2976	254	22	il-6	il-6	NUM
iajs-2976	254	23	)	)	PUNCT
iajs-2976	254	24	,	,	PUNCT
iajs-2976	254	25	and	and	CCONJ
iajs-2976	254	26	diabetic	diabetic	ADJ
iajs-2976	254	27	myopathy	myopathy	ADJ
iajs-2976	254	28	(	(	PUNCT
iajs-2976	254	29	mb	mb	NOUN
iajs-2976	254	30	)	)	PUNCT
iajs-2976	254	31	.	.	PUNCT
iajs-2976	255	1	additionally	additionally	ADV
iajs-2976	255	2	,	,	PUNCT
iajs-2976	255	3	ubiquinone	ubiquinone	PROPN
iajs-2976	255	4	supplementation	supplementation	NOUN
iajs-2976	255	5	increases	increase	VERB
iajs-2976	255	6	no	no	DET
iajs-2976	255	7	levels	level	NOUN
iajs-2976	255	8	which	which	PRON
iajs-2976	255	9	could	could	AUX
iajs-2976	255	10	be	be	AUX
iajs-2976	255	11	reduced	reduce	VERB
iajs-2976	255	12	in	in	ADP
iajs-2976	255	13	diabetic	diabetic	ADJ
iajs-2976	255	14	endotheliopathy	endotheliopathy	ADJ
iajs-2976	255	15	(	(	PUNCT
iajs-2976	255	16	no	no	NOUN
iajs-2976	255	17	)	)	PUNCT
iajs-2976	255	18	.	.	PUNCT
iajs-2976	256	1	in	in	ADP
iajs-2976	256	2	this	this	DET
iajs-2976	256	3	study	study	NOUN
iajs-2976	256	4	,	,	PUNCT
iajs-2976	256	5	ubiquinone	ubiquinone	PROPN
iajs-2976	256	6	was	be	AUX
iajs-2976	256	7	found	find	VERB
iajs-2976	256	8	to	to	PART
iajs-2976	256	9	be	be	AUX
iajs-2976	256	10	capable	capable	ADJ
iajs-2976	256	11	of	of	ADP
iajs-2976	256	12	alleviating	alleviate	VERB
iajs-2976	256	13	diabetic	diabetic	ADJ
iajs-2976	256	14	complications	complication	NOUN
iajs-2976	256	15	as	as	ADP
iajs-2976	256	16	a	a	DET
iajs-2976	256	17	therapeutic	therapeutic	ADJ
iajs-2976	256	18	agent	agent	NOUN
iajs-2976	256	19	.	.	PUNCT
iajs-2976	257	1	acknowledgments	acknowledgment	NOUN
iajs-2976	257	2	the	the	DET
iajs-2976	257	3	authors	author	NOUN
iajs-2976	257	4	expressed	express	VERB
iajs-2976	257	5	gratitude	gratitude	NOUN
iajs-2976	257	6	to	to	PART
iajs-2976	257	7	hawler	hawler	VERB
iajs-2976	257	8	medical	medical	PROPN
iajs-2976	257	9	university	university	PROPN
iajs-2976	257	10	for	for	ADP
iajs-2976	257	11	providing	provide	VERB
iajs-2976	257	12	one	one	NUM
iajs-2976	257	13	of	of	ADP
iajs-2976	257	14	them	they	PRON
iajs-2976	257	15	the	the	DET
iajs-2976	257	16	opportunity	opportunity	NOUN
iajs-2976	257	17	to	to	PART
iajs-2976	257	18	study	study	VERB
iajs-2976	257	19	as	as	ADP
iajs-2976	257	20	a	a	DET
iajs-2976	257	21	master	master	NOUN
iajs-2976	257	22	's	's	PART
iajs-2976	257	23	candidate	candidate	NOUN
iajs-2976	257	24	in	in	ADP
iajs-2976	257	25	the	the	DET
iajs-2976	257	26	pharmacology	pharmacology	NOUN
iajs-2976	257	27	department	department	NOUN
iajs-2976	257	28	and	and	CCONJ
iajs-2976	257	29	conduct	conduct	VERB
iajs-2976	257	30	the	the	DET
iajs-2976	257	31	investigation	investigation	NOUN
iajs-2976	257	32	.	.	PUNCT
iajs-2976	258	1	the	the	DET
iajs-2976	258	2	authors	author	NOUN
iajs-2976	258	3	express	express	VERB
iajs-2976	258	4	their	their	PRON
iajs-2976	258	5	gratitude	gratitude	NOUN
iajs-2976	258	6	to	to	ADP
iajs-2976	258	7	soran	soran	PROPN
iajs-2976	258	8	university	university	PROPN
iajs-2976	258	9	(	(	PUNCT
iajs-2976	258	10	in	in	ADP
iajs-2976	258	11	particular	particular	ADJ
iajs-2976	258	12	sarbast	sarbast	PROPN
iajs-2976	258	13	a.	a.	NOUN
iajs-2976	258	14	mahmud	mahmud	PROPN
iajs-2976	258	15	)	)	PUNCT
iajs-2976	258	16	for	for	ADP
iajs-2976	258	17	providing	provide	VERB
iajs-2976	258	18	the	the	DET
iajs-2976	258	19	necessary	necessary	ADJ
iajs-2976	258	20	resources	resource	NOUN
iajs-2976	258	21	required	require	VERB
iajs-2976	258	22	for	for	ADP
iajs-2976	258	23	conducting	conduct	VERB
iajs-2976	258	24	a	a	DET
iajs-2976	258	25	part	part	NOUN
iajs-2976	258	26	of	of	ADP
iajs-2976	258	27	the	the	DET
iajs-2976	258	28	research	research	NOUN
iajs-2976	258	29	in	in	ADP
iajs-2976	258	30	their	their	PRON
iajs-2976	258	31	animal	animal	NOUN
iajs-2976	258	32	house	house	NOUN
iajs-2976	258	33	.	.	PUNCT
iajs-2976	259	1	references	reference	NOUN
iajs-2976	259	2	1	1	NUM
iajs-2976	259	3	.	.	X
iajs-2976	259	4	zhang	zhang	PROPN
iajs-2976	259	5	,	,	PUNCT
iajs-2976	259	6	p.	p.	PROPN
iajs-2976	259	7	;	;	PUNCT
iajs-2976	259	8	zhang	zhang	PROPN
iajs-2976	259	9	,	,	PUNCT
iajs-2976	259	10	x.	x.	PROPN
iajs-2976	259	11	;	;	PUNCT
iajs-2976	259	12	brown	brown	PROPN
iajs-2976	259	13	,	,	PUNCT
iajs-2976	259	14	j.	j.	PROPN
iajs-2976	259	15	;	;	PUNCT
iajs-2976	259	16	vistisen	vistisen	PROPN
iajs-2976	259	17	,	,	PUNCT
iajs-2976	259	18	d.	d.	PROPN
iajs-2976	259	19	;	;	PUNCT
iajs-2976	259	20	sicree	sicree	PROPN
iajs-2976	259	21	,	,	PUNCT
iajs-2976	259	22	r.	r.	PROPN
iajs-2976	259	23	;	;	PUNCT
iajs-2976	259	24	shaw	shaw	PROPN
iajs-2976	259	25	,	,	PUNCT
iajs-2976	259	26	j.	j.	PROPN
iajs-2976	259	27	nichols	nichols	PROPN
iajs-2976	259	28	,	,	PUNCT
iajs-2976	259	29	g.	g.	PROPN
iajs-2976	259	30	global	global	PROPN
iajs-2976	259	31	healthcare	healthcare	PROPN
iajs-2976	259	32	expenditure	expenditure	NOUN
iajs-2976	259	33	on	on	ADP
iajs-2976	259	34	diabetes	diabetes	NOUN
iajs-2976	259	35	for	for	ADP
iajs-2976	259	36	2010	2010	NUM
iajs-2976	259	37	and	and	CCONJ
iajs-2976	259	38	2030	2030	NUM
iajs-2976	259	39	.	.	PUNCT
iajs-2976	260	1	diabetes	diabetes	NOUN
iajs-2976	260	2	research	research	NOUN
iajs-2976	260	3	and	and	CCONJ
iajs-2976	260	4	clinical	clinical	ADJ
iajs-2976	260	5	practice	practice	NOUN
iajs-2976	260	6	,	,	PUNCT
iajs-2976	260	7	2010,87(3),293	2010,87(3),293	NUM
iajs-2976	260	8	-	-	SYM
iajs-2976	260	9	301	301	NUM
iajs-2976	260	10	https://doi.org/10.1016/j.diabres.2010.01.026	https://doi.org/10.1016/j.diabres.2010.01.026	PROPN
iajs-2976	260	11	2	2	NUM
iajs-2976	260	12	.	.	PUNCT
iajs-2976	260	13	world	world	NOUN
iajs-2976	260	14	health	health	NOUN
iajs-2976	260	15	,	,	PUNCT
iajs-2976	260	16	o.	o.	PROPN
iajs-2976	260	17	global	global	ADJ
iajs-2976	260	18	status	status	NOUN
iajs-2976	260	19	report	report	NOUN
iajs-2976	260	20	on	on	ADP
iajs-2976	260	21	noncommunicable	noncommunicable	ADJ
iajs-2976	260	22	diseases	disease	NOUN
iajs-2976	260	23	2010	2010	NUM
iajs-2976	260	24	.	.	PUNCT
iajs-2976	261	1	geneva	geneva	PROPN
iajs-2976	261	2	:	:	PUNCT
iajs-2976	261	3	world	world	PROPN
iajs-2976	261	4	health	health	PROPN
iajs-2976	261	5	organization	organization	NOUN
iajs-2976	261	6	,	,	PUNCT
iajs-2976	261	7	2011	2011	NUM
iajs-2976	261	8	.	.	PUNCT
iajs-2976	262	1	available	available	ADJ
iajs-2976	262	2	from	from	ADP
iajs-2976	262	3	:	:	PUNCT
iajs-2976	262	4	https://apps.who.int/iris/handle/10665/44579	https://apps.who.int/iris/handle/10665/44579	NUM
iajs-2976	262	5	.	.	PUNCT
iajs-2976	263	1	3	3	X
iajs-2976	263	2	.	.	X
iajs-2976	263	3	selvin	selvin	PROPN
iajs-2976	263	4	,	,	PUNCT
iajs-2976	263	5	e.	e.	PROPN
iajs-2976	263	6	;	;	PUNCT
iajs-2976	263	7	coresh	coresh	PROPN
iajs-2976	263	8	,	,	PUNCT
iajs-2976	263	9	j.	j.	PROPN
iajs-2976	263	10	;	;	PUNCT
iajs-2976	263	11	golden	golden	PROPN
iajs-2976	263	12	,	,	PUNCT
iajs-2976	263	13	s.	s.	PROPN
iajs-2976	263	14	h.	h.	PROPN
iajs-2976	263	15	;	;	PUNCT
iajs-2976	263	16	boland	boland	PROPN
iajs-2976	263	17	,	,	PUNCT
iajs-2976	263	18	l.	l.	PROPN
iajs-2976	263	19	l.	l.	PROPN
iajs-2976	263	20	;	;	PUNCT
iajs-2976	263	21	brancati	brancati	PROPN
iajs-2976	263	22	,	,	PUNCT
iajs-2976	263	23	f.	f.	PROPN
iajs-2976	263	24	l	l	PROPN
iajs-2976	263	25	..	..	PUNCT
iajs-2976	263	26	steffes	steffe	NOUN
iajs-2976	263	27	,	,	PUNCT
iajs-2976	263	28	m.	m.	NOUN
iajs-2976	263	29	w.	w.	PROPN
iajs-2976	263	30	glycemic	glycemic	PROPN
iajs-2976	263	31	control	control	PROPN
iajs-2976	263	32	,	,	PUNCT
iajs-2976	263	33	atherosclerosis	atherosclerosis	NOUN
iajs-2976	263	34	,	,	PUNCT
iajs-2976	263	35	and	and	CCONJ
iajs-2976	263	36	risk	risk	NOUN
iajs-2976	263	37	factors	factor	NOUN
iajs-2976	263	38	for	for	ADP
iajs-2976	263	39	cardiovascular	cardiovascular	ADJ
iajs-2976	263	40	disease	disease	NOUN
iajs-2976	263	41	in	in	ADP
iajs-2976	263	42	individuals	individual	NOUN
iajs-2976	263	43	with	with	ADP
iajs-2976	263	44	diabetes	diabetes	NOUN
iajs-2976	263	45	:	:	PUNCT
iajs-2976	263	46	the	the	DET
iajs-2976	263	47	atherosclerosis	atherosclerosis	NOUN
iajs-2976	263	48	risk	risk	NOUN
iajs-2976	263	49	in	in	ADP
iajs-2976	263	50	communities	community	NOUN
iajs-2976	263	51	study	study	NOUN
iajs-2976	263	52	.	.	PUNCT
iajs-2976	264	1	diabetes	diabetes	NOUN
iajs-2976	264	2	care	care	NOUN
iajs-2976	264	3	,	,	PUNCT
iajs-2976	264	4	2005,28(8),1965	2005,28(8),1965	NUM
iajs-2976	264	5	-	-	SYM
iajs-2976	264	6	73	73	NUM
iajs-2976	264	7	https://doi.org/10.2337/diacare.28.8.1965	https://doi.org/10.2337/diacare.28.8.1965	NOUN
iajs-2976	264	8	4	4	NUM
iajs-2976	264	9	.	.	X
iajs-2976	265	1	fowler	fowler	PROPN
iajs-2976	265	2	,	,	PUNCT
iajs-2976	265	3	m.	m.	NOUN
iajs-2976	265	4	j.	j.	PROPN
iajs-2976	265	5	microvascular	microvascular	PROPN
iajs-2976	265	6	and	and	CCONJ
iajs-2976	265	7	macrovascular	macrovascular	ADJ
iajs-2976	265	8	complications	complication	NOUN
iajs-2976	265	9	of	of	ADP
iajs-2976	265	10	diabetes	diabetes	NOUN
iajs-2976	265	11	.	.	PUNCT
iajs-2976	266	1	clinical	clinical	ADJ
iajs-2976	266	2	diabetes	diabetes	NOUN
iajs-2976	266	3	,	,	PUNCT
iajs-2976	266	4	2008,26(2),77	2008,26(2),77	NUM
iajs-2976	266	5	-	-	SYM
iajs-2976	266	6	82	82	NUM
iajs-2976	266	7	https://doi.org/10.2337/diaclin.26.2.77	https://doi.org/10.2337/diaclin.26.2.77	ADJ
iajs-2976	266	8	5	5	NUM
iajs-2976	266	9	.	.	PUNCT
iajs-2976	266	10	severino	severino	NOUN
iajs-2976	266	11	,	,	PUNCT
iajs-2976	266	12	p.	p.	NOUN
iajs-2976	266	13	;	;	PUNCT
iajs-2976	266	14	d’amato	d’amato	NOUN
iajs-2976	266	15	,	,	PUNCT
iajs-2976	266	16	a.	a.	NOUN
iajs-2976	266	17	;	;	PUNCT
iajs-2976	266	18	netti	netti	PROPN
iajs-2976	266	19	,	,	PUNCT
iajs-2976	266	20	l.	l.	PROPN
iajs-2976	266	21	;	;	PUNCT
iajs-2976	266	22	pucci	pucci	PROPN
iajs-2976	266	23	,	,	PUNCT
iajs-2976	266	24	m.	m.	NOUN
iajs-2976	266	25	;	;	PUNCT
iajs-2976	266	26	infusino	infusino	PROPN
iajs-2976	266	27	,	,	PUNCT
iajs-2976	266	28	f.	f.	PROPN
iajs-2976	266	29	;	;	PUNCT
iajs-2976	266	30	maestrini	maestrini	PROPN
iajs-2976	266	31	,	,	PUNCT
iajs-2976	266	32	v.	v.	PROPN
iajs-2976	266	33	;	;	PUNCT
iajs-2976	266	34	mancone	mancone	PROPN
iajs-2976	266	35	,	,	PUNCT
iajs-2976	266	36	m	m	PROPN
iajs-2976	266	37	..	..	PUNCT
iajs-2976	266	38	fedele	fedele	PROPN
iajs-2976	266	39	,	,	PUNCT
iajs-2976	266	40	f.	f.	PROPN
iajs-2976	266	41	myocardial	myocardial	ADJ
iajs-2976	266	42	ischemia	ischemia	NOUN
iajs-2976	266	43	and	and	CCONJ
iajs-2976	266	44	diabetes	diabetes	NOUN
iajs-2976	266	45	mellitus	mellitus	NOUN
iajs-2976	266	46	:	:	PUNCT
iajs-2976	266	47	role	role	NOUN
iajs-2976	266	48	of	of	ADP
iajs-2976	266	49	oxidative	oxidative	ADJ
iajs-2976	266	50	stress	stress	NOUN
iajs-2976	266	51	in	in	ADP
iajs-2976	266	52	the	the	DET
iajs-2976	266	53	connection	connection	NOUN
iajs-2976	266	54	between	between	ADP
iajs-2976	266	55	cardiac	cardiac	ADJ
iajs-2976	266	56	metabolism	metabolism	NOUN
iajs-2976	266	57	and	and	CCONJ
iajs-2976	266	58	coronary	coronary	ADJ
iajs-2976	266	59	blood	blood	NOUN
iajs-2976	266	60	flow	flow	NOUN
iajs-2976	266	61	.	.	PUNCT
iajs-2976	267	1	journal	journal	NOUN
iajs-2976	267	2	of	of	ADP
iajs-2976	267	3	diabetes	diabetes	NOUN
iajs-2976	267	4	research	research	NOUN
iajs-2976	267	5	,	,	PUNCT
iajs-2976	267	6	2019,2019	2019,2019	NUM
iajs-2976	267	7	,	,	PUNCT
iajs-2976	267	8	9489826	9489826	NUM
iajs-2976	267	9	https://doi.org/10.1155/2019/9489826	https://doi.org/10.1155/2019/9489826	PROPN
iajs-2976	267	10	6	6	NUM
iajs-2976	267	11	.	.	PUNCT
iajs-2976	268	1	ates	ates	PROPN
iajs-2976	268	2	,	,	PUNCT
iajs-2976	268	3	o.	o.	PROPN
iajs-2976	268	4	;	;	PUNCT
iajs-2976	268	5	bilen	bilen	PROPN
iajs-2976	268	6	,	,	PUNCT
iajs-2976	268	7	h.	h.	PROPN
iajs-2976	268	8	;	;	PUNCT
iajs-2976	268	9	keles	kele	NOUN
iajs-2976	268	10	,	,	PUNCT
iajs-2976	268	11	s.	s.	PROPN
iajs-2976	268	12	;	;	PUNCT
iajs-2976	268	13	alp	alp	PROPN
iajs-2976	268	14	,	,	PUNCT
iajs-2976	268	15	h.	h.	PROPN
iajs-2976	268	16	h.	h.	PROPN
iajs-2976	268	17	;	;	PUNCT
iajs-2976	269	1	keleş	keleş	PROPN
iajs-2976	269	2	,	,	PUNCT
iajs-2976	269	3	m.	m.	PROPN
iajs-2976	269	4	s.	s.	PROPN
iajs-2976	269	5	;	;	PUNCT
iajs-2976	269	6	yıldırım	yıldırım	PROPN
iajs-2976	269	7	,	,	PUNCT
iajs-2976	269	8	k.	k.	PROPN
iajs-2976	269	9	;	;	PUNCT
iajs-2976	269	10	ondaş	ondaş	PROPN
iajs-2976	269	11	,	,	PUNCT
iajs-2976	269	12	o.	o.	PROPN
iajs-2976	269	13	;	;	PUNCT
iajs-2976	269	14	pınar	pınar	PROPN
iajs-2976	269	15	,	,	PUNCT
iajs-2976	269	16	l.	l.	PROPN
iajs-2976	269	17	c.;civelekler	c.;civelekler	PROPN
iajs-2976	269	18	,	,	PUNCT
iajs-2976	269	19	m	m	PROPN
iajs-2976	269	20	..	..	PUNCT
iajs-2976	269	21	baykal	baykal	NOUN
iajs-2976	269	22	,	,	PUNCT
iajs-2976	269	23	o.	o.	PROPN
iajs-2976	269	24	plasma	plasma	PROPN
iajs-2976	269	25	coenzyme	coenzyme	PROPN
iajs-2976	269	26	q10	q10	PROPN
iajs-2976	269	27	levels	level	NOUN
iajs-2976	269	28	in	in	ADP
iajs-2976	269	29	type	type	NOUN
iajs-2976	269	30	2	2	NUM
iajs-2976	269	31	diabetic	diabetic	ADJ
iajs-2976	269	32	patients	patient	NOUN
iajs-2976	269	33	with	with	ADP
iajs-2976	269	34	retinopathy	retinopathy	ADJ
iajs-2976	269	35	.	.	PUNCT
iajs-2976	270	1	int	int	NOUN
iajs-2976	270	2	j	j	PROPN
iajs-2976	270	3	ophthalmol	ophthalmol	PROPN
iajs-2976	270	4	,	,	PUNCT
iajs-2976	270	5	2013,6(5),675	2013,6(5),675	NOUN
iajs-2976	270	6	-	-	SYM
iajs-2976	270	7	9.available	9.available	NUM
iajs-2976	270	8	from	from	ADP
iajs-2976	270	9	:	:	PUNCT
iajs-2976	270	10	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3808920/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3808920/	ADJ
iajs-2976	270	11	7	7	NUM
iajs-2976	270	12	.	.	PUNCT
iajs-2976	270	13	giacco	giacco	PROPN
iajs-2976	270	14	,	,	PUNCT
iajs-2976	270	15	f	f	PROPN
iajs-2976	270	16	..	..	PUNCT
iajs-2976	270	17	brownlee	brownlee	PROPN
iajs-2976	270	18	,	,	PUNCT
iajs-2976	270	19	m.	m.	NOUN
iajs-2976	270	20	oxidative	oxidative	ADJ
iajs-2976	270	21	stress	stress	NOUN
iajs-2976	270	22	and	and	CCONJ
iajs-2976	270	23	diabetic	diabetic	ADJ
iajs-2976	270	24	complications	complication	NOUN
iajs-2976	270	25	.	.	PUNCT
iajs-2976	271	1	circulation	circulation	NOUN
iajs-2976	271	2	research	research	NOUN
iajs-2976	271	3	,	,	PUNCT
iajs-2976	271	4	2010,107(9),1058	2010,107(9),1058	NUM
iajs-2976	271	5	-	-	SYM
iajs-2976	271	6	70	70	NUM
iajs-2976	271	7	https://doi.org/10.1161/circresaha.110.223545	https://doi.org/10.1161/circresaha.110.223545	NUM
iajs-2976	271	8	8	8	NUM
iajs-2976	271	9	.	.	PUNCT
iajs-2976	272	1	fernandes	fernande	NOUN
iajs-2976	272	2	,	,	PUNCT
iajs-2976	272	3	s.	s.	PROPN
iajs-2976	272	4	m.	m.	PROPN
iajs-2976	272	5	;	;	PUNCT
iajs-2976	272	6	cordeiro	cordeiro	PROPN
iajs-2976	272	7	,	,	PUNCT
iajs-2976	272	8	p.	p.	NOUN
iajs-2976	272	9	m.	m.	NOUN
iajs-2976	272	10	;	;	PUNCT
iajs-2976	272	11	watanabe	watanabe	PROPN
iajs-2976	272	12	,	,	PUNCT
iajs-2976	272	13	m.	m.	NOUN
iajs-2976	272	14	;	;	PUNCT
iajs-2976	272	15	fonseca	fonseca	PROPN
iajs-2976	272	16	,	,	PUNCT
iajs-2976	272	17	c.	c.	PROPN
iajs-2976	272	18	d.	d.	PROPN
iajs-2976	273	1	d	d	PROPN
iajs-2976	273	2	..	..	PUNCT
iajs-2976	273	3	vattimo	vattimo	ADJ
iajs-2976	273	4	,	,	PUNCT
iajs-2976	274	1	m.	m.	PROPN
iajs-2976	274	2	d.	d.	PROPN
iajs-2976	274	3	f.	f.	PROPN
iajs-2976	274	4	f.	f.	PROPN
iajs-2976	275	1	the	the	DET
iajs-2976	275	2	role	role	NOUN
iajs-2976	275	3	of	of	ADP
iajs-2976	275	4	oxidative	oxidative	ADJ
iajs-2976	275	5	stress	stress	NOUN
iajs-2976	275	6	in	in	ADP
iajs-2976	275	7	streptozotocin	streptozotocin	NOUN
iajs-2976	275	8	-	-	PUNCT
iajs-2976	275	9	induced	induce	VERB
iajs-2976	275	10	diabetic	diabetic	ADJ
iajs-2976	275	11	nephropathy	nephropathy	NOUN
iajs-2976	275	12	in	in	ADP
iajs-2976	275	13	rats	rat	NOUN
iajs-2976	275	14	.	.	PUNCT
iajs-2976	276	1	archives	archive	NOUN
iajs-2976	276	2	of	of	ADP
iajs-2976	276	3	endocrinology	endocrinology	NOUN
iajs-2976	276	4	and	and	CCONJ
iajs-2976	276	5	metabolism	metabolism	NOUN
iajs-2976	276	6	,	,	PUNCT
iajs-2976	276	7	2016,60,443	2016,60,443	NOUN
iajs-2976	276	8	-	-	SYM
iajs-2976	276	9	9	9	NUM
iajs-2976	276	10	https://doi.org/10.1590/2359-3997000000188	https://doi.org/10.1590/2359-3997000000188	PROPN
iajs-2976	276	11	9	9	NUM
iajs-2976	276	12	.	.	PUNCT
iajs-2976	277	1	m	m	PROPN
iajs-2976	277	2	santos	santos	PROPN
iajs-2976	277	3	,	,	PUNCT
iajs-2976	277	4	j.	j.	PROPN
iajs-2976	277	5	;	;	PUNCT
iajs-2976	277	6	mohammad	mohammad	PROPN
iajs-2976	277	7	,	,	PUNCT
iajs-2976	277	8	g.	g.	PROPN
iajs-2976	277	9	;	;	PUNCT
iajs-2976	277	10	zhong	zhong	PROPN
iajs-2976	277	11	,	,	PUNCT
iajs-2976	277	12	q	q	X
iajs-2976	277	13	..	..	PUNCT
iajs-2976	277	14	a	a	DET
iajs-2976	277	15	kowluru	kowluru	NOUN
iajs-2976	277	16	,	,	PUNCT
iajs-2976	277	17	r.	r.	PROPN
iajs-2976	277	18	diabetic	diabetic	PROPN
iajs-2976	277	19	retinopathy	retinopathy	NOUN
iajs-2976	277	20	,	,	PUNCT
iajs-2976	277	21	superoxide	superoxide	NOUN
iajs-2976	277	22	damage	damage	NOUN
iajs-2976	277	23	and	and	CCONJ
iajs-2976	277	24	antioxidants	antioxidant	NOUN
iajs-2976	277	25	.	.	PUNCT
iajs-2976	278	1	current	current	ADJ
iajs-2976	278	2	pharmaceutical	pharmaceutical	NOUN
iajs-2976	278	3	biotechnology	biotechnology	NOUN
iajs-2976	278	4	,	,	PUNCT
iajs-2976	278	5	2011,12(3),352	2011,12(3),352	NUM
iajs-2976	278	6	-	-	SYM
iajs-2976	278	7	61	61	NUM
iajs-2976	278	8	https://doi.org/10.2174/138920111794480507	https://doi.org/10.2174/138920111794480507	NOUN
iajs-2976	278	9	https://doi.org/10.1016/j.diabres.2010.01.026	https://doi.org/10.1016/j.diabres.2010.01.026	PRON
iajs-2976	278	10	https://apps.who.int/iris/handle/10665/44579	https://apps.who.int/iris/handle/10665/44579	ADJ
iajs-2976	278	11	https://doi.org/10.2337/diacare.28.8.1965	https://doi.org/10.2337/diacare.28.8.1965	NOUN
iajs-2976	278	12	https://doi.org/10.2337/diaclin.26.2.77	https://doi.org/10.2337/diaclin.26.2.77	PROPN
iajs-2976	278	13	https://doi.org/10.1155/2019/9489826	https://doi.org/10.1155/2019/9489826	PROPN
iajs-2976	279	1	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3808920/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3808920/	ADJ
iajs-2976	279	2	https://doi.org/10.1161/circresaha.110.223545	https://doi.org/10.1161/circresaha.110.223545	PROPN
iajs-2976	279	3	https://doi.org/10.1590/2359-3997000000188	https://doi.org/10.1590/2359-3997000000188	PROPN
iajs-2976	279	4	https://doi.org/10.2174/138920111794480507	https://doi.org/10.2174/138920111794480507	NOUN
iajs-2976	279	5	ihjpas	ihjpa	NOUN
iajs-2976	279	6	.	.	PUNCT
iajs-2976	280	1	36(2)2023	36(2)2023	NUM
iajs-2976	280	2	98	98	NUM
iajs-2976	280	3	10	10	NUM
iajs-2976	280	4	.	.	PUNCT
iajs-2976	281	1	yang	yang	PROPN
iajs-2976	281	2	,	,	PUNCT
iajs-2976	281	3	j.	j.	PROPN
iajs-2976	281	4	;	;	PUNCT
iajs-2976	281	5	lane	lane	PROPN
iajs-2976	281	6	,	,	PUNCT
iajs-2976	281	7	p.	p.	PROPN
iajs-2976	281	8	h.	h.	PROPN
iajs-2976	281	9	;	;	PUNCT
iajs-2976	281	10	pollock	pollock	NOUN
iajs-2976	281	11	,	,	PUNCT
iajs-2976	281	12	j.	j.	PROPN
iajs-2976	281	13	s	s	PROPN
iajs-2976	281	14	..	..	PUNCT
iajs-2976	281	15	carmines	carmines	PROPN
iajs-2976	281	16	,	,	PUNCT
iajs-2976	281	17	p.	p.	NOUN
iajs-2976	281	18	k.	k.	PROPN
iajs-2976	282	1	protein	protein	NOUN
iajs-2976	282	2	kinase	kinase	PROPN
iajs-2976	282	3	c	c	NOUN
iajs-2976	282	4	-	-	PUNCT
iajs-2976	282	5	dependent	dependent	ADJ
iajs-2976	282	6	nad	nad	NOUN
iajs-2976	282	7	(	(	PUNCT
iajs-2976	282	8	p	p	NOUN
iajs-2976	282	9	)	)	PUNCT
iajs-2976	282	10	h	h	NOUN
iajs-2976	282	11	oxidase	oxidase	NOUN
iajs-2976	282	12	activation	activation	NOUN
iajs-2976	282	13	induced	induce	VERB
iajs-2976	282	14	by	by	ADP
iajs-2976	282	15	type	type	NOUN
iajs-2976	282	16	1	1	NUM
iajs-2976	282	17	diabetes	diabetes	NOUN
iajs-2976	282	18	in	in	ADP
iajs-2976	282	19	renal	renal	ADJ
iajs-2976	282	20	medullary	medullary	ADJ
iajs-2976	282	21	thick	thick	ADJ
iajs-2976	282	22	ascending	ascend	VERB
iajs-2976	282	23	limb	limb	NOUN
iajs-2976	282	24	.	.	PUNCT
iajs-2976	283	1	hypertension	hypertension	NOUN
iajs-2976	283	2	,	,	PUNCT
iajs-2976	283	3	2010,55(2),468	2010,55(2),468	NUM
iajs-2976	283	4	-	-	SYM
iajs-2976	283	5	73	73	NUM
iajs-2976	283	6	https://doi.org/10.1161/hypertensionaha.109.145714	https://doi.org/10.1161/hypertensionaha.109.145714	NOUN
iajs-2976	283	7	11	11	NUM
iajs-2976	283	8	.	.	PUNCT
iajs-2976	283	9	sies	sies	PROPN
iajs-2976	283	10	,	,	PUNCT
iajs-2976	283	11	h.	h.	PROPN
iajs-2976	283	12	;	;	PUNCT
iajs-2976	283	13	berndt	berndt	PROPN
iajs-2976	283	14	,	,	PUNCT
iajs-2976	283	15	c	c	X
iajs-2976	283	16	..	..	PUNCT
iajs-2976	283	17	jones	jones	PROPN
iajs-2976	283	18	,	,	PUNCT
iajs-2976	283	19	d.	d.	PROPN
iajs-2976	283	20	p.	p.	PROPN
iajs-2976	283	21	oxidative	oxidative	ADJ
iajs-2976	283	22	stress	stress	NOUN
iajs-2976	283	23	.	.	PUNCT
iajs-2976	284	1	annual	annual	ADJ
iajs-2976	284	2	review	review	NOUN
iajs-2976	284	3	of	of	ADP
iajs-2976	284	4	biochemistry	biochemistry	NOUN
iajs-2976	284	5	.	.	PUNCT
iajs-2976	285	1	2017,86,715	2017,86,715	NOUN
iajs-2976	285	2	-	-	SYM
iajs-2976	285	3	48	48	NUM
iajs-2976	285	4	https://doi.org/10.1146/annurev-biochem-061516-045037	https://doi.org/10.1146/annurev-biochem-061516-045037	PROPN
iajs-2976	285	5	12	12	NUM
iajs-2976	285	6	.	.	PUNCT
iajs-2976	286	1	pizzino	pizzino	PROPN
iajs-2976	286	2	,	,	PUNCT
iajs-2976	286	3	g.	g.	PROPN
iajs-2976	286	4	;	;	PUNCT
iajs-2976	286	5	irrera	irrera	NOUN
iajs-2976	286	6	,	,	PUNCT
iajs-2976	286	7	n.	n.	NOUN
iajs-2976	286	8	;	;	PUNCT
iajs-2976	286	9	cucinotta	cucinotta	PROPN
iajs-2976	286	10	,	,	PUNCT
iajs-2976	286	11	m.	m.	NOUN
iajs-2976	286	12	;	;	PUNCT
iajs-2976	286	13	pallio	pallio	NOUN
iajs-2976	286	14	,	,	PUNCT
iajs-2976	286	15	g.	g.	PROPN
iajs-2976	286	16	;	;	PUNCT
iajs-2976	286	17	mannino	mannino	PROPN
iajs-2976	286	18	,	,	PUNCT
iajs-2976	286	19	f.	f.	PROPN
iajs-2976	286	20	;	;	PUNCT
iajs-2976	286	21	arcoraci	arcoraci	NOUN
iajs-2976	286	22	,	,	PUNCT
iajs-2976	286	23	v.	v.	PROPN
iajs-2976	286	24	;	;	PUNCT
iajs-2976	286	25	squadrito	squadrito	PROPN
iajs-2976	286	26	,	,	PUNCT
iajs-2976	286	27	f.	f.	PROPN
iajs-2976	286	28	;	;	PUNCT
iajs-2976	286	29	altavilla	altavilla	PROPN
iajs-2976	286	30	,	,	PUNCT
iajs-2976	286	31	d	d	X
iajs-2976	286	32	..	..	PUNCT
iajs-2976	286	33	bitto	bitto	NOUN
iajs-2976	286	34	,	,	PUNCT
iajs-2976	286	35	a.	a.	NOUN
iajs-2976	286	36	oxidative	oxidative	ADJ
iajs-2976	286	37	stress	stress	NOUN
iajs-2976	286	38	:	:	PUNCT
iajs-2976	286	39	harms	harm	NOUN
iajs-2976	286	40	and	and	CCONJ
iajs-2976	286	41	benefits	benefit	NOUN
iajs-2976	286	42	for	for	ADP
iajs-2976	286	43	human	human	ADJ
iajs-2976	286	44	health	health	NOUN
iajs-2976	286	45	.	.	PUNCT
iajs-2976	287	1	oxidative	oxidative	ADJ
iajs-2976	287	2	medicine	medicine	NOUN
iajs-2976	287	3	and	and	CCONJ
iajs-2976	287	4	cellular	cellular	ADJ
iajs-2976	287	5	longevity	longevity	NOUN
iajs-2976	287	6	,	,	PUNCT
iajs-2976	287	7	2017,2017,8416763	2017,2017,8416763	PROPN
iajs-2976	287	8	https://doi.org/10.1155/2017/8416763	https://doi.org/10.1155/2017/8416763	PROPN
iajs-2976	287	9	13	13	NUM
iajs-2976	287	10	.	.	PUNCT
iajs-2976	288	1	alshehri	alshehri	PROPN
iajs-2976	288	2	,	,	PUNCT
iajs-2976	288	3	a.	a.	NOUN
iajs-2976	288	4	m.	m.	NOUN
iajs-2976	288	5	metabolic	metabolic	PROPN
iajs-2976	288	6	syndrome	syndrome	PROPN
iajs-2976	288	7	and	and	CCONJ
iajs-2976	288	8	cardiovascular	cardiovascular	ADJ
iajs-2976	288	9	risk	risk	NOUN
iajs-2976	288	10	.	.	PUNCT
iajs-2976	289	1	journal	journal	NOUN
iajs-2976	289	2	of	of	ADP
iajs-2976	289	3	family	family	NOUN
iajs-2976	289	4	and	and	CCONJ
iajs-2976	289	5	community	community	NOUN
iajs-2976	289	6	medicine	medicine	NOUN
iajs-2976	289	7	,	,	PUNCT
iajs-2976	289	8	2010,17(2),73.available	2010,17(2),73.available	NUM
iajs-2976	289	9	from	from	ADP
iajs-2976	289	10	:	:	PUNCT
iajs-2976	289	11	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3045098/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3045098/	PROPN
iajs-2976	289	12	14	14	NUM
iajs-2976	289	13	.	.	PUNCT
iajs-2976	290	1	dos	do	NOUN
iajs-2976	290	2	santos	santos	PROPN
iajs-2976	290	3	,	,	PUNCT
iajs-2976	290	4	j.	j.	PROPN
iajs-2976	290	5	m.	m.	PROPN
iajs-2976	290	6	;	;	PUNCT
iajs-2976	290	7	de	de	PROPN
iajs-2976	290	8	oliveira	oliveira	PROPN
iajs-2976	290	9	,	,	PUNCT
iajs-2976	290	10	d.	d.	PROPN
iajs-2976	290	11	s.	s.	PROPN
iajs-2976	290	12	;	;	PUNCT
iajs-2976	290	13	moreli	moreli	PROPN
iajs-2976	290	14	,	,	PUNCT
iajs-2976	290	15	m.	m.	NOUN
iajs-2976	290	16	l	l	PROPN
iajs-2976	290	17	..	..	PUNCT
iajs-2976	290	18	benite	benite	PROPN
iajs-2976	290	19	-	-	PUNCT
iajs-2976	290	20	ribeiro	ribeiro	PROPN
iajs-2976	290	21	,	,	PUNCT
iajs-2976	290	22	s.	s.	PROPN
iajs-2976	290	23	a.	a.	PROPN
iajs-2976	291	1	the	the	DET
iajs-2976	291	2	role	role	NOUN
iajs-2976	291	3	of	of	ADP
iajs-2976	291	4	mitochondrial	mitochondrial	ADJ
iajs-2976	291	5	dna	dna	NOUN
iajs-2976	291	6	damage	damage	NOUN
iajs-2976	291	7	at	at	ADP
iajs-2976	291	8	skeletal	skeletal	ADJ
iajs-2976	291	9	muscle	muscle	NOUN
iajs-2976	291	10	oxidative	oxidative	ADJ
iajs-2976	291	11	stress	stress	NOUN
iajs-2976	291	12	on	on	ADP
iajs-2976	291	13	the	the	DET
iajs-2976	291	14	development	development	NOUN
iajs-2976	291	15	of	of	ADP
iajs-2976	291	16	type	type	NOUN
iajs-2976	291	17	2	2	NUM
iajs-2976	291	18	diabetes	diabetes	NOUN
iajs-2976	291	19	.	.	PUNCT
iajs-2976	292	1	molecular	molecular	ADJ
iajs-2976	292	2	and	and	CCONJ
iajs-2976	292	3	cellular	cellular	ADJ
iajs-2976	292	4	biochemistry	biochemistry	NOUN
iajs-2976	292	5	.	.	PUNCT
iajs-2976	293	1	2018,449(1),251	2018,449(1),251	NUM
iajs-2976	293	2	-	-	SYM
iajs-2976	293	3	5	5	NUM
iajs-2976	293	4	https://doi.org/10.1007/s11010-018-3361-5	https://doi.org/10.1007/s11010-018-3361-5	NUM
iajs-2976	293	5	15	15	NUM
iajs-2976	293	6	.	.	PUNCT
iajs-2976	294	1	dos	do	NOUN
iajs-2976	294	2	santos	santos	PROPN
iajs-2976	294	3	,	,	PUNCT
iajs-2976	294	4	j.	j.	PROPN
iajs-2976	294	5	m.	m.	PROPN
iajs-2976	294	6	;	;	PUNCT
iajs-2976	294	7	tewari	tewari	PROPN
iajs-2976	294	8	,	,	PUNCT
iajs-2976	294	9	s	s	PROPN
iajs-2976	294	10	..	..	PUNCT
iajs-2976	294	11	mendes	mende	NOUN
iajs-2976	294	12	,	,	PUNCT
iajs-2976	294	13	r.	r.	PROPN
iajs-2976	294	14	h.	h.	PROPN
iajs-2976	295	1	the	the	DET
iajs-2976	295	2	role	role	NOUN
iajs-2976	295	3	of	of	ADP
iajs-2976	295	4	oxidative	oxidative	ADJ
iajs-2976	295	5	stress	stress	NOUN
iajs-2976	295	6	in	in	ADP
iajs-2976	295	7	the	the	DET
iajs-2976	295	8	development	development	NOUN
iajs-2976	295	9	of	of	ADP
iajs-2976	295	10	diabetes	diabetes	NOUN
iajs-2976	295	11	mellitus	mellitus	NOUN
iajs-2976	295	12	and	and	CCONJ
iajs-2976	295	13	its	its	PRON
iajs-2976	295	14	complications	complication	NOUN
iajs-2976	295	15	.	.	PUNCT
iajs-2976	296	1	journal	journal	PROPN
iajs-2976	296	2	of	of	ADP
iajs-2976	296	3	diabetes	diabetes	NOUN
iajs-2976	296	4	research	research	NOUN
iajs-2976	296	5	,	,	PUNCT
iajs-2976	296	6	2019,2019,4189813	2019,2019,4189813	PROPN
iajs-2976	296	7	https://doi.org/10.1155/2019/4189813	https://doi.org/10.1155/2019/4189813	PROPN
iajs-2976	296	8	16	16	NUM
iajs-2976	296	9	.	.	PUNCT
iajs-2976	297	1	lamb	lamb	PROPN
iajs-2976	297	2	,	,	PUNCT
iajs-2976	297	3	r	r	PROPN
iajs-2976	297	4	..	..	PUNCT
iajs-2976	297	5	goldstein	goldstein	PROPN
iajs-2976	297	6	,	,	PUNCT
iajs-2976	297	7	b.	b.	PROPN
iajs-2976	297	8	modulating	modulate	VERB
iajs-2976	297	9	an	an	DET
iajs-2976	297	10	oxidative‐inflammatory	oxidative‐inflammatory	ADJ
iajs-2976	297	11	cascade	cascade	NOUN
iajs-2976	297	12	:	:	PUNCT
iajs-2976	297	13	potential	potential	ADJ
iajs-2976	297	14	new	new	ADJ
iajs-2976	297	15	treatment	treatment	NOUN
iajs-2976	297	16	strategy	strategy	NOUN
iajs-2976	297	17	for	for	ADP
iajs-2976	297	18	improving	improve	VERB
iajs-2976	297	19	glucose	glucose	NOUN
iajs-2976	297	20	metabolism	metabolism	NOUN
iajs-2976	297	21	,	,	PUNCT
iajs-2976	297	22	insulin	insulin	NOUN
iajs-2976	297	23	resistance	resistance	NOUN
iajs-2976	297	24	,	,	PUNCT
iajs-2976	297	25	and	and	CCONJ
iajs-2976	297	26	vascular	vascular	ADJ
iajs-2976	297	27	function	function	NOUN
iajs-2976	297	28	.	.	PUNCT
iajs-2976	298	1	international	international	ADJ
iajs-2976	298	2	journal	journal	NOUN
iajs-2976	298	3	of	of	ADP
iajs-2976	298	4	clinical	clinical	ADJ
iajs-2976	298	5	practice	practice	NOUN
iajs-2976	298	6	.	.	PUNCT
iajs-2976	299	1	2008,62(7),1087	2008,62(7),1087	NUM
iajs-2976	299	2	-	-	SYM
iajs-2976	299	3	95	95	NUM
iajs-2976	299	4	https://doi.org/10.1111/j.17421241.2008.01789.x	https://doi.org/10.1111/j.17421241.2008.01789.x	NUM
iajs-2976	299	5	17	17	NUM
iajs-2976	299	6	.	.	PUNCT
iajs-2976	300	1	wojcik	wojcik	PROPN
iajs-2976	300	2	,	,	PUNCT
iajs-2976	300	3	m.	m.	NOUN
iajs-2976	300	4	;	;	PUNCT
iajs-2976	300	5	burzynska	burzynska	NOUN
iajs-2976	300	6	-	-	PUNCT
iajs-2976	300	7	pedziwiatr	pedziwiatr	ADJ
iajs-2976	300	8	,	,	PUNCT
iajs-2976	300	9	i	i	PROPN
iajs-2976	300	10	..	..	PUNCT
iajs-2976	300	11	wozniak	wozniak	PROPN
iajs-2976	300	12	,	,	PUNCT
iajs-2976	300	13	l.	l.	PROPN
iajs-2976	300	14	a	a	DET
iajs-2976	300	15	review	review	NOUN
iajs-2976	300	16	of	of	ADP
iajs-2976	300	17	natural	natural	ADJ
iajs-2976	300	18	and	and	CCONJ
iajs-2976	300	19	synthetic	synthetic	ADJ
iajs-2976	300	20	antioxidants	antioxidant	NOUN
iajs-2976	300	21	important	important	ADJ
iajs-2976	300	22	for	for	ADP
iajs-2976	300	23	health	health	NOUN
iajs-2976	300	24	and	and	CCONJ
iajs-2976	300	25	longevity	longevity	NOUN
iajs-2976	300	26	.	.	PUNCT
iajs-2976	301	1	current	current	ADJ
iajs-2976	301	2	medicinal	medicinal	ADJ
iajs-2976	301	3	chemistry	chemistry	NOUN
iajs-2976	301	4	,	,	PUNCT
iajs-2976	301	5	2010,17(28),326288	2010,17(28),326288	NUM
iajs-2976	301	6	https://doi.org/10.2174/092986710792231950	https://doi.org/10.2174/092986710792231950	NUM
iajs-2976	301	7	18	18	NUM
iajs-2976	301	8	.	.	PUNCT
iajs-2976	302	1	zhang	zhang	PROPN
iajs-2976	302	2	,	,	PUNCT
iajs-2976	302	3	j.	j.	PROPN
iajs-2976	302	4	;	;	PUNCT
iajs-2976	302	5	yuan	yuan	PROPN
iajs-2976	302	6	,	,	PUNCT
iajs-2976	302	7	k.	k.	PROPN
iajs-2976	302	8	;	;	PUNCT
iajs-2976	302	9	zhou	zhou	PROPN
iajs-2976	302	10	,	,	PUNCT
iajs-2976	302	11	w.-l	w.-l	PROPN
iajs-2976	302	12	.	.	PUNCT
iajs-2976	302	13	;	;	PUNCT
iajs-2976	303	1	zhou	zhou	PROPN
iajs-2976	303	2	,	,	PUNCT
iajs-2976	303	3	j	j	PROPN
iajs-2976	303	4	..	..	PROPN
iajs-2976	303	5	yang	yang	PROPN
iajs-2976	303	6	,	,	PUNCT
iajs-2976	303	7	p.	p.	PROPN
iajs-2976	303	8	studies	study	NOUN
iajs-2976	303	9	on	on	ADP
iajs-2976	303	10	the	the	DET
iajs-2976	303	11	active	active	ADJ
iajs-2976	303	12	components	component	NOUN
iajs-2976	303	13	andantioxidant	andantioxidant	NOUN
iajs-2976	303	14	activities	activity	NOUN
iajs-2976	303	15	of	of	ADP
iajs-2976	303	16	the	the	DET
iajs-2976	303	17	extracts	extract	NOUN
iajs-2976	303	18	of	of	ADP
iajs-2976	303	19	mimosa	mimosa	NOUN
iajs-2976	303	20	pudica	pudica	PROPN
iajs-2976	303	21	linn	linn	PROPN
iajs-2976	303	22	.	.	PUNCT
iajs-2976	304	1	from	from	ADP
iajs-2976	304	2	southern	southern	ADJ
iajs-2976	304	3	china.pharmacognosy	china.pharmacognosy	PROPN
iajs-2976	304	4	magazin	magazin	NOUN
iajs-2976	304	5	,	,	PUNCT
iajs-2976	304	6	2011,7(25),35	2011,7(25),35	NUM
iajs-2976	304	7	https://doi.org/10.4103%2f0973-1296.75899	https://doi.org/10.4103%2f0973-1296.75899	NUM
iajs-2976	304	8	19	19	NUM
iajs-2976	304	9	.	.	PUNCT
iajs-2976	304	10	makni	makni	ADJ
iajs-2976	304	11	,	,	PUNCT
iajs-2976	304	12	m.	m.	NOUN
iajs-2976	304	13	;	;	PUNCT
iajs-2976	304	14	sefi	sefi	PROPN
iajs-2976	304	15	,	,	PUNCT
iajs-2976	304	16	m.	m.	NOUN
iajs-2976	304	17	;	;	PUNCT
iajs-2976	304	18	fetoui	fetoui	ADJ
iajs-2976	304	19	,	,	PUNCT
iajs-2976	304	20	h.	h.	PROPN
iajs-2976	304	21	;	;	PUNCT
iajs-2976	304	22	garoui	garoui	PROPN
iajs-2976	304	23	,	,	PUNCT
iajs-2976	304	24	e.	e.	PROPN
iajs-2976	304	25	m.	m.	PROPN
iajs-2976	304	26	;	;	PUNCT
iajs-2976	304	27	gargouri	gargouri	PROPN
iajs-2976	304	28	,	,	PUNCT
iajs-2976	304	29	n.	n.	PROPN
iajs-2976	304	30	k.	k.	PROPN
iajs-2976	304	31	;	;	PUNCT
iajs-2976	304	32	boudawara	boudawara	PROPN
iajs-2976	304	33	,	,	PUNCT
iajs-2976	304	34	t	t	PROPN
iajs-2976	304	35	..	..	PUNCT
iajs-2976	304	36	zeghal	zeghal	NOUN
iajs-2976	304	37	,	,	PUNCT
iajs-2976	304	38	n.	n.	NOUN
iajs-2976	304	39	flax	flax	NOUN
iajs-2976	304	40	and	and	CCONJ
iajs-2976	304	41	pumpkin	pumpkin	ADJ
iajs-2976	304	42	seeds	seed	NOUN
iajs-2976	304	43	mixture	mixture	NOUN
iajs-2976	304	44	ameliorates	ameliorate	VERB
iajs-2976	304	45	diabetic	diabetic	ADJ
iajs-2976	304	46	nephropathy	nephropathy	NOUN
iajs-2976	304	47	in	in	ADP
iajs-2976	304	48	rats	rat	NOUN
iajs-2976	304	49	.	.	PUNCT
iajs-2976	305	1	food	food	NOUN
iajs-2976	305	2	and	and	CCONJ
iajs-2976	305	3	chemical	chemical	NOUN
iajs-2976	305	4	toxicology	toxicology	NOUN
iajs-2976	305	5	,	,	PUNCT
iajs-2976	305	6	2010,48(8	2010,48(8	NOUN
iajs-2976	305	7	-	-	PUNCT
iajs-2976	305	8	9),2407	9),2407	NUM
iajs-2976	305	9	-	-	PUNCT
iajs-2976	305	10	12	12	NUM
iajs-2976	305	11	https://doi.org/10.1016/j.fct.2010.05.079	https://doi.org/10.1016/j.fct.2010.05.079	NOUN
iajs-2976	305	12	20	20	NUM
iajs-2976	305	13	.	.	PUNCT
iajs-2976	306	1	crane	crane	NOUN
iajs-2976	306	2	,	,	PUNCT
iajs-2976	306	3	f.	f.	PROPN
iajs-2976	306	4	l.	l.	PROPN
iajs-2976	306	5	biochemical	biochemical	ADJ
iajs-2976	306	6	functions	function	NOUN
iajs-2976	306	7	of	of	ADP
iajs-2976	306	8	coenzyme	coenzyme	PROPN
iajs-2976	306	9	q10	q10	PROPN
iajs-2976	306	10	.	.	PROPN
iajs-2976	306	11	journal	journal	PROPN
iajs-2976	306	12	of	of	ADP
iajs-2976	306	13	the	the	DET
iajs-2976	306	14	american	american	PROPN
iajs-2976	306	15	college	college	PROPN
iajs-2976	306	16	of	of	ADP
iajs-2976	306	17	nutrition	nutrition	NOUN
iajs-2976	306	18	,	,	PUNCT
iajs-2976	306	19	2001,20(6),591	2001,20(6),591	NOUN
iajs-2976	306	20	-	-	SYM
iajs-2976	306	21	8	8	NUM
iajs-2976	306	22	https://doi.org/10.1080/07315724.2001.10719063	https://doi.org/10.1080/07315724.2001.10719063	PROPN
iajs-2976	306	23	21	21	NUM
iajs-2976	306	24	.	.	PUNCT
iajs-2976	307	1	noh	noh	PROPN
iajs-2976	307	2	,	,	PUNCT
iajs-2976	307	3	y.	y.	PROPN
iajs-2976	307	4	;	;	PUNCT
iajs-2976	307	5	kim	kim	PROPN
iajs-2976	307	6	,	,	PUNCT
iajs-2976	307	7	k.	k.	PROPN
iajs-2976	307	8	;	;	PUNCT
iajs-2976	307	9	shim	shim	NOUN
iajs-2976	307	10	,	,	PUNCT
iajs-2976	307	11	m.	m.	NOUN
iajs-2976	307	12	;	;	PUNCT
iajs-2976	307	13	choi	choi	NOUN
iajs-2976	307	14	,	,	PUNCT
iajs-2976	307	15	s.	s.	PROPN
iajs-2976	307	16	;	;	PUNCT
iajs-2976	307	17	choi	choi	PROPN
iajs-2976	307	18	,	,	PUNCT
iajs-2976	307	19	s.	s.	PROPN
iajs-2976	307	20	;	;	PUNCT
iajs-2976	307	21	ellisman	ellisman	NOUN
iajs-2976	307	22	,	,	PUNCT
iajs-2976	307	23	m.	m.	NOUN
iajs-2976	307	24	;	;	PUNCT
iajs-2976	307	25	weinreb	weinreb	PROPN
iajs-2976	307	26	,	,	PUNCT
iajs-2976	307	27	r.	r.	PROPN
iajs-2976	307	28	;	;	PUNCT
iajs-2976	307	29	perkins	perkins	PROPN
iajs-2976	307	30	,	,	PUNCT
iajs-2976	307	31	g	g	PROPN
iajs-2976	307	32	..	..	SYM
iajs-2976	307	33	ju	ju	PROPN
iajs-2976	307	34	,	,	PUNCT
iajs-2976	307	35	w.	w.	NOUN
iajs-2976	307	36	inhibition	inhibition	NOUN
iajs-2976	307	37	of	of	ADP
iajs-2976	307	38	oxidative	oxidative	ADJ
iajs-2976	307	39	stress	stress	NOUN
iajs-2976	307	40	by	by	ADP
iajs-2976	307	41	coenzyme	coenzyme	PROPN
iajs-2976	307	42	q10	q10	PROPN
iajs-2976	307	43	increases	increase	VERB
iajs-2976	307	44	mitochondrial	mitochondrial	ADJ
iajs-2976	307	45	mass	mass	NOUN
iajs-2976	307	46	and	and	CCONJ
iajs-2976	307	47	improves	improve	VERB
iajs-2976	307	48	bioenergetic	bioenergetic	ADJ
iajs-2976	307	49	function	function	NOUN
iajs-2976	307	50	in	in	ADP
iajs-2976	307	51	optic	optic	ADJ
iajs-2976	307	52	nerve	nerve	NOUN
iajs-2976	307	53	head	head	NOUN
iajs-2976	307	54	astrocytes	astrocyte	NOUN
iajs-2976	307	55	.	.	PUNCT
iajs-2976	308	1	cell	cell	NOUN
iajs-2976	308	2	death	death	NOUN
iajs-2976	308	3	&	&	CCONJ
iajs-2976	308	4	disease	disease	PROPN
iajs-2976	308	5	.	.	PUNCT
iajs-2976	309	1	2013,4(10),e820	2013,4(10),e820	X
iajs-2976	309	2	-	-	PUNCT
iajs-2976	309	3	e	e	NOUN
iajs-2976	309	4	https://doi.org/10.1038/cddis.2013.341	https://doi.org/10.1038/cddis.2013.341	PROPN
iajs-2976	309	5	22	22	NUM
iajs-2976	309	6	.	.	PUNCT
iajs-2976	310	1	bhagavan	bhagavan	PROPN
iajs-2976	310	2	,	,	PUNCT
iajs-2976	310	3	h.	h.	PROPN
iajs-2976	310	4	n	n	CCONJ
iajs-2976	310	5	..	..	PUNCT
iajs-2976	310	6	chopra	chopra	PROPN
iajs-2976	310	7	,	,	PUNCT
iajs-2976	310	8	r.	r.	PROPN
iajs-2976	310	9	k.	k.	PROPN
iajs-2976	311	1	coenzyme	coenzyme	PROPN
iajs-2976	311	2	q10	q10	PROPN
iajs-2976	311	3	:	:	PUNCT
iajs-2976	311	4	absorption	absorption	NOUN
iajs-2976	311	5	,	,	PUNCT
iajs-2976	311	6	tissue	tissue	NOUN
iajs-2976	311	7	uptake	uptake	NOUN
iajs-2976	311	8	,	,	PUNCT
iajs-2976	311	9	metabolism	metabolism	NOUN
iajs-2976	311	10	and	and	CCONJ
iajs-2976	311	11	pharmacokinetics	pharmacokinetic	NOUN
iajs-2976	311	12	.	.	PUNCT
iajs-2976	312	1	free	free	ADJ
iajs-2976	312	2	radical	radical	ADJ
iajs-2976	312	3	research	research	NOUN
iajs-2976	312	4	.	.	PUNCT
iajs-2976	313	1	2006,40(5),445	2006,40(5),445	NOUN
iajs-2976	313	2	-	-	PUNCT
iajs-2976	313	3	53	53	NUM
iajs-2976	313	4	https://doi.org/10.1080/10715760600617843	https://doi.org/10.1080/10715760600617843	NOUN
iajs-2976	313	5	.	.	PUNCT
iajs-2976	314	1	23	23	NUM
iajs-2976	314	2	.	.	PUNCT
iajs-2976	314	3	shekelle	shekelle	NOUN
iajs-2976	314	4	,	,	PUNCT
iajs-2976	314	5	p.	p.	PROPN
iajs-2976	314	6	;	;	PUNCT
iajs-2976	314	7	morton	morton	PROPN
iajs-2976	314	8	,	,	PUNCT
iajs-2976	314	9	s	s	PROPN
iajs-2976	314	10	..	..	PUNCT
iajs-2976	314	11	hardy	hardy	ADJ
iajs-2976	314	12	,	,	PUNCT
iajs-2976	314	13	m.	m.	NOUN
iajs-2976	314	14	effect	effect	NOUN
iajs-2976	314	15	of	of	ADP
iajs-2976	314	16	supplemental	supplemental	ADJ
iajs-2976	314	17	antioxidants	antioxidant	NOUN
iajs-2976	314	18	vitamin	vitamin	NOUN
iajs-2976	314	19	c	c	NOUN
iajs-2976	314	20	,	,	PUNCT
iajs-2976	314	21	vitamin	vitamin	NOUN
iajs-2976	314	22	e	e	NOUN
iajs-2976	314	23	,	,	PUNCT
iajs-2976	314	24	and	and	CCONJ
iajs-2976	314	25	coenzyme	coenzyme	PROPN
iajs-2976	314	26	q10	q10	PROPN
iajs-2976	314	27	for	for	ADP
iajs-2976	314	28	the	the	DET
iajs-2976	314	29	prevention	prevention	NOUN
iajs-2976	314	30	and	and	CCONJ
iajs-2976	314	31	treatment	treatment	NOUN
iajs-2976	314	32	of	of	ADP
iajs-2976	314	33	cardiovascular	cardiovascular	ADJ
iajs-2976	314	34	disease	disease	NOUN
iajs-2976	314	35	.	.	PUNCT
iajs-2976	315	1	evidence	evidence	NOUN
iajs-2976	315	2	report	report	NOUN
iajs-2976	315	3	/	/	SYM
iajs-2976	315	4	technology	technology	NOUN
iajs-2976	315	5	assessment	assessment	NOUN
iajs-2976	315	6	(	(	PUNCT
iajs-2976	315	7	summary	summary	NOUN
iajs-2976	315	8	)	)	PUNCT
iajs-2976	315	9	.	.	PUNCT
iajs-2976	316	1	2003,(83),1	2003,(83),1	X
iajs-2976	316	2	-	-	PUNCT
iajs-2976	316	3	3.available	3.available	NUM
iajs-2976	316	4	from	from	ADP
iajs-2976	316	5	:	:	PUNCT
iajs-2976	316	6	https://europepmc.org/books/nbk37059	https://europepmc.org/books/nbk37059	PROPN
iajs-2976	316	7	.	.	PUNCT
iajs-2976	317	1	24	24	NUM
iajs-2976	317	2	.	.	PUNCT
iajs-2976	317	3	zduńska	zduńska	PROPN
iajs-2976	317	4	,	,	PUNCT
iajs-2976	317	5	k.	k.	PROPN
iajs-2976	317	6	;	;	PUNCT
iajs-2976	317	7	dana	dana	PROPN
iajs-2976	317	8	,	,	PUNCT
iajs-2976	317	9	a.	a.	PROPN
iajs-2976	317	10	;	;	PUNCT
iajs-2976	317	11	kolodziejczak	kolodziejczak	PROPN
iajs-2976	317	12	,	,	PUNCT
iajs-2976	317	13	a	a	DET
iajs-2976	317	14	..	..	PUNCT
iajs-2976	317	15	rotsztejn	rotsztejn	NOUN
iajs-2976	317	16	,	,	PUNCT
iajs-2976	317	17	h.	h.	NOUN
iajs-2976	317	18	antioxidant	antioxidant	ADJ
iajs-2976	317	19	properties	property	NOUN
iajs-2976	317	20	of	of	ADP
iajs-2976	317	21	ferulic	ferulic	ADJ
iajs-2976	317	22	acid	acid	NOUN
iajs-2976	317	23	https://doi.org/10.1161/hypertensionaha.109.145714	https://doi.org/10.1161/hypertensionaha.109.145714	PROPN
iajs-2976	317	24	https://doi.org/10.1146/annurev-biochem-061516-045037	https://doi.org/10.1146/annurev-biochem-061516-045037	PROPN
iajs-2976	317	25	https://doi.org/10.1155/2017/8416763	https://doi.org/10.1155/2017/8416763	PROPN
iajs-2976	317	26	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3045098/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3045098/	PROPN
iajs-2976	317	27	https://doi.org/10.1007/s11010-018-3361-5	https://doi.org/10.1007/s11010-018-3361-5	NUM
iajs-2976	317	28	https://doi.org/10.1155/2019/4189813	https://doi.org/10.1155/2019/4189813	PROPN
iajs-2976	317	29	https://doi.org/10.1111/j.1742-1241.2008.01789.x	https://doi.org/10.1111/j.1742-1241.2008.01789.x	PROPN
iajs-2976	317	30	https://doi.org/10.1111/j.1742-1241.2008.01789.x	https://doi.org/10.1111/j.1742-1241.2008.01789.x	PROPN
iajs-2976	317	31	https://doi.org/10.2174/092986710792231950	https://doi.org/10.2174/092986710792231950	X
iajs-2976	318	1	https://doi.org/10.4103%2f0973-1296.75899	https://doi.org/10.4103%2f0973-1296.75899	PROPN
iajs-2976	318	2	https://doi.org/10.1016/j.fct.2010.05.079	https://doi.org/10.1016/j.fct.2010.05.079	PROPN
iajs-2976	318	3	https://doi.org/10.1080/07315724.2001.10719063	https://doi.org/10.1080/07315724.2001.10719063	PROPN
iajs-2976	319	1	https://doi.org/10.1038/cddis.2013.341	https://doi.org/10.1038/cddis.2013.341	PROPN
iajs-2976	319	2	https://doi.org/10.1080/10715760600617843	https://doi.org/10.1080/10715760600617843	X
iajs-2976	319	3	https://europepmc.org/books/nbk37059	https://europepmc.org/books/nbk37059	PROPN
iajs-2976	319	4	ihjpas	ihjpas	PROPN
iajs-2976	319	5	.	.	PUNCT
iajs-2976	320	1	36(2)2023	36(2)2023	NUM
iajs-2976	320	2	99	99	NUM
iajs-2976	320	3	and	and	CCONJ
iajs-2976	320	4	its	its	PRON
iajs-2976	320	5	possible	possible	ADJ
iajs-2976	320	6	application	application	NOUN
iajs-2976	320	7	.	.	PUNCT
iajs-2976	321	1	skin	skin	NOUN
iajs-2976	321	2	pharmacology	pharmacology	NOUN
iajs-2976	321	3	and	and	CCONJ
iajs-2976	321	4	physiology	physiology	NOUN
iajs-2976	321	5	.	.	PUNCT
iajs-2976	322	1	2018,31(6),332	2018,31(6),332	NUM
iajs-2976	322	2	-	-	SYM
iajs-2976	322	3	6	6	NUM
iajs-2976	322	4	https://doi.org/10.1159/000491755	https://doi.org/10.1159/000491755	ADJ
iajs-2976	322	5	.	.	PUNCT
iajs-2976	323	1	25	25	NUM
iajs-2976	323	2	.	.	X
iajs-2976	323	3	baschiera	baschiera	PROPN
iajs-2976	323	4	,	,	PUNCT
iajs-2976	323	5	e.	e.	PROPN
iajs-2976	323	6	;	;	PUNCT
iajs-2976	323	7	sorrentino	sorrentino	PROPN
iajs-2976	323	8	,	,	PUNCT
iajs-2976	323	9	u.	u.	PROPN
iajs-2976	323	10	;	;	PUNCT
iajs-2976	323	11	calderan	calderan	NOUN
iajs-2976	323	12	,	,	PUNCT
iajs-2976	323	13	c.	c.	PROPN
iajs-2976	323	14	;	;	PUNCT
iajs-2976	323	15	desbats	desbat	NOUN
iajs-2976	323	16	,	,	PUNCT
iajs-2976	323	17	m.	m.	NOUN
iajs-2976	323	18	a	a	DET
iajs-2976	323	19	..	..	PUNCT
iajs-2976	323	20	salviati	salviati	PROPN
iajs-2976	323	21	,	,	PUNCT
iajs-2976	323	22	l.	l.	NOUN
iajs-2976	323	23	the	the	DET
iajs-2976	323	24	multiple	multiple	ADJ
iajs-2976	323	25	roles	role	NOUN
iajs-2976	323	26	of	of	ADP
iajs-2976	323	27	coenzyme	coenzyme	PROPN
iajs-2976	323	28	q	q	PROPN
iajs-2976	323	29	in	in	ADP
iajs-2976	323	30	cellular	cellular	ADJ
iajs-2976	323	31	homeostasis	homeostasis	NOUN
iajs-2976	323	32	and	and	CCONJ
iajs-2976	323	33	their	their	PRON
iajs-2976	323	34	relevance	relevance	NOUN
iajs-2976	323	35	for	for	ADP
iajs-2976	323	36	the	the	DET
iajs-2976	323	37	pathogenesis	pathogenesis	NOUN
iajs-2976	323	38	of	of	ADP
iajs-2976	323	39	coenzyme	coenzyme	PROPN
iajs-2976	323	40	q	q	PROPN
iajs-2976	323	41	deficiency	deficiency	NOUN
iajs-2976	323	42	.	.	PUNCT
iajs-2976	324	1	free	free	ADJ
iajs-2976	324	2	radical	radical	ADJ
iajs-2976	324	3	biology	biology	NOUN
iajs-2976	324	4	and	and	CCONJ
iajs-2976	324	5	medicine	medicine	NOUN
iajs-2976	324	6	,	,	PUNCT
iajs-2976	324	7	2021,166,277	2021,166,277	PROPN
iajs-2976	324	8	-	-	PUNCT
iajs-2976	324	9	86.available	86.available	NUM
iajs-2976	324	10	from	from	ADP
iajs-2976	324	11	:	:	PUNCT
iajs-2976	324	12	https://www.sciencedirect.com/science/article/pii/s0891584921001374	https://www.sciencedirect.com/science/article/pii/s0891584921001374	X
iajs-2976	324	13	.	.	PUNCT
iajs-2976	325	1	26	26	NUM
iajs-2976	325	2	.	.	PUNCT
iajs-2976	326	1	rodríguez	rodríguez	NOUN
iajs-2976	326	2	-	-	PUNCT
iajs-2976	326	3	carrizalez	carrizalez	PROPN
iajs-2976	326	4	,	,	PUNCT
iajs-2976	326	5	a.	a.	PROPN
iajs-2976	326	6	d.	d.	PROPN
iajs-2976	326	7	;	;	PUNCT
iajs-2976	326	8	castellanos	castellanos	PROPN
iajs-2976	326	9	-	-	PUNCT
iajs-2976	326	10	gonzález	gonzález	PROPN
iajs-2976	326	11	,	,	PUNCT
iajs-2976	326	12	j.	j.	PROPN
iajs-2976	326	13	a.	a.	PROPN
iajs-2976	326	14	;	;	PUNCT
iajs-2976	326	15	martínez	martínez	PROPN
iajs-2976	326	16	-	-	PUNCT
iajs-2976	326	17	romero	romero	PROPN
iajs-2976	326	18	,	,	PUNCT
iajs-2976	326	19	e.	e.	PROPN
iajs-2976	326	20	c.	c.	PROPN
iajs-2976	326	21	;	;	PUNCT
iajs-2976	326	22	miller	miller	PROPN
iajs-2976	326	23	arrevillaga	arrevillaga	PROPN
iajs-2976	326	24	,	,	PUNCT
iajs-2976	326	25	g.	g.	PROPN
iajs-2976	326	26	;	;	PUNCT
iajs-2976	326	27	pacheco	pacheco	PROPN
iajs-2976	326	28	-	-	PUNCT
iajs-2976	326	29	moisés	moisés	PROPN
iajs-2976	326	30	,	,	PUNCT
iajs-2976	326	31	f.	f.	PROPN
iajs-2976	326	32	p.	p.	PROPN
iajs-2976	326	33	;	;	PUNCT
iajs-2976	326	34	román	román	NOUN
iajs-2976	326	35	-	-	PUNCT
iajs-2976	326	36	pintos	pintos	NOUN
iajs-2976	326	37	,	,	PUNCT
iajs-2976	326	38	l.	l.	PROPN
iajs-2976	326	39	m	m	PROPN
iajs-2976	326	40	..	..	PUNCT
iajs-2976	326	41	miranda	miranda	NOUN
iajs-2976	326	42	-	-	PUNCT
iajs-2976	326	43	díaz	díaz	NOUN
iajs-2976	326	44	,	,	PUNCT
iajs-2976	326	45	a.	a.	NOUN
iajs-2976	326	46	g.	g.	NOUN
iajs-2976	326	47	the	the	DET
iajs-2976	326	48	effect	effect	NOUN
iajs-2976	326	49	of	of	ADP
iajs-2976	326	50	ubiquinone	ubiquinone	PROPN
iajs-2976	326	51	and	and	CCONJ
iajs-2976	326	52	combined	combine	VERB
iajs-2976	326	53	antioxidant	antioxidant	NOUN
iajs-2976	326	54	therapy	therapy	NOUN
iajs-2976	326	55	on	on	ADP
iajs-2976	326	56	oxidative	oxidative	ADJ
iajs-2976	326	57	stress	stress	NOUN
iajs-2976	326	58	markers	marker	NOUN
iajs-2976	326	59	in	in	ADP
iajs-2976	326	60	non	non	ADJ
iajs-2976	326	61	proliferative	proliferative	ADJ
iajs-2976	326	62	diabetic	diabetic	ADJ
iajs-2976	326	63	retinopathy	retinopathy	NOUN
iajs-2976	326	64	:	:	PUNCT
iajs-2976	326	65	a	a	DET
iajs-2976	326	66	phase	phase	NOUN
iajs-2976	326	67	iia	iia	NOUN
iajs-2976	326	68	,	,	PUNCT
iajs-2976	326	69	randomized	randomize	VERB
iajs-2976	326	70	,	,	PUNCT
iajs-2976	326	71	double	double	ADJ
iajs-2976	326	72	-	-	PUNCT
iajs-2976	326	73	blind	blind	ADJ
iajs-2976	326	74	,	,	PUNCT
iajs-2976	326	75	and	and	CCONJ
iajs-2976	326	76	placebo	placebo	NOUN
iajs-2976	326	77	controlled	control	VERB
iajs-2976	326	78	study	study	NOUN
iajs-2976	326	79	.	.	PUNCT
iajs-2976	327	1	redox	redox	ADJ
iajs-2976	327	2	report	report	NOUN
iajs-2976	327	3	.	.	PUNCT
iajs-2976	328	1	2016,21(4),155	2016,21(4),155	NUM
iajs-2976	328	2	-	-	SYM
iajs-2976	328	3	63	63	NUM
iajs-2976	328	4	https://doi.org/10.1179/1351000215y.0000000040	https://doi.org/10.1179/1351000215y.0000000040	NOUN
iajs-2976	328	5	.	.	PUNCT
iajs-2976	329	1	27	27	NUM
iajs-2976	329	2	.	.	X
iajs-2976	330	1	lee	lee	PROPN
iajs-2976	330	2	,	,	PUNCT
iajs-2976	330	3	b.-j	b.-j	PROPN
iajs-2976	330	4	.	.	PUNCT
iajs-2976	330	5	;	;	PUNCT
iajs-2976	330	6	huang	huang	PROPN
iajs-2976	330	7	,	,	PUNCT
iajs-2976	330	8	y.-c	y.-c	PROPN
iajs-2976	330	9	.	.	PUNCT
iajs-2976	330	10	;	;	PUNCT
iajs-2976	331	1	chen	chen	PROPN
iajs-2976	331	2	,	,	PUNCT
iajs-2976	331	3	s.-j	s.-j	PROPN
iajs-2976	331	4	..	..	PUNCT
iajs-2976	331	5	lin	lin	PROPN
iajs-2976	331	6	,	,	PUNCT
iajs-2976	331	7	p.-t	p.-t	PROPN
iajs-2976	331	8	.	.	PUNCT
iajs-2976	332	1	coenzyme	coenzyme	PROPN
iajs-2976	332	2	q10	q10	PROPN
iajs-2976	332	3	supplementation	supplementation	NOUN
iajs-2976	332	4	reduces	reduce	VERB
iajs-2976	332	5	oxidative	oxidative	ADJ
iajs-2976	332	6	stress	stress	NOUN
iajs-2976	332	7	and	and	CCONJ
iajs-2976	332	8	increases	increase	VERB
iajs-2976	332	9	antioxidant	antioxidant	ADJ
iajs-2976	332	10	enzyme	enzyme	NOUN
iajs-2976	332	11	activity	activity	NOUN
iajs-2976	332	12	in	in	ADP
iajs-2976	332	13	patients	patient	NOUN
iajs-2976	332	14	with	with	ADP
iajs-2976	332	15	coronary	coronary	ADJ
iajs-2976	332	16	artery	artery	NOUN
iajs-2976	332	17	disease	disease	NOUN
iajs-2976	332	18	.	.	PUNCT
iajs-2976	333	1	nutrition	nutrition	NOUN
iajs-2976	333	2	.	.	PUNCT
iajs-2976	334	1	2012,28(3),250	2012,28(3),250	NUM
iajs-2976	334	2	-	-	SYM
iajs-2976	334	3	5	5	NUM
iajs-2976	334	4	https://doi.org/10.1016/j.nut.2011.06.004	https://doi.org/10.1016/j.nut.2011.06.004	VERB
iajs-2976	334	5	28	28	NUM
iajs-2976	334	6	.	.	PUNCT
iajs-2976	335	1	del	del	PROPN
iajs-2976	335	2	rio	rio	PROPN
iajs-2976	335	3	,	,	PUNCT
iajs-2976	335	4	d.	d.	PROPN
iajs-2976	335	5	;	;	PUNCT
iajs-2976	335	6	stewart	stewart	PROPN
iajs-2976	335	7	,	,	PUNCT
iajs-2976	335	8	a.	a.	PROPN
iajs-2976	335	9	j	j	PROPN
iajs-2976	335	10	..	..	PUNCT
iajs-2976	335	11	pellegrini	pellegrini	PROPN
iajs-2976	335	12	,	,	PUNCT
iajs-2976	335	13	n.	n.	PROPN
iajs-2976	335	14	a	a	DET
iajs-2976	335	15	review	review	NOUN
iajs-2976	335	16	of	of	ADP
iajs-2976	335	17	recent	recent	ADJ
iajs-2976	335	18	studies	study	NOUN
iajs-2976	335	19	on	on	ADP
iajs-2976	335	20	malondialdehyde	malondialdehyde	PROPN
iajs-2976	335	21	as	as	ADP
iajs-2976	335	22	toxic	toxic	ADJ
iajs-2976	335	23	molecule	molecule	NOUN
iajs-2976	335	24	and	and	CCONJ
iajs-2976	335	25	biological	biological	ADJ
iajs-2976	335	26	marker	marker	NOUN
iajs-2976	335	27	of	of	ADP
iajs-2976	335	28	oxidative	oxidative	ADJ
iajs-2976	335	29	stress	stress	NOUN
iajs-2976	335	30	.	.	PUNCT
iajs-2976	336	1	nutrition	nutrition	NOUN
iajs-2976	336	2	,	,	PUNCT
iajs-2976	336	3	metabolism	metabolism	NOUN
iajs-2976	336	4	and	and	CCONJ
iajs-2976	336	5	cardiovascular	cardiovascular	ADJ
iajs-2976	336	6	diseases	disease	NOUN
iajs-2976	336	7	.	.	PUNCT
iajs-2976	337	1	2005,15(4),316	2005,15(4),316	NUM
iajs-2976	337	2	-	-	SYM
iajs-2976	337	3	28	28	NUM
iajs-2976	337	4	https://doi.org/10.1016/j.numecd.2005.05.003	https://doi.org/10.1016/j.numecd.2005.05.003	PROPN
iajs-2976	337	5	29	29	NUM
iajs-2976	337	6	.	.	PUNCT
iajs-2976	337	7	jain	jain	PROPN
iajs-2976	337	8	,	,	PUNCT
iajs-2976	337	9	s.	s.	PROPN
iajs-2976	337	10	k.	k.	PROPN
iajs-2976	337	11	;	;	PUNCT
iajs-2976	337	12	kannan	kannan	PROPN
iajs-2976	337	13	,	,	PUNCT
iajs-2976	337	14	k.	k.	PROPN
iajs-2976	337	15	;	;	PUNCT
iajs-2976	337	16	lim	lim	PROPN
iajs-2976	337	17	,	,	PUNCT
iajs-2976	337	18	g.	g.	PROPN
iajs-2976	337	19	;	;	PUNCT
iajs-2976	337	20	matthews	matthews	NOUN
iajs-2976	337	21	-	-	PUNCT
iajs-2976	337	22	greer	greer	PROPN
iajs-2976	337	23	,	,	PUNCT
iajs-2976	337	24	j.	j.	PROPN
iajs-2976	337	25	;	;	PUNCT
iajs-2976	337	26	mcvie	mcvie	NOUN
iajs-2976	337	27	,	,	PUNCT
iajs-2976	337	28	r	r	PROPN
iajs-2976	337	29	..	..	PUNCT
iajs-2976	337	30	bocchini	bocchini	PROPN
iajs-2976	337	31	jr	jr	PROPN
iajs-2976	337	32	,	,	PUNCT
iajs-2976	337	33	j.	j.	PROPN
iajs-2976	337	34	a.	a.	PROPN
iajs-2976	337	35	elevated	elevated	PROPN
iajs-2976	337	36	blood	blood	NOUN
iajs-2976	337	37	interleukin-6	interleukin-6	NUM
iajs-2976	337	38	levels	level	NOUN
iajs-2976	337	39	in	in	ADP
iajs-2976	337	40	hyperketonemic	hyperketonemic	ADJ
iajs-2976	337	41	type	type	NOUN
iajs-2976	337	42	1	1	NUM
iajs-2976	337	43	diabetic	diabetic	ADJ
iajs-2976	337	44	patients	patient	NOUN
iajs-2976	337	45	and	and	CCONJ
iajs-2976	337	46	secretion	secretion	NOUN
iajs-2976	337	47	by	by	ADP
iajs-2976	337	48	acetoacetate	acetoacetate	NOUN
iajs-2976	337	49	-	-	PUNCT
iajs-2976	337	50	treated	treat	VERB
iajs-2976	337	51	cultured	cultured	ADJ
iajs-2976	337	52	u937	u937	PROPN
iajs-2976	337	53	monocytes	monocyte	NOUN
iajs-2976	337	54	.	.	PUNCT
iajs-2976	338	1	diabetes	diabetes	NOUN
iajs-2976	338	2	care	care	NOUN
iajs-2976	338	3	.	.	PUNCT
iajs-2976	339	1	2003,26(7),2139	2003,26(7),2139	X
iajs-2976	339	2	-	-	SYM
iajs-2976	339	3	43	43	NUM
iajs-2976	339	4	https://doi.org/10.2337/diacare.26.7.2139	https://doi.org/10.2337/diacare.26.7.2139	ADJ
iajs-2976	339	5	30	30	NUM
iajs-2976	339	6	.	.	PUNCT
iajs-2976	340	1	drzewoski	drzewoski	PROPN
iajs-2976	340	2	,	,	PUNCT
iajs-2976	340	3	j.	j.	PROPN
iajs-2976	340	4	gliclazide	gliclazide	PROPN
iajs-2976	340	5	,	,	PUNCT
iajs-2976	340	6	inflammation	inflammation	NOUN
iajs-2976	340	7	and	and	CCONJ
iajs-2976	340	8	atherosclerosis	atherosclerosis	NOUN
iajs-2976	340	9	.	.	PUNCT
iajs-2976	341	1	anti	anti	ADJ
iajs-2976	341	2	-	-	ADJ
iajs-2976	341	3	inflammatory	inflammatory	ADJ
iajs-2976	341	4	&	&	CCONJ
iajs-2976	341	5	antiallergy	antiallergy	NOUN
iajs-2976	341	6	agents	agent	NOUN
iajs-2976	341	7	in	in	ADP
iajs-2976	341	8	medicinal	medicinal	ADJ
iajs-2976	341	9	chemistry	chemistry	NOUN
iajs-2976	341	10	(	(	PUNCT
iajs-2976	341	11	formerly	formerly	ADV
iajs-2976	341	12	current	current	ADJ
iajs-2976	341	13	medicinal	medicinal	ADJ
iajs-2976	341	14	chemistry	chemistry	NOUN
iajs-2976	341	15	-	-	PUNCT
iajs-2976	341	16	antiinflammatory	antiinflammatory	NOUN
iajs-2976	341	17	and	and	CCONJ
iajs-2976	341	18	anti	anti	ADJ
iajs-2976	341	19	-	-	ADJ
iajs-2976	341	20	allergy	allergy	ADJ
iajs-2976	341	21	agents	agent	NOUN
iajs-2976	341	22	)	)	PUNCT
iajs-2976	341	23	.	.	PUNCT
iajs-2976	342	1	2008,7(3),224	2008,7(3),224	NUM
iajs-2976	342	2	-	-	SYM
iajs-2976	342	3	30	30	NUM
iajs-2976	342	4	https://doi.org/10.2174/187152308785699263	https://doi.org/10.2174/187152308785699263	NUM
iajs-2976	342	5	31	31	NUM
iajs-2976	342	6	.	.	PUNCT
iajs-2976	343	1	naseem	naseem	PROPN
iajs-2976	343	2	,	,	PUNCT
iajs-2976	343	3	k.	k.	PROPN
iajs-2976	343	4	m.	m.	NOUN
iajs-2976	343	5	the	the	DET
iajs-2976	343	6	role	role	NOUN
iajs-2976	343	7	of	of	ADP
iajs-2976	343	8	nitric	nitric	ADJ
iajs-2976	343	9	oxide	oxide	NOUN
iajs-2976	343	10	in	in	ADP
iajs-2976	343	11	cardiovascular	cardiovascular	ADJ
iajs-2976	343	12	diseases	disease	NOUN
iajs-2976	343	13	.	.	PUNCT
iajs-2976	344	1	molecular	molecular	ADJ
iajs-2976	344	2	aspects	aspect	NOUN
iajs-2976	344	3	of	of	ADP
iajs-2976	344	4	medicine	medicine	NOUN
iajs-2976	344	5	.	.	PUNCT
iajs-2976	345	1	2005,26(1	2005,26(1	PROPN
iajs-2976	345	2	-	-	PUNCT
iajs-2976	345	3	2),33	2),33	NUM
iajs-2976	345	4	-	-	SYM
iajs-2976	345	5	65	65	NUM
iajs-2976	345	6	https://doi.org/10.1016/j.mam.2004.09.003	https://doi.org/10.1016/j.mam.2004.09.003	PROPN
iajs-2976	345	7	32	32	NUM
iajs-2976	345	8	.	.	PUNCT
iajs-2976	346	1	kashyap	kashyap	PROPN
iajs-2976	346	2	,	,	PUNCT
iajs-2976	346	3	s.	s.	PROPN
iajs-2976	346	4	r.	r.	PROPN
iajs-2976	346	5	;	;	PUNCT
iajs-2976	346	6	roman	roman	PROPN
iajs-2976	346	7	,	,	PUNCT
iajs-2976	346	8	l.	l.	PROPN
iajs-2976	346	9	j.	j.	PROPN
iajs-2976	346	10	;	;	PUNCT
iajs-2976	346	11	lamont	lamont	PROPN
iajs-2976	346	12	,	,	PUNCT
iajs-2976	346	13	j.	j.	PROPN
iajs-2976	346	14	;	;	PUNCT
iajs-2976	346	15	masters	master	NOUN
iajs-2976	346	16	,	,	PUNCT
iajs-2976	346	17	b.	b.	PROPN
iajs-2976	346	18	s.	s.	PROPN
iajs-2976	346	19	s.	s.	PROPN
iajs-2976	346	20	;	;	PUNCT
iajs-2976	346	21	bajaj	bajaj	PROPN
iajs-2976	346	22	,	,	PUNCT
iajs-2976	346	23	m.	m.	NOUN
iajs-2976	346	24	;	;	PUNCT
iajs-2976	346	25	suraamornkul	suraamornkul	PROPN
iajs-2976	346	26	,	,	PUNCT
iajs-2976	346	27	s.	s.	PROPN
iajs-2976	346	28	;	;	PUNCT
iajs-2976	346	29	belfort	belfort	PROPN
iajs-2976	346	30	,	,	PUNCT
iajs-2976	346	31	r.	r.	PROPN
iajs-2976	346	32	;	;	PUNCT
iajs-2976	346	33	berria	berria	PROPN
iajs-2976	346	34	,	,	PUNCT
iajs-2976	346	35	r.	r.	PROPN
iajs-2976	346	36	;	;	PUNCT
iajs-2976	346	37	kellogg	kellogg	PROPN
iajs-2976	346	38	jr	jr	PROPN
iajs-2976	346	39	,	,	PUNCT
iajs-2976	346	40	d.	d.	PROPN
iajs-2976	346	41	l	l	PROPN
iajs-2976	346	42	..	..	PUNCT
iajs-2976	347	1	liu	liu	PROPN
iajs-2976	347	2	,	,	PUNCT
iajs-2976	347	3	y.	y.	PROPN
iajs-2976	347	4	insulin	insulin	PROPN
iajs-2976	347	5	resistance	resistance	NOUN
iajs-2976	347	6	is	be	AUX
iajs-2976	347	7	associated	associate	VERB
iajs-2976	347	8	with	with	ADP
iajs-2976	347	9	impaired	impaired	ADJ
iajs-2976	347	10	nitric	nitric	ADJ
iajs-2976	347	11	oxide	oxide	NOUN
iajs-2976	347	12	synthase	synthase	NOUN
iajs-2976	347	13	activity	activity	NOUN
iajs-2976	347	14	in	in	ADP
iajs-2976	347	15	skeletal	skeletal	ADJ
iajs-2976	347	16	muscle	muscle	NOUN
iajs-2976	347	17	of	of	ADP
iajs-2976	347	18	type	type	NOUN
iajs-2976	347	19	2	2	NUM
iajs-2976	347	20	diabetic	diabetic	ADJ
iajs-2976	347	21	subjects	subject	NOUN
iajs-2976	347	22	.	.	PUNCT
iajs-2976	348	1	the	the	DET
iajs-2976	348	2	journal	journal	NOUN
iajs-2976	348	3	of	of	ADP
iajs-2976	348	4	clinical	clinical	ADJ
iajs-2976	348	5	endocrinology	endocrinology	NOUN
iajs-2976	348	6	&	&	CCONJ
iajs-2976	348	7	metabolism	metabolism	NOUN
iajs-2976	348	8	.	.	PUNCT
iajs-2976	349	1	2005,90(2),1100	2005,90(2),1100	NUM
iajs-2976	349	2	-	-	SYM
iajs-2976	349	3	5	5	NUM
iajs-2976	349	4	https://doi.org/10.1210/jc.2004-0745	https://doi.org/10.1210/jc.2004-0745	NOUN
iajs-2976	349	5	33	33	NUM
iajs-2976	349	6	.	.	PUNCT
iajs-2976	350	1	kunitomo	kunitomo	PROPN
iajs-2976	350	2	,	,	PUNCT
iajs-2976	350	3	m.	m.	NOUN
iajs-2976	350	4	;	;	PUNCT
iajs-2976	350	5	yamaguchi	yamaguchi	PROPN
iajs-2976	350	6	,	,	PUNCT
iajs-2976	350	7	y.	y.	PROPN
iajs-2976	350	8	;	;	PUNCT
iajs-2976	350	9	kagota	kagota	PROPN
iajs-2976	350	10	,	,	PUNCT
iajs-2976	350	11	s	s	PROPN
iajs-2976	350	12	..	..	X
iajs-2976	350	13	otsubo	otsubo	PROPN
iajs-2976	350	14	,	,	PUNCT
iajs-2976	350	15	k.	k.	PROPN
iajs-2976	350	16	beneficial	beneficial	ADJ
iajs-2976	350	17	effect	effect	NOUN
iajs-2976	350	18	of	of	ADP
iajs-2976	350	19	coenzyme	coenzyme	PROPN
iajs-2976	350	20	q10	q10	PROPN
iajs-2976	350	21	on	on	ADP
iajs-2976	350	22	increased	increase	VERB
iajs-2976	350	23	oxidative	oxidative	ADJ
iajs-2976	350	24	and	and	CCONJ
iajs-2976	350	25	nitrative	nitrative	ADJ
iajs-2976	350	26	stress	stress	NOUN
iajs-2976	350	27	and	and	CCONJ
iajs-2976	350	28	inflammation	inflammation	NOUN
iajs-2976	350	29	and	and	CCONJ
iajs-2976	350	30	individual	individual	ADJ
iajs-2976	350	31	metabolic	metabolic	NOUN
iajs-2976	350	32	components	component	NOUN
iajs-2976	350	33	developing	develop	VERB
iajs-2976	350	34	in	in	ADP
iajs-2976	350	35	a	a	DET
iajs-2976	350	36	rat	rat	NOUN
iajs-2976	350	37	model	model	NOUN
iajs-2976	350	38	of	of	ADP
iajs-2976	350	39	metabolic	metabolic	NOUN
iajs-2976	350	40	syndrome	syndrome	NOUN
iajs-2976	350	41	.	.	PUNCT
iajs-2976	351	1	journal	journal	NOUN
iajs-2976	351	2	of	of	ADP
iajs-2976	351	3	pharmacological	pharmacological	ADJ
iajs-2976	351	4	sciences	science	NOUN
iajs-2976	351	5	.	.	PUNCT
iajs-2976	352	1	2008,0806040111https://doi.org/10.1254	2008,0806040111https://doi.org/10.1254	NUM
iajs-2976	352	2	/	/	SYM
iajs-2976	352	3	jphs.fp0072365	jphs.fp0072365	PROPN
iajs-2976	352	4	34	34	NUM
iajs-2976	352	5	.	.	PUNCT
iajs-2976	353	1	turunen	turunen	PROPN
iajs-2976	353	2	,	,	PUNCT
iajs-2976	353	3	m.	m.	NOUN
iajs-2976	353	4	;	;	PUNCT
iajs-2976	353	5	appelkvist	appelkvist	ADJ
iajs-2976	353	6	,	,	PUNCT
iajs-2976	353	7	e.-l	e.-l	PROPN
iajs-2976	353	8	.	.	PUNCT
iajs-2976	353	9	;	;	PUNCT
iajs-2976	354	1	sindelar	sindelar	NOUN
iajs-2976	354	2	,	,	PUNCT
iajs-2976	354	3	p	p	X
iajs-2976	354	4	..	..	X
iajs-2976	354	5	dallner	dallner	NOUN
iajs-2976	354	6	,	,	PUNCT
iajs-2976	354	7	g.	g.	PROPN
iajs-2976	354	8	blood	blood	NOUN
iajs-2976	354	9	concentration	concentration	NOUN
iajs-2976	354	10	of	of	ADP
iajs-2976	354	11	coenzyme	coenzyme	PROPN
iajs-2976	354	12	q10	q10	PROPN
iajs-2976	354	13	increases	increase	VERB
iajs-2976	354	14	in	in	ADP
iajs-2976	354	15	rats	rat	NOUN
iajs-2976	354	16	when	when	SCONJ
iajs-2976	354	17	esterified	esterify	VERB
iajs-2976	354	18	forms	form	NOUN
iajs-2976	354	19	are	be	AUX
iajs-2976	354	20	administered	administer	VERB
iajs-2976	354	21	.	.	PUNCT
iajs-2976	355	1	the	the	DET
iajs-2976	355	2	journal	journal	NOUN
iajs-2976	355	3	of	of	ADP
iajs-2976	355	4	nutrition	nutrition	NOUN
iajs-2976	355	5	.	.	PUNCT
iajs-2976	356	1	1999,129(12),2113	1999,129(12),2113	NUM
iajs-2976	356	2	-	-	SYM
iajs-2976	356	3	8.available	8.available	NUM
iajs-2976	356	4	from	from	ADP
iajs-2976	356	5	:	:	PUNCT
iajs-2976	356	6	https://academic.oup.com/jn/article/129/12/2113/4722094	https://academic.oup.com/jn/article/129/12/2113/4722094	PROPN
iajs-2976	356	7	35	35	NUM
iajs-2976	356	8	.	.	PUNCT
iajs-2976	357	1	kim	kim	PROPN
iajs-2976	357	2	,	,	PUNCT
iajs-2976	357	3	h.-n	h.-n	PROPN
iajs-2976	357	4	.	.	PUNCT
iajs-2976	357	5	;	;	PUNCT
iajs-2976	357	6	jeon	jeon	PROPN
iajs-2976	357	7	,	,	PUNCT
iajs-2976	357	8	d.-g	d.-g	PROPN
iajs-2976	357	9	.	.	PUNCT
iajs-2976	357	10	;	;	PUNCT
iajs-2976	358	1	lim	lim	PROPN
iajs-2976	358	2	,	,	PUNCT
iajs-2976	358	3	y	y	PROPN
iajs-2976	358	4	..	..	PUNCT
iajs-2976	358	5	jang	jang	PROPN
iajs-2976	358	6	,	,	PUNCT
iajs-2976	358	7	i.-s	i.-	NOUN
iajs-2976	358	8	.	.	PUNCT
iajs-2976	359	1	the	the	DET
iajs-2976	359	2	effects	effect	NOUN
iajs-2976	359	3	of	of	ADP
iajs-2976	359	4	coenzyme	coenzyme	PROPN
iajs-2976	359	5	q	q	PROPN
iajs-2976	359	6	10	10	NUM
iajs-2976	359	7	supplement	supplement	NOUN
iajs-2976	359	8	on	on	ADP
iajs-2976	359	9	blood	blood	NOUN
iajs-2976	359	10	lipid	lipid	NOUN
iajs-2976	359	11	indices	index	NOUN
iajs-2976	359	12	and	and	CCONJ
iajs-2976	359	13	hepatic	hepatic	ADJ
iajs-2976	359	14	antioxidant	antioxidant	ADJ
iajs-2976	359	15	defense	defense	NOUN
iajs-2976	359	16	system	system	NOUN
iajs-2976	359	17	in	in	ADP
iajs-2976	359	18	sd	sd	NOUN
iajs-2976	359	19	rats	rat	NOUN
iajs-2976	359	20	fed	feed	VERB
iajs-2976	359	21	a	a	DET
iajs-2976	359	22	high	high	ADJ
iajs-2976	359	23	cholesterol	cholesterol	NOUN
iajs-2976	359	24	diet	diet	NOUN
iajs-2976	359	25	.	.	PUNCT
iajs-2976	360	1	laboratory	laboratory	NOUN
iajs-2976	360	2	animal	animal	NOUN
iajs-2976	360	3	research	research	NOUN
iajs-2976	360	4	.	.	PUNCT
iajs-2976	361	1	2019,35(1),1	2019,35(1),1	NUM
iajs-2976	361	2	-	-	SYM
iajs-2976	361	3	8	8	NUM
iajs-2976	361	4	https://doi.org/10.1186/s42826-019-0013-1	https://doi.org/10.1186/s42826-019-0013-1	NUM
iajs-2976	361	5	36	36	NUM
iajs-2976	361	6	.	.	PUNCT
iajs-2976	362	1	ibrahim	ibrahim	PROPN
iajs-2976	362	2	,	,	PUNCT
iajs-2976	362	3	w.	w.	PROPN
iajs-2976	362	4	h.	h.	PROPN
iajs-2976	362	5	;	;	PUNCT
iajs-2976	362	6	bhagavan	bhagavan	PROPN
iajs-2976	362	7	,	,	PUNCT
iajs-2976	362	8	h.	h.	PROPN
iajs-2976	362	9	n.	n.	PROPN
iajs-2976	362	10	;	;	PUNCT
iajs-2976	362	11	chopra	chopra	PROPN
iajs-2976	362	12	,	,	PUNCT
iajs-2976	362	13	r.	r.	PROPN
iajs-2976	362	14	k	k	PROPN
iajs-2976	362	15	..	..	PROPN
iajs-2976	362	16	chow	chow	PROPN
iajs-2976	362	17	,	,	PUNCT
iajs-2976	362	18	c.	c.	PROPN
iajs-2976	362	19	k.	k.	PROPN
iajs-2976	363	1	dietary	dietary	ADJ
iajs-2976	363	2	coenzyme	coenzyme	PROPN
iajs-2976	363	3	q10	q10	PROPN
iajs-2976	363	4	and	and	CCONJ
iajs-2976	363	5	vitamin	vitamin	PROPN
iajs-2976	363	6	e	e	NOUN
iajs-2976	363	7	alter	alter	VERB
iajs-2976	363	8	the	the	DET
iajs-2976	363	9	status	status	NOUN
iajs-2976	363	10	of	of	ADP
iajs-2976	363	11	these	these	DET
iajs-2976	363	12	compounds	compound	NOUN
iajs-2976	363	13	in	in	ADP
iajs-2976	363	14	rat	rat	NOUN
iajs-2976	363	15	tissues	tissue	NOUN
iajs-2976	363	16	and	and	CCONJ
iajs-2976	363	17	mitochondria	mitochondria	NOUN
iajs-2976	363	18	.	.	PUNCT
iajs-2976	364	1	the	the	DET
iajs-2976	364	2	journal	journal	NOUN
iajs-2976	364	3	of	of	ADP
iajs-2976	364	4	nutrition	nutrition	NOUN
iajs-2976	364	5	.	.	PUNCT
iajs-2976	365	1	2000,130(9),2343	2000,130(9),2343	NOUN
iajs-2976	365	2	-	-	SYM
iajs-2976	365	3	8	8	NUM
iajs-2976	365	4	https://doi.org/10.1093/jn/130.9.2343	https://doi.org/10.1093/jn/130.9.2343	PROPN
iajs-2976	365	5	https://doi.org/10.1159/000491755	https://doi.org/10.1159/000491755	ADV
iajs-2976	365	6	https://www.sciencedirect.com/science/article/pii/s0891584921001374	https://www.sciencedirect.com/science/article/pii/s0891584921001374	NOUN
iajs-2976	365	7	https://doi.org/10.1179/1351000215y.0000000040	https://doi.org/10.1179/1351000215y.0000000040	NOUN
iajs-2976	365	8	https://doi.org/10.1016/j.nut.2011.06.004	https://doi.org/10.1016/j.nut.2011.06.004	AUX
iajs-2976	365	9	https://doi.org/10.1016/j.numecd.2005.05.003	https://doi.org/10.1016/j.numecd.2005.05.003	PROPN
iajs-2976	365	10	https://doi.org/10.2337/diacare.26.7.2139	https://doi.org/10.2337/diacare.26.7.2139	ADJ
iajs-2976	365	11	https://doi.org/10.2174/187152308785699263	https://doi.org/10.2174/187152308785699263	X
iajs-2976	365	12	https://doi.org/10.1016/j.mam.2004.09.003	https://doi.org/10.1016/j.mam.2004.09.003	PROPN
iajs-2976	365	13	https://doi.org/10.1210/jc.2004-0745	https://doi.org/10.1210/jc.2004-0745	NOUN
iajs-2976	365	14	https://doi.org/10.1254/jphs.fp0072365	https://doi.org/10.1254/jphs.fp0072365	NOUN
iajs-2976	365	15	https://academic.oup.com/jn/article/129/12/2113/4722094	https://academic.oup.com/jn/article/129/12/2113/4722094	NUM
iajs-2976	365	16	https://doi.org/10.1186/s42826-019-0013-1	https://doi.org/10.1186/s42826-019-0013-1	NUM
iajs-2976	366	1	https://doi.org/10.1093/jn/130.9.2343	https://doi.org/10.1093/jn/130.9.2343	PROPN
iajs-2976	366	2	ihjpas	ihjpa	VERB
iajs-2976	366	3	.	.	PUNCT
iajs-2976	367	1	36(2)2023	36(2)2023	NUM
iajs-2976	367	2	100	100	NUM
iajs-2976	367	3	37	37	NUM
iajs-2976	367	4	.	.	PUNCT
iajs-2976	368	1	hidaka	hidaka	PROPN
iajs-2976	368	2	,	,	PUNCT
iajs-2976	368	3	t.	t.	PROPN
iajs-2976	368	4	;	;	PUNCT
iajs-2976	368	5	fujii	fujii	PROPN
iajs-2976	368	6	,	,	PUNCT
iajs-2976	368	7	k.	k.	PROPN
iajs-2976	368	8	;	;	PUNCT
iajs-2976	368	9	funahashi	funahashi	PROPN
iajs-2976	368	10	,	,	PUNCT
iajs-2976	368	11	i.	i.	NOUN
iajs-2976	368	12	;	;	PUNCT
iajs-2976	368	13	fukutomi	fukutomi	NOUN
iajs-2976	368	14	,	,	PUNCT
iajs-2976	368	15	n	n	CCONJ
iajs-2976	368	16	..	..	PUNCT
iajs-2976	368	17	hosoe	hosoe	PROPN
iajs-2976	368	18	,	,	PUNCT
iajs-2976	368	19	k.	k.	PROPN
iajs-2976	368	20	safety	safety	PROPN
iajs-2976	368	21	assessment	assessment	NOUN
iajs-2976	368	22	of	of	ADP
iajs-2976	368	23	coenzyme	coenzyme	PROPN
iajs-2976	368	24	q10	q10	PROPN
iajs-2976	368	25	(	(	PUNCT
iajs-2976	368	26	coq10	coq10	PROPN
iajs-2976	368	27	)	)	PUNCT
iajs-2976	368	28	.	.	PUNCT
iajs-2976	369	1	biofactors	biofactor	NOUN
iajs-2976	369	2	.	.	PUNCT
iajs-2976	370	1	2008,32(1‐4),199	2008,32(1‐4),199	X
iajs-2976	370	2	-	-	SYM
iajs-2976	370	3	208	208	NUM
iajs-2976	370	4	https://doi.org/10.1002/biof.5520320124	https://doi.org/10.1002/biof.5520320124	NOUN
iajs-2976	370	5	38	38	NUM
iajs-2976	370	6	.	.	PUNCT
iajs-2976	371	1	ganda	ganda	NOUN
iajs-2976	371	2	,	,	PUNCT
iajs-2976	371	3	o.	o.	PROPN
iajs-2976	371	4	p.	p.	PROPN
iajs-2976	371	5	;	;	PUNCT
iajs-2976	371	6	rossini	rossini	PROPN
iajs-2976	371	7	,	,	PUNCT
iajs-2976	371	8	a.	a.	NOUN
iajs-2976	371	9	a	a	X
iajs-2976	371	10	..	..	PUNCT
iajs-2976	371	11	like	like	INTJ
iajs-2976	371	12	,	,	PUNCT
iajs-2976	371	13	a.	a.	NOUN
iajs-2976	371	14	a.	a.	NOUN
iajs-2976	371	15	studies	study	NOUN
iajs-2976	371	16	on	on	ADP
iajs-2976	371	17	streptozotocin	streptozotocin	PROPN
iajs-2976	371	18	diabetes	diabete	NOUN
iajs-2976	371	19	.	.	PUNCT
iajs-2976	372	1	diabetes	diabetes	NOUN
iajs-2976	372	2	.	.	PUNCT
iajs-2976	373	1	1976,25(7),595	1976,25(7),595	PROPN
iajs-2976	373	2	-	-	SYM
iajs-2976	373	3	603	603	NUM
iajs-2976	373	4	https://doi.org/10.2337/diab.25.7.595	https://doi.org/10.2337/diab.25.7.595	PROPN
iajs-2976	373	5	39	39	NUM
iajs-2976	373	6	.	.	PUNCT
iajs-2976	374	1	arison	arison	PROPN
iajs-2976	374	2	,	,	PUNCT
iajs-2976	374	3	r.	r.	PROPN
iajs-2976	374	4	;	;	PUNCT
iajs-2976	374	5	ciaccio	ciaccio	PROPN
iajs-2976	374	6	,	,	PUNCT
iajs-2976	374	7	e.	e.	PROPN
iajs-2976	374	8	;	;	PUNCT
iajs-2976	374	9	glitzer	glitzer	NOUN
iajs-2976	374	10	,	,	PUNCT
iajs-2976	374	11	m.	m.	NOUN
iajs-2976	374	12	;	;	PUNCT
iajs-2976	374	13	cassaro	cassaro	PROPN
iajs-2976	374	14	,	,	PUNCT
iajs-2976	374	15	j	j	PROPN
iajs-2976	374	16	..	..	PUNCT
iajs-2976	374	17	pruss	pruss	NOUN
iajs-2976	374	18	,	,	PUNCT
iajs-2976	374	19	m.	m.	NOUN
iajs-2976	374	20	light	light	NOUN
iajs-2976	374	21	and	and	CCONJ
iajs-2976	374	22	electron	electron	NOUN
iajs-2976	374	23	microscopy	microscopy	NOUN
iajs-2976	374	24	of	of	ADP
iajs-2976	374	25	lesions	lesion	NOUN
iajs-2976	374	26	in	in	ADP
iajs-2976	374	27	rats	rat	NOUN
iajs-2976	374	28	rendered	render	VERB
iajs-2976	374	29	diabetic	diabetic	ADJ
iajs-2976	374	30	with	with	ADP
iajs-2976	374	31	streptozotocin	streptozotocin	PROPN
iajs-2976	374	32	.	.	PUNCT
iajs-2976	375	1	diabetes	diabetes	NOUN
iajs-2976	375	2	.	.	PUNCT
iajs-2976	376	1	1967,16(1),51	1967,16(1),51	NUM
iajs-2976	376	2	-	-	SYM
iajs-2976	376	3	6	6	NUM
iajs-2976	377	1	https://doi.org/10.2337/diab.16.1.51	https://doi.org/10.2337/diab.16.1.51	NOUN
iajs-2976	377	2	40	40	NUM
iajs-2976	377	3	.	.	PUNCT
iajs-2976	378	1	brøndum	brøndum	PROPN
iajs-2976	378	2	,	,	PUNCT
iajs-2976	378	3	e.	e.	PROPN
iajs-2976	378	4	;	;	PUNCT
iajs-2976	378	5	nilsson	nilsson	PROPN
iajs-2976	378	6	,	,	PUNCT
iajs-2976	378	7	h	h	PROPN
iajs-2976	378	8	..	..	PUNCT
iajs-2976	378	9	aalkjaer	aalkjaer	PROPN
iajs-2976	378	10	,	,	PUNCT
iajs-2976	378	11	c.	c.	PROPN
iajs-2976	378	12	functional	functional	ADJ
iajs-2976	378	13	abnormalities	abnormality	NOUN
iajs-2976	378	14	in	in	ADP
iajs-2976	378	15	isolated	isolated	ADJ
iajs-2976	378	16	arteries	artery	NOUN
iajs-2976	378	17	from	from	ADP
iajs-2976	378	18	gotokakizaki	gotokakizaki	NOUN
iajs-2976	378	19	and	and	CCONJ
iajs-2976	378	20	streptozotocin	streptozotocin	NOUN
iajs-2976	378	21	-	-	PUNCT
iajs-2976	378	22	treated	treat	VERB
iajs-2976	378	23	diabetic	diabetic	ADJ
iajs-2976	378	24	rat	rat	NOUN
iajs-2976	378	25	models	model	NOUN
iajs-2976	378	26	.	.	PUNCT
iajs-2976	379	1	hormone	hormone	NOUN
iajs-2976	379	2	and	and	CCONJ
iajs-2976	379	3	metabolic	metabolic	NOUN
iajs-2976	379	4	research	research	NOUN
iajs-2976	379	5	.	.	PUNCT
iajs-2976	380	1	2005,37(s1),5660.available.from	2005,37(s1),5660.available.from	X
iajs-2976	380	2	:	:	PUNCT
iajs-2976	380	3	https://www.thiemeconnect.com	https://www.thiemeconnect.com	NUM
iajs-2976	380	4	/	/	SYM
iajs-2976	380	5	products	product	NOUN
iajs-2976	380	6	/	/	SYM
iajs-2976	380	7	ejournals	ejournal	NOUN
iajs-2976	380	8	/	/	SYM
iajs-2976	380	9	html/10.1	html/10.1	SYM
iajs-2976	380	10	055	055	NUM
iajs-2976	380	11	/	/	SYM
iajs-2976	380	12	s-2005	s-2005	PROPN
iajs-2976	380	13	-	-	PUNCT
iajs-2976	380	14	861370	861370	NUM
iajs-2976	380	15	41	41	NUM
iajs-2976	380	16	.	.	PUNCT
iajs-2976	381	1	furman	furman	PROPN
iajs-2976	381	2	,	,	PUNCT
iajs-2976	381	3	b.	b.	PROPN
iajs-2976	381	4	l.	l.	PROPN
iajs-2976	381	5	streptozotocin‐induced	streptozotocin‐induce	VERB
iajs-2976	381	6	diabetic	diabetic	ADJ
iajs-2976	381	7	models	model	NOUN
iajs-2976	381	8	in	in	ADP
iajs-2976	381	9	mice	mouse	NOUN
iajs-2976	381	10	and	and	CCONJ
iajs-2976	381	11	rats	rat	NOUN
iajs-2976	381	12	.	.	PUNCT
iajs-2976	382	1	current	current	ADJ
iajs-2976	382	2	protocols	protocol	NOUN
iajs-2976	382	3	in	in	ADP
iajs-2976	382	4	pharmacology	pharmacology	NOUN
iajs-2976	382	5	.	.	PUNCT
iajs-2976	383	1	2015,70(1),5.47	2015,70(1),5.47	X
iajs-2976	383	2	.	.	NOUN
iajs-2976	383	3	1	1	NUM
iajs-2976	383	4	-	-	SYM
iajs-2976	383	5	5	5	NUM
iajs-2976	383	6	..	..	SYM
iajs-2976	383	7	20	20	NUM
iajs-2976	383	8	https://doi.org/10.1002/0471141755.ph0547s70	https://doi.org/10.1002/0471141755.ph0547s70	PROPN
iajs-2976	383	9	42	42	NUM
iajs-2976	383	10	.	.	PUNCT
iajs-2976	384	1	damasceno	damasceno	PROPN
iajs-2976	384	2	,	,	PUNCT
iajs-2976	384	3	d.	d.	PROPN
iajs-2976	384	4	c.	c.	PROPN
iajs-2976	384	5	;	;	PUNCT
iajs-2976	384	6	netto	netto	PROPN
iajs-2976	384	7	,	,	PUNCT
iajs-2976	384	8	a.	a.	NOUN
iajs-2976	384	9	o.	o.	PROPN
iajs-2976	384	10	;	;	PUNCT
iajs-2976	384	11	iessi	iessi	PROPN
iajs-2976	384	12	,	,	PUNCT
iajs-2976	384	13	i.	i.	PROPN
iajs-2976	384	14	l.	l.	PROPN
iajs-2976	384	15	;	;	PUNCT
iajs-2976	384	16	gallego	gallego	PROPN
iajs-2976	384	17	,	,	PUNCT
iajs-2976	384	18	f.	f.	PROPN
iajs-2976	384	19	q.	q.	PROPN
iajs-2976	384	20	;	;	PUNCT
iajs-2976	384	21	corvino	corvino	PROPN
iajs-2976	384	22	,	,	PUNCT
iajs-2976	384	23	s.	s.	PROPN
iajs-2976	384	24	b.	b.	PROPN
iajs-2976	384	25	;	;	PUNCT
iajs-2976	384	26	dallaqua	dallaqua	PROPN
iajs-2976	384	27	,	,	PUNCT
iajs-2976	384	28	b.	b.	PROPN
iajs-2976	384	29	;	;	PUNCT
iajs-2976	384	30	sinzato	sinzato	PROPN
iajs-2976	384	31	,	,	PUNCT
iajs-2976	384	32	y.	y.	PROPN
iajs-2976	384	33	k.	k.	PROPN
iajs-2976	384	34	;	;	PUNCT
iajs-2976	385	1	bueno	bueno	PROPN
iajs-2976	385	2	,	,	PUNCT
iajs-2976	385	3	a.	a.	PROPN
iajs-2976	385	4	;	;	PUNCT
iajs-2976	385	5	calderon	calderon	PROPN
iajs-2976	385	6	,	,	PUNCT
iajs-2976	385	7	i.	i.	PROPN
iajs-2976	385	8	m.	m.	PROPN
iajs-2976	385	9	p	p	X
iajs-2976	385	10	..	..	PUNCT
iajs-2976	385	11	rudge	rudge	PROPN
iajs-2976	385	12	,	,	PUNCT
iajs-2976	385	13	m.	m.	NOUN
iajs-2976	385	14	v.	v.	ADP
iajs-2976	385	15	c.	c.	PROPN
iajs-2976	385	16	streptozotocin	streptozotocin	PROPN
iajs-2976	385	17	-	-	PUNCT
iajs-2976	385	18	induced	induce	VERB
iajs-2976	385	19	diabetes	diabetes	NOUN
iajs-2976	385	20	models	model	NOUN
iajs-2976	385	21	:	:	PUNCT
iajs-2976	385	22	pathophysiological	pathophysiological	ADJ
iajs-2976	385	23	mechanisms	mechanism	NOUN
iajs-2976	385	24	and	and	CCONJ
iajs-2976	385	25	fetal	fetal	ADJ
iajs-2976	385	26	outcomes	outcome	NOUN
iajs-2976	385	27	.	.	PUNCT
iajs-2976	385	28	biomed	biome	VERB
iajs-2976	385	29	research	research	NOUN
iajs-2976	385	30	international	international	ADJ
iajs-2976	385	31	.	.	PUNCT
iajs-2976	386	1	2014;2014:819065	2014;2014:819065	NUM
iajs-2976	386	2	https://doi.org/10.1155/2014/819065	https://doi.org/10.1155/2014/819065	PROPN
iajs-2976	386	3	43	43	NUM
iajs-2976	386	4	.	.	PUNCT
iajs-2976	387	1	li	li	PROPN
iajs-2976	387	2	,	,	PUNCT
iajs-2976	387	3	f.	f.	PROPN
iajs-2976	387	4	;	;	PUNCT
iajs-2976	387	5	you	you	PRON
iajs-2976	387	6	,	,	PUNCT
iajs-2976	387	7	m.	m.	NOUN
iajs-2976	387	8	;	;	PUNCT
iajs-2976	387	9	li	li	PROPN
iajs-2976	387	10	,	,	PUNCT
iajs-2976	387	11	s.	s.	PROPN
iajs-2976	387	12	;	;	PUNCT
iajs-2976	387	13	hu	hu	PROPN
iajs-2976	387	14	,	,	PUNCT
iajs-2976	387	15	j.	j.	PROPN
iajs-2976	387	16	;	;	PUNCT
iajs-2976	387	17	liu	liu	PROPN
iajs-2976	387	18	,	,	PUNCT
iajs-2976	387	19	c.	c.	PROPN
iajs-2976	387	20	;	;	PUNCT
iajs-2976	387	21	gong	gong	PROPN
iajs-2976	387	22	,	,	PUNCT
iajs-2976	387	23	y.	y.	PROPN
iajs-2976	387	24	;	;	PUNCT
iajs-2976	387	25	yang	yang	PROPN
iajs-2976	387	26	,	,	PUNCT
iajs-2976	387	27	h	h	PROPN
iajs-2976	387	28	..	..	PROPN
iajs-2976	387	29	xu	xu	PROPN
iajs-2976	387	30	,	,	PUNCT
iajs-2976	387	31	f.	f.	PROPN
iajs-2976	387	32	based	base	VERB
iajs-2976	387	33	point	point	NOUN
iajs-2976	387	34	-	-	PUNCT
iajs-2976	387	35	of	of	ADP
iajs-2976	387	36	-	-	PUNCT
iajs-2976	387	37	care	care	NOUN
iajs-2976	387	38	immunoassays	immunoassay	NOUN
iajs-2976	387	39	:	:	PUNCT
iajs-2976	387	40	recent	recent	ADJ
iajs-2976	387	41	advances	advance	NOUN
iajs-2976	387	42	and	and	CCONJ
iajs-2976	387	43	emerging	emerge	VERB
iajs-2976	387	44	trends	trend	NOUN
iajs-2976	387	45	.	.	PUNCT
iajs-2976	388	1	biotechnology	biotechnology	NOUN
iajs-2976	388	2	advances	advance	NOUN
iajs-2976	388	3	.	.	PUNCT
iajs-2976	389	1	202039,107442	202039,107442	NUM
iajs-2976	389	2	https://doi.org/10.1016/j.biotechadv.2019.107442	https://doi.org/10.1016/j.biotechadv.2019.107442	VERB
iajs-2976	389	3	44	44	NUM
iajs-2976	389	4	.	.	PUNCT
iajs-2976	390	1	zhao	zhao	PROPN
iajs-2976	390	2	,	,	PUNCT
iajs-2976	390	3	y	y	PROPN
iajs-2976	390	4	..	..	PUNCT
iajs-2976	390	5	ying	ying	PROPN
iajs-2976	390	6	;	;	PUNCT
iajs-2976	390	7	l.	l.	PROPN
iajs-2976	390	8	r&d	r&d	PROPN
iajs-2976	390	9	,	,	PUNCT
iajs-2976	390	10	manufacture	manufacture	NOUN
iajs-2976	390	11	,	,	PUNCT
iajs-2976	390	12	and	and	CCONJ
iajs-2976	390	13	market	market	NOUN
iajs-2976	390	14	.	.	PUNCT
iajs-2976	391	1	in	in	ADP
iajs-2976	391	2	:	:	PUNCT
iajs-2976	391	3	song	song	PROPN
iajs-2976	391	4	h	h	PROPN
iajs-2976	391	5	..	..	PUNCT
iajs-2976	391	6	yao	yao	PROPN
iajs-2976	391	7	j.	j.	PROPN
iajs-2976	391	8	e.	e.	PROPN
iajs-2976	391	9	,	,	PUNCT
iajs-2976	391	10	editors	editor	NOUN
iajs-2976	391	11	.	.	PUNCT
iajs-2976	392	1	in	in	ADP
iajs-2976	392	2	vitro	vitro	X
iajs-2976	392	3	diagnostic	diagnostic	ADJ
iajs-2976	392	4	industry	industry	NOUN
iajs-2976	392	5	in	in	ADP
iajs-2976	392	6	china	china	PROPN
iajs-2976	392	7	.	.	PUNCT
iajs-2976	393	1	singapore	singapore	PROPN
iajs-2976	393	2	:	:	PUNCT
iajs-2976	393	3	springer	springer	PROPN
iajs-2976	393	4	singapore	singapore	PROPN
iajs-2976	393	5	;	;	PUNCT
iajs-2976	393	6	2021	2021	NUM
iajs-2976	393	7	,	,	PUNCT
iajs-2976	393	8	147	147	NUM
iajs-2976	393	9	-	-	SYM
iajs-2976	393	10	60	60	NUM
iajs-2976	393	11	https://doi.org/10.1007/978-981-16-2316-5_14	https://doi.org/10.1007/978-981-16-2316-5_14	NUM
iajs-2976	393	12	45	45	NUM
iajs-2976	393	13	.	.	PUNCT
iajs-2976	394	1	brownlee	brownlee	PROPN
iajs-2976	394	2	,	,	PUNCT
iajs-2976	394	3	m.	m.	NOUN
iajs-2976	394	4	biochemistry	biochemistry	NOUN
iajs-2976	394	5	and	and	CCONJ
iajs-2976	394	6	molecular	molecular	ADJ
iajs-2976	394	7	cell	cell	NOUN
iajs-2976	394	8	biology	biology	NOUN
iajs-2976	394	9	of	of	ADP
iajs-2976	394	10	diabetic	diabetic	ADJ
iajs-2976	394	11	complications	complication	NOUN
iajs-2976	394	12	.	.	PUNCT
iajs-2976	395	1	nature	nature	NOUN
iajs-2976	395	2	.	.	PUNCT
iajs-2976	396	1	2001,414(6865),813	2001,414(6865),813	NUM
iajs-2976	396	2	-	-	SYM
iajs-2976	396	3	20	20	NUM
iajs-2976	396	4	https://doi.org/10.1038/414813a	https://doi.org/10.1038/414813a	NOUN
iajs-2976	396	5	46	46	NUM
iajs-2976	396	6	.	.	PUNCT
iajs-2976	396	7	tiwari	tiwari	PROPN
iajs-2976	396	8	,	,	PUNCT
iajs-2976	396	9	b.	b.	PROPN
iajs-2976	396	10	k.	k.	PROPN
iajs-2976	396	11	;	;	PUNCT
iajs-2976	396	12	pandey	pandey	PROPN
iajs-2976	396	13	,	,	PUNCT
iajs-2976	396	14	k.	k.	PROPN
iajs-2976	396	15	b.	b.	PROPN
iajs-2976	396	16	;	;	PUNCT
iajs-2976	396	17	abidi	abidi	PROPN
iajs-2976	396	18	,	,	PUNCT
iajs-2976	396	19	a.	a.	PROPN
iajs-2976	396	20	b	b	PROPN
iajs-2976	396	21	..	..	PUNCT
iajs-2976	396	22	rizvi	rizvi	PROPN
iajs-2976	396	23	,	,	PUNCT
iajs-2976	396	24	s.	s.	PROPN
iajs-2976	396	25	i.	i.	PROPN
iajs-2976	396	26	markers	marker	NOUN
iajs-2976	396	27	of	of	ADP
iajs-2976	396	28	oxidative	oxidative	ADJ
iajs-2976	396	29	stress	stress	NOUN
iajs-2976	396	30	during	during	ADP
iajs-2976	396	31	diabetes	diabetes	NOUN
iajs-2976	396	32	mellitus	mellitus	NOUN
iajs-2976	396	33	.	.	PUNCT
iajs-2976	397	1	journal	journal	PROPN
iajs-2976	397	2	of	of	ADP
iajs-2976	397	3	biomarkers	biomarker	NOUN
iajs-2976	397	4	,	,	PUNCT
iajs-2976	397	5	2013;2013:378790	2013;2013:378790	NUM
iajs-2976	397	6	https://doi.org/10.1155/2013/378790	https://doi.org/10.1155/2013/378790	NOUN
iajs-2976	397	7	47	47	NUM
iajs-2976	397	8	.	.	PUNCT
iajs-2976	398	1	wu	wu	PROPN
iajs-2976	398	2	,	,	PUNCT
iajs-2976	398	3	j	j	PROPN
iajs-2976	398	4	..	..	PUNCT
iajs-2976	398	5	yan	yan	PROPN
iajs-2976	398	6	;	;	PUNCT
iajs-2976	398	7	l.-j	l.-j	PROPN
iajs-2976	398	8	.	.	PUNCT
iajs-2976	399	1	streptozotocin	streptozotocin	NOUN
iajs-2976	399	2	-	-	PUNCT
iajs-2976	399	3	induced	induce	VERB
iajs-2976	399	4	type	type	NOUN
iajs-2976	399	5	1	1	NUM
iajs-2976	399	6	diabetes	diabetes	NOUN
iajs-2976	399	7	in	in	ADP
iajs-2976	399	8	rodents	rodent	NOUN
iajs-2976	399	9	as	as	ADP
iajs-2976	399	10	a	a	DET
iajs-2976	399	11	model	model	NOUN
iajs-2976	399	12	for	for	ADP
iajs-2976	399	13	studying	study	VERB
iajs-2976	399	14	mitochondrial	mitochondrial	ADJ
iajs-2976	399	15	mechanisms	mechanism	NOUN
iajs-2976	399	16	of	of	ADP
iajs-2976	399	17	diabetic	diabetic	ADJ
iajs-2976	399	18	β	β	PROPN
iajs-2976	399	19	cell	cell	NOUN
iajs-2976	399	20	glucotoxicity	glucotoxicity	NOUN
iajs-2976	399	21	.	.	PUNCT
iajs-2976	400	1	diabetes	diabetes	NOUN
iajs-2976	400	2	,	,	PUNCT
iajs-2976	400	3	metabolic	metabolic	NOUN
iajs-2976	400	4	syndrome	syndrome	NOUN
iajs-2976	400	5	and	and	CCONJ
iajs-2976	400	6	obesity	obesity	NOUN
iajs-2976	400	7	:	:	PUNCT
iajs-2976	400	8	targets	target	NOUN
iajs-2976	400	9	and	and	CCONJ
iajs-2976	400	10	therapy	therapy	NOUN
iajs-2976	400	11	.	.	PUNCT
iajs-2976	401	1	2015,8,181	2015,8,181	PROPN
iajs-2976	401	2	https://doi.org/10.2147%2fdmso.s82272	https://doi.org/10.2147%2fdmso.s82272	PROPN
iajs-2976	401	3	48	48	NUM
iajs-2976	401	4	.	.	PUNCT
iajs-2976	402	1	ahmadvand	ahmadvand	PROPN
iajs-2976	402	2	,	,	PUNCT
iajs-2976	402	3	h.	h.	PROPN
iajs-2976	402	4	effects	effect	NOUN
iajs-2976	402	5	of	of	ADP
iajs-2976	402	6	coenzyme	coenzyme	PROPN
iajs-2976	402	7	q10	q10	PROPN
iajs-2976	402	8	on	on	ADP
iajs-2976	402	9	hemoglobin	hemoglobin	PROPN
iajs-2976	402	10	a1c	a1c	PROPN
iajs-2976	402	11	,	,	PUNCT
iajs-2976	402	12	serum	serum	NOUN
iajs-2976	402	13	urea	urea	NOUN
iajs-2976	402	14	and	and	CCONJ
iajs-2976	402	15	creatinine	creatinine	NOUN
iajs-2976	402	16	in	in	ADP
iajs-2976	402	17	alloxan	alloxan	NOUN
iajs-2976	402	18	-	-	PUNCT
iajs-2976	402	19	induced	induce	VERB
iajs-2976	402	20	type	type	NOUN
iajs-2976	402	21	1	1	NUM
iajs-2976	402	22	diabetic	diabetic	ADJ
iajs-2976	402	23	rats	rat	NOUN
iajs-2976	402	24	.	.	PUNCT
iajs-2976	403	1	iranian	iranian	ADJ
iajs-2976	403	2	journal	journal	PROPN
iajs-2976	403	3	of	of	ADP
iajs-2976	403	4	pharmacology	pharmacology	NOUN
iajs-2976	403	5	and	and	CCONJ
iajs-2976	403	6	therapeutics	therapeutic	NOUN
iajs-2976	403	7	.	.	PUNCT
iajs-2976	404	1	2012,11(2),64	2012,11(2),64	NUM
iajs-2976	404	2	-	-	SYM
iajs-2976	404	3	0.available	0.available	NUM
iajs-2976	404	4	from	from	ADP
iajs-2976	404	5	:	:	PUNCT
iajs-2976	404	6	http://ijpt.iums.ac.ir/article-1-245-en.html	http://ijpt.iums.ac.ir/article-1-245-en.html	PROPN
iajs-2976	404	7	49	49	NUM
iajs-2976	404	8	.	.	PUNCT
iajs-2976	405	1	luo	luo	PROPN
iajs-2976	405	2	,	,	PUNCT
iajs-2976	405	3	k.	k.	PROPN
iajs-2976	405	4	;	;	PUNCT
iajs-2976	405	5	yu	yu	PROPN
iajs-2976	405	6	,	,	PUNCT
iajs-2976	405	7	j.	j.	PROPN
iajs-2976	405	8	h.	h.	PROPN
iajs-2976	405	9	;	;	PUNCT
iajs-2976	405	10	quan	quan	PROPN
iajs-2976	405	11	,	,	PUNCT
iajs-2976	405	12	y.	y.	PROPN
iajs-2976	405	13	;	;	PUNCT
iajs-2976	405	14	shin	shin	PROPN
iajs-2976	405	15	,	,	PUNCT
iajs-2976	405	16	y.	y.	PROPN
iajs-2976	405	17	j.	j.	PROPN
iajs-2976	405	18	;	;	PUNCT
iajs-2976	405	19	lee	lee	PROPN
iajs-2976	405	20	,	,	PUNCT
iajs-2976	405	21	k.	k.	PROPN
iajs-2976	405	22	e.	e.	PROPN
iajs-2976	405	23	;	;	PUNCT
iajs-2976	405	24	kim	kim	PROPN
iajs-2976	405	25	,	,	PUNCT
iajs-2976	405	26	h.	h.	PROPN
iajs-2976	405	27	l.	l.	PROPN
iajs-2976	405	28	;	;	PUNCT
iajs-2976	405	29	ko	ko	PROPN
iajs-2976	405	30	,	,	PUNCT
iajs-2976	405	31	e.	e.	PROPN
iajs-2976	405	32	j.	j.	PROPN
iajs-2976	405	33	;	;	PUNCT
iajs-2976	405	34	chung	chung	PROPN
iajs-2976	405	35	,	,	PUNCT
iajs-2976	405	36	b.	b.	PROPN
iajs-2976	405	37	h.	h.	PROPN
iajs-2976	405	38	;	;	PUNCT
iajs-2976	405	39	lim	lim	PROPN
iajs-2976	405	40	,	,	PUNCT
iajs-2976	405	41	s.	s.	PROPN
iajs-2976	405	42	w	w	PROPN
iajs-2976	405	43	..	..	PROPN
iajs-2976	405	44	yang	yang	PROPN
iajs-2976	405	45	,	,	PUNCT
iajs-2976	405	46	c.	c.	PROPN
iajs-2976	405	47	w.	w.	PROPN
iajs-2976	405	48	therapeutic	therapeutic	ADJ
iajs-2976	405	49	potential	potential	NOUN
iajs-2976	405	50	of	of	ADP
iajs-2976	405	51	coenzyme	coenzyme	PROPN
iajs-2976	405	52	q10	q10	PROPN
iajs-2976	405	53	in	in	ADP
iajs-2976	405	54	mitochondrial	mitochondrial	ADJ
iajs-2976	405	55	dysfunction	dysfunction	NOUN
iajs-2976	405	56	during	during	ADP
iajs-2976	405	57	tacrolimus	tacrolimus	NOUN
iajs-2976	405	58	-	-	PUNCT
iajs-2976	405	59	induced	induce	VERB
iajs-2976	405	60	beta	beta	NOUN
iajs-2976	405	61	cell	cell	NOUN
iajs-2976	405	62	injury	injury	NOUN
iajs-2976	405	63	.	.	PUNCT
iajs-2976	406	1	scientific	scientific	ADJ
iajs-2976	406	2	reports	report	NOUN
iajs-2976	406	3	.	.	PUNCT
iajs-2976	407	1	2019,9(1),1	2019,9(1),1	NUM
iajs-2976	407	2	-	-	SYM
iajs-2976	407	3	12	12	NUM
iajs-2976	407	4	https://doi.org/10.1038/s41598-019-44475-x	https://doi.org/10.1038/s41598-019-44475-x	PROPN
iajs-2976	407	5	50	50	NUM
iajs-2976	407	6	.	.	PUNCT
iajs-2976	408	1	modi	modi	PROPN
iajs-2976	408	2	,	,	PUNCT
iajs-2976	408	3	k.	k.	PROPN
iajs-2976	408	4	;	;	PUNCT
iajs-2976	408	5	santani	santani	PROPN
iajs-2976	408	6	,	,	PUNCT
iajs-2976	408	7	d.	d.	PROPN
iajs-2976	408	8	;	;	PUNCT
iajs-2976	408	9	goyal	goyal	PROPN
iajs-2976	408	10	,	,	PUNCT
iajs-2976	408	11	r	r	PROPN
iajs-2976	408	12	..	..	PUNCT
iajs-2976	408	13	bhatt	bhatt	PROPN
iajs-2976	408	14	,	,	PUNCT
iajs-2976	408	15	p.	p.	NOUN
iajs-2976	408	16	effect	effect	NOUN
iajs-2976	408	17	of	of	ADP
iajs-2976	408	18	coenzyme	coenzyme	PROPN
iajs-2976	408	19	q10	q10	PROPN
iajs-2976	408	20	on	on	ADP
iajs-2976	408	21	catalase	catalase	NOUN
iajs-2976	408	22	activity	activity	NOUN
iajs-2976	408	23	and	and	CCONJ
iajs-2976	408	24	other	other	ADJ
iajs-2976	408	25	antioxidant	antioxidant	ADJ
iajs-2976	408	26	parameters	parameter	NOUN
iajs-2976	408	27	in	in	ADP
iajs-2976	408	28	streptozotocin	streptozotocin	NOUN
iajs-2976	408	29	-	-	PUNCT
iajs-2976	408	30	induced	induce	VERB
iajs-2976	408	31	diabetic	diabetic	ADJ
iajs-2976	408	32	rats	rat	NOUN
iajs-2976	408	33	.	.	PUNCT
iajs-2976	409	1	biological	biological	ADJ
iajs-2976	409	2	trace	trace	NOUN
iajs-2976	409	3	element	element	NOUN
iajs-2976	409	4	research	research	NOUN
iajs-2976	409	5	.	.	PUNCT
iajs-2976	410	1	2006,109(1),25	2006,109(1),25	NUM
iajs-2976	410	2	-	-	SYM
iajs-2976	410	3	33	33	NUM
iajs-2976	410	4	https://doi.org/10.1385/bter:109:1:025	https://doi.org/10.1385/bter:109:1:025	PROPN
iajs-2976	410	5	51	51	NUM
iajs-2976	410	6	.	.	PUNCT
iajs-2976	410	7	hodgson	hodgson	PROPN
iajs-2976	410	8	,	,	PUNCT
iajs-2976	410	9	j.	j.	PROPN
iajs-2976	410	10	;	;	PUNCT
iajs-2976	410	11	watts	watts	PROPN
iajs-2976	410	12	,	,	PUNCT
iajs-2976	410	13	g.	g.	PROPN
iajs-2976	410	14	;	;	PUNCT
iajs-2976	410	15	playford	playford	PROPN
iajs-2976	410	16	,	,	PUNCT
iajs-2976	410	17	d.	d.	PROPN
iajs-2976	410	18	;	;	PUNCT
iajs-2976	410	19	burke	burke	PROPN
iajs-2976	410	20	,	,	PUNCT
iajs-2976	410	21	v	v	PROPN
iajs-2976	410	22	..	..	PUNCT
iajs-2976	410	23	croft	croft	PROPN
iajs-2976	410	24	,	,	PUNCT
iajs-2976	410	25	k.	k.	PROPN
iajs-2976	410	26	coenzyme	coenzyme	PROPN
iajs-2976	410	27	q10	q10	PROPN
iajs-2976	410	28	improves	improve	VERB
iajs-2976	410	29	blood	blood	NOUN
iajs-2976	410	30	pressure	pressure	NOUN
iajs-2976	410	31	and	and	CCONJ
iajs-2976	410	32	glycaemic	glycaemic	NOUN
iajs-2976	410	33	control	control	NOUN
iajs-2976	410	34	:	:	PUNCT
iajs-2976	410	35	a	a	DET
iajs-2976	410	36	controlled	control	VERB
iajs-2976	410	37	trial	trial	NOUN
iajs-2976	410	38	in	in	ADP
iajs-2976	410	39	subjects	subject	NOUN
iajs-2976	410	40	with	with	ADP
iajs-2976	410	41	type	type	NOUN
iajs-2976	410	42	2	2	NUM
iajs-2976	410	43	diabetes	diabetes	NOUN
iajs-2976	410	44	.	.	PUNCT
iajs-2976	411	1	european	european	ADJ
iajs-2976	411	2	journal	journal	PROPN
iajs-2976	411	3	of	of	ADP
iajs-2976	411	4	clinical	clinical	ADJ
iajs-2976	411	5	nutrition	nutrition	NOUN
iajs-2976	411	6	,	,	PUNCT
iajs-2976	411	7	2002,56(11),1137	2002,56(11),1137	NUM
iajs-2976	411	8	-	-	SYM
iajs-2976	411	9	42	42	NUM
iajs-2976	411	10	https://doi.org/10.1038/sj.ejcn.1601464	https://doi.org/10.1038/sj.ejcn.1601464	NOUN
iajs-2976	411	11	https://doi.org/10.1002/biof.5520320124	https://doi.org/10.1002/biof.5520320124	NOUN
iajs-2976	412	1	https://doi.org/10.2337/diab.25.7.595	https://doi.org/10.2337/diab.25.7.595	PROPN
iajs-2976	412	2	https://doi.org/10.2337/diab.16.1.51	https://doi.org/10.2337/diab.16.1.51	PROPN
iajs-2976	412	3	https://doi.org/10.1002/0471141755.ph0547s70	https://doi.org/10.1002/0471141755.ph0547s70	PROPN
iajs-2976	412	4	https://doi.org/10.1155/2014/819065	https://doi.org/10.1155/2014/819065	PROPN
iajs-2976	412	5	https://doi.org/10.1016/j.biotechadv.2019.107442	https://doi.org/10.1016/j.biotechadv.2019.107442	VERB
iajs-2976	412	6	https://doi.org/10.1007/978-981-16-2316-5_14	https://doi.org/10.1007/978-981-16-2316-5_14	NOUN
iajs-2976	412	7	https://doi.org/10.1038/414813a	https://doi.org/10.1038/414813a	X
iajs-2976	412	8	https://doi.org/10.1155/2013/378790	https://doi.org/10.1155/2013/378790	NOUN
iajs-2976	412	9	https://doi.org/10.2147%2fdmso.s82272	https://doi.org/10.2147%2fdmso.s82272	ADJ
iajs-2976	412	10	http://ijpt.iums.ac.ir/article-1-245-en.html	http://ijpt.iums.ac.ir/article-1-245-en.html	PROPN
iajs-2976	412	11	https://doi.org/10.1038/s41598-019-44475-x	https://doi.org/10.1038/s41598-019-44475-x	NOUN
iajs-2976	412	12	https://doi.org/10.1385/bter:109:1:025	https://doi.org/10.1385/bter:109:1:025	PROPN
iajs-2976	412	13	https://doi.org/10.1038/sj.ejcn.1601464	https://doi.org/10.1038/sj.ejcn.1601464	PROPN
iajs-2976	412	14	ihjpas	ihjpa	VERB
iajs-2976	412	15	.	.	PUNCT
iajs-2976	413	1	36(2)2023	36(2)2023	NUM
iajs-2976	413	2	101	101	NUM
iajs-2976	413	3	52	52	NUM
iajs-2976	413	4	.	.	PUNCT
iajs-2976	413	5	rauscher	rauscher	NOUN
iajs-2976	413	6	,	,	PUNCT
iajs-2976	413	7	f.	f.	PROPN
iajs-2976	413	8	m.	m.	PROPN
iajs-2976	413	9	;	;	PUNCT
iajs-2976	414	1	sanders	sanders	PROPN
iajs-2976	414	2	,	,	PUNCT
iajs-2976	414	3	r.	r.	PROPN
iajs-2976	414	4	a	a	PROPN
iajs-2976	414	5	..	..	PUNCT
iajs-2976	414	6	watkins	watkins	PROPN
iajs-2976	414	7	iii	iii	PROPN
iajs-2976	414	8	,	,	PUNCT
iajs-2976	414	9	j.	j.	PROPN
iajs-2976	414	10	b.	b.	PROPN
iajs-2976	414	11	effects	effect	NOUN
iajs-2976	414	12	of	of	ADP
iajs-2976	414	13	coenzyme	coenzyme	PROPN
iajs-2976	414	14	q10	q10	PROPN
iajs-2976	414	15	treatment	treatment	NOUN
iajs-2976	414	16	on	on	ADP
iajs-2976	414	17	antioxidant	antioxidant	ADJ
iajs-2976	414	18	pathways	pathway	NOUN
iajs-2976	414	19	in	in	ADP
iajs-2976	414	20	normal	normal	ADJ
iajs-2976	414	21	and	and	CCONJ
iajs-2976	414	22	streptozotocin‐induced	streptozotocin‐induced	ADJ
iajs-2976	414	23	diabetic	diabetic	ADJ
iajs-2976	414	24	rats	rat	NOUN
iajs-2976	414	25	.	.	PUNCT
iajs-2976	415	1	journal	journal	NOUN
iajs-2976	415	2	of	of	ADP
iajs-2976	415	3	biochemical	biochemical	ADJ
iajs-2976	415	4	and	and	CCONJ
iajs-2976	415	5	molecular	molecular	ADJ
iajs-2976	415	6	toxicology	toxicology	NOUN
iajs-2976	415	7	,	,	PUNCT
iajs-2976	415	8	2001,15(1),41	2001,15(1),41	NUM
iajs-2976	415	9	-	-	SYM
iajs-2976	415	10	6	6	NUM
iajs-2976	415	11	https://doi.org/10.1002/10990461(2001)15:1%3c41::aid-jbt5%3e3.0.co;2-z	https://doi.org/10.1002/10990461(2001)15:1%3c41::aid-jbt5%3e3.0.co;2-z	SYM
iajs-2976	415	12	53	53	NUM
iajs-2976	415	13	.	.	PUNCT
iajs-2976	415	14	cui	cui	PROPN
iajs-2976	415	15	,	,	PUNCT
iajs-2976	415	16	x.-p	x.-p	PROPN
iajs-2976	415	17	.	.	PUNCT
iajs-2976	415	18	;	;	PUNCT
iajs-2976	416	1	li	li	PROPN
iajs-2976	416	2	,	,	PUNCT
iajs-2976	416	3	b.-y	b.-y	NOUN
iajs-2976	416	4	.	.	PUNCT
iajs-2976	416	5	;	;	PUNCT
iajs-2976	417	1	gao	gao	PROPN
iajs-2976	417	2	,	,	PUNCT
iajs-2976	417	3	h.-q	h.-q	PROPN
iajs-2976	417	4	.	.	PUNCT
iajs-2976	417	5	;	;	PUNCT
iajs-2976	417	6	wei	wei	PROPN
iajs-2976	417	7	,	,	PUNCT
iajs-2976	417	8	n.	n.	PROPN
iajs-2976	417	9	;	;	PUNCT
iajs-2976	417	10	wang	wang	PROPN
iajs-2976	417	11	,	,	PUNCT
iajs-2976	417	12	w.-l	w.-l	PROPN
iajs-2976	417	13	..	..	PUNCT
iajs-2976	417	14	lu	lu	PROPN
iajs-2976	417	15	,	,	PUNCT
iajs-2976	417	16	m.	m.	NOUN
iajs-2976	417	17	effects	effect	NOUN
iajs-2976	417	18	of	of	ADP
iajs-2976	417	19	grape	grape	NOUN
iajs-2976	417	20	seed	seed	NOUN
iajs-2976	417	21	proanthocyanidin	proanthocyanidin	VERB
iajs-2976	417	22	extracts	extract	NOUN
iajs-2976	417	23	on	on	ADP
iajs-2976	417	24	peripheral	peripheral	ADJ
iajs-2976	417	25	nerves	nerve	NOUN
iajs-2976	417	26	in	in	ADP
iajs-2976	417	27	streptozocin	streptozocin	NOUN
iajs-2976	417	28	-	-	PUNCT
iajs-2976	417	29	induced	induce	VERB
iajs-2976	417	30	diabetic	diabetic	ADJ
iajs-2976	417	31	rats	rat	NOUN
iajs-2976	417	32	.	.	PUNCT
iajs-2976	418	1	journal	journal	NOUN
iajs-2976	418	2	of	of	ADP
iajs-2976	418	3	nutritional	nutritional	ADJ
iajs-2976	418	4	science	science	NOUN
iajs-2976	418	5	and	and	CCONJ
iajs-2976	418	6	vitaminology	vitaminology	NOUN
iajs-2976	418	7	,	,	PUNCT
iajs-2976	418	8	2008,54(4),321	2008,54(4),321	NUM
iajs-2976	418	9	-	-	SYM
iajs-2976	418	10	8	8	NUM
iajs-2976	418	11	https://doi.org/10.3177/jnsv.54.321	https://doi.org/10.3177/jnsv.54.321	PROPN
iajs-2976	418	12	54	54	NUM
iajs-2976	418	13	.	.	PUNCT
iajs-2976	419	1	samimi	samimi	PROPN
iajs-2976	419	2	,	,	PUNCT
iajs-2976	419	3	f.	f.	PROPN
iajs-2976	419	4	;	;	PUNCT
iajs-2976	419	5	baazm	baazm	PROPN
iajs-2976	419	6	,	,	PUNCT
iajs-2976	419	7	m.	m.	NOUN
iajs-2976	419	8	;	;	PUNCT
iajs-2976	419	9	eftekhar	eftekhar	PROPN
iajs-2976	419	10	,	,	PUNCT
iajs-2976	419	11	e.	e.	PROPN
iajs-2976	419	12	;	;	PUNCT
iajs-2976	419	13	rajabi	rajabi	PROPN
iajs-2976	419	14	,	,	PUNCT
iajs-2976	419	15	s.	s.	PROPN
iajs-2976	419	16	;	;	PUNCT
iajs-2976	419	17	goodarzi	goodarzi	PROPN
iajs-2976	419	18	,	,	PUNCT
iajs-2976	419	19	m.	m.	NOUN
iajs-2976	419	20	t	t	PROPN
iajs-2976	419	21	..	..	PROPN
iajs-2976	419	22	mashayekhi	mashayekhi	PROPN
iajs-2976	419	23	,	,	PUNCT
iajs-2976	419	24	f.	f.	PROPN
iajs-2976	419	25	j.	j.	PROPN
iajs-2976	419	26	possible	possible	ADJ
iajs-2976	419	27	antioxidant	antioxidant	ADJ
iajs-2976	419	28	mechanism	mechanism	NOUN
iajs-2976	419	29	of	of	ADP
iajs-2976	419	30	coenzyme	coenzyme	PROPN
iajs-2976	419	31	q10	q10	PROPN
iajs-2976	419	32	in	in	ADP
iajs-2976	419	33	diabetes	diabetes	NOUN
iajs-2976	419	34	:	:	PUNCT
iajs-2976	419	35	impact	impact	NOUN
iajs-2976	419	36	on	on	ADP
iajs-2976	419	37	sirt1	sirt1	NOUN
iajs-2976	419	38	/	/	SYM
iajs-2976	419	39	nrf2	nrf2	NOUN
iajs-2976	419	40	signaling	signal	VERB
iajs-2976	419	41	pathways	pathway	NOUN
iajs-2976	419	42	.	.	PUNCT
iajs-2976	420	1	research	research	NOUN
iajs-2976	420	2	in	in	ADP
iajs-2976	420	3	pharmaceutical	pharmaceutical	ADJ
iajs-2976	420	4	sciences	science	NOUN
iajs-2976	420	5	.	.	PUNCT
iajs-2976	421	1	2019,14(6),524	2019,14(6),524	NUM
iajs-2976	421	2	https://doi.org/10.4103%2f17355362.272561	https://doi.org/10.4103%2f17355362.272561	PROPN
iajs-2976	421	3	55	55	NUM
iajs-2976	421	4	.	.	PUNCT
iajs-2976	422	1	stadler	stadl	ADJ
iajs-2976	422	2	,	,	PUNCT
iajs-2976	422	3	k.	k.	PROPN
iajs-2976	422	4	;	;	PUNCT
iajs-2976	422	5	bonini	bonini	PROPN
iajs-2976	422	6	,	,	PUNCT
iajs-2976	422	7	m.	m.	NOUN
iajs-2976	422	8	g.	g.	PROPN
iajs-2976	422	9	;	;	PUNCT
iajs-2976	422	10	dallas	dallas	PROPN
iajs-2976	422	11	,	,	PUNCT
iajs-2976	422	12	s.	s.	PROPN
iajs-2976	422	13	;	;	PUNCT
iajs-2976	422	14	jiang	jiang	PROPN
iajs-2976	422	15	,	,	PUNCT
iajs-2976	422	16	j.	j.	PROPN
iajs-2976	422	17	;	;	PUNCT
iajs-2976	422	18	radi	radi	PROPN
iajs-2976	422	19	,	,	PUNCT
iajs-2976	422	20	r.	r.	PROPN
iajs-2976	422	21	;	;	PUNCT
iajs-2976	422	22	mason	mason	PROPN
iajs-2976	422	23	,	,	PUNCT
iajs-2976	422	24	r.	r.	PROPN
iajs-2976	422	25	p	p	PROPN
iajs-2976	422	26	..	..	PUNCT
iajs-2976	422	27	kadiiska	kadiiska	PROPN
iajs-2976	422	28	,	,	PUNCT
iajs-2976	422	29	m.	m.	PROPN
iajs-2976	422	30	b.	b.	PROPN
iajs-2976	422	31	involvement	involvement	PROPN
iajs-2976	422	32	of	of	ADP
iajs-2976	422	33	inducible	inducible	ADJ
iajs-2976	422	34	nitric	nitric	ADJ
iajs-2976	422	35	oxide	oxide	NOUN
iajs-2976	422	36	synthase	synthase	NOUN
iajs-2976	422	37	in	in	ADP
iajs-2976	422	38	hydroxyl	hydroxyl	NOUN
iajs-2976	422	39	radical	radical	ADJ
iajs-2976	422	40	-	-	PUNCT
iajs-2976	422	41	mediated	mediate	VERB
iajs-2976	422	42	lipid	lipid	NOUN
iajs-2976	422	43	peroxidation	peroxidation	NOUN
iajs-2976	422	44	in	in	ADP
iajs-2976	422	45	streptozotocin	streptozotocin	NOUN
iajs-2976	422	46	-	-	PUNCT
iajs-2976	422	47	induced	induce	VERB
iajs-2976	422	48	diabetes	diabetes	NOUN
iajs-2976	422	49	.	.	PUNCT
iajs-2976	423	1	free	free	ADJ
iajs-2976	423	2	radical	radical	ADJ
iajs-2976	423	3	biology	biology	NOUN
iajs-2976	423	4	and	and	CCONJ
iajs-2976	423	5	medicine	medicine	NOUN
iajs-2976	423	6	.	.	PUNCT
iajs-2976	424	1	2008,45(6),866	2008,45(6),866	NUM
iajs-2976	424	2	-	-	SYM
iajs-2976	424	3	74	74	NUM
iajs-2976	424	4	https://doi.org/10.1016/j.freeradbiomed.2008.06.023	https://doi.org/10.1016/j.freeradbiomed.2008.06.023	NOUN
iajs-2976	424	5	56	56	NUM
iajs-2976	424	6	.	.	PUNCT
iajs-2976	425	1	hajizadeh	hajizadeh	PROPN
iajs-2976	425	2	,	,	PUNCT
iajs-2976	425	3	m.	m.	PROPN
iajs-2976	425	4	r.	r.	PROPN
iajs-2976	425	5	;	;	PUNCT
iajs-2976	425	6	eftekhar	eftekhar	PROPN
iajs-2976	425	7	,	,	PUNCT
iajs-2976	425	8	e.	e.	PROPN
iajs-2976	425	9	;	;	PUNCT
iajs-2976	425	10	zal	zal	PROPN
iajs-2976	425	11	,	,	PUNCT
iajs-2976	425	12	f.	f.	PROPN
iajs-2976	425	13	;	;	PUNCT
iajs-2976	425	14	jafarian	jafarian	PROPN
iajs-2976	425	15	,	,	PUNCT
iajs-2976	425	16	a	a	DET
iajs-2976	425	17	..	..	PUNCT
iajs-2976	425	18	mostafavi	mostafavi	NOUN
iajs-2976	425	19	-	-	PUNCT
iajs-2976	425	20	pour	pour	NOUN
iajs-2976	425	21	,	,	PUNCT
iajs-2976	425	22	z.	z.	PROPN
iajs-2976	425	23	mulberry	mulberry	PROPN
iajs-2976	425	24	leaf	leaf	NOUN
iajs-2976	425	25	extract	extract	NOUN
iajs-2976	425	26	attenuates	attenuate	VERB
iajs-2976	425	27	oxidative	oxidative	ADJ
iajs-2976	425	28	stress	stress	NOUN
iajs-2976	425	29	-	-	PUNCT
iajs-2976	425	30	mediated	mediate	VERB
iajs-2976	425	31	testosterone	testosterone	NOUN
iajs-2976	425	32	depletion	depletion	NOUN
iajs-2976	425	33	in	in	ADP
iajs-2976	425	34	streptozotocin	streptozotocin	NOUN
iajs-2976	425	35	-	-	PUNCT
iajs-2976	425	36	induced	induce	VERB
iajs-2976	425	37	diabetic	diabetic	ADJ
iajs-2976	425	38	rats	rat	NOUN
iajs-2976	425	39	.	.	PUNCT
iajs-2976	426	1	iranian	iranian	ADJ
iajs-2976	426	2	journal	journal	PROPN
iajs-2976	426	3	of	of	ADP
iajs-2976	426	4	medical	medical	ADJ
iajs-2976	426	5	sciences	science	NOUN
iajs-2976	426	6	,	,	PUNCT
iajs-2976	426	7	2014,39(2),123.available	2014,39(2),123.available	NOUN
iajs-2976	426	8	from	from	ADP
iajs-2976	426	9	:	:	PUNCT
iajs-2976	426	10	http://ijms.sums.ac.ir/article_39595.html	http://ijms.sums.ac.ir/article_39595.html	PROPN
iajs-2976	426	11	57	57	NUM
iajs-2976	426	12	.	.	PUNCT
iajs-2976	427	1	ahmadvand	ahmadvand	PROPN
iajs-2976	427	2	,	,	PUNCT
iajs-2976	427	3	h.	h.	PROPN
iajs-2976	427	4	;	;	PUNCT
iajs-2976	427	5	tavafi	tavafi	PROPN
iajs-2976	427	6	,	,	PUNCT
iajs-2976	427	7	m	m	PROPN
iajs-2976	427	8	..	..	PUNCT
iajs-2976	427	9	khosrowbeygi	khosrowbeygi	PROPN
iajs-2976	427	10	,	,	PUNCT
iajs-2976	427	11	a.	a.	NOUN
iajs-2976	427	12	amelioration	amelioration	NOUN
iajs-2976	427	13	of	of	ADP
iajs-2976	427	14	altered	altered	ADJ
iajs-2976	427	15	antioxidant	antioxidant	ADJ
iajs-2976	427	16	enzymes	enzyme	NOUN
iajs-2976	427	17	activity	activity	NOUN
iajs-2976	427	18	and	and	CCONJ
iajs-2976	427	19	glomerulosclerosis	glomerulosclerosis	NOUN
iajs-2976	427	20	by	by	ADP
iajs-2976	427	21	coenzyme	coenzyme	PROPN
iajs-2976	427	22	q10	q10	PROPN
iajs-2976	427	23	in	in	ADP
iajs-2976	427	24	alloxan	alloxan	NOUN
iajs-2976	427	25	-	-	PUNCT
iajs-2976	427	26	induced	induce	VERB
iajs-2976	427	27	diabetic	diabetic	ADJ
iajs-2976	427	28	rats	rat	NOUN
iajs-2976	427	29	.	.	PUNCT
iajs-2976	428	1	journal	journal	NOUN
iajs-2976	428	2	of	of	ADP
iajs-2976	428	3	diabetes	diabetes	NOUN
iajs-2976	428	4	and	and	CCONJ
iajs-2976	428	5	its	its	PRON
iajs-2976	428	6	complications	complication	NOUN
iajs-2976	428	7	,	,	PUNCT
iajs-2976	428	8	2012,26(6),476	2012,26(6),476	PROPN
iajs-2976	428	9	-	-	SYM
iajs-2976	428	10	82	82	NUM
iajs-2976	428	11	https://doi.org/10.1016/j.jdiacomp.2012.06.004	https://doi.org/10.1016/j.jdiacomp.2012.06.004	VERB
iajs-2976	428	12	58	58	NUM
iajs-2976	428	13	.	.	PUNCT
iajs-2976	429	1	rizwan	rizwan	PROPN
iajs-2976	429	2	,	,	PUNCT
iajs-2976	429	3	h.	h.	PROPN
iajs-2976	429	4	;	;	PUNCT
iajs-2976	429	5	pal	pal	NOUN
iajs-2976	429	6	,	,	PUNCT
iajs-2976	429	7	s.	s.	PROPN
iajs-2976	429	8	;	;	PUNCT
iajs-2976	429	9	sabnam	sabnam	PROPN
iajs-2976	429	10	,	,	PUNCT
iajs-2976	429	11	s	s	NOUN
iajs-2976	429	12	..	..	X
iajs-2976	429	13	pal	pal	NOUN
iajs-2976	429	14	,	,	PUNCT
iajs-2976	429	15	a.	a.	NOUN
iajs-2976	429	16	high	high	ADJ
iajs-2976	429	17	glucose	glucose	NOUN
iajs-2976	429	18	augments	augment	VERB
iajs-2976	429	19	ros	ros	PROPN
iajs-2976	429	20	generation	generation	NOUN
iajs-2976	429	21	regulates	regulate	VERB
iajs-2976	429	22	mitochondrial	mitochondrial	ADJ
iajs-2976	429	23	dysfunction	dysfunction	NOUN
iajs-2976	429	24	and	and	CCONJ
iajs-2976	429	25	apoptosis	apoptosis	NOUN
iajs-2976	429	26	via	via	ADP
iajs-2976	429	27	stress	stress	NOUN
iajs-2976	429	28	signalling	signal	VERB
iajs-2976	429	29	cascades	cascade	NOUN
iajs-2976	429	30	in	in	ADP
iajs-2976	429	31	keratinocytes	keratinocyte	NOUN
iajs-2976	429	32	.	.	PUNCT
iajs-2976	430	1	life	life	NOUN
iajs-2976	430	2	sciences	science	NOUN
iajs-2976	430	3	.	.	PUNCT
iajs-2976	431	1	2020,241,117148	2020,241,117148	NUM
iajs-2976	431	2	https://doi.org/10.1016/j.lfs.2019.117148	https://doi.org/10.1016/j.lfs.2019.117148	PROPN
iajs-2976	431	3	59	59	NUM
iajs-2976	431	4	.	.	PUNCT
iajs-2976	431	5	incalza	incalza	PROPN
iajs-2976	431	6	,	,	PUNCT
iajs-2976	431	7	m.	m.	NOUN
iajs-2976	431	8	a.	a.	PROPN
iajs-2976	431	9	;	;	PUNCT
iajs-2976	431	10	d'oria	d'oria	PROPN
iajs-2976	431	11	,	,	PUNCT
iajs-2976	431	12	r.	r.	PROPN
iajs-2976	431	13	;	;	PUNCT
iajs-2976	431	14	natalicchio	natalicchio	NOUN
iajs-2976	431	15	,	,	PUNCT
iajs-2976	431	16	a.	a.	NOUN
iajs-2976	431	17	;	;	PUNCT
iajs-2976	431	18	perrini	perrini	PROPN
iajs-2976	431	19	,	,	PUNCT
iajs-2976	431	20	s.	s.	PROPN
iajs-2976	431	21	;	;	PUNCT
iajs-2976	431	22	laviola	laviola	PROPN
iajs-2976	431	23	,	,	PUNCT
iajs-2976	431	24	l	l	PROPN
iajs-2976	431	25	..	..	PUNCT
iajs-2976	431	26	giorgino	giorgino	NOUN
iajs-2976	431	27	,	,	PUNCT
iajs-2976	431	28	f.	f.	PROPN
iajs-2976	431	29	oxidative	oxidative	ADJ
iajs-2976	431	30	stress	stress	NOUN
iajs-2976	431	31	and	and	CCONJ
iajs-2976	431	32	reactive	reactive	ADJ
iajs-2976	431	33	oxygen	oxygen	NOUN
iajs-2976	431	34	species	specie	NOUN
iajs-2976	431	35	in	in	ADP
iajs-2976	431	36	endothelial	endothelial	ADJ
iajs-2976	431	37	dysfunction	dysfunction	NOUN
iajs-2976	431	38	associated	associate	VERB
iajs-2976	431	39	with	with	ADP
iajs-2976	431	40	cardiovascular	cardiovascular	ADJ
iajs-2976	431	41	and	and	CCONJ
iajs-2976	431	42	metabolic	metabolic	NOUN
iajs-2976	431	43	diseases	disease	NOUN
iajs-2976	431	44	.	.	PUNCT
iajs-2976	432	1	vascular	vascular	ADJ
iajs-2976	432	2	pharmacology	pharmacology	NOUN
iajs-2976	432	3	.	.	PUNCT
iajs-2976	433	1	2018,100,1	2018,100,1	ADV
iajs-2976	433	2	-	-	SYM
iajs-2976	433	3	19	19	NUM
iajs-2976	433	4	https://doi.org/10.1016/j.vph.2017.05.005	https://doi.org/10.1016/j.vph.2017.05.005	NOUN
iajs-2976	433	5	60	60	NUM
iajs-2976	433	6	.	.	PUNCT
iajs-2976	434	1	thongnak	thongnak	NOUN
iajs-2976	434	2	,	,	PUNCT
iajs-2976	434	3	l.	l.	PROPN
iajs-2976	434	4	;	;	PUNCT
iajs-2976	434	5	pongchaidecha	pongchaidecha	ADJ
iajs-2976	434	6	,	,	PUNCT
iajs-2976	434	7	a.	a.	NOUN
iajs-2976	434	8	;	;	PUNCT
iajs-2976	434	9	jaikumkao	jaikumkao	PROPN
iajs-2976	434	10	,	,	PUNCT
iajs-2976	434	11	k.	k.	PROPN
iajs-2976	434	12	;	;	PUNCT
iajs-2976	434	13	chatsudthipong	chatsudthipong	PROPN
iajs-2976	434	14	,	,	PUNCT
iajs-2976	434	15	v.	v.	CCONJ
iajs-2976	434	16	;	;	PUNCT
iajs-2976	434	17	chattipakorn	chattipakorn	ADJ
iajs-2976	434	18	,	,	PUNCT
iajs-2976	434	19	n	n	CCONJ
iajs-2976	434	20	..	..	PUNCT
iajs-2976	434	21	lungkaphin	lungkaphin	PROPN
iajs-2976	434	22	,	,	PUNCT
iajs-2976	434	23	a.	a.	NOUN
iajs-2976	434	24	the	the	DET
iajs-2976	434	25	additive	additive	ADJ
iajs-2976	434	26	effects	effect	NOUN
iajs-2976	434	27	of	of	ADP
iajs-2976	434	28	atorvastatin	atorvastatin	NOUN
iajs-2976	434	29	and	and	CCONJ
iajs-2976	434	30	insulin	insulin	NOUN
iajs-2976	434	31	on	on	ADP
iajs-2976	434	32	renal	renal	ADJ
iajs-2976	434	33	function	function	NOUN
iajs-2976	434	34	and	and	CCONJ
iajs-2976	434	35	renal	renal	ADJ
iajs-2976	434	36	organic	organic	ADJ
iajs-2976	434	37	anion	anion	NOUN
iajs-2976	434	38	transporter	transporter	NOUN
iajs-2976	434	39	3	3	NUM
iajs-2976	434	40	function	function	NOUN
iajs-2976	434	41	in	in	ADP
iajs-2976	434	42	diabetic	diabetic	ADJ
iajs-2976	434	43	rats	rat	NOUN
iajs-2976	434	44	.	.	PUNCT
iajs-2976	435	1	scientific	scientific	ADJ
iajs-2976	435	2	reports	report	NOUN
iajs-2976	435	3	.	.	PUNCT
iajs-2976	436	1	2017,7(1),1	2017,7(1),1	NUM
iajs-2976	436	2	-	-	SYM
iajs-2976	436	3	11	11	NUM
iajs-2976	436	4	https://doi.org/10.1038/s41598-017-13206-5	https://doi.org/10.1038/s41598-017-13206-5	NUM
iajs-2976	436	5	61	61	NUM
iajs-2976	436	6	.	.	PUNCT
iajs-2976	437	1	raghavan	raghavan	PROPN
iajs-2976	437	2	,	,	PUNCT
iajs-2976	437	3	s.	s.	PROPN
iajs-2976	437	4	;	;	PUNCT
iajs-2976	437	5	subramaniyam	subramaniyam	PROPN
iajs-2976	437	6	,	,	PUNCT
iajs-2976	437	7	g	g	PROPN
iajs-2976	437	8	..	..	PUNCT
iajs-2976	437	9	shanmugam	shanmugam	NOUN
iajs-2976	437	10	,	,	PUNCT
iajs-2976	437	11	n.	n.	NOUN
iajs-2976	437	12	proinflammatory	proinflammatory	ADJ
iajs-2976	437	13	effects	effect	NOUN
iajs-2976	437	14	of	of	ADP
iajs-2976	437	15	malondialdehyde	malondialdehyde	NOUN
iajs-2976	437	16	in	in	ADP
iajs-2976	437	17	lymphocytes	lymphocyte	NOUN
iajs-2976	437	18	.	.	PUNCT
iajs-2976	438	1	journal	journal	NOUN
iajs-2976	438	2	of	of	ADP
iajs-2976	438	3	leukocyte	leukocyte	NOUN
iajs-2976	438	4	biology	biology	NOUN
iajs-2976	438	5	,	,	PUNCT
iajs-2976	438	6	2012,92(5),1055	2012,92(5),1055	NOUN
iajs-2976	438	7	-	-	SYM
iajs-2976	438	8	67	67	NUM
iajs-2976	438	9	https://doi.org/10.1189/jlb.1211617	https://doi.org/10.1189/jlb.1211617	PROPN
iajs-2976	438	10	62	62	NUM
iajs-2976	438	11	.	.	PUNCT
iajs-2976	439	1	ott	ott	PROPN
iajs-2976	439	2	,	,	PUNCT
iajs-2976	439	3	c.	c.	PROPN
iajs-2976	439	4	;	;	PUNCT
iajs-2976	439	5	jacobs	jacobs	PROPN
iajs-2976	439	6	,	,	PUNCT
iajs-2976	439	7	k.	k.	PROPN
iajs-2976	439	8	;	;	PUNCT
iajs-2976	439	9	haucke	haucke	PROPN
iajs-2976	439	10	,	,	PUNCT
iajs-2976	439	11	e.	e.	PROPN
iajs-2976	439	12	;	;	PUNCT
iajs-2976	439	13	santos	santos	PROPN
iajs-2976	439	14	,	,	PUNCT
iajs-2976	439	15	a.	a.	NOUN
iajs-2976	439	16	n.	n.	NOUN
iajs-2976	439	17	;	;	PUNCT
iajs-2976	439	18	grune	grune	NOUN
iajs-2976	439	19	,	,	PUNCT
iajs-2976	439	20	t	t	PROPN
iajs-2976	439	21	..	..	PUNCT
iajs-2976	439	22	simm	simm	PROPN
iajs-2976	439	23	,	,	PUNCT
iajs-2976	439	24	a.	a.	NOUN
iajs-2976	439	25	role	role	NOUN
iajs-2976	439	26	of	of	ADP
iajs-2976	439	27	advanced	advanced	ADJ
iajs-2976	439	28	glycation	glycation	NOUN
iajs-2976	439	29	end	end	NOUN
iajs-2976	439	30	products	product	NOUN
iajs-2976	439	31	in	in	ADP
iajs-2976	439	32	cellular	cellular	ADJ
iajs-2976	439	33	signaling	signaling	NOUN
iajs-2976	439	34	.	.	PUNCT
iajs-2976	440	1	redox	redox	ADJ
iajs-2976	440	2	biology	biology	NOUN
iajs-2976	440	3	.	.	PUNCT
iajs-2976	441	1	2014,2,411	2014,2,411	NUM
iajs-2976	441	2	-	-	PUNCT
iajs-2976	441	3	29	29	NUM
iajs-2976	441	4	https://doi.org/10.1016/j.redox.2013.12.016	https://doi.org/10.1016/j.redox.2013.12.016	PROPN
iajs-2976	441	5	63	63	NUM
iajs-2976	441	6	.	.	PUNCT
iajs-2976	442	1	pickering	pickering	PROPN
iajs-2976	442	2	,	,	PUNCT
iajs-2976	442	3	r.	r.	PROPN
iajs-2976	442	4	j.	j.	PROPN
iajs-2976	442	5	;	;	PUNCT
iajs-2976	442	6	rosado	rosado	NOUN
iajs-2976	442	7	,	,	PUNCT
iajs-2976	442	8	c.	c.	PROPN
iajs-2976	442	9	j.	j.	PROPN
iajs-2976	442	10	;	;	PUNCT
iajs-2976	442	11	sharma	sharma	PROPN
iajs-2976	442	12	,	,	PUNCT
iajs-2976	442	13	a.	a.	NOUN
iajs-2976	442	14	;	;	PUNCT
iajs-2976	442	15	buksh	buksh	PROPN
iajs-2976	442	16	,	,	PUNCT
iajs-2976	442	17	s.	s.	PROPN
iajs-2976	442	18	;	;	PUNCT
iajs-2976	442	19	tate	tate	PROPN
iajs-2976	442	20	,	,	PUNCT
iajs-2976	442	21	m	m	PROPN
iajs-2976	442	22	..	..	PUNCT
iajs-2976	442	23	de	de	X
iajs-2976	442	24	haan	haan	PROPN
iajs-2976	442	25	,	,	PUNCT
iajs-2976	442	26	j.	j.	PROPN
iajs-2976	442	27	b.	b.	PROPN
iajs-2976	443	1	recent	recent	ADJ
iajs-2976	443	2	novel	novel	NOUN
iajs-2976	443	3	approaches	approach	NOUN
iajs-2976	443	4	to	to	PART
iajs-2976	443	5	limit	limit	VERB
iajs-2976	443	6	oxidative	oxidative	ADJ
iajs-2976	443	7	stress	stress	NOUN
iajs-2976	443	8	and	and	CCONJ
iajs-2976	443	9	inflammation	inflammation	NOUN
iajs-2976	443	10	in	in	ADP
iajs-2976	443	11	diabetic	diabetic	ADJ
iajs-2976	443	12	complications	complication	NOUN
iajs-2976	443	13	.	.	PUNCT
iajs-2976	444	1	clinical	clinical	ADJ
iajs-2976	444	2	&	&	CCONJ
iajs-2976	444	3	translational	translational	ADJ
iajs-2976	444	4	immunology	immunology	NOUN
iajs-2976	444	5	.	.	PUNCT
iajs-2976	445	1	2018,7(4),e1016	2018,7(4),e1016	NUM
iajs-2976	445	2	https://doi.org/10.1002/cti2.1016	https://doi.org/10.1002/cti2.1016	PROPN
iajs-2976	446	1	https://doi.org/10.1002/1099-0461(2001)15:1%3c41::aid-jbt5%3e3.0.co;2-z	https://doi.org/10.1002/1099-0461(2001)15:1%3c41::aid-jbt5%3e3.0.co;2-z	NOUN
iajs-2976	446	2	https://doi.org/10.1002/1099-0461(2001)15:1%3c41::aid-jbt5%3e3.0.co;2-z	https://doi.org/10.1002/1099-0461(2001)15:1%3c41::aid-jbt5%3e3.0.co;2-z	NOUN
iajs-2976	446	3	https://doi.org/10.3177/jnsv.54.321	https://doi.org/10.3177/jnsv.54.321	PROPN
iajs-2976	447	1	https://doi.org/10.4103%2f1735-5362.272561	https://doi.org/10.4103%2f1735-5362.272561	PROPN
iajs-2976	447	2	https://doi.org/10.4103%2f1735-5362.272561	https://doi.org/10.4103%2f1735-5362.272561	NOUN
iajs-2976	447	3	https://doi.org/10.1016/j.freeradbiomed.2008.06.023	https://doi.org/10.1016/j.freeradbiomed.2008.06.023	X
iajs-2976	448	1	http://ijms.sums.ac.ir/article_39595.html	http://ijms.sums.ac.ir/article_39595.html	PROPN
iajs-2976	448	2	https://doi.org/10.1016/j.jdiacomp.2012.06.004	https://doi.org/10.1016/j.jdiacomp.2012.06.004	NOUN
iajs-2976	448	3	https://doi.org/10.1016/j.lfs.2019.117148	https://doi.org/10.1016/j.lfs.2019.117148	PROPN
iajs-2976	448	4	https://doi.org/10.1016/j.vph.2017.05.005	https://doi.org/10.1016/j.vph.2017.05.005	VERB
iajs-2976	448	5	https://doi.org/10.1038/s41598-017-13206-5	https://doi.org/10.1038/s41598-017-13206-5	PROPN
iajs-2976	449	1	https://doi.org/10.1189/jlb.1211617	https://doi.org/10.1189/jlb.1211617	PROPN
iajs-2976	449	2	https://doi.org/10.1016/j.redox.2013.12.016	https://doi.org/10.1016/j.redox.2013.12.016	PROPN
iajs-2976	449	3	https://doi.org/10.1002/cti2.1016	https://doi.org/10.1002/cti2.1016	PROPN
iajs-2976	449	4	ihjpas	ihjpa	VERB
iajs-2976	449	5	.	.	PUNCT
iajs-2976	450	1	36(2)2023	36(2)2023	NUM
iajs-2976	450	2	102	102	NUM
iajs-2976	450	3	64	64	NUM
iajs-2976	450	4	.	.	PUNCT
iajs-2976	451	1	rahimi	rahimi	NOUN
iajs-2976	451	2	-	-	PUNCT
iajs-2976	451	3	madiseh	madiseh	NOUN
iajs-2976	451	4	,	,	PUNCT
iajs-2976	451	5	m.	m.	NOUN
iajs-2976	451	6	;	;	PUNCT
iajs-2976	451	7	malekpour	malekpour	NOUN
iajs-2976	451	8	-	-	PUNCT
iajs-2976	451	9	tehrani	tehrani	ADJ
iajs-2976	451	10	,	,	PUNCT
iajs-2976	451	11	a.	a.	NOUN
iajs-2976	451	12	;	;	PUNCT
iajs-2976	451	13	bahmani	bahmani	NOUN
iajs-2976	451	14	,	,	PUNCT
iajs-2976	451	15	m	m	PROPN
iajs-2976	451	16	..	..	PUNCT
iajs-2976	451	17	rafieian	rafieian	ADJ
iajs-2976	451	18	-	-	PUNCT
iajs-2976	451	19	kopaei	kopaei	PROPN
iajs-2976	451	20	,	,	PUNCT
iajs-2976	451	21	m.	m.	NOUN
iajs-2976	451	22	the	the	DET
iajs-2976	451	23	research	research	NOUN
iajs-2976	451	24	and	and	CCONJ
iajs-2976	451	25	development	development	NOUN
iajs-2976	451	26	on	on	ADP
iajs-2976	451	27	the	the	DET
iajs-2976	451	28	antioxidants	antioxidant	NOUN
iajs-2976	451	29	in	in	ADP
iajs-2976	451	30	prevention	prevention	NOUN
iajs-2976	451	31	of	of	ADP
iajs-2976	451	32	diabetic	diabetic	ADJ
iajs-2976	451	33	complications	complication	NOUN
iajs-2976	451	34	.	.	PUNCT
iajs-2976	452	1	asian	asian	PROPN
iajs-2976	452	2	pacific	pacific	PROPN
iajs-2976	452	3	journal	journal	PROPN
iajs-2976	452	4	of	of	ADP
iajs-2976	452	5	tropical	tropical	ADJ
iajs-2976	452	6	medicine	medicine	NOUN
iajs-2976	452	7	,	,	PUNCT
iajs-2976	452	8	2016,9(9),825	2016,9(9),825	PROPN
iajs-2976	452	9	-	-	SYM
iajs-2976	452	10	31	31	NUM
iajs-2976	452	11	https://doi.org/10.1016/j.apjtm.2016.07.001	https://doi.org/10.1016/j.apjtm.2016.07.001	PROPN
iajs-2976	452	12	65	65	NUM
iajs-2976	452	13	.	.	PUNCT
iajs-2976	453	1	ohtsu	ohtsu	PROPN
iajs-2976	453	2	,	,	PUNCT
iajs-2976	453	3	a.	a.	NOUN
iajs-2976	453	4	;	;	PUNCT
iajs-2976	453	5	shibutani	shibutani	PROPN
iajs-2976	453	6	,	,	PUNCT
iajs-2976	453	7	y.	y.	PROPN
iajs-2976	453	8	;	;	PUNCT
iajs-2976	453	9	seno	seno	PROPN
iajs-2976	453	10	,	,	PUNCT
iajs-2976	453	11	k.	k.	PROPN
iajs-2976	453	12	;	;	PUNCT
iajs-2976	453	13	iwata	iwata	PROPN
iajs-2976	453	14	,	,	PUNCT
iajs-2976	453	15	h.	h.	PROPN
iajs-2976	453	16	;	;	PUNCT
iajs-2976	453	17	kuwayama	kuwayama	PROPN
iajs-2976	453	18	,	,	PUNCT
iajs-2976	453	19	t	t	PROPN
iajs-2976	453	20	..	..	PUNCT
iajs-2976	453	21	shirasuna	shirasuna	PROPN
iajs-2976	453	22	,	,	PUNCT
iajs-2976	453	23	k.	k.	PROPN
iajs-2976	454	1	advanced	advanced	ADJ
iajs-2976	454	2	glycation	glycation	NOUN
iajs-2976	454	3	end	end	NOUN
iajs-2976	454	4	products	product	NOUN
iajs-2976	454	5	and	and	CCONJ
iajs-2976	454	6	lipopolysaccharides	lipopolysaccharide	NOUN
iajs-2976	454	7	stimulate	stimulate	VERB
iajs-2976	454	8	interleukin‑6	interleukin‑6	NOUN
iajs-2976	454	9	secretion	secretion	NOUN
iajs-2976	454	10	via	via	ADP
iajs-2976	454	11	the	the	DET
iajs-2976	454	12	rage	rage	NOUN
iajs-2976	454	13	/	/	SYM
iajs-2976	454	14	tlr4‑nf‑κb‑ros	tlr4‑nf‑κb‑ros	NOUN
iajs-2976	454	15	pathways	pathway	NOUN
iajs-2976	454	16	and	and	CCONJ
iajs-2976	454	17	resveratrol	resveratrol	NOUN
iajs-2976	454	18	attenuates	attenuate	VERB
iajs-2976	454	19	these	these	DET
iajs-2976	454	20	inflammatory	inflammatory	ADJ
iajs-2976	454	21	responses	response	NOUN
iajs-2976	454	22	in	in	ADP
iajs-2976	454	23	mouse	mouse	NOUN
iajs-2976	454	24	macrophages	macrophage	NOUN
iajs-2976	454	25	.	.	PUNCT
iajs-2976	455	1	experimental	experimental	ADJ
iajs-2976	455	2	and	and	CCONJ
iajs-2976	455	3	therapeutic	therapeutic	ADJ
iajs-2976	455	4	medicine	medicine	NOUN
iajs-2976	455	5	.	.	PUNCT
iajs-2976	456	1	2017,14(5),4363	2017,14(5),4363	X
iajs-2976	456	2	-	-	SYM
iajs-2976	456	3	70	70	NUM
iajs-2976	457	1	https://doi.org/10.3892/etm.2017.5045	https://doi.org/10.3892/etm.2017.5045	PROPN
iajs-2976	457	2	66	66	NUM
iajs-2976	457	3	.	.	PUNCT
iajs-2976	457	4	taniguchi	taniguchi	PROPN
iajs-2976	457	5	,	,	PUNCT
iajs-2976	457	6	k.	k.	PROPN
iajs-2976	457	7	;	;	PUNCT
iajs-2976	457	8	karin	karin	PROPN
iajs-2976	457	9	,	,	PUNCT
iajs-2976	457	10	m.	m.	NOUN
iajs-2976	457	11	nf	nf	PROPN
iajs-2976	457	12	-	-	PUNCT
iajs-2976	457	13	κb	κb	ADJ
iajs-2976	457	14	,	,	PUNCT
iajs-2976	457	15	inflammation	inflammation	NOUN
iajs-2976	457	16	,	,	PUNCT
iajs-2976	457	17	immunity	immunity	NOUN
iajs-2976	457	18	and	and	CCONJ
iajs-2976	457	19	cancer	cancer	NOUN
iajs-2976	457	20	:	:	PUNCT
iajs-2976	457	21	coming	come	VERB
iajs-2976	457	22	of	of	ADP
iajs-2976	457	23	age	age	NOUN
iajs-2976	457	24	.	.	PUNCT
iajs-2976	458	1	nature	nature	NOUN
iajs-2976	458	2	reviews	review	VERB
iajs-2976	458	3	immunology	immunology	NOUN
iajs-2976	458	4	.	.	PUNCT
iajs-2976	459	1	2018,18(5),309	2018,18(5),309	NOUN
iajs-2976	459	2	-	-	SYM
iajs-2976	459	3	24	24	NUM
iajs-2976	459	4	67	67	NUM
iajs-2976	459	5	.	.	PUNCT
iajs-2976	460	1	maheshwari	maheshwari	PROPN
iajs-2976	460	2	,	,	PUNCT
iajs-2976	460	3	r.	r.	PROPN
iajs-2976	460	4	a.	a.	PROPN
iajs-2976	460	5	;	;	PUNCT
iajs-2976	460	6	parmar	parmar	PROPN
iajs-2976	460	7	,	,	PUNCT
iajs-2976	460	8	g.	g.	PROPN
iajs-2976	460	9	r.	r.	PROPN
iajs-2976	460	10	;	;	PUNCT
iajs-2976	460	11	hinsu	hinsu	PROPN
iajs-2976	460	12	,	,	PUNCT
iajs-2976	460	13	d.	d.	PROPN
iajs-2976	460	14	;	;	PUNCT
iajs-2976	460	15	seth	seth	PROPN
iajs-2976	460	16	,	,	PUNCT
iajs-2976	460	17	a.	a.	PROPN
iajs-2976	460	18	k	k	PROPN
iajs-2976	460	19	..	..	PUNCT
iajs-2976	460	20	balaraman	balaraman	PROPN
iajs-2976	460	21	,	,	PUNCT
iajs-2976	460	22	r.	r.	PROPN
iajs-2976	460	23	novel	novel	PROPN
iajs-2976	460	24	therapeutic	therapeutic	ADJ
iajs-2976	460	25	intervention	intervention	NOUN
iajs-2976	460	26	of	of	ADP
iajs-2976	460	27	coenzyme	coenzyme	PROPN
iajs-2976	460	28	q10	q10	PROPN
iajs-2976	460	29	and	and	CCONJ
iajs-2976	460	30	its	its	PRON
iajs-2976	460	31	combination	combination	NOUN
iajs-2976	460	32	with	with	ADP
iajs-2976	460	33	pioglitazone	pioglitazone	NOUN
iajs-2976	460	34	on	on	ADP
iajs-2976	460	35	the	the	DET
iajs-2976	460	36	mrna	mrna	PROPN
iajs-2976	460	37	expression	expression	NOUN
iajs-2976	460	38	level	level	NOUN
iajs-2976	460	39	of	of	ADP
iajs-2976	460	40	adipocytokines	adipocytokine	NOUN
iajs-2976	460	41	in	in	ADP
iajs-2976	460	42	diabetic	diabetic	ADJ
iajs-2976	460	43	rats	rat	NOUN
iajs-2976	460	44	.	.	PUNCT
iajs-2976	461	1	life	life	NOUN
iajs-2976	461	2	sciences	science	NOUN
iajs-2976	461	3	.	.	PUNCT
iajs-2976	462	1	2020,258,118155	2020,258,118155	NUM
iajs-2976	462	2	https://doi.org/10.1016/j.lfs.2020.118155	https://doi.org/10.1016/j.lfs.2020.118155	PROPN
iajs-2976	462	3	68	68	NUM
iajs-2976	462	4	.	.	PUNCT
iajs-2976	463	1	mezzano	mezzano	PROPN
iajs-2976	463	2	,	,	PUNCT
iajs-2976	463	3	s.	s.	PROPN
iajs-2976	463	4	;	;	PUNCT
iajs-2976	463	5	aros	aros	PROPN
iajs-2976	463	6	,	,	PUNCT
iajs-2976	463	7	c.	c.	PROPN
iajs-2976	463	8	;	;	PUNCT
iajs-2976	463	9	droguett	droguett	PROPN
iajs-2976	463	10	,	,	PUNCT
iajs-2976	463	11	a.	a.	NOUN
iajs-2976	463	12	;	;	PUNCT
iajs-2976	463	13	burgos	burgos	PROPN
iajs-2976	463	14	,	,	PUNCT
iajs-2976	463	15	m.	m.	PROPN
iajs-2976	463	16	e.	e.	PROPN
iajs-2976	463	17	;	;	PUNCT
iajs-2976	463	18	ardiles	ardile	NOUN
iajs-2976	463	19	,	,	PUNCT
iajs-2976	463	20	l.	l.	PROPN
iajs-2976	463	21	;	;	PUNCT
iajs-2976	463	22	flores	flores	PROPN
iajs-2976	463	23	,	,	PUNCT
iajs-2976	463	24	c.	c.	PROPN
iajs-2976	463	25	;	;	PUNCT
iajs-2976	463	26	schneider	schneider	PROPN
iajs-2976	463	27	,	,	PUNCT
iajs-2976	463	28	h.	h.	PROPN
iajs-2976	463	29	;	;	PUNCT
iajs-2976	463	30	ruiz	ruiz	NOUN
iajs-2976	463	31	-	-	PUNCT
iajs-2976	463	32	ortega	ortega	PROPN
iajs-2976	463	33	,	,	PUNCT
iajs-2976	463	34	m	m	PROPN
iajs-2976	463	35	..	..	PUNCT
iajs-2976	463	36	egido	egido	PROPN
iajs-2976	463	37	,	,	PUNCT
iajs-2976	463	38	j.	j.	PROPN
iajs-2976	463	39	nf	nf	PROPN
iajs-2976	463	40	-	-	PUNCT
iajs-2976	463	41	κb	κb	NOUN
iajs-2976	463	42	activation	activation	NOUN
iajs-2976	463	43	and	and	CCONJ
iajs-2976	463	44	overexpression	overexpression	NOUN
iajs-2976	463	45	of	of	ADP
iajs-2976	463	46	regulated	regulated	ADJ
iajs-2976	463	47	genes	gene	NOUN
iajs-2976	463	48	in	in	ADP
iajs-2976	463	49	human	human	ADJ
iajs-2976	463	50	diabetic	diabetic	ADJ
iajs-2976	463	51	nephropathy	nephropathy	NOUN
iajs-2976	463	52	.	.	PUNCT
iajs-2976	464	1	nephrology	nephrology	NOUN
iajs-2976	464	2	dialysis	dialysis	NOUN
iajs-2976	464	3	transplantation	transplantation	NOUN
iajs-2976	464	4	.	.	PUNCT
iajs-2976	465	1	2004,19(10),2505	2004,19(10),2505	PROPN
iajs-2976	465	2	-	-	SYM
iajs-2976	465	3	12	12	NUM
iajs-2976	465	4	https://doi.org/10.1093/ndt/gfh207	https://doi.org/10.1093/ndt/gfh207	NOUN
iajs-2976	465	5	69	69	NUM
iajs-2976	465	6	.	.	PUNCT
iajs-2976	466	1	navarro	navarro	PROPN
iajs-2976	466	2	-	-	PUNCT
iajs-2976	466	3	gonzalez	gonzalez	PROPN
iajs-2976	466	4	,	,	PUNCT
iajs-2976	466	5	j.	j.	PROPN
iajs-2976	466	6	f	f	PROPN
iajs-2976	466	7	..	..	PUNCT
iajs-2976	466	8	mora	mora	PROPN
iajs-2976	466	9	-	-	PUNCT
iajs-2976	466	10	fernandez	fernandez	PROPN
iajs-2976	466	11	,	,	PUNCT
iajs-2976	466	12	c.	c.	NOUN
iajs-2976	466	13	the	the	DET
iajs-2976	466	14	role	role	NOUN
iajs-2976	466	15	of	of	ADP
iajs-2976	466	16	inflammatory	inflammatory	ADJ
iajs-2976	466	17	cytokines	cytokine	NOUN
iajs-2976	466	18	in	in	ADP
iajs-2976	466	19	diabetic	diabetic	ADJ
iajs-2976	466	20	nephropathy	nephropathy	NOUN
iajs-2976	466	21	.	.	PUNCT
iajs-2976	467	1	journal	journal	NOUN
iajs-2976	467	2	of	of	ADP
iajs-2976	467	3	the	the	DET
iajs-2976	467	4	american	american	ADJ
iajs-2976	467	5	society	society	NOUN
iajs-2976	467	6	of	of	ADP
iajs-2976	467	7	nephrology	nephrology	NOUN
iajs-2976	467	8	,	,	PUNCT
iajs-2976	467	9	2008,19(3),433	2008,19(3),433	NUM
iajs-2976	467	10	-	-	SYM
iajs-2976	467	11	42	42	NUM
iajs-2976	467	12	https://doi.org/10.1681/asn.2007091048	https://doi.org/10.1681/asn.2007091048	PROPN
iajs-2976	467	13	70	70	NUM
iajs-2976	467	14	.	.	PUNCT
iajs-2976	468	1	navarro	navarro	PROPN
iajs-2976	468	2	,	,	PUNCT
iajs-2976	468	3	j.	j.	PROPN
iajs-2976	468	4	f	f	PROPN
iajs-2976	468	5	..	..	PUNCT
iajs-2976	468	6	mora	mora	PROPN
iajs-2976	468	7	,	,	PUNCT
iajs-2976	468	8	c.	c.	PROPN
iajs-2976	468	9	role	role	NOUN
iajs-2976	468	10	of	of	ADP
iajs-2976	468	11	inflammation	inflammation	NOUN
iajs-2976	468	12	in	in	ADP
iajs-2976	468	13	diabetic	diabetic	ADJ
iajs-2976	468	14	complications	complication	NOUN
iajs-2976	468	15	.	.	PUNCT
iajs-2976	469	1	nephrology	nephrology	NOUN
iajs-2976	469	2	dialysis	dialysis	NOUN
iajs-2976	469	3	transplantation	transplantation	NOUN
iajs-2976	469	4	.	.	PUNCT
iajs-2976	470	1	2005,20(12),2601	2005,20(12),2601	X
iajs-2976	470	2	-	-	SYM
iajs-2976	470	3	4	4	NUM
iajs-2976	470	4	https://doi.org/10.1093/ndt/gfi155	https://doi.org/10.1093/ndt/gfi155	PROPN
iajs-2976	470	5	71	71	NUM
iajs-2976	470	6	.	.	PUNCT
iajs-2976	471	1	prabhakar	prabhakar	NOUN
iajs-2976	471	2	,	,	PUNCT
iajs-2976	471	3	o.	o.	PROPN
iajs-2976	471	4	cerebroprotective	cerebroprotective	ADJ
iajs-2976	471	5	effect	effect	NOUN
iajs-2976	471	6	of	of	ADP
iajs-2976	471	7	resveratrol	resveratrol	NOUN
iajs-2976	471	8	through	through	ADP
iajs-2976	471	9	antioxidant	antioxidant	ADJ
iajs-2976	471	10	and	and	CCONJ
iajs-2976	471	11	antiinflammatory	antiinflammatory	NOUN
iajs-2976	471	12	effects	effect	NOUN
iajs-2976	471	13	in	in	ADP
iajs-2976	471	14	diabetic	diabetic	ADJ
iajs-2976	471	15	rats	rat	NOUN
iajs-2976	471	16	.	.	PUNCT
iajs-2976	472	1	naunyn	naunyn	PROPN
iajs-2976	472	2	-	-	PUNCT
iajs-2976	472	3	schmiedeberg	schmiedeberg	PROPN
iajs-2976	472	4	's	's	PART
iajs-2976	472	5	archives	archive	NOUN
iajs-2976	472	6	of	of	ADP
iajs-2976	472	7	pharmacology	pharmacology	NOUN
iajs-2976	472	8	.	.	PUNCT
iajs-2976	473	1	2013,386(8),705	2013,386(8),705	NUM
iajs-2976	473	2	-	-	SYM
iajs-2976	473	3	10	10	NUM
iajs-2976	473	4	https://doi.org/10.1007/s00210-013-0871-2	https://doi.org/10.1007/s00210-013-0871-2	NUM
iajs-2976	473	5	72	72	NUM
iajs-2976	473	6	.	.	PUNCT
iajs-2976	474	1	ojo	ojo	NOUN
iajs-2976	474	2	,	,	PUNCT
iajs-2976	474	3	o.	o.	NOUN
iajs-2976	474	4	a.	a.	PROPN
iajs-2976	474	5	;	;	PUNCT
iajs-2976	474	6	amanze	amanze	PROPN
iajs-2976	474	7	,	,	PUNCT
iajs-2976	474	8	j.	j.	PROPN
iajs-2976	474	9	c.	c.	PROPN
iajs-2976	474	10	;	;	PUNCT
iajs-2976	474	11	oni	oni	PROPN
iajs-2976	474	12	,	,	PUNCT
iajs-2976	474	13	a.	a.	NOUN
iajs-2976	474	14	i.	i.	PROPN
iajs-2976	474	15	;	;	PUNCT
iajs-2976	474	16	grant	grant	PROPN
iajs-2976	474	17	,	,	PUNCT
iajs-2976	474	18	s.	s.	PROPN
iajs-2976	474	19	;	;	PUNCT
iajs-2976	474	20	iyobhebhe	iyobhebhe	NOUN
iajs-2976	474	21	,	,	PUNCT
iajs-2976	474	22	m.	m.	NOUN
iajs-2976	474	23	;	;	PUNCT
iajs-2976	474	24	elebiyo	elebiyo	PROPN
iajs-2976	474	25	,	,	PUNCT
iajs-2976	474	26	t.	t.	PROPN
iajs-2976	474	27	c.	c.	PROPN
iajs-2976	474	28	;	;	PUNCT
iajs-2976	474	29	rotimi	rotimi	PROPN
iajs-2976	474	30	,	,	PUNCT
iajs-2976	474	31	d.	d.	PROPN
iajs-2976	474	32	;	;	PUNCT
iajs-2976	474	33	asogwa	asogwa	PROPN
iajs-2976	474	34	,	,	PUNCT
iajs-2976	474	35	n.	n.	PROPN
iajs-2976	474	36	t.	t.	PROPN
iajs-2976	474	37	;	;	PUNCT
iajs-2976	474	38	oyinloye	oyinloye	PROPN
iajs-2976	474	39	,	,	PUNCT
iajs-2976	474	40	b.	b.	PROPN
iajs-2976	474	41	e	e	PROPN
iajs-2976	474	42	..	..	PUNCT
iajs-2976	474	43	ajiboye	ajiboye	PROPN
iajs-2976	474	44	,	,	PUNCT
iajs-2976	474	45	b.	b.	PROPN
iajs-2976	474	46	o.	o.	PROPN
iajs-2976	474	47	antidiabetic	antidiabetic	ADJ
iajs-2976	474	48	activity	activity	NOUN
iajs-2976	474	49	of	of	ADP
iajs-2976	474	50	avocado	avocado	ADJ
iajs-2976	474	51	seeds	seed	NOUN
iajs-2976	474	52	(	(	PUNCT
iajs-2976	474	53	persea	persea	NOUN
iajs-2976	474	54	americana	americana	NOUN
iajs-2976	474	55	mill	mill	NOUN
iajs-2976	474	56	.	.	PUNCT
iajs-2976	474	57	)	)	PUNCT
iajs-2976	475	1	in	in	ADP
iajs-2976	475	2	diabetic	diabetic	ADJ
iajs-2976	475	3	rats	rat	NOUN
iajs-2976	475	4	via	via	ADP
iajs-2976	475	5	activation	activation	NOUN
iajs-2976	475	6	of	of	ADP
iajs-2976	475	7	pi3k	pi3k	PROPN
iajs-2976	475	8	/	/	SYM
iajs-2976	475	9	akt	akt	PROPN
iajs-2976	475	10	signaling	signal	VERB
iajs-2976	475	11	pathway	pathway	NOUN
iajs-2976	475	12	.	.	PUNCT
iajs-2976	476	1	scientific	scientific	ADJ
iajs-2976	476	2	reports	report	NOUN
iajs-2976	476	3	.	.	PUNCT
iajs-2976	477	1	2022,12(1),1	2022,12(1),1	NUM
iajs-2976	477	2	-	-	SYM
iajs-2976	477	3	17	17	NUM
iajs-2976	477	4	https://doi.org/10.1038/s41598-022-07015-8	https://doi.org/10.1038/s41598-022-07015-8	NUM
iajs-2976	477	5	73	73	NUM
iajs-2976	477	6	.	.	PUNCT
iajs-2976	478	1	lacasa	lacasa	PROPN
iajs-2976	478	2	,	,	PUNCT
iajs-2976	478	3	d.	d.	PROPN
iajs-2976	478	4	l.	l.	PROPN
iajs-2976	478	5	;	;	PUNCT
iajs-2976	478	6	taleb	taleb	PROPN
iajs-2976	478	7	,	,	PUNCT
iajs-2976	478	8	s.	s.	PROPN
iajs-2976	478	9	;	;	PUNCT
iajs-2976	478	10	keophiphath	keophiphath	PROPN
iajs-2976	478	11	,	,	PUNCT
iajs-2976	478	12	m.	m.	NOUN
iajs-2976	478	13	;	;	PUNCT
iajs-2976	478	14	miranville	miranville	NOUN
iajs-2976	478	15	,	,	PUNCT
iajs-2976	478	16	a	a	PRON
iajs-2976	478	17	..	..	PUNCT
iajs-2976	478	18	clement	clement	PROPN
iajs-2976	478	19	,	,	PUNCT
iajs-2976	478	20	k.	k.	PROPN
iajs-2976	478	21	macrophage	macrophage	ADV
iajs-2976	478	22	-	-	PUNCT
iajs-2976	478	23	secreted	secrete	VERB
iajs-2976	478	24	factors	factor	NOUN
iajs-2976	478	25	impair	impair	VERB
iajs-2976	478	26	human	human	ADJ
iajs-2976	478	27	adipogenesis	adipogenesis	NOUN
iajs-2976	478	28	:	:	PUNCT
iajs-2976	478	29	involvement	involvement	NOUN
iajs-2976	478	30	of	of	ADP
iajs-2976	478	31	proinflammatory	proinflammatory	ADJ
iajs-2976	478	32	state	state	NOUN
iajs-2976	478	33	in	in	ADP
iajs-2976	478	34	preadipocytes	preadipocyte	NOUN
iajs-2976	478	35	.	.	PUNCT
iajs-2976	479	1	endocrinology	endocrinology	NOUN
iajs-2976	479	2	.	.	PUNCT
iajs-2976	480	1	2007,148(2),868	2007,148(2),868	NUM
iajs-2976	480	2	-	-	SYM
iajs-2976	480	3	77	77	NUM
iajs-2976	480	4	https://doi.org/10.1210/en.2006-0687	https://doi.org/10.1210/en.2006-0687	NOUN
iajs-2976	480	5	74	74	NUM
iajs-2976	480	6	.	.	PUNCT
iajs-2976	481	1	suresh	suresh	PROPN
iajs-2976	481	2	,	,	PUNCT
iajs-2976	481	3	y	y	PROPN
iajs-2976	481	4	..	..	PUNCT
iajs-2976	481	5	das	das	PROPN
iajs-2976	481	6	,	,	PUNCT
iajs-2976	481	7	u.	u.	PROPN
iajs-2976	481	8	n.	n.	PROPN
iajs-2976	481	9	differential	differential	ADJ
iajs-2976	481	10	effect	effect	NOUN
iajs-2976	481	11	of	of	ADP
iajs-2976	481	12	saturated	saturate	VERB
iajs-2976	481	13	,	,	PUNCT
iajs-2976	481	14	monounsaturated	monounsaturate	VERB
iajs-2976	481	15	,	,	PUNCT
iajs-2976	481	16	and	and	CCONJ
iajs-2976	481	17	polyunsaturated	polyunsaturated	ADJ
iajs-2976	481	18	fatty	fatty	NOUN
iajs-2976	481	19	acids	acid	NOUN
iajs-2976	481	20	on	on	ADP
iajs-2976	481	21	alloxan	alloxan	NOUN
iajs-2976	481	22	-	-	PUNCT
iajs-2976	481	23	induced	induce	VERB
iajs-2976	481	24	diabetes	diabetes	NOUN
iajs-2976	481	25	mellitus	mellitus	NOUN
iajs-2976	481	26	.	.	PUNCT
iajs-2976	482	1	prostaglandins	prostaglandin	NOUN
iajs-2976	482	2	,	,	PUNCT
iajs-2976	482	3	leukotrienes	leukotriene	NOUN
iajs-2976	482	4	and	and	CCONJ
iajs-2976	482	5	essential	essential	ADJ
iajs-2976	482	6	fatty	fatty	NOUN
iajs-2976	482	7	acids	acid	NOUN
iajs-2976	482	8	.	.	PUNCT
iajs-2976	483	1	2006,74(3),199	2006,74(3),199	NUM
iajs-2976	483	2	-	-	PUNCT
iajs-2976	483	3	213	213	NUM
iajs-2976	483	4	https://doi.org/10.1016/j.plefa.2005.11.006	https://doi.org/10.1016/j.plefa.2005.11.006	NUM
iajs-2976	483	5	75	75	NUM
iajs-2976	483	6	.	.	PUNCT
iajs-2976	484	1	anwar	anwar	PROPN
iajs-2976	484	2	,	,	PUNCT
iajs-2976	484	3	m.	m.	NOUN
iajs-2976	484	4	;	;	PUNCT
iajs-2976	484	5	abd	abd	PROPN
iajs-2976	484	6	el	el	PROPN
iajs-2976	484	7	-	-	PUNCT
iajs-2976	484	8	moniem	moniem	PROPN
iajs-2976	484	9	,	,	PUNCT
iajs-2976	484	10	m.	m.	NOUN
iajs-2976	484	11	;	;	PUNCT
iajs-2976	484	12	megahed	megahe	VERB
iajs-2976	484	13	,	,	PUNCT
iajs-2976	484	14	h.	h.	PROPN
iajs-2976	484	15	a.	a.	PROPN
iajs-2976	484	16	;	;	PUNCT
iajs-2976	485	1	el	el	PROPN
iajs-2976	485	2	-	-	PROPN
iajs-2976	485	3	toukhy	toukhy	PROPN
iajs-2976	485	4	,	,	PUNCT
iajs-2976	485	5	s.	s.	PROPN
iajs-2976	485	6	e.	e.	PROPN
iajs-2976	485	7	;	;	PUNCT
iajs-2976	485	8	mohammed	mohammed	PROPN
iajs-2976	485	9	,	,	PUNCT
iajs-2976	485	10	n.	n.	PROPN
iajs-2976	485	11	a	a	X
iajs-2976	485	12	..	..	PUNCT
iajs-2976	485	13	youness	youness	NOUN
iajs-2976	485	14	,	,	PUNCT
iajs-2976	485	15	e.	e.	PROPN
iajs-2976	485	16	r.	r.	PROPN
iajs-2976	485	17	effect	effect	PROPN
iajs-2976	485	18	of	of	ADP
iajs-2976	485	19	coenzyme	coenzyme	PROPN
iajs-2976	485	20	q10	q10	PROPN
iajs-2976	485	21	supplementation	supplementation	NOUN
iajs-2976	485	22	on	on	ADP
iajs-2976	485	23	markers	marker	NOUN
iajs-2976	485	24	of	of	ADP
iajs-2976	485	25	oxidative	oxidative	ADJ
iajs-2976	485	26	stress	stress	NOUN
iajs-2976	485	27	in	in	ADP
iajs-2976	485	28	streptozotocin	streptozotocin	NOUN
iajs-2976	485	29	induced	induce	VERB
iajs-2976	485	30	diabetic	diabetic	ADJ
iajs-2976	485	31	rats	rat	NOUN
iajs-2976	485	32	.	.	PUNCT
iajs-2976	486	1	journal	journal	NOUN
iajs-2976	486	2	of	of	ADP
iajs-2976	486	3	applied	apply	VERB
iajs-2976	486	4	pharmaceutical	pharmaceutical	ADJ
iajs-2976	486	5	science	science	NOUN
iajs-2976	486	6	,	,	PUNCT
iajs-2976	486	7	2014,4(6),00915	2014,4(6),00915	NUM
iajs-2976	486	8	http://dx.doi.org/10.7324/japs.2014.40602	http://dx.doi.org/10.7324/japs.2014.40602	NOUN
iajs-2976	486	9	76	76	NUM
iajs-2976	486	10	.	.	PUNCT
iajs-2976	487	1	suresh	suresh	PROPN
iajs-2976	487	2	,	,	PUNCT
iajs-2976	487	3	v	v	PROPN
iajs-2976	487	4	..	..	PUNCT
iajs-2976	487	5	reddy	reddy	PROPN
iajs-2976	487	6	,	,	PUNCT
iajs-2976	487	7	a.	a.	NOUN
iajs-2976	487	8	dysregulation	dysregulation	NOUN
iajs-2976	487	9	of	of	ADP
iajs-2976	487	10	nitric	nitric	ADJ
iajs-2976	487	11	oxide	oxide	NOUN
iajs-2976	487	12	synthases	synthase	NOUN
iajs-2976	487	13	during	during	ADP
iajs-2976	487	14	early	early	ADJ
iajs-2976	487	15	and	and	CCONJ
iajs-2976	487	16	late	late	ADJ
iajs-2976	487	17	pathophysiological	pathophysiological	ADJ
iajs-2976	487	18	conditions	condition	NOUN
iajs-2976	487	19	of	of	ADP
iajs-2976	487	20	diabetes	diabetes	NOUN
iajs-2976	487	21	mellitus	mellitus	NOUN
iajs-2976	487	22	leads	lead	VERB
iajs-2976	487	23	to	to	ADP
iajs-2976	487	24	amassing	amass	VERB
iajs-2976	487	25	of	of	ADP
iajs-2976	487	26	microvascular	microvascular	ADJ
iajs-2976	487	27	impedement	impedement	NOUN
iajs-2976	487	28	.	.	PUNCT
iajs-2976	488	1	journal	journal	NOUN
iajs-2976	488	2	of	of	ADP
iajs-2976	488	3	diabetes	diabetes	PROPN
iajs-2976	488	4	&	&	CCONJ
iajs-2976	488	5	metabolic	metabolic	NOUN
iajs-2976	488	6	disorders	disorder	NOUN
iajs-2976	488	7	.	.	PUNCT
iajs-2976	489	1	2021,20(1),989	2021,20(1),989	NUM
iajs-2976	489	2	-	-	PUNCT
iajs-2976	489	3	1002	1002	NUM
iajs-2976	489	4	https://doi.org/10.1007/s40200-021-00799-y	https://doi.org/10.1007/s40200-021-00799-y	NOUN
iajs-2976	489	5	https://doi.org/10.1016/j.apjtm.2016.07.001	https://doi.org/10.1016/j.apjtm.2016.07.001	VERB
iajs-2976	489	6	https://doi.org/10.3892/etm.2017.5045	https://doi.org/10.3892/etm.2017.5045	ADJ
iajs-2976	489	7	https://doi.org/10.1016/j.lfs.2020.118155	https://doi.org/10.1016/j.lfs.2020.118155	PROPN
iajs-2976	489	8	https://doi.org/10.1093/ndt/gfh207	https://doi.org/10.1093/ndt/gfh207	PROPN
iajs-2976	489	9	https://doi.org/10.1681/asn.2007091048	https://doi.org/10.1681/asn.2007091048	PROPN
iajs-2976	489	10	https://doi.org/10.1093/ndt/gfi155	https://doi.org/10.1093/ndt/gfi155	PROPN
iajs-2976	489	11	https://doi.org/10.1007/s00210-013-0871-2	https://doi.org/10.1007/s00210-013-0871-2	NOUN
iajs-2976	489	12	https://doi.org/10.1038/s41598-022-07015-8	https://doi.org/10.1038/s41598-022-07015-8	NUM
iajs-2976	489	13	https://doi.org/10.1210/en.2006-0687	https://doi.org/10.1210/en.2006-0687	NOUN
iajs-2976	489	14	https://doi.org/10.1016/j.plefa.2005.11.006	https://doi.org/10.1016/j.plefa.2005.11.006	NOUN
iajs-2976	489	15	http://dx.doi.org/10.7324/japs.2014.40602	http://dx.doi.org/10.7324/japs.2014.40602	NOUN
iajs-2976	489	16	https://doi.org/10.1007/s40200-021-00799-y	https://doi.org/10.1007/s40200-021-00799-y	PROPN
iajs-2976	489	17	ihjpas	ihjpas	PROPN
iajs-2976	489	18	.	.	PUNCT
iajs-2976	490	1	36(2)2023	36(2)2023	NUM
iajs-2976	490	2	103	103	NUM
iajs-2976	490	3	77	77	NUM
iajs-2976	490	4	.	.	PUNCT
iajs-2976	491	1	ozkul	ozkul	ADJ
iajs-2976	491	2	,	,	PUNCT
iajs-2976	491	3	a.	a.	NOUN
iajs-2976	491	4	;	;	PUNCT
iajs-2976	491	5	ayhan	ayhan	PROPN
iajs-2976	491	6	,	,	PUNCT
iajs-2976	491	7	m.	m.	NOUN
iajs-2976	491	8	;	;	PUNCT
iajs-2976	491	9	yenisey	yenisey	NOUN
iajs-2976	491	10	,	,	PUNCT
iajs-2976	491	11	c.	c.	PROPN
iajs-2976	491	12	;	;	PUNCT
iajs-2976	491	13	akyol	akyol	PROPN
iajs-2976	491	14	,	,	PUNCT
iajs-2976	491	15	a.	a.	NOUN
iajs-2976	491	16	;	;	PUNCT
iajs-2976	491	17	guney	guney	NOUN
iajs-2976	491	18	,	,	PUNCT
iajs-2976	491	19	e	e	NOUN
iajs-2976	491	20	..	..	PUNCT
iajs-2976	491	21	ergin	ergin	NOUN
iajs-2976	491	22	,	,	PUNCT
iajs-2976	491	23	f.	f.	PROPN
iajs-2976	491	24	a.	a.	NOUN
iajs-2976	492	1	the	the	DET
iajs-2976	492	2	role	role	NOUN
iajs-2976	492	3	of	of	ADP
iajs-2976	492	4	oxidative	oxidative	ADJ
iajs-2976	492	5	stress	stress	NOUN
iajs-2976	492	6	and	and	CCONJ
iajs-2976	492	7	endothelial	endothelial	ADJ
iajs-2976	492	8	injury	injury	NOUN
iajs-2976	492	9	in	in	ADP
iajs-2976	492	10	diabetic	diabetic	ADJ
iajs-2976	492	11	neuropathy	neuropathy	ADJ
iajs-2976	492	12	and	and	CCONJ
iajs-2976	492	13	neuropathic	neuropathic	ADJ
iajs-2976	492	14	pain	pain	NOUN
iajs-2976	492	15	.	.	PUNCT
iajs-2976	493	1	neuroendocrinology	neuroendocrinology	NOUN
iajs-2976	493	2	letters	letter	NOUN
iajs-2976	493	3	.	.	PUNCT
iajs-2976	494	1	2010,31(2),261	2010,31(2),261	NUM
iajs-2976	494	2	-	-	SYM
iajs-2976	494	3	4.available	4.available	NUM
iajs-2976	494	4	from	from	ADP
iajs-2976	494	5	:	:	PUNCT
iajs-2976	494	6	https://www.nel.edu/the-role-of-oxidative-stress-andendothelial-injury-in-diabetic-neuropathy-and-neuropathic-pain-1080	https://www.nel.edu/the-role-of-oxidative-stress-andendothelial-injury-in-diabetic-neuropathy-and-neuropathic-pain-1080	NOUN
iajs-2976	494	7	78	78	NUM
iajs-2976	494	8	.	.	PUNCT
iajs-2976	495	1	rehman	rehman	PROPN
iajs-2976	495	2	,	,	PUNCT
iajs-2976	495	3	k.	k.	PROPN
iajs-2976	495	4	;	;	PUNCT
iajs-2976	495	5	khan	khan	PROPN
iajs-2976	495	6	,	,	PUNCT
iajs-2976	495	7	i.	i.	PROPN
iajs-2976	495	8	i.	i.	PROPN
iajs-2976	495	9	;	;	PUNCT
iajs-2976	495	10	akash	akash	PROPN
iajs-2976	495	11	,	,	PUNCT
iajs-2976	495	12	m.	m.	NOUN
iajs-2976	495	13	s.	s.	PROPN
iajs-2976	495	14	h.	h.	PROPN
iajs-2976	495	15	;	;	PUNCT
iajs-2976	495	16	jabeen	jabeen	PROPN
iajs-2976	495	17	,	,	PUNCT
iajs-2976	495	18	k	k	X
iajs-2976	495	19	..	..	PUNCT
iajs-2976	495	20	haider	haider	PROPN
iajs-2976	495	21	,	,	PUNCT
iajs-2976	495	22	k.	k.	PROPN
iajs-2976	495	23	naringenin	naringenin	PROPN
iajs-2976	495	24	downregulates	downregulates	PROPN
iajs-2976	495	25	inflammation‐mediated	inflammation‐mediate	VERB
iajs-2976	495	26	nitric	nitric	ADJ
iajs-2976	495	27	oxide	oxide	NOUN
iajs-2976	495	28	overproduction	overproduction	NOUN
iajs-2976	495	29	and	and	CCONJ
iajs-2976	495	30	potentiates	potentiate	VERB
iajs-2976	495	31	endogenous	endogenous	ADJ
iajs-2976	495	32	antioxidant	antioxidant	ADJ
iajs-2976	495	33	status	status	NOUN
iajs-2976	495	34	during	during	ADP
iajs-2976	495	35	hyperglycemia	hyperglycemia	NOUN
iajs-2976	495	36	.	.	PUNCT
iajs-2976	496	1	journal	journal	PROPN
iajs-2976	496	2	of	of	ADP
iajs-2976	496	3	food	food	NOUN
iajs-2976	496	4	biochemistry	biochemistry	NOUN
iajs-2976	496	5	,	,	PUNCT
iajs-2976	496	6	2020,44(10),e13422	2020,44(10),e13422	NUM
iajs-2976	496	7	https://doi.org/10.1111/jfbc.13422	https://doi.org/10.1111/jfbc.13422	X
iajs-2976	496	8	79	79	NUM
iajs-2976	496	9	.	.	PUNCT
iajs-2976	497	1	tsai	tsai	PROPN
iajs-2976	497	2	,	,	PUNCT
iajs-2976	497	3	k.-l	k.-l	PROPN
iajs-2976	497	4	.	.	PUNCT
iajs-2976	497	5	;	;	PUNCT
iajs-2976	497	6	huang	huang	PROPN
iajs-2976	497	7	,	,	PUNCT
iajs-2976	497	8	y.-h	y.-h	PROPN
iajs-2976	497	9	.	.	PUNCT
iajs-2976	497	10	;	;	PUNCT
iajs-2976	497	11	kao	kao	PROPN
iajs-2976	497	12	,	,	PUNCT
iajs-2976	497	13	c.-l	c.-l	PROPN
iajs-2976	497	14	.	.	PUNCT
iajs-2976	497	15	;	;	PUNCT
iajs-2976	497	16	yang	yang	PROPN
iajs-2976	497	17	,	,	PUNCT
iajs-2976	497	18	d.-m	d.-m	PROPN
iajs-2976	497	19	.	.	PUNCT
iajs-2976	497	20	;	;	PUNCT
iajs-2976	497	21	lee	lee	PROPN
iajs-2976	497	22	,	,	PUNCT
iajs-2976	497	23	h.-c	h.-c	PROPN
iajs-2976	497	24	.	.	PUNCT
iajs-2976	497	25	;	;	PUNCT
iajs-2976	497	26	chou	chou	NOUN
iajs-2976	497	27	,	,	PUNCT
iajs-2976	497	28	h.-y	h.-y	NOUN
iajs-2976	497	29	.	.	PUNCT
iajs-2976	498	1	;	;	PUNCT
iajs-2976	498	2	chen	chen	PROPN
iajs-2976	498	3	,	,	PUNCT
iajs-2976	498	4	y.-c	y.-c	PROPN
iajs-2976	498	5	.	.	PUNCT
iajs-2976	498	6	;	;	PUNCT
iajs-2976	498	7	chiou	chiou	NOUN
iajs-2976	498	8	,	,	PUNCT
iajs-2976	498	9	g.-y	g.-y	PROPN
iajs-2976	498	10	.	.	PUNCT
iajs-2976	498	11	;	;	PUNCT
iajs-2976	498	12	chen	chen	PROPN
iajs-2976	498	13	,	,	PUNCT
iajs-2976	498	14	l.-h	l.-h	PROPN
iajs-2976	498	15	..	..	PUNCT
iajs-2976	498	16	yang	yang	PROPN
iajs-2976	498	17	,	,	PUNCT
iajs-2976	498	18	y.-p	y.-p	PROPN
iajs-2976	498	19	.	.	PUNCT
iajs-2976	499	1	a	a	DET
iajs-2976	499	2	novel	novel	ADJ
iajs-2976	499	3	mechanism	mechanism	NOUN
iajs-2976	499	4	of	of	ADP
iajs-2976	499	5	coenzyme	coenzyme	PROPN
iajs-2976	499	6	q10	q10	PROPN
iajs-2976	499	7	protects	protect	VERB
iajs-2976	499	8	against	against	ADP
iajs-2976	499	9	human	human	ADJ
iajs-2976	499	10	endothelial	endothelial	NOUN
iajs-2976	499	11	cells	cell	NOUN
iajs-2976	499	12	from	from	ADP
iajs-2976	499	13	oxidative	oxidative	ADJ
iajs-2976	499	14	stress	stress	NOUN
iajs-2976	499	15	-	-	PUNCT
iajs-2976	499	16	induced	induce	VERB
iajs-2976	499	17	injury	injury	NOUN
iajs-2976	499	18	by	by	ADP
iajs-2976	499	19	modulating	modulate	VERB
iajs-2976	499	20	no	no	PRON
iajs-2976	499	21	-	-	PUNCT
iajs-2976	499	22	related	relate	VERB
iajs-2976	499	23	pathways	pathway	NOUN
iajs-2976	499	24	.	.	PUNCT
iajs-2976	500	1	the	the	DET
iajs-2976	500	2	journal	journal	NOUN
iajs-2976	500	3	of	of	ADP
iajs-2976	500	4	nutritional	nutritional	ADJ
iajs-2976	500	5	biochemistry	biochemistry	NOUN
iajs-2976	500	6	,	,	PUNCT
iajs-2976	500	7	2012,23(5),458	2012,23(5),458	PROPN
iajs-2976	500	8	-	-	SYM
iajs-2976	500	9	68	68	NUM
iajs-2976	500	10	https://doi.org/10.1016/j.jnutbio.2011.01.011	https://doi.org/10.1016/j.jnutbio.2011.01.011	NUM
iajs-2976	500	11	80	80	NUM
iajs-2976	500	12	.	.	PUNCT
iajs-2976	501	1	aldous	aldous	PROPN
iajs-2976	501	2	,	,	PUNCT
iajs-2976	501	3	s.	s.	PROPN
iajs-2976	501	4	j.	j.	PROPN
iajs-2976	501	5	cardiac	cardiac	PROPN
iajs-2976	501	6	biomarkers	biomarker	NOUN
iajs-2976	501	7	in	in	ADP
iajs-2976	501	8	acute	acute	ADJ
iajs-2976	501	9	myocardial	myocardial	ADJ
iajs-2976	501	10	infarction	infarction	NOUN
iajs-2976	501	11	.	.	PUNCT
iajs-2976	502	1	international	international	ADJ
iajs-2976	502	2	journal	journal	NOUN
iajs-2976	502	3	of	of	ADP
iajs-2976	502	4	cardiology	cardiology	NOUN
iajs-2976	502	5	.	.	PUNCT
iajs-2976	503	1	2013,164(3),282	2013,164(3),282	NUM
iajs-2976	503	2	-	-	SYM
iajs-2976	503	3	94	94	NUM
iajs-2976	503	4	https://doi.org/10.1016/j.ijcard.2012.01.081	https://doi.org/10.1016/j.ijcard.2012.01.081	PROPN
iajs-2976	503	5	81	81	NUM
iajs-2976	503	6	.	.	PUNCT
iajs-2976	503	7	pervaiz	pervaiz	PROPN
iajs-2976	503	8	,	,	PUNCT
iajs-2976	503	9	s.	s.	PROPN
iajs-2976	503	10	;	;	PUNCT
iajs-2976	503	11	waskiewicz	waskiewicz	PROPN
iajs-2976	503	12	,	,	PUNCT
iajs-2976	503	13	d.	d.	PROPN
iajs-2976	503	14	;	;	PUNCT
iajs-2976	503	15	anderson	anderson	PROPN
iajs-2976	503	16	,	,	PUNCT
iajs-2976	503	17	f.	f.	PROPN
iajs-2976	503	18	p.	p.	PROPN
iajs-2976	503	19	;	;	PUNCT
iajs-2976	504	1	lawson	lawson	PROPN
iajs-2976	504	2	,	,	PUNCT
iajs-2976	504	3	c.	c.	PROPN
iajs-2976	504	4	j.	j.	PROPN
iajs-2976	504	5	;	;	PUNCT
iajs-2976	504	6	lohmann	lohmann	PROPN
iajs-2976	504	7	,	,	PUNCT
iajs-2976	504	8	t.	t.	PROPN
iajs-2976	504	9	p.	p.	PROPN
iajs-2976	504	10	;	;	PUNCT
iajs-2976	504	11	feng	feng	PROPN
iajs-2976	504	12	,	,	PUNCT
iajs-2976	504	13	y.	y.	PROPN
iajs-2976	504	14	j.	j.	PROPN
iajs-2976	504	15	;	;	PUNCT
iajs-2976	504	16	contois	contois	PROPN
iajs-2976	504	17	,	,	PUNCT
iajs-2976	504	18	j.	j.	PROPN
iajs-2976	504	19	h	h	PROPN
iajs-2976	504	20	..	..	PROPN
iajs-2976	504	21	wu	wu	PROPN
iajs-2976	504	22	,	,	PUNCT
iajs-2976	504	23	a.	a.	PROPN
iajs-2976	504	24	h.	h.	PROPN
iajs-2976	504	25	comparative	comparative	ADJ
iajs-2976	504	26	analysis	analysis	NOUN
iajs-2976	504	27	of	of	ADP
iajs-2976	504	28	cardiac	cardiac	ADJ
iajs-2976	504	29	troponin	troponin	ADJ
iajs-2976	504	30	i	i	PROPN
iajs-2976	504	31	and	and	CCONJ
iajs-2976	504	32	creatine	creatine	VERB
iajs-2976	504	33	kinase‐mb	kinase‐mb	PROPN
iajs-2976	504	34	as	as	ADP
iajs-2976	504	35	markers	marker	NOUN
iajs-2976	504	36	of	of	ADP
iajs-2976	504	37	acute	acute	ADJ
iajs-2976	504	38	myocardial	myocardial	ADJ
iajs-2976	504	39	infarction	infarction	NOUN
iajs-2976	504	40	.	.	PUNCT
iajs-2976	505	1	clinical	clinical	ADJ
iajs-2976	505	2	cardiology	cardiology	NOUN
iajs-2976	505	3	.	.	PUNCT
iajs-2976	506	1	1997,20(3),269	1997,20(3),269	NUM
iajs-2976	506	2	-	-	SYM
iajs-2976	506	3	71	71	NUM
iajs-2976	506	4	https://doi.org/10.1002/clc.4960200316	https://doi.org/10.1002/clc.4960200316	PROPN
iajs-2976	506	5	82	82	NUM
iajs-2976	506	6	.	.	PUNCT
iajs-2976	507	1	kiessling	kiessle	VERB
iajs-2976	507	2	,	,	PUNCT
iajs-2976	507	3	w.	w.	PROPN
iajs-2976	507	4	;	;	PUNCT
iajs-2976	507	5	ricker	ricker	PROPN
iajs-2976	507	6	,	,	PUNCT
iajs-2976	507	7	k.	k.	PROPN
iajs-2976	507	8	;	;	PUNCT
iajs-2976	507	9	pflughaupt	pflughaupt	PROPN
iajs-2976	507	10	,	,	PUNCT
iajs-2976	507	11	k.	k.	PROPN
iajs-2976	507	12	;	;	PUNCT
iajs-2976	507	13	mertens	mertens	PROPN
iajs-2976	507	14	,	,	PUNCT
iajs-2976	507	15	h	h	NOUN
iajs-2976	507	16	..	..	PUNCT
iajs-2976	507	17	haubitz	haubitz	PROPN
iajs-2976	507	18	,	,	PUNCT
iajs-2976	507	19	i.	i.	PROPN
iajs-2976	507	20	serum	serum	PROPN
iajs-2976	507	21	myoglobin	myoglobin	PROPN
iajs-2976	507	22	in	in	ADP
iajs-2976	507	23	primary	primary	ADJ
iajs-2976	507	24	and	and	CCONJ
iajs-2976	507	25	secondary	secondary	ADJ
iajs-2976	507	26	skeletal	skeletal	ADJ
iajs-2976	507	27	muscle	muscle	NOUN
iajs-2976	507	28	disorders	disorder	NOUN
iajs-2976	507	29	.	.	PUNCT
iajs-2976	508	1	journal	journal	PROPN
iajs-2976	508	2	of	of	ADP
iajs-2976	508	3	neurology	neurology	NOUN
iajs-2976	508	4	,	,	PUNCT
iajs-2976	508	5	1981,224(3),229	1981,224(3),229	NUM
iajs-2976	508	6	-	-	SYM
iajs-2976	508	7	33	33	NUM
iajs-2976	508	8	https://doi.org/10.1007/bf00313285	https://doi.org/10.1007/bf00313285	NUM
iajs-2976	508	9	83	83	NUM
iajs-2976	508	10	.	.	PUNCT
iajs-2976	509	1	odum	odum	PROPN
iajs-2976	509	2	,	,	PUNCT
iajs-2976	509	3	e.	e.	PROPN
iajs-2976	509	4	p.	p.	PROPN
iajs-2976	509	5	;	;	PUNCT
iajs-2976	509	6	young	young	ADJ
iajs-2976	509	7	,	,	PUNCT
iajs-2976	509	8	e.	e.	PROPN
iajs-2976	509	9	e.	e.	PROPN
iajs-2976	509	10	elevated	elevate	VERB
iajs-2976	509	11	cardiac	cardiac	ADJ
iajs-2976	509	12	troponin	troponin	PROPN
iajs-2976	509	13	i	i	PROPN
iajs-2976	509	14	,	,	PUNCT
iajs-2976	509	15	creatine	creatine	PROPN
iajs-2976	509	16	kinase	kinase	PROPN
iajs-2976	509	17	and	and	CCONJ
iajs-2976	509	18	myoglobin	myoglobin	PROPN
iajs-2976	509	19	and	and	CCONJ
iajs-2976	509	20	their	their	PRON
iajs-2976	509	21	relationship	relationship	NOUN
iajs-2976	509	22	with	with	ADP
iajs-2976	509	23	cardiovascular	cardiovascular	ADJ
iajs-2976	509	24	risk	risk	NOUN
iajs-2976	509	25	factors	factor	NOUN
iajs-2976	509	26	in	in	ADP
iajs-2976	509	27	patients	patient	NOUN
iajs-2976	509	28	with	with	ADP
iajs-2976	509	29	type	type	NOUN
iajs-2976	509	30	2	2	NUM
iajs-2976	509	31	diabetes	diabetes	NOUN
iajs-2976	509	32	.	.	PUNCT
iajs-2976	510	1	diabetes	diabetes	NOUN
iajs-2976	510	2	&	&	CCONJ
iajs-2976	510	3	metabolic	metabolic	PROPN
iajs-2976	510	4	syndrome	syndrome	PROPN
iajs-2976	510	5	:	:	PUNCT
iajs-2976	510	6	clinical	clinical	ADJ
iajs-2976	510	7	research	research	NOUN
iajs-2976	510	8	&	&	CCONJ
iajs-2976	510	9	reviews	review	NOUN
iajs-2976	510	10	.	.	PUNCT
iajs-2976	511	1	2018,12(2),141	2018,12(2),141	NUM
iajs-2976	511	2	-	-	SYM
iajs-2976	511	3	5	5	NUM
iajs-2976	511	4	https://doi.org/10.1016/j.dsx.2017.12.001	https://doi.org/10.1016/j.dsx.2017.12.001	NOUN
iajs-2976	511	5	84	84	NUM
iajs-2976	511	6	.	.	PUNCT
iajs-2976	512	1	kon	kon	PROPN
iajs-2976	512	2	,	,	PUNCT
iajs-2976	512	3	m.	m.	NOUN
iajs-2976	512	4	;	;	PUNCT
iajs-2976	512	5	tanabe	tanabe	PROPN
iajs-2976	512	6	,	,	PUNCT
iajs-2976	512	7	k.	k.	PROPN
iajs-2976	512	8	;	;	PUNCT
iajs-2976	512	9	akimoto	akimoto	PROPN
iajs-2976	512	10	,	,	PUNCT
iajs-2976	512	11	t.	t.	PROPN
iajs-2976	512	12	;	;	PUNCT
iajs-2976	512	13	kimura	kimura	PROPN
iajs-2976	512	14	,	,	PUNCT
iajs-2976	512	15	f.	f.	PROPN
iajs-2976	512	16	;	;	PUNCT
iajs-2976	512	17	tanimura	tanimura	ADV
iajs-2976	512	18	,	,	PUNCT
iajs-2976	512	19	y.	y.	PROPN
iajs-2976	512	20	;	;	PUNCT
iajs-2976	512	21	shimizu	shimizu	PROPN
iajs-2976	512	22	,	,	PUNCT
iajs-2976	512	23	k.	k.	PROPN
iajs-2976	512	24	;	;	PUNCT
iajs-2976	512	25	okamoto	okamoto	PROPN
iajs-2976	512	26	,	,	PUNCT
iajs-2976	512	27	t	t	PROPN
iajs-2976	512	28	..	..	PUNCT
iajs-2976	512	29	kono	kono	PROPN
iajs-2976	512	30	,	,	PUNCT
iajs-2976	512	31	i.	i.	NOUN
iajs-2976	512	32	reducing	reduce	VERB
iajs-2976	512	33	exercise	exercise	NOUN
iajs-2976	512	34	-	-	PUNCT
iajs-2976	512	35	induced	induce	VERB
iajs-2976	512	36	muscular	muscular	ADJ
iajs-2976	512	37	injury	injury	NOUN
iajs-2976	512	38	in	in	ADP
iajs-2976	512	39	kendo	kendo	PROPN
iajs-2976	512	40	athletes	athlete	NOUN
iajs-2976	512	41	with	with	ADP
iajs-2976	512	42	supplementation	supplementation	NOUN
iajs-2976	512	43	of	of	ADP
iajs-2976	512	44	coenzyme	coenzyme	PROPN
iajs-2976	512	45	q10	q10	PROPN
iajs-2976	512	46	.	.	PROPN
iajs-2976	513	1	british	british	PROPN
iajs-2976	513	2	journal	journal	PROPN
iajs-2976	513	3	of	of	ADP
iajs-2976	513	4	nutrition	nutrition	NOUN
iajs-2976	513	5	,	,	PUNCT
iajs-2976	513	6	2008,100(4),903	2008,100(4),903	NUM
iajs-2976	513	7	-	-	SYM
iajs-2976	513	8	9	9	NUM
iajs-2976	513	9	https://doi.org/10.1017/s0007114508926544	https://doi.org/10.1017/s0007114508926544	NUM
iajs-2976	513	10	85	85	NUM
iajs-2976	513	11	.	.	PUNCT
iajs-2976	514	1	cirilli	cirilli	PROPN
iajs-2976	514	2	,	,	PUNCT
iajs-2976	514	3	i.	i.	PROPN
iajs-2976	514	4	;	;	PUNCT
iajs-2976	514	5	damiani	damiani	PROPN
iajs-2976	514	6	,	,	PUNCT
iajs-2976	514	7	e.	e.	PROPN
iajs-2976	514	8	;	;	PUNCT
iajs-2976	514	9	dludla	dludla	ADJ
iajs-2976	514	10	,	,	PUNCT
iajs-2976	514	11	p.	p.	NOUN
iajs-2976	514	12	v.	v.	PROPN
iajs-2976	514	13	;	;	PUNCT
iajs-2976	514	14	hargreaves	hargreaves	PROPN
iajs-2976	514	15	,	,	PUNCT
iajs-2976	514	16	i.	i.	PROPN
iajs-2976	514	17	;	;	PUNCT
iajs-2976	514	18	marcheggiani	marcheggiani	PROPN
iajs-2976	514	19	,	,	PUNCT
iajs-2976	514	20	f.	f.	PROPN
iajs-2976	514	21	;	;	PUNCT
iajs-2976	514	22	millichap	millichap	ADV
iajs-2976	514	23	,	,	PUNCT
iajs-2976	514	24	l.	l.	PROPN
iajs-2976	514	25	e.	e.	PROPN
iajs-2976	514	26	;	;	PUNCT
iajs-2976	514	27	orlando	orlando	PROPN
iajs-2976	514	28	,	,	PUNCT
iajs-2976	514	29	p.	p.	PROPN
iajs-2976	514	30	;	;	PUNCT
iajs-2976	514	31	silvestri	silvestri	PROPN
iajs-2976	514	32	,	,	PUNCT
iajs-2976	514	33	s	s	PROPN
iajs-2976	514	34	..	..	PUNCT
iajs-2976	514	35	tiano	tiano	PROPN
iajs-2976	514	36	,	,	PUNCT
iajs-2976	514	37	l.	l.	PROPN
iajs-2976	514	38	role	role	NOUN
iajs-2976	514	39	of	of	ADP
iajs-2976	514	40	coenzyme	coenzyme	PROPN
iajs-2976	514	41	q10	q10	PROPN
iajs-2976	514	42	in	in	ADP
iajs-2976	514	43	health	health	NOUN
iajs-2976	514	44	and	and	CCONJ
iajs-2976	514	45	disease	disease	PROPN
iajs-2976	514	46	:	:	PUNCT
iajs-2976	514	47	an	an	DET
iajs-2976	514	48	update	update	NOUN
iajs-2976	514	49	on	on	ADP
iajs-2976	514	50	the	the	DET
iajs-2976	514	51	last	last	ADJ
iajs-2976	514	52	10	10	NUM
iajs-2976	514	53	years	year	NOUN
iajs-2976	514	54	(	(	PUNCT
iajs-2976	514	55	2010–2020	2010–2020	NUM
iajs-2976	514	56	)	)	PUNCT
iajs-2976	514	57	.	.	PUNCT
iajs-2976	515	1	antioxidants	antioxidant	NOUN
iajs-2976	515	2	.	.	PUNCT
iajs-2976	516	1	2021,10(8),1325	2021,10(8),1325	NUM
iajs-2976	516	2	https://doi.org/10.3390/antiox10081325	https://doi.org/10.3390/antiox10081325	PROPN
iajs-2976	516	3	86	86	NUM
iajs-2976	516	4	.	.	PUNCT
iajs-2976	517	1	shittu	shittu	ADJ
iajs-2976	517	2	,	,	PUNCT
iajs-2976	517	3	s.-t	s.-t	NOUN
iajs-2976	517	4	.	.	PUNCT
iajs-2976	518	1	t.	t.	NOUN
iajs-2976	518	2	;	;	PUNCT
iajs-2976	518	3	oyeyemi	oyeyemi	PROPN
iajs-2976	518	4	,	,	PUNCT
iajs-2976	518	5	w.	w.	PROPN
iajs-2976	518	6	a.	a.	PROPN
iajs-2976	518	7	;	;	PUNCT
iajs-2976	518	8	lasisi	lasisi	PROPN
iajs-2976	518	9	,	,	PUNCT
iajs-2976	518	10	t.	t.	PROPN
iajs-2976	518	11	j.	j.	PROPN
iajs-2976	518	12	;	;	PUNCT
iajs-2976	518	13	shittu	shittu	PROPN
iajs-2976	518	14	,	,	PUNCT
iajs-2976	518	15	s.	s.	PROPN
iajs-2976	518	16	a.-s	a.-s	PROPN
iajs-2976	518	17	.	.	PUNCT
iajs-2976	518	18	;	;	PUNCT
iajs-2976	519	1	lawal	lawal	PROPN
iajs-2976	519	2	,	,	PUNCT
iajs-2976	519	3	t.	t.	PROPN
iajs-2976	519	4	t	t	PROPN
iajs-2976	519	5	..	..	PUNCT
iajs-2976	519	6	olujobi	olujobi	NOUN
iajs-2976	519	7	,	,	PUNCT
iajs-2976	519	8	s.	s.	PROPN
iajs-2976	519	9	t.	t.	PROPN
iajs-2976	519	10	aqueous	aqueous	ADJ
iajs-2976	519	11	leaf	leaf	NOUN
iajs-2976	519	12	extract	extract	NOUN
iajs-2976	519	13	of	of	ADP
iajs-2976	519	14	ocimum	ocimum	PROPN
iajs-2976	519	15	gratissimum	gratissimum	PROPN
iajs-2976	519	16	improves	improve	VERB
iajs-2976	519	17	hematological	hematological	ADJ
iajs-2976	519	18	parameters	parameter	NOUN
iajs-2976	519	19	in	in	ADP
iajs-2976	519	20	alloxaninduced	alloxaninduce	VERB
iajs-2976	519	21	diabetic	diabetic	ADJ
iajs-2976	519	22	rats	rat	NOUN
iajs-2976	519	23	via	via	ADP
iajs-2976	519	24	its	its	PRON
iajs-2976	519	25	antioxidant	antioxidant	ADJ
iajs-2976	519	26	properties	property	NOUN
iajs-2976	519	27	.	.	PUNCT
iajs-2976	520	1	international	international	ADJ
iajs-2976	520	2	journal	journal	PROPN
iajs-2976	520	3	of	of	ADP
iajs-2976	520	4	applied	apply	VERB
iajs-2976	520	5	and	and	CCONJ
iajs-2976	520	6	basic	basic	ADJ
iajs-2976	520	7	medical	medical	ADJ
iajs-2976	520	8	research	research	NOUN
iajs-2976	520	9	,	,	PUNCT
iajs-2976	520	10	2016,6(2),96	2016,6(2),96	NUM
iajs-2976	520	11	https://doi.org/10.4103%2f2229-516x.179016	https://doi.org/10.4103%2f2229-516x.179016	NOUN
iajs-2976	520	12	87	87	NUM
iajs-2976	520	13	.	.	PUNCT
iajs-2976	521	1	fagbohun	fagbohun	PROPN
iajs-2976	521	2	,	,	PUNCT
iajs-2976	521	3	o.	o.	PROPN
iajs-2976	521	4	f.	f.	PROPN
iajs-2976	521	5	;	;	PUNCT
iajs-2976	521	6	awoniran	awoniran	NOUN
iajs-2976	521	7	,	,	PUNCT
iajs-2976	521	8	p.	p.	PROPN
iajs-2976	521	9	o.	o.	PROPN
iajs-2976	521	10	;	;	PUNCT
iajs-2976	521	11	babalola	babalola	PROPN
iajs-2976	521	12	,	,	PUNCT
iajs-2976	521	13	o.	o.	PROPN
iajs-2976	521	14	o.	o.	PROPN
iajs-2976	521	15	;	;	PUNCT
iajs-2976	521	16	agboola	agboola	PROPN
iajs-2976	521	17	,	,	PUNCT
iajs-2976	521	18	f.	f.	PROPN
iajs-2976	521	19	k	k	PROPN
iajs-2976	521	20	..	..	PUNCT
iajs-2976	521	21	msagati	msagati	PROPN
iajs-2976	521	22	,	,	PUNCT
iajs-2976	521	23	t.	t.	NOUN
iajs-2976	521	24	a.	a.	NOUN
iajs-2976	521	25	changes	change	NOUN
iajs-2976	521	26	in	in	ADP
iajs-2976	521	27	the	the	DET
iajs-2976	521	28	biochemical	biochemical	ADJ
iajs-2976	521	29	,	,	PUNCT
iajs-2976	521	30	hematological	hematological	ADJ
iajs-2976	521	31	and	and	CCONJ
iajs-2976	521	32	histopathological	histopathological	ADJ
iajs-2976	521	33	parameters	parameter	NOUN
iajs-2976	521	34	in	in	ADP
iajs-2976	521	35	stz	stz	ADJ
iajs-2976	521	36	-	-	PUNCT
iajs-2976	521	37	induced	induce	VERB
iajs-2976	521	38	diabetic	diabetic	ADJ
iajs-2976	521	39	rats	rat	NOUN
iajs-2976	521	40	and	and	CCONJ
iajs-2976	521	41	the	the	DET
iajs-2976	521	42	ameliorative	ameliorative	ADJ
iajs-2976	521	43	effect	effect	NOUN
iajs-2976	521	44	of	of	ADP
iajs-2976	521	45	kigelia	kigelia	PROPN
iajs-2976	521	46	africana	africana	PROPN
iajs-2976	521	47	fruit	fruit	NOUN
iajs-2976	521	48	extract	extract	NOUN
iajs-2976	521	49	.	.	PUNCT
iajs-2976	522	1	heliyon	heliyon	NOUN
iajs-2976	522	2	.	.	PUNCT
iajs-2976	523	1	2020,6(5),e03989	2020,6(5),e03989	NUM
iajs-2976	523	2	https://doi.org/10.1016/j.heliyon.2020.e03989	https://doi.org/10.1016/j.heliyon.2020.e03989	PROPN
iajs-2976	523	3	88	88	NUM
iajs-2976	523	4	.	.	PUNCT
iajs-2976	524	1	dallak	dallak	ADJ
iajs-2976	524	2	,	,	PUNCT
iajs-2976	524	3	m.	m.	NOUN
iajs-2976	524	4	;	;	PUNCT
iajs-2976	524	5	bin	bin	PROPN
iajs-2976	524	6	-	-	PUNCT
iajs-2976	524	7	jaliah	jaliah	PROPN
iajs-2976	524	8	,	,	PUNCT
iajs-2976	524	9	i.	i.	NOUN
iajs-2976	524	10	antioxidant	antioxidant	NOUN
iajs-2976	524	11	activity	activity	NOUN
iajs-2976	524	12	of	of	ADP
iajs-2976	524	13	citrullus	citrullus	PROPN
iajs-2976	524	14	colocynthis	colocynthis	NOUN
iajs-2976	524	15	pulp	pulp	NOUN
iajs-2976	524	16	extract	extract	NOUN
iajs-2976	524	17	in	in	ADP
iajs-2976	524	18	the	the	DET
iajs-2976	524	19	rbc	rbc	PROPN
iajs-2976	524	20	’s	’s	NOUN
iajs-2976	524	21	of	of	ADP
iajs-2976	524	22	alloxan	alloxan	NOUN
iajs-2976	524	23	-	-	PUNCT
iajs-2976	524	24	induced	induce	VERB
iajs-2976	524	25	diabetic	diabetic	ADJ
iajs-2976	524	26	rats	rat	NOUN
iajs-2976	524	27	.	.	PUNCT
iajs-2976	525	1	pakistan	pakistan	PROPN
iajs-2976	525	2	journal	journal	PROPN
iajs-2976	525	3	of	of	ADP
iajs-2976	525	4	physiology	physiology	NOUN
iajs-2976	525	5	,	,	PUNCT
iajs-2976	525	6	2010,6(1),1	2010,6(1),1	NUM
iajs-2976	525	7	-	-	SYM
iajs-2976	525	8	5.available	5.available	NUM
iajs-2976	525	9	from	from	ADP
iajs-2976	525	10	:	:	PUNCT
iajs-2976	525	11	http://pjp.pps.org.pk/index.php/pjp/article/view/837	http://pjp.pps.org.pk/index.php/pjp/article/view/837	PROPN
iajs-2976	525	12	https://www.nel.edu/the-role-of-oxidative-stress-and-endothelial-injury-in-diabetic-neuropathy-and-neuropathic-pain-1080	https://www.nel.edu/the-role-of-oxidative-stress-and-endothelial-injury-in-diabetic-neuropathy-and-neuropathic-pain-1080	PROPN
iajs-2976	525	13	https://www.nel.edu/the-role-of-oxidative-stress-and-endothelial-injury-in-diabetic-neuropathy-and-neuropathic-pain-1080	https://www.nel.edu/the-role-of-oxidative-stress-and-endothelial-injury-in-diabetic-neuropathy-and-neuropathic-pain-1080	PROPN
iajs-2976	525	14	https://doi.org/10.1111/jfbc.13422	https://doi.org/10.1111/jfbc.13422	PUNCT
iajs-2976	525	15	https://doi.org/10.1016/j.jnutbio.2011.01.011	https://doi.org/10.1016/j.jnutbio.2011.01.011	NOUN
iajs-2976	526	1	https://doi.org/10.1016/j.ijcard.2012.01.081	https://doi.org/10.1016/j.ijcard.2012.01.081	PROPN
iajs-2976	526	2	https://doi.org/10.1002/clc.4960200316	https://doi.org/10.1002/clc.4960200316	PROPN
iajs-2976	526	3	https://doi.org/10.1007/bf00313285	https://doi.org/10.1007/bf00313285	NUM
iajs-2976	526	4	https://doi.org/10.1016/j.dsx.2017.12.001	https://doi.org/10.1016/j.dsx.2017.12.001	NOUN
iajs-2976	526	5	https://doi.org/10.1017/s0007114508926544	https://doi.org/10.1017/s0007114508926544	NUM
iajs-2976	526	6	https://doi.org/10.3390/antiox10081325	https://doi.org/10.3390/antiox10081325	PROPN
iajs-2976	526	7	https://doi.org/10.4103%2f2229-516x.179016	https://doi.org/10.4103%2f2229-516x.179016	PROPN
iajs-2976	526	8	https://doi.org/10.1016/j.heliyon.2020.e03989	https://doi.org/10.1016/j.heliyon.2020.e03989	PROPN
iajs-2976	526	9	http://pjp.pps.org.pk/index.php/pjp/article/view/837	http://pjp.pps.org.pk/index.php/pjp/article/view/837	PROPN
iajs-2976	526	10	ihjpas	ihjpas	PROPN
iajs-2976	526	11	.	.	PUNCT
iajs-2976	527	1	36(2)2023	36(2)2023	NUM
iajs-2976	527	2	104	104	NUM
iajs-2976	527	3	89	89	NUM
iajs-2976	527	4	.	.	PUNCT
iajs-2976	528	1	xulu	xulu	PROPN
iajs-2976	528	2	,	,	PUNCT
iajs-2976	528	3	n.	n.	NOUN
iajs-2976	528	4	;	;	PUNCT
iajs-2976	528	5	ngubane	ngubane	NOUN
iajs-2976	528	6	,	,	PUNCT
iajs-2976	528	7	p.	p.	PROPN
iajs-2976	528	8	;	;	PUNCT
iajs-2976	528	9	khathi	khathi	PROPN
iajs-2976	528	10	,	,	PUNCT
iajs-2976	528	11	a.	a.	NOUN
iajs-2976	528	12	;	;	PUNCT
iajs-2976	528	13	booysen	booysen	VERB
iajs-2976	528	14	,	,	PUNCT
iajs-2976	528	15	i	i	PRON
iajs-2976	528	16	..	..	PUNCT
iajs-2976	528	17	sibiya	sibiya	PROPN
iajs-2976	528	18	,	,	PUNCT
iajs-2976	528	19	n.	n.	PROPN
iajs-2976	528	20	heamanetic	heamanetic	ADJ
iajs-2976	528	21	effects	effect	NOUN
iajs-2976	528	22	of	of	ADP
iajs-2976	528	23	a	a	DET
iajs-2976	528	24	dioxidovanadium	dioxidovanadium	NOUN
iajs-2976	528	25	(	(	PUNCT
iajs-2976	528	26	v	v	NOUN
iajs-2976	528	27	)	)	PUNCT
iajs-2976	528	28	complex	complex	NOUN
iajs-2976	528	29	in	in	ADP
iajs-2976	528	30	stz	stz	ADJ
iajs-2976	528	31	-	-	PUNCT
iajs-2976	528	32	induced	induce	VERB
iajs-2976	528	33	diabetic	diabetic	ADJ
iajs-2976	528	34	male	male	ADJ
iajs-2976	528	35	sprague	sprague	NOUN
iajs-2976	528	36	dawley	dawley	NOUN
iajs-2976	528	37	rats	rat	NOUN
iajs-2976	528	38	.	.	PUNCT
iajs-2976	529	1	diabetes	diabetes	NOUN
iajs-2976	529	2	,	,	PUNCT
iajs-2976	529	3	metabolic	metabolic	NOUN
iajs-2976	529	4	syndrome	syndrome	NOUN
iajs-2976	529	5	and	and	CCONJ
iajs-2976	529	6	obesity	obesity	NOUN
iajs-2976	529	7	:	:	PUNCT
iajs-2976	529	8	targets	target	NOUN
iajs-2976	529	9	and	and	CCONJ
iajs-2976	529	10	therapy	therapy	NOUN
iajs-2976	529	11	.	.	PUNCT
iajs-2976	530	1	2021,14,4321	2021,14,4321	NUM
iajs-2976	530	2	https://doi.org/10.2147%2fdmso.s214726	https://doi.org/10.2147%2fdmso.s214726	NOUN
iajs-2976	530	3	90	90	NUM
iajs-2976	530	4	.	.	PUNCT
iajs-2976	531	1	kennedy	kennedy	PROPN
iajs-2976	531	2	,	,	PUNCT
iajs-2976	531	3	l	l	PROPN
iajs-2976	531	4	..	..	PUNCT
iajs-2976	531	5	baynes	baynes	PROPN
iajs-2976	531	6	,	,	PUNCT
iajs-2976	531	7	j.	j.	PROPN
iajs-2976	531	8	non	non	ADJ
iajs-2976	531	9	-	-	ADJ
iajs-2976	531	10	enzymatic	enzymatic	ADJ
iajs-2976	531	11	glycosylation	glycosylation	NOUN
iajs-2976	531	12	and	and	CCONJ
iajs-2976	531	13	the	the	DET
iajs-2976	531	14	chronic	chronic	ADJ
iajs-2976	531	15	complications	complication	NOUN
iajs-2976	531	16	of	of	ADP
iajs-2976	531	17	diabetes	diabetes	NOUN
iajs-2976	531	18	:	:	PUNCT
iajs-2976	531	19	an	an	DET
iajs-2976	531	20	overview	overview	NOUN
iajs-2976	531	21	.	.	PUNCT
iajs-2976	532	1	diabetologia	diabetologia	NOUN
iajs-2976	532	2	.	.	PUNCT
iajs-2976	533	1	1984,26(2),93	1984,26(2),93	NUM
iajs-2976	533	2	-	-	SYM
iajs-2976	533	3	8	8	NUM
iajs-2976	533	4	https://doi.org/10.1007/bf00281113	https://doi.org/10.1007/bf00281113	NOUN
iajs-2976	533	5	91	91	NUM
iajs-2976	533	6	.	.	PUNCT
iajs-2976	534	1	kolanjiappan	kolanjiappan	PROPN
iajs-2976	534	2	,	,	PUNCT
iajs-2976	534	3	k.	k.	PROPN
iajs-2976	534	4	;	;	PUNCT
iajs-2976	534	5	manoharan	manoharan	NOUN
iajs-2976	534	6	,	,	PUNCT
iajs-2976	534	7	s.	s.	PROPN
iajs-2976	534	8	;	;	PUNCT
iajs-2976	534	9	kayalvizhi	kayalvizhi	PROPN
iajs-2976	534	10	,	,	PUNCT
iajs-2976	534	11	m.	m.	NOUN
iajs-2976	534	12	measurement	measurement	NOUN
iajs-2976	534	13	of	of	ADP
iajs-2976	534	14	erythrocyte	erythrocyte	PROPN
iajs-2976	534	15	lipids	lipid	NOUN
iajs-2976	534	16	,	,	PUNCT
iajs-2976	534	17	lipid	lipid	NOUN
iajs-2976	534	18	peroxidation	peroxidation	NOUN
iajs-2976	534	19	,	,	PUNCT
iajs-2976	534	20	antioxidants	antioxidant	NOUN
iajs-2976	534	21	and	and	CCONJ
iajs-2976	534	22	osmotic	osmotic	ADJ
iajs-2976	534	23	fragility	fragility	NOUN
iajs-2976	534	24	in	in	ADP
iajs-2976	534	25	cervical	cervical	ADJ
iajs-2976	534	26	cancer	cancer	NOUN
iajs-2976	534	27	patients	patient	NOUN
iajs-2976	534	28	.	.	PUNCT
iajs-2976	535	1	clinica	clinica	PROPN
iajs-2976	535	2	chimica	chimica	PROPN
iajs-2976	535	3	acta	acta	PROPN
iajs-2976	535	4	.	.	PUNCT
iajs-2976	536	1	2002,326(1	2002,326(1	PROPN
iajs-2976	536	2	-	-	PUNCT
iajs-2976	536	3	2),143	2),143	NUM
iajs-2976	536	4	-	-	PUNCT
iajs-2976	536	5	9	9	NUM
iajs-2976	536	6	https://doi.org/10.1016/s0009-8981(02)00300-5	https://doi.org/10.1016/s0009-8981(02)00300-5	NOUN
iajs-2976	536	7	92	92	NUM
iajs-2976	536	8	.	.	PUNCT
iajs-2976	536	9	chalew	chalew	PROPN
iajs-2976	536	10	,	,	PUNCT
iajs-2976	536	11	s.	s.	PROPN
iajs-2976	536	12	;	;	PUNCT
iajs-2976	536	13	hamdan	hamdan	PROPN
iajs-2976	536	14	,	,	PUNCT
iajs-2976	536	15	m.	m.	NOUN
iajs-2976	536	16	racial	racial	ADJ
iajs-2976	536	17	disparity	disparity	NOUN
iajs-2976	536	18	in	in	ADP
iajs-2976	536	19	hba1c	hba1c	PROPN
iajs-2976	536	20	persists	persist	NOUN
iajs-2976	536	21	when	when	SCONJ
iajs-2976	536	22	fructosamine	fructosamine	NOUN
iajs-2976	536	23	is	be	AUX
iajs-2976	536	24	used	use	VERB
iajs-2976	536	25	as	as	ADP
iajs-2976	536	26	a	a	DET
iajs-2976	536	27	surrogate	surrogate	NOUN
iajs-2976	536	28	for	for	SCONJ
iajs-2976	536	29	mean	mean	VERB
iajs-2976	536	30	blood	blood	NOUN
iajs-2976	536	31	glucose	glucose	NOUN
iajs-2976	536	32	in	in	ADP
iajs-2976	536	33	youth	youth	NOUN
iajs-2976	536	34	with	with	ADP
iajs-2976	536	35	type	type	NOUN
iajs-2976	536	36	1	1	NUM
iajs-2976	536	37	diabetes	diabetes	NOUN
iajs-2976	536	38	.	.	PUNCT
iajs-2976	537	1	pediatric	pediatric	ADJ
iajs-2976	537	2	diabetes	diabetes	NOUN
iajs-2976	537	3	.	.	PUNCT
iajs-2976	538	1	2018,19(7),1243	2018,19(7),1243	NUM
iajs-2976	538	2	-	-	SYM
iajs-2976	538	3	8	8	NUM
iajs-2976	538	4	https://doi.org/10.1111/pedi.12696	https://doi.org/10.1111/pedi.12696	NOUN
iajs-2976	538	5	93	93	NUM
iajs-2976	538	6	.	.	PUNCT
iajs-2976	539	1	niu	niu	PROPN
iajs-2976	539	2	,	,	PUNCT
iajs-2976	539	3	x.	x.	PROPN
iajs-2976	539	4	;	;	PUNCT
iajs-2976	539	5	xiao	xiao	PROPN
iajs-2976	539	6	,	,	PUNCT
iajs-2976	539	7	r.	r.	PROPN
iajs-2976	539	8	;	;	PUNCT
iajs-2976	539	9	wang	wang	PROPN
iajs-2976	539	10	,	,	PUNCT
iajs-2976	539	11	n.	n.	PROPN
iajs-2976	539	12	;	;	PUNCT
iajs-2976	539	13	wang	wang	PROPN
iajs-2976	539	14	,	,	PUNCT
iajs-2976	539	15	z.	z.	PROPN
iajs-2976	539	16	;	;	PUNCT
iajs-2976	539	17	zhang	zhang	PROPN
iajs-2976	539	18	,	,	PUNCT
iajs-2976	539	19	y.	y.	PROPN
iajs-2976	539	20	;	;	PUNCT
iajs-2976	539	21	xia	xia	PROPN
iajs-2976	539	22	,	,	PUNCT
iajs-2976	539	23	q	q	PROPN
iajs-2976	539	24	..	..	PUNCT
iajs-2976	539	25	yang	yang	PROPN
iajs-2976	539	26	,	,	PUNCT
iajs-2976	539	27	x.	x.	VERB
iajs-2976	539	28	the	the	DET
iajs-2976	539	29	molecular	molecular	ADJ
iajs-2976	539	30	mechanisms	mechanism	NOUN
iajs-2976	539	31	and	and	CCONJ
iajs-2976	539	32	rational	rational	ADJ
iajs-2976	539	33	design	design	NOUN
iajs-2976	539	34	of	of	ADP
iajs-2976	539	35	anti	anti	ADJ
iajs-2976	539	36	-	-	ADJ
iajs-2976	539	37	diabetic	diabetic	ADJ
iajs-2976	539	38	vanadium	vanadium	NOUN
iajs-2976	539	39	compounds	compound	NOUN
iajs-2976	539	40	.	.	PUNCT
iajs-2976	540	1	current	current	ADJ
iajs-2976	540	2	topics	topic	NOUN
iajs-2976	540	3	in	in	ADP
iajs-2976	540	4	medicinal	medicinal	ADJ
iajs-2976	540	5	chemistry	chemistry	NOUN
iajs-2976	540	6	.	.	PUNCT
iajs-2976	541	1	2016;16(8):811	2016;16(8):811	NUM
iajs-2976	541	2	-	-	PUNCT
iajs-2976	541	3	22	22	NUM
iajs-2976	541	4	http://dx.doi.org/10.2174/1568026615666150827094652	http://dx.doi.org/10.2174/1568026615666150827094652	PROPN
iajs-2976	541	5	94	94	NUM
iajs-2976	541	6	.	.	PUNCT
iajs-2976	542	1	abdel	abdel	NOUN
iajs-2976	542	2	-	-	PUNCT
iajs-2976	542	3	moneim	moneim	PROPN
iajs-2976	542	4	,	,	PUNCT
iajs-2976	542	5	a.	a.	NOUN
iajs-2976	542	6	;	;	PUNCT
iajs-2976	542	7	zanaty	zanaty	NUM
iajs-2976	542	8	,	,	PUNCT
iajs-2976	542	9	m.	m.	NOUN
iajs-2976	542	10	i.	i.	PROPN
iajs-2976	542	11	;	;	PUNCT
iajs-2976	542	12	el	el	PROPN
iajs-2976	542	13	-	-	PUNCT
iajs-2976	542	14	sayed	sayed	PROPN
iajs-2976	542	15	,	,	PUNCT
iajs-2976	542	16	a.	a.	NOUN
iajs-2976	542	17	;	;	PUNCT
iajs-2976	542	18	khalil	khalil	PROPN
iajs-2976	542	19	,	,	PUNCT
iajs-2976	542	20	r.	r.	PROPN
iajs-2976	542	21	g	g	PROPN
iajs-2976	542	22	..	..	PUNCT
iajs-2976	542	23	rahman	rahman	PROPN
iajs-2976	542	24	,	,	PUNCT
iajs-2976	542	25	h.	h.	PROPN
iajs-2976	542	26	a.	a.	NOUN
iajs-2976	542	27	relation	relation	NOUN
iajs-2976	542	28	between	between	ADP
iajs-2976	542	29	oxidative	oxidative	ADJ
iajs-2976	542	30	stress	stress	NOUN
iajs-2976	542	31	and	and	CCONJ
iajs-2976	542	32	hematologic	hematologic	NOUN
iajs-2976	542	33	abnormalities	abnormality	NOUN
iajs-2976	542	34	in	in	ADP
iajs-2976	542	35	children	child	NOUN
iajs-2976	542	36	with	with	ADP
iajs-2976	542	37	type	type	NOUN
iajs-2976	542	38	1	1	NUM
iajs-2976	542	39	diabetes	diabetes	NOUN
iajs-2976	542	40	.	.	PUNCT
iajs-2976	543	1	canadian	canadian	ADJ
iajs-2976	543	2	journal	journal	PROPN
iajs-2976	543	3	of	of	ADP
iajs-2976	543	4	diabetes	diabetes	NOUN
iajs-2976	543	5	,	,	PUNCT
iajs-2976	543	6	2020,44(3),222	2020,44(3),222	NUM
iajs-2976	543	7	-	-	SYM
iajs-2976	543	8	8	8	NUM
iajs-2976	543	9	https://doi.org/10.1016/j.jcjd.2019.07.153	https://doi.org/10.1016/j.jcjd.2019.07.153	NUM
iajs-2976	543	10	95	95	NUM
iajs-2976	543	11	.	.	PUNCT
iajs-2976	544	1	davì	davì	PROPN
iajs-2976	544	2	,	,	PUNCT
iajs-2976	544	3	g.	g.	PROPN
iajs-2976	544	4	;	;	PUNCT
iajs-2976	544	5	chiarelli	chiarelli	PROPN
iajs-2976	544	6	,	,	PUNCT
iajs-2976	544	7	f.	f.	PROPN
iajs-2976	544	8	;	;	PUNCT
iajs-2976	544	9	santilli	santilli	PROPN
iajs-2976	544	10	,	,	PUNCT
iajs-2976	544	11	f.	f.	PROPN
iajs-2976	544	12	;	;	PUNCT
iajs-2976	544	13	pomilio	pomilio	PROPN
iajs-2976	544	14	,	,	PUNCT
iajs-2976	544	15	m.	m.	NOUN
iajs-2976	544	16	;	;	PUNCT
iajs-2976	544	17	vigneri	vigneri	PROPN
iajs-2976	544	18	,	,	PUNCT
iajs-2976	544	19	s.	s.	PROPN
iajs-2976	544	20	;	;	PUNCT
iajs-2976	544	21	falco	falco	PROPN
iajs-2976	544	22	,	,	PUNCT
iajs-2976	544	23	a.	a.	NOUN
iajs-2976	544	24	;	;	PUNCT
iajs-2976	544	25	basili	basili	NOUN
iajs-2976	544	26	,	,	PUNCT
iajs-2976	544	27	s.	s.	PROPN
iajs-2976	544	28	;	;	PUNCT
iajs-2976	544	29	ciabattoni	ciabattoni	ADJ
iajs-2976	544	30	,	,	PUNCT
iajs-2976	544	31	g	g	NOUN
iajs-2976	544	32	..	..	PUNCT
iajs-2976	544	33	patrono	patrono	PROPN
iajs-2976	544	34	,	,	PUNCT
iajs-2976	544	35	c.	c.	NOUN
iajs-2976	544	36	enhanced	enhance	VERB
iajs-2976	544	37	lipid	lipid	NOUN
iajs-2976	544	38	peroxidation	peroxidation	NOUN
iajs-2976	544	39	and	and	CCONJ
iajs-2976	544	40	platelet	platelet	NOUN
iajs-2976	544	41	activation	activation	NOUN
iajs-2976	544	42	in	in	ADP
iajs-2976	544	43	the	the	DET
iajs-2976	544	44	early	early	ADJ
iajs-2976	544	45	phase	phase	NOUN
iajs-2976	544	46	of	of	ADP
iajs-2976	544	47	type	type	NOUN
iajs-2976	544	48	1	1	NUM
iajs-2976	544	49	diabetes	diabetes	NOUN
iajs-2976	544	50	mellitus	mellitus	NOUN
iajs-2976	544	51	:	:	PUNCT
iajs-2976	544	52	role	role	NOUN
iajs-2976	544	53	of	of	ADP
iajs-2976	544	54	interleukin-6	interleukin-6	NUM
iajs-2976	544	55	and	and	CCONJ
iajs-2976	544	56	disease	disease	NOUN
iajs-2976	544	57	duration	duration	NOUN
iajs-2976	544	58	.	.	PUNCT
iajs-2976	545	1	circulation	circulation	NOUN
iajs-2976	545	2	.	.	PUNCT
iajs-2976	546	1	2003,107(25),3199	2003,107(25),3199	NUM
iajs-2976	546	2	-	-	SYM
iajs-2976	546	3	203	203	NUM
iajs-2976	546	4	https://doi.org/10.1161/01.cir.0000074205.17807.d0	https://doi.org/10.1161/01.cir.0000074205.17807.d0	NOUN
iajs-2976	546	5	.	.	PUNCT
iajs-2976	547	1	https://doi.org/10.2147%2fdmso.s214726	https://doi.org/10.2147%2fdmso.s214726	PROPN
iajs-2976	547	2	https://doi.org/10.1007/bf00281113	https://doi.org/10.1007/bf00281113	X
iajs-2976	547	3	https://doi.org/10.1016/s0009-8981(02)00300-5	https://doi.org/10.1016/s0009-8981(02)00300-5	PROPN
iajs-2976	547	4	https://doi.org/10.1111/pedi.12696	https://doi.org/10.1111/pedi.12696	NOUN
iajs-2976	547	5	http://dx.doi.org/10.2174/1568026615666150827094652	http://dx.doi.org/10.2174/1568026615666150827094652	VERB
iajs-2976	548	1	https://doi.org/10.1016/j.jcjd.2019.07.153	https://doi.org/10.1016/j.jcjd.2019.07.153	NOUN
iajs-2976	548	2	https://doi.org/10.1161/01.cir.0000074205.17807.d0	https://doi.org/10.1161/01.cir.0000074205.17807.d0	NOUN